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ABSTRACT 
 
Lawsonia intracellularis causes proliferative enteropathies in juvenile mammals. The 
porcine (PPE) and equine (EPE) diseases are worldwide. Rabbits and hamsters are naturally 
susceptible, the latter being a classic modeling-host for PPE. None is known for EPE, besides 
foals. An in vitro evaluation of antimicrobial efficacy against L. intracellularis is difficult. This 
study aimed to validate a laboratory animal EPE model and to investigate pharmacokinetics (PK) 
and efficacy of gallium maltolate (GaM) as an alternative antimicrobial therapy. Infected animals 
were inoculated with cell-cultured L. intracellularis and infection was verified with clinically 
utilized diagnostic tests. 
Initially, 2 groups of EPE-infected rabbits were compared to 1 uninfected group. After 
inoculation (PI), EPE-infected rabbits showed mild clinical signs; detectable seroconversion, 
fecal shedding, gross lesions in intestinal tissues (IT), and early immuno-histochemistry labeling 
of L. intracellularis antigen. Thus, a humane EPE-rabbit model was achieved. Subsequently, 
EPE-infected hamsters were compared to uninfected and PPE-infected hamsters; whereas, PPE-
infected rabbits were compared to EPE-infected rabbits. EPE-hamsters did not develop infection, 
unlike PPE-infected controls; and PPE-rabbits did not develop IT lesions or seroconversion 
comparable to EPE-rabbits. 
Therefore rabbits were chosen as the EPE modeling-host for the GaM studies. First, GaM 
PK and IT concentrations of Ga and Fe were measured. Then, GaM efficacy was compared to a 
current EPE antimicrobial treatment. During sampling, the intra-arterial catheters in the rabbits’ 
ears were protected with a novel moleskin-cover, allowing repeated sampling while minimally 
restrained. 
The PK study was based on the comparison of EPE-infected and uninfected rabbits, after  
a single treatment with GaM, collection of serial blood samples and IT samples. The only 
differing PK parameter, between groups, was a decrease in the terminal phase rate constant of 
the EPE-rabbits, so a 48h dosing interval was chosen for the efficacy study.  
In the efficacy study, 3 groups of EPE-infected rabbits were treated with GaM, 
doxycycline and a placebo, respectively. No differences were noted between treatments, in terms 
of lesions and fecal shedding. GaM appears no more efficacious than doxycycline in EPE- 
rabbits. In conclusion, albeit GaM tolerance appeared adequate in rabbits, results do not support 
its use in EPE-infected animals. 
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CHAPTER 1  
 
INTRODUCTION 
 
 
‘Give a man a horse he can ride.Give a man a boat he can sail.” 
                                                                                        J. Thomson 
  Equine proliferative enteropathy, EPE, reported since the early 1980’s in sporadic and 
isolated cases, is now an important equine gastrointestinal illness, with frequent reported 
outbreaks of economic significance. As recently reviewed, EPE is caused by Lawsonia  
intracellularis, an intracellular bacterium affecting the small intestine of many other mammalian 
and avian species, both among domestic and wildlife animals (Pusterla & Gebhart, 2009).  
Lawsonia intracellularis is now the focus of attention in many centers of the equine industry 
around world (e.g., Kentucky, USA or Ontario, Canada etc.).  A few review publications about 
porcine proliferative enteropathy (PPE) showed that EPE in horses parallels what was observed 
since 1931 in juvenile pigs. The bacterial cause was only suspected in the early 1970’s, and 
taxonomically classified in 1995 (Lawson & McOrist, 1993; Lawson & Gebhart, 2000). 
The characteristic enteropathy generated by this bacterium appears similar in all the 
species affected (not only horses and pigs, but also hamsters). The typical lesions reported in 
susceptible animals are: a similar pattern of mucosal hyperplasia, lack of cell differentiation, 
malabsorption and reduced inflammatory response.  Thus far, humans seem not to be part of the 
broad target of this bacterium (Michalski et al., 2006).  Lawsonia intracellularis customarily 
targets young animals undergoing stressful situations (e.g. weaning, deworming, commingling 
and traveling), and very seldom adult animals, where it usually constitutes a secondary pathogen 
(e.g., complicated salmonellosis or digestive tract lymphoma).  
The intracellular location of this pathogen affords it with protection from the effects of 
humoral and cellular immune-response and classical first line antimicrobial drugs.  As reports of 
cases of treatment failure in light of exacerbated clinical signs, and the economic impact on the 
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industry are increasing (Frazer, 2008), the need for novel antimicrobial alternatives is 
acknowledged both in research and clinical settings.  
In the context of a potential antimicrobial alternative, the compound gallium maltolate, 
appears as an obvious candidate. It has already been safely administered, orally, to multiple 
animal species: rodents, dogs, horses and humans. Gallium has iron mimicking abilities in 
regards to its metabolism, but it is virtually unable to complete redox reactions (Bernstein et al., 
2000).  This feature could be utilized against iron dependent bacteria, hopefully without setting 
up a situation for future antimicrobial resistance. 
The general objective of this project was to test a laboratory animal infection model for L. 
intracellularis, to estimate appropriate PK parameters for gallium, before an efficacy study can 
occur, which would compare gallium maltolate and the current clinical treatments against EPE.  
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CHAPTER 2  
LITERATURE REVIEW 
“ …there is a touch of divinity,…and a special halo  about a horse that should forever exempt him from 
indignities.” 
             H. Melville 
2.1: Equine Proliferative Enteropathy: Lawsonia intracellularis infection in 
horses and present knowledge of the disease 
 
The gastrointestinal tract of horses is the object of many life-threatening ailments, 
mechanical or inflammatory, affecting the small or large intestine. They might also present as 
combined disturbances, whose clinical appearance is complicated by inter-twined pathogeneses 
of different lesions.  This dissertation will focus on an emerging bacterial infection of the small 
intestine, Equine Proliferative Enteropathy (EPE), caused by Lawsonia intracellularis a pathogen 
that recently is receiving appreciable attention in equine medicine.    
 
2.1.1. Gastro-enteric diseases in foals 
 
Gastrointestinal (GI) inflammatory disorders are amongst the most important causes of 
morbidity and mortality in horses of all ages. GI conditions challenge clinicians’ knowledge, 
diagnostic procedures and therapy, as reviewed by Feary & Hassel, in 2006.  Even more 
complicated is the gastroenterology of young horses (younger than 8 - 10 months of age), with 
multifaceted presentations predominant at different pediatric ages, and clinical signs common 
between many etiologies. Usually these diseases develop rapidly and can result in acute or 
chronic debilitation, due to diarrhea, fever, colic, gastric reflux, and culminating potentially with 
shock and death (Feary & Hassel, 2006).   
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Infectious diarrhea is a clinical condition that may require veterinary intervention at least 
once for ~80% of foals, within their first 6 months of life (Urquhart, 1981).  Foal diarrhea can be 
due to infectious and non-infectious causes.  In foals and weanlings, dietary indiscretion, over-
feeding and lactose intolerance, nutritional intoxications (e.g., cantharidin toxicity, related to 
alfalfa hay feedings), non-steroidal anti-inflammatory drugs (NSAIDs) toxicity, sand 
enteropathies, and gastro-duodenal ulceration, should be considered as differential diagnoses 
(Urquhart, 1981, Sweeney, 1987; Magdesian, 2005).   
Several non-infectious causes can be excluded through detailed history and appropriate 
diagnostics (Baverud, et al., 1998; Frank, et al., 1998; Feary & Hassel, 2006). Also, the age of 
the patient is a determinant factor in diagnosis of foal-heat diarrhea and neonatal asphyxia-
associated gastro-enteropathies, as are typical of neonates, much younger than the EPE’s target 
population (Urquhart, 1981; Magdesian, et al., 2002; Magdesian, 2005; Frazer, 2008; Lavoie & 
Drolet, 2009, Pusterla & Gebhart, 2009).   
Many infectious agents are implicated in diarrhea and malabsorption processes in foals, 
whether as single or combined pathogenic causes.  The most common infectious causes are 
Salmonella spp. and Clostridium spp.; Rhodococcus equi and Lawsonia intracellularis for 
bacteria; Adenovirus, Rotavirus and Coronavirus for viruses; and nematodes and a few 
protozoan species for parasites (Feary & Hassel, 2006; Frederick, et al., 2009).  A brief mention 
of each group of differential etiologies follows below, as the reasoning process of the attending 
clinician should include these possibilities when admitting foals with colic, diarrhea, marked 
weight loss and/or ventral edema.  
Rotavirus, Adenovirus and Coronavirus infections typically present with profuse diarrhea 
and cannot be confirmed, or excluded, solely on the basis of foal age and history (Browning, et 
al., 1991).  Adenoviral infection may cause severe diarrhea and in some cases lead to 
intussusceptions and death.  In some cases, Adenovirus and Rotavirus are cofactors in causing 
infectious diarrhea, but pure rotaviral infections in foals are common and can cause severe acute 
diarrhea, with a very brief incubation period (hours) after inoculation.  Investigation on adult 
horses showed that the world-wide seroprevalence is 100% and vaccination of mares has been 
possible since the late 1990s (Powell, et al., 1997).  It appears more common in younger foals 
(up to 2.5 months of age) than coronaviral infections, whose role within enteric diseases needs 
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yet to be clarified (Browning, et al., 1991; Guy, et al., 2000).  Currently an effective and reliable 
ELISA test for Rotavirus is available (Frederick, et al., 2009), whereas Coronavirus diarrhea 
outbreaks in horses are more difficult to demonstrate, although a PCR technique has been 
recently reported (Frederick, et al., 2009; Pusterla, et al., 2013).    
For parasitic infections, Strongyloides westerii is probably the most common cause of 
colitis and diarrhea in foals younger than 1 month of age, but ascarids (Parascaris equorum) are 
considered the more pathogenic causing a variety of signs, from unthrifty appearance, to colic 
and death, in foals younger than 6 months of age. This holds particularly true, if foals are kept on 
a poor deworming program, or raised in areas where anti-helmintic resistance is possible (e.g., 
Kentucky, USA) (Feary & Hassel, 2006; Lyons, et al., 2006).  Removal of these parasites by use 
of parasiticides before maturation (e.g., P. equorum has a minimum pre-patent period of about 8-
10 weeks), lessens the possibility of pathologic effects.  Modern anti-helmintic regimens have 
this common aim, but they also have caused the emergence of several sources of resistance, such 
that small strongyles (or cyathostomes) are often a cause of colitis, acute and chronic diarrhea, 
particularly in horses between 1-6 years of age (Feary & Hassel, 2006).  In temperate areas, 
cyathostomiasis’ occurrence is typical of late winter and spring months, whereas in South-
Eastern USA, and other subtropical regions, it is more characteristic of late fall and winter (Feary 
& Hassel, 2006).  Interestingly, this pattern matches the typical period of EPE’s onset in 
weanlings in the Northern Hemisphere (Frazer, 2008). Testing for fecal parasitic egg-counts can 
lead to exclusion of parasitoses, or to the understanding of their role as co-factors in the 
symptomatology.  Foals on good anti-helmintic treatment routines, typically present only small 
strongyle larvae (Lyons & Tolliver, 2003).  Recently, a study conducted on Thoroughbred 
breeding farms, in central Kentucky, reported that the percentage of parasite eggs in feces of 
foals younger than 12 months of age (i.e., the age range for EPE) was 39% for P. equorum, 32% 
for Strongyles spp., 2% for Strongyloides westerii, and 28% for the protozoan Eimeria leuckarti  
(Lyons, et al., 2006).  More than one foal harbored S. westeri infections in 29% of the tested 
farms, whereas 86% of foals harbored P. equorum and small Strongyles spp.  Again, E. leuckarti 
was detected in foals’ feces on 86% of farms year around, except December (Lyons, et al., 
2006).  Last, but not least, Crytptosporidium spp. should be considered, but it is less common 
and can be excluded upon negative results of fecal material examination (Frank, et al., 1998). 
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With regards to bacterial infections, the most common pathogens for foals of 
suckling/weaning age remain Salmonella spp. and Clostridium perfringens, while Clostridium 
difficile seems more common in foals between the ages of 2 weeks to 4 months. However, 
Salmonella spp. and Clostridium spp. are the most common pathogens isolated from horse fecal 
material at any age (East, et al., 1998; Magdesian, et al., 2002; Frederick, et al., 2009). Their 
diagnosis rests on repeated culture tests for the bacterial isolation (at least 5 in 5 consecutive 
days, for suspected salmonellosis) or PCR techniques. Specifically for Clostridia, PCR 
techniques are utilized to isolate not only the bacterial DNA, but also the enterotoxins.  
Unfortunately, culture tests are not very sensitive (20%, in Salmonella cases) and even PCR 
testing sometimes fails to detect clostridial enterotoxin, or signals false positives (Palmer, et al., 
1985).  Indirect tests, although non-specific, may support the diagnosis of salmonellosis, as in the 
case of WBC count in fecal smears (>10 cells/high power field) (Morris, et al., 1983). 
Rhodococcus equi occasionally causes enteritis and colitis, and so does Neorickettsia risticii, but 
only in rare cases in this age range (Feary & Hassel, 2006).  Finally, EPE is now a well described 
emerging disease, which in the past 20 years has reached world-wide distribution and whose case 
presentations have been extensively reviewed (Lawson & Gebhart, 2000; Magdesian, et al., 
2002; Feary & Hassel, 2006; Lavoie & Drolet, 2009; Pusterla & Gebhart, 2009).  
 
2.1.2. Equine proliferative enteropathy: from sporadic beginnings to outbreaks. 
 
The first EPE case reported was a 6-month-old Arabian filly admitted in a semi-comatose 
condition to the Veterinary Teaching Hospital at University of California – Davis, in 1982 
(Duhamel & Wheeldon, 1982).  The filly had a 4-day-long history of anorexia, depression and 
black loose feces, while at pasture with its dam.  Despite intensive treatment, the filly died 12 h 
after admission and was necropsied shortly after. On post-mortem examination, large 
hemorrhagic gastro-duodenal ulcers and extensive, irregular mural thickening (up to 12 mm) 
with prominent corrugation of the mucosal surface was detected in the distal duodenum, jejunum 
and ileum.  Also, flattened nodules in the mucosa were noted in the proximal to mid-ileum, some 
3-7 mm in diameter, along with sparse large colon mucosal inflammation.  On histopathology, 
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intestinal crypts appeared hyperplastic, elongated and branched, containing occasionally purulent 
material (Duhamel & Wheeldon, 1982).  
Epithelial cells of the enteric crypts’ characteristically contained comma-like rod shaped 
bacteria localized at the apex. The bacterial structures, located within the cytoplasm, were faintly 
visible with Levaditi-Manovelian stain, but were clearly detected on electron microscope 
examination (Duhamel & Wheeldon, 1982).  Negative culture and staining were obtained for 
routine gastro-intestinal (GI) bacteriology, as well as for Salmonella spp. and Mycobacterium 
spp.  A McMasters’ egg-count was also negative and consistent with recent deworming.  The 
bacteria detected were identified as Campylobacter sputorum subsp. mucosalis, the “at the time” 
suspected bacterial etiologic agent of porcine intestinal adenomatosis (later renamed porcine 
proliferative enteropathy – or PPE), and also reported as a cause of disease in sheep, hamsters 
and the blue fox (Wagner, et al., 1973; Rowland & Lawson 1975; Vandenberghe & Hoorens, 
1980; Landsverk, 1981; Duhamel & Wheeldon, 1982). In the 1980’s, the bacterium did not fit 
the complete Campylobacter definition and testing. It indeed constituted a new genus and 
species, Lawsonia intracellularis, was finally identified and coded in the early 1990’s, after 
being renamed a few times (Jones, et al., 1993a; Gebhart, et al., 1993; McOrist, et al., 1995a).   
In 1996, the second case of EPE was detected in a 5-month-old filly at the Veterinary 
Diagnostic Laboratory of the University of Kentucky, with a week-long history of depression, 
lethargy, anorexia and profuse watery diarrhea (Williams, et al., 1996).  The etiology of this case 
was ascribed to a L. intracellularis-like bacterium on the basis of necropsy results. The 
thickening and corrugated lesions were confined to jejunum, with a multifocal, discoidal pattern 
and a diffuse thickening, and an even more pronounced rugose pattern in the ileum (Williams, et 
al., 1996). Bacteria were consistently noted in the apex of the epithelial cells of the enteric crypts 
through Warthin-Starry silver impregnation method and confirmed through electron microscopy 
and other DNA sequencing tests (See Chapter 2.2).  Bacterial colonization was not demonstrated 
anywhere else (Williams, et al., 1996). 
The third case was reported in 1998 in a 6-month-old Quarter Horse colt admitted for 
diarrhea of 3 days duration at the Veterinary Teaching Hospital at Purdue University (Frank, et 
al., 1998).  The foal, recently vaccinated and dewormed, showed the first clinical signs while at a 
horse show. The foal had fever, profuse projectile diarrhea, depression and mild dehydration. It 
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was in good body condition and had normal cardiac and respiratory rates.  Hyperfibrinogenemia, 
leucocytosis with left shift, hypoproteinemia with hypoalbuminemia, azotemia and hyponatremia 
were detected (Frank, et al., 1998).  Several infectious diseases were excluded by microbiology 
and parasitology test results. Infiltrative bowel diseases (i.e., granulomatous enteritis, 
eosinophilic gastroenteritis and intestinal lymphosarcoma) were considered in the differential 
diagnoses list (Frank, et al., 1998).  The foal underwent supportive treatment with fluid-therapy 
and plasma transfusions, but no antimicrobial (AM) therapy. After the fever abated, 
corticosteroid therapy was initiated in an attempt to treat the suspected infiltrative disorder.  
Following clinical improvement, the colt was discharged, but re-admitted within a few weeks.  
On the second admission, its physical and clinico-pathological condition had relapsed and 
worsened. Euthanasia was elected due to poor prognosis (Frank, et al., 1998).  At necropsy, 
thickening and multi-nodular corrugation of the intestinal mucosa, associated with sub-mucosal 
edema, was detected in duodenum, jejunum and ileum, along with small foci of mucosal 
ulceration and necrosis, covered with fibrin. Histologically, hyperplastic enteric crypts, 
elongated, tortuous, and, at times, “herniated” in the sub-mucosa, were detected.  Intestinal villi 
appeared blunted and fused together and the crypts’ epithelium appeared multi-layered and 
lacking mucous vacuoles (i.e., showing sign of immaturity).  The area of ulceration showed 
granulation tissue replacing the damaged mucosa.  Rod-shaped microorganisms were noted again 
at cells’ apex and immunohistochemistry (IHC) and polymerase chain reaction (PCR) 
techniques, previously described for PPE (see Chapter 2.2), were used to confirm the diagnosis 
on the tissues of the affected foal (McOrist, et al., 1987; Cooper, et al., 1997a).   
A miniature foal, admitted for weight loss and diarrhea to the Veterinary Teaching 
Hospital at Iowa State University and deceased shortly after, was diagnosed only after post-
mortem examination, adding to the list of fatalities during that time period (Brees, et al., 1999). 
Until 1999, L. intracellularis infection in foals was considered debilitating and invariably fatal 
and through journal editorials, clinicians advocated for an early diagnostic technique, to deal in a 
timely fashion with an infection that was gaining notoriety and knowledge only in necropsy 
settings (Duhamel & Wheeldon, 1982; Williams, et al., 1996; Frank, et al., 1998; Smith, 1998; 
Brees, et al., 1999).  
In 2000, EPE came to international attention, and was officially defined and named 
according to similarities to PPE’s presentation (Lawson & McOrist 1993; McOrist, et al., 1995a; 
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Lavoie, et al., 2000; Lawson & Gebhart, 2000; Lavoie & Drolet, 2009).  Lavoie and coworkers 
reported the findings and the outcomes of 3 outbreaks in 3 different farms, 2 of which were in 
Quebec and one in Ontario, Canada. The former 2 farms were Arabian horse breeding 
operations, related by transport and commingling of foals; the third one dealt with 
Thoroughbreds horses and different routines.  The 2 outbreaks in Quebec occurred in large 
farms, where the number of broodmares and weanlings recently increased.  Weanlings were 
housed together in pens of 4, during the day, and paired 2 per stall, at night.  On those premises, 
not only EPE was detected, but also other infective stressors were diagnosed (e.g., R. equi and S. 
equi, among others).  Two farms were not close to piggeries, but were bordered by a forest, with 
access to wildlife, and a creek running through the pastures was used for watering purposes.  
However, one Québécoise farm was not far from a piggery and a dog moved unrestrictedly 
between the 2 structures (Lavoie, et al., 2000).  All the index cases died, despite treatment.  Two 
foals died on the first and 1 on the second Quebec farm, and 1 on the Ontario farm.  The 5
th
 foal 
died on the first farm 6 weeks after, and despite, an initial clinical recovery.  All deceased foals 
were cachectic and affected by other diseases concomitantly to EPE, such as: ascaridiasis (1/5), 
gastric ulcers and gastritis (3/5) and concurrent pulmonary or broncho-pulmonary pathology (all 
5), similarly to many surviving foals (Lavoie, et al., 2000).  
The typical presenting signs were depression, poor body condition, despite a good 
appetite, profuse diarrhea, ventral edema and colic (as reported for EPE by other authors 
(Duhamel & Wheeldon, 1982; Williams, et al., 1996; Frank, et al., 1998; Lavoie, et al., 2000; 
Bihr, 2003)). Consistent blood work findings were: marked mature leucocytosis, 
hyperfibrinogenemia and hypoproteinemia.  Only in 2 cases total serum proteins were above 60 
g/L, as foals were concomitantly affected by S. equi.  The main management difference between 
deceased and survivor foals appeared due to the AM therapy (see Chapter 2.3). Supportive 
therapy alone did not lead to survival (Lavoie, et al., 2000).  The diagnosis of EPE was achieved 
through the post-mortem examination of the deceased foals.  Diagnosis was obtained through 
gross and histopathologic evaluation of the bowels (particularly as lesions were confined to distal 
jejunum and ileum, or ileum alone) and ileal tissue PCR – although the bench tests were not 
always in agreement (2/5 cases).  Survivors, treated on the basis of the diagnosis achieved at 
necropsy, were tested for fecal PCR (negative in most cases) and for seroconversion, which 
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never yielded high titers (1:120 max).  In conclusion, with the appropriate AM therapy, 24 out of 
29 affected foals recovered, in the first EPE outbreak (Lavoie, et al., 2000).   
Shortly after Lavoie’s report, a case of surgical and medical management of EPE was 
published. A 3-month-old Arabian filly was admitted to Auburn University Veterinary Teaching 
Hospital, after recurrent abdominal pain of a week’s duration (Schumacher, et al., 2000).  The 
only bout of diarrhea reported in her history was of a couple weeks from birth and it was 
seemingly unrelated to the clinical condition on admission.  Despite normal vital parameters, the 
filly appeared markedly underweight. The ultrasonographic examination allowed visualization of 
thickened small intestine, with loss of discernible architecture of the three-layered wall’s 
(Schumacher, et al., 2000).  The filly underwent exploratory laparotomy, as abdominal pain was 
unrelenting.  Distal jejunum and ileum were severely thickened and the GI sections proximal to 
the mural thickening were distended, hypomotile and fluid filled, explaining the origin of pain.  
Surgeons collected a diagnostic biopsy from the thickened tracts, and by-passed the affected 
small intestine with a side-to-side anastomosis between normal jejunum and cecum. Diagnosis 
was achieved through special stains and AM therapy was changed accordingly, leading to a full 
recovery and conditions comparable to unaffected herdmates, within a couple of months 
(Schumacher, et al., 2000).   
Since these latter reports, clinical EPE cases have been reported in multiple localities of 
North America, Europe, Brazil, Australia, Japan and South Aftrica, suggesting that EPE has 
worldwide distribution, either presenting as isolated cases or outbreaks (Bihr, 2003; McClintock 
& Collins, 2004; Deprez, et al., 2005; Dauvillier, et al., 2006; Sampieri, et al., 2006; Feary, et 
al., 2007; Frazer, 2008; Guimarães-Ladeira, et al., 2009; Lavoie & Drolet, 2009; Merlo, et al., 
2009; Shimizu, et al., 2010).   
 
2.1.3. Epidemiology and clinical appearance of EPE 
 
In the past 20 years, L. intracellularis has been reported in red deer, foxes, grey wolves, 
dogs, calves, hedgehogs, rabbits, hamsters, ostriches, macaques and a giraffe, but it seems not to 
constitute a zoonosis, although such debates have been heated for a while (Collins, et al., 1983; 
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Hotchkiss, et al., 1996; Cooper, et al., 1997b; Duhamel, et al., 1998; Klein, et al., 1999; Herbst, 
et al., 2003; Tomanova, et al., 2003; Michalski, et al., 2006; Jacobson, et al., 2010).  Clinical L. 
intracellularis infection most commonly occurs in foals between 4 and 7 months of age, but 
range from 2 to 13 months, with no gender or breed predisposition (Lavoie, et al., 2000; Frazer, 
2008; Lavoie & Drolet, 2009).  Age is also a contributing factor in other species, including pigs, 
hamsters and deer (Jasni, et al., 1994a; Drolet, et al., 1996).  Both pigs and horses are affected as 
nursing or weanling animals, and, although it is suspected that immunosuppression plays a major 
role in the pathogenesis, any kind of stress can constitute a predisposing factor, including 
vaccination, anti-helmintic therapies, transport, overcrowding and commingling, ration changes 
and/or intensive training (Smith, 1998; Lavoie, et al., 2000; Dauvillier, et al., 2006).  
L. intracellularis is now considered endemic in North America, with clinical disease in 
foals observed primarily between August and January (Frazer, 2008; Pusterla, et al., 2009a).  
Exposure is related to the per-oral contamination with feces, so infected animals represent a 
reservoir for infection for their herd-mates (Lawson & Gebhart, 2000; Pusterla & Gebhart, 2009; 
Pusterla, et al., 2010a). Pigs and foals are known to shed L. intracellularis for up to 12 weeks 
post-infection (Guedes & Gebhart, 2003a; Pusterla, et al., 2010a).  Debate exists about the 
potential of cross-contamination between pigs and horses, as the first outbreak was reported in 
the vicinity of a piggery (Smith, 1998; Lavoie, et al., 2000).  However, L. intracellularis 
becomes inactivated by direct exposure to atmospheric oxygen, making cross-contamination 
through inanimate objects unlikely (Smith, 1998), even though it was shown that PPE L. 
intracellularis could survive almost 2 weeks in the environment.   
The genomic similarity of equine and porcine strains is approximately 98%, on the basis 
of results of 16S rDNA sequencing (Cooper, et al., 1997b; Lawson & Gebhart, 2000), and 
hamsters and other rodents could be infected with a porcine strain with variable success (Cooper, 
et al., 1997b; Smith, 1998; Smith & Lawson, 2001; Vannucci, et al., 2010).  Furthermore, the 
possibility of cross-infection from reservoirs other than pigs has been suggested, ranging from 
animals living on the farms’ premises (i.e., dogs, cats, mice), or the surrounding wildlife (e.g., 
deer, rabbits, hares, etc.) (Cooper, et al., 1997b; Duhamel, et al., 1998; Lawson & Gebhart, 2000; 
Herbst, et al., 2003; Pusterla, et al., 2008a; Pusterla, et al., 2008b; Collins, et al., 2011; Pusterla, 
et al., 2012a).  However, whether cross-infection is possible thus far remains speculative, and 
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complicates the assessment and control plans for EPE in horse farms (Pusterla, et al., 2008a; 
Pusterla, et al., 2009a). 
The severity of clinical EPE varies between affected horses within a group, as some may 
exhibit fever, repeated episodes of colic, whether or not complicated by persistent diarrhea and 
tenesmus (Duhamel & Wheeldon, 1982; Williams, et al., 1996; Frank, et al., 1998; Lavoie, et al., 
2000; Bihr, 2003). Most affected subjects present with marked ventral edema (pot-bellied 
appearance) and hypoproteinemia, overt weight loss, depression and inappetance (Duhamel & 
Wheeldon, 1982; Williams, et al., 1996; Frank, et al., 1998; Lavoie, et al., 2000, Bihr, 2003).  In 
other cases, fever is absent, clinical GI signs, and edema, are less obvious, but body condition is 
generally poor and debilitation is chronic (Lavoie, et al., 2000; Sampieri, et al., 2006; Lavoie & 
Drolet, 2009). Some horses seroconvert and shed L. intracellularis in feces without ever showing 
clinical signs (Pusterla, et al., 2008a; Lavoie & Drolet, 2009).  Recently, 3 EPE clinical forms 
have been identified (similarly to PPE): an acute presentation; a classical form and a subclinical 
form. In addition, a very recent report about a fulminant enteritis form, associated with DIC, has 
been published (Page, et al., 2011a; Page, et al., 2012). Clinically affected horses may die, or be 
euthanized, due to severe enteropathy and accompanying biochemical imbalances, dependent on 
small intestinal malabsorption (Wong, et al., 2009), or signs of colic may be so severe to warrant 
exploratory surgery (Schumacher, et al., 2000; Sampieri, et al., 2006; Frazer, 2008).  In affected 
foals, both jejunal and ileal walls are grossly thickened and corrugated, and, on ultrasonographic 
examination, intestinal loops have a typical “doughnut-like” appearance, which today is 
considered a pathognomonic sign of EPE (Schumacher, et al., 2000; Sampieri, et al., 2006; 
Frazer, 2008).  
  
2.1.4. Pathogenesis of EPE 
 
EPE is by definition an enteropathy, since inflammatory infiltration with reticulo-
endothelial cells was typically seldom detected on histological examination (McOrist, et al., 
1995a; Lavoie, et al., 2000; Lawson & Gebhart, 2000).  Contamination and infection occur 
through the fecal-oral route and infected herd-mates have a pivotal role as reservoirs in 
propagating the infection to naïve foals (McOrist, et al., 1993; McOrist, et al., 1995a).  In horses, 
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the progression of EPE pathogenesis has been confirmed through epidemiological evaluation of 
outbreaks and the reproduction of a L. intracellularis infection model in foals. (Lavoie, et al., 
2000; Lavoie & Drolet, 2009; Pusterla, et al., 2010a)  Experimental incubation is reportedly 2 to 
3 weeks in pigs and horses, and is likely similar for other species (Pusterla, et al., 2010a).  
Pathological lesions in horses are similar to those found in pigs and hamsters with PPE and PPE-
derived enteropathy, respectively, as reviewed in 2 classic publications (Lawson & Gebhart, 
2000; Smith & Lawson 2001).  
 Development of L. intracellularis infection is widely influenced by the presence of an 
active intestinal bacterial flora, as pathogen-free piglets inoculated with in vitro grown L. 
intracellularis do not develop infection, whereas piglets infected with filtered mucosal 
homogenates – wherein L. intracellularis is not the only pathogen – develop disease easily 
(McOrist, et al., 1993; McOrist, et al., 1994).  Similarly, gnotobiotic piglets infected with in vitro 
grown inoculum develop infection (McOrist & Lawson, 1989).   
As initial studies were not performed with purified bacterial cell culture, but with filtered 
mucosal homogenates containing an undefined bacterial flora along with L. intracellularis, the 
first phases of infection and its early cellular effects are still in the process of being clarified 
(Frisk & Wagner, 1977; Jacoby, 1978; Johnson & Jacoby, 1978).  Initially, it was controversial 
whether L. intracellularis had a flagellum (which would facilitate movement towards, or within, 
the intracellular space) as no typical remnants were detected in the cell wall.  It is now confirmed 
that the bacterium is a flagellated microorganism (McOrist, et al., 1995a).  One of the 
fundamental steps of infection for obligate intracellular bacteria is the phase of attachment to the 
cell surface. However, micrographic description of L. intracellularis is very limited (McOrist & 
Lawson, 1989; Jasni, et al., 1994a). Such findings were controversial, because the luminal-
attached pathogens did not always stain as expected, when tested with immunological reagents, 
suggesting either that they were not L. intracellularis, or that L. intracellularis expresses phase-
variable antigens (McOrist, et al., 1989).    
In one study, the process of adhesion and entry in cultured rat cells appeared rapid 
(minutes to hours), with only a small percentage of bacteria not entering cells or causing damage 
to the cell wall (Lawson, et al., 1995).  In another study, crypt enterocytes appeared damaged at 
the site of entry, although the infection process was centrifuge-assisted and potentially the 
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damage was caused by centrifugation (McOrist, et al., 1995b). More recent studies in pigs (one 
in ligated intestinal loops in vitro, and one in vivo) confirmed L. intracellularis and brush-border 
interactions within 3-6 h, and up to 12 h, from exposure, moving into the lamina propria and 
connective tissue, hypothesizing an active role of the lamina propria in the spread of infection 
(Boutrup, et al., 2010a; Boutrup, et al., 2010b).  Nonetheless, polyclonal serum and monoclonal 
antibodies only stunt, but don’t stop, the infection process in cell monolayers, suggesting that 
multiple entry pathways could be possible (Smith & McOrist, 1997; Smith & Lawson, 2001).  
After attachment, L. intracellularis enters within the enterocytes singularly in vacuoles, 
or membrane bound vesicles, through a process similar to phagocytosis observed for other 
intracellular bacteria (i.e., Chlamydia spp., Shigella spp., Yersinia spp. and Cl. piliformis) (Jasni, 
et al., 1994b; Smith & Lawson, 2001).  The ingress in the cell appears associated not with 
bacterial viability, but rather with host-cell susceptibility, requiring cellular metabolism and actin 
polymers re-arrangements (Lawson, et al., 1993; Lawson, et al., 1995).  Once within the infected 
enterocytes, bacteria escape the cell vacuoles and replicate freely, in proximity of the cell’s 
apical pole, where they are able to escape the intervention and destruction by phago-lysosomes 
(Gebhart, et al., 1993; McOrist, et al., 1995a; McOrist, et al., 1995b).  Several bacterial species 
(i.e., Listeria spp., Shigella, Rickettsia and Cl. piliformis) also utilize a vacuole-mediated escape 
system within the cytoplasm and do not associate with any intracellular organelles, producing 
toxins to exit the vacuole.  Seemingly, L. intracellularis might use a similar system, although the 
type of toxin produced is yet undetermined. A documented haemolytic activity in vitro has been 
extensively reviewed (Smith & Lawson, 2001).   
L. intracellularis replication is concomitant to the replication of infected host-cells, and 
we assume that they are tightly linked. Within the intestinal wall structure, the location of tubular 
crypts is typically at the base of the epithelial layer, and here cells undergo an active mitotic 
phase. The most developed enterocytes, ready to exert their nutrient absorption’s function are the 
most superficially (closer to the lumen) located within the crypts. The tropism of L. 
intracellularis for crypts’ deeper cells is known, and appears to be one of its physiological 
requirements, as it affords the infection to use the continuous hyperactive mitotic activity not 
only for boosting its own replication process, but also to maximize and mediate in vivo the rapid 
colonization of the intestinal epithelium (Lawson, et al., 1993; McOrist, et al., 1995b).  Crude 
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estimates from in vitro evaluation show that L. intracellularis is a highly specialized intracellular 
pathogen, which can divide q 8 h, and in the presence of a synthetic peptide, in the culture 
systems, it can divide or spread infection even faster.  Bacterial division occasionally occurs by 
septation, but the transfer from cell to cell has not been reported, implying that the spread of 
infected cells is not based on migration of bacteria, but on migration of colonized cells (Gebhart, 
et al., 1993). As a result, the first structural changes in the intestine derived from L. 
intracellularis infection is a profound mucosal hyperplasia, predominantly caused by 
proliferation of crypt epithelium, which starts locally, in infected islands, where, amidst normal 
epithelium, only infected cells are proliferative (Gebhart, et al., 1993).  Eventually, in a 
segmental fashion, infection extends to the entire distal jejunum and ileum, and potentially to the 
duodenum (Duhamel & Wheeldon, 1982; Williams, et al., 1996; Frank, et al., 1998).  Such 
pattern of replication and infection explains the continuous mitotic activity, generating 
hyperplastic crypts composed of immature enterocytes, with stunted villi and an almost atrophic 
brush border, along with concomitant decreased enzymatic and absorptive capacities, 
progressing to a stage of adenomatosis, as they become elongated, frequently branched and 
potentially “herniating” in the submucosa (Frank, et al., 1998). The lamina propria, especially 
around crypts, appears expanded by moderate numbers of macrophages, lymphocytes, plasma 
cells and, occasionally, eosinophils (Schumacher, et al., 2000).  
Although the molecular and genetic basis for the enhanced proliferation and the rapid 
bacterial division is still unknown and under investigation, in vitro and in vivo experiments 
suggest that infected enterocytes divide at a rate 4-fold faster than non-infected cells, but once 
hyperplasia develops, the proliferation rate appears to wane (Lawson, et al. 1993; McOrist, et al., 
1994b).  In the chronic stages of EPE, the mucosa can be corrugated, with ulcers and focal 
submucosal erosions, necrosis and hemorrhages (uncommon), and edema (Williams, et al., 1996; 
Frank, et al., 1998; Smith & Lawson, 2001). Occasionally, mononuclear inflammation and 
muscular hypertrophy are reported in affected intestinal segments. Rapid enterocyte proliferation 
with a lack of differentiation is associated with the clinical signs, ultrasonographic changes and 
macroscopic appearance on gross pathology, as well as the microscopic findings.   
In EPE, diarrhea develops due to malabsorption and increased small intestinal 
permeability (See Sub-chapter 2.5), particularly because small intestinal disaccharidase activity 
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is reduced. When small intestinal absorption is reduced, along with reduced uptake of protein, 
lipids and minerals, too many carbohydrates reach the large colon, where they are metabolized 
by intestinal flora and produce an osmotic type of diarrhea (Sweeney, 1987).  This is more 
probable than large intestinal inflammation due to EPE, as L. intracellularis infection in this 
latter tract of foals’ intestine is rare, although it was demonstrated in rabbits, and occasionally in 
pigs and hamsters (Hotchkiss & Merritt, 1996; Hotchkiss, et al., 1996; Lawson & Gebhart, 2000; 
Vannucci, et al., 2010).   
The protein losing enteropathy process leads to the hallmark signs of hypoproteinemia (< 
50 g/L) and ill-thrift appearance of affected foals (Duhamel & Wheeldon, 1982; Williams, et al., 
1996; Frank, et al., 1998; Lavoie, et al., 2000; Bihr, 2003).  Hypoproteinemia arises from the 
conjunction of increased intestinal permeability and overall decreased absorption of amino acids, 
while normal systemic protein catabolism continues, or is increased, depending on disease stage.  
Hypoalbuminemia, in particular, leads to low plasma colloid-osmotic pressure and formation of 
ventral edema (Frank, et al. 1998; Sampieri, et al., 2006).  In some EPE-affected foals anemia 
develops, due to the lack of nutrients and possibly to a systemic response to the infection 
(Lavoie, et al., 2000).     
The insight on the role of humoral, mucosal and cellular immunity and their phases of 
development of EPE is limited, as studies on L. intracellularis foals models and vaccination 
investigations are in progress (Pusterla, et al., 2009b; Pusterla, et al., 2010a; Pusterla, et al. 
2010b).  It is clear that foals can mount a humoral response versus L. intracellularis (see Sub-
chapter 2.3.4), but whether serum antibodies are protective remains to be elucidated (Pusterla, et 
al., 2010a).  
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”‘Il  n’ existe pas de sciences appliquées, mais seulement des application de la science.” 
“There are no such things as applied sciences, only applications of science.” 
                                                                                                                                                                                                                            L. Pasteur 
2.2. Lawsonia intracellularis: the challenges of its discovery. 
 
The clinical presentation of proliferative enteropathy was first reported in 1931 in swine 
(Porcine Proliferative Enteropathy, PPE), and more recently in horses (Equine Proliferative 
Enteropathy, EPE), while the causative etiologic agent, Lawsonia intracellularis was not 
detected, within the cells, until the early 1970s (Biester & Schwarte 1931; Rowland, et al., 
1973). Regardless of when it was recognized, today PPE causes major economic losses 
worldwide, in the porcine production industry, and losses associated with EPE appear to follow a 
similar trend (McOrist & Gebhart, 1999; Lawson & Gebhart, 2000, Frazer 2008).     
Lawsonia intracellularis, named in honor of its discoverer, G. H. K. Lawson (McOrist, et 
al., 1995a), is a gram-negative, non-spore-forming, straight to slightly curved rod bacterium, 
1.25 - 2 m long, and 0.25 - 0.43 m wide.  It is flagellated and non-pigmented, with cellular 
sections typical of a gram-negative prokaryote, exhibiting a wavy, tri-laminated, outer cellular 
wall structure and dense cytoplasmic granules (McOrist, et al., 1995a).  Characteristically, L. 
intracellularis is detected, in the small intestinal epithelium layer, free-floating in the cytoplasm, 
at the apex of enterocytes, where it survives and replicates as an obligate intracellular bacterium 
(McOrist, et al., 1995a).  Its multiplication occurs by septum formation, or by fission, and 
requires an almost anaerobic atmosphere for growth (Gebhart, et al. 1993; Lawson, et al., 1993).   
L. intracellularis retains carbol fuchsin, when stained by modified Ziehl-Neelsen method, 
exhibiting acid-fast staining in smears of intestinal epithelium and enterocytes (McOrist, et al., 
1995a). It was first isolated from porcine intestinal epithelial cells affected by PPE and, 
apparently it does not infect cells, unless a normal intestinal flora is present (See Chapter 2.1.4.) 
(McCartney, et al., 1984; Boosinger, et al., 1985; McOrist & Lawson, 1989).  Having found the 
bacteria in the diseased animals; reproduced the bacterial colonization in pure cell-culture, 
starting from infected tissues; and having obtained PPE lesions in porcine intestine from the 
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cultured organism, researchers fulfilled Koch's postulates and warranted the denomination of L. 
intracellularis as a pathogenic species (Koch, 1890; McOrist, et al., 1995a).   
Although not completely understood at the time, the first strain was deposited in 1989 
(1482/89) in the National Collection of Type Cultures, London, UK and named as strain NCTC 
12656T.  It was cultured in a rat enterocyte cell-line monolayer after infection with a bacterial 
suspension, from a natural case of porcine disease.  Strain NCTC 12656T reproduces effectively, 
but causes no noticeable cytopathic effect in rat enterocytes, nor is a threat to culture survival.  
Another strain deposited in 2000, PHE/MN1-00, was collected in Minnesota from a pig affected 
with proliferative hemorrhagic enteropathy (PHE), and its full genomic sequence has been 
deposited (http://www.straininfo.net/strains/681612).   
The exact taxonomy of L. intracellularis took decades to be completely identified, as its 
characterization and understanding kept eluding researchers and empirical therapies for a long 
while (Gebhart, et al., 1993; McOrist, et al., 1993; McOrist, et al., 1995a).  Its etiology was 
ascribed to different genera, or species, in the 1980s (e.g., Campylobacter hyointestinalis, 
Campylobacter sputorum subsp. mucosalis) and it was temporarily named Ileal Symbiont 
intracellularis in 1993, until it could be better defined (Duhamel & Wheeldon, 1982; Gebhart, et 
al. 1983; McCartney, et al., 1984; Boosinger, et al., 1985; Gebhart, et al., 1993).  Initially, the 
investigation of this infective pathogen was hampered by the reduced supply available for 
taxonomy studies, because L. intracellularis cell-free cultures failed and successful growth in 
vitro was cumbersome (Gebhart, et al., 1993; Lawson, et al., 1993).  Cultivation in vitro of 
individual strains is now feasible, although it mandatorily requires enterocyte cell-culture and 
“microaerophilia” to succeed (Lawson, et al., 1993; Guedes & Gebhart, 2003b; Yeh, et al., 2006; 
Watarai, et al., 2008; Pusterla, et al., 2010a).  Microaerophilia indicates an anaerobic condition 
with nitrogen and carbon dioxide replacing the evacuated room air, to obtain a gas mixture with 
8% O2 and 7% CO2.  Initially, isolated strains were maintained in IEC-18 and ATCC CRL1589 
cell cultures, for at least 20 passages (Lawson, et al., 1993). 
The identification of L. intracellularis in tissue culture cells and in the naturally affected 
porcine ileal epithelia occurred through the species-specific recombinant DNA probes reported 
by Gebhart and coworkers (1991) and, later, by McOrist and colleagues (1995).  The bacterium 
had novel immunological and DNA probe reactions, compared with Campylobacter spp. 
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(McOrist, et al., 1987), and, through 16S ribosomal DNA (rDNA) amplification and sequencing, 
it was shown that it belonged to the  subdivision of the class Proteobacteria (Gebhart, et al., 
1993). Moreover, the DNA sequences, determined from each purified bacterial preparation, were 
most similar to the sulfate-reducing proteobacterium Desulfovibrio desulfuricans (Gebhart, et al., 
1993).  At that stage, L. intracellularis was believed to colonize the apex of the cytoplasm of 
mammalian enterocytes only, particularly pigs and hamsters (Rowland & Lawson 1974, Lawson, 
et al., 1985). Today it is determined that L. intracellularis has a broad range of host-
susceptibility, with high likelihood for infection across species (Cooper, et al., 1997a; Herbst, et 
al., 2003), and it is known to infect a variety of mammalian and avian species (Drolet, et al., 
1996; Cooper, et al., 1997a; Cooper, et al., 1997b; Lemarchand, et al., 1997; Duhamel, et al., 
1998; Frank, et al., 1998; Klein, et al., 1999; Herbst, et al., 2003).   
To determine beyond doubts that L. intracellularis constituted a new genus and species, 
McOrist and colleagues (1995) compared it, through fermentative and biochemical taxonomic 
tests, with Rickettsia spp. and Desulfovibrio desulfuricans, among others (McOrist, et al., 
1995a). Although they are obligate intracellular bacteria, occurring free in epithelial cells 
cytoplasm, Rickettsia spp. were excluded because they have different rDNA sequencing data, 
structure and habitat. Moreover, one of the Rickettsiales’ requirements is an insect-host during 
the life cycle (e.g,. may-fly for Neorickettsia risticii) (Moulder, 1985; Weisburg, et al., 1991).  
The differences with Desulfovibrio spp. were more subtle.  Although the 2 species appeared 
similar for morphology (91% DNA similarity) and habitat (mammalian GIT) (Gibson, et al., 
1993), electrophoretic protein profiles, DNA probe and monoclonal antibody reactions, 
confirmed the unique novelty of L. intracellularis (McOrist, et al., 1995a). 
   
2.2.1. The challenges of a timely-fashioned clinical diagnosis: past and present 
techniques. 
 
As described in the first EPE case reports (See chapter 2.1.2.), achieving ante-mortem 
diagnosis represented the prime challenge (Duhamel & Wheeldon, 1982; Williams, et al., 1996; 
Frank, et al., 1998), but when EPE resulted to be the equine equivalent of PPE, diagnostic 
techniques and therapeutic approaches were readily borrowed from the porcine industry’s 
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experience (Williams, et al., 1996; Lavoie, et al., 2000).  Unfortunately, L. intracellularis 
isolation from feces, intestinal mucosa, or intestinal content is impractical, laborious and not 
100% reliable, due to the capricious behavior of the bacterium, and, hence, it is clinically 
impractical (Lawson, et al., 1993; McOrist, et al., 1993).   
Today, immediate clinical assessment and tentative ante-mortem diagnosis of EPE are 
possible on the basis of specific GIT clinical signs that are accompanied with hypoproteinemia 
and hypoalbuminemia, and detection, through ultrasonography, of a thickened small intestinal 
wall (Schumacher, et al., 2000; Sampieri, et al., 2006).  Regardless of the technique used, both 
PPE and EPE have been diagnosed typically by the presence of bacteria within the apical 
cytoplasm of actively proliferating crypts’ cells in post-mortem histopathology, or in surgical 
biopsy material (Schumacher, et al., 2000; Guedes, et al., 2002a). To date, utilization of routine 
endoscopic-guided duodenal biopsies for IHC or PCR analysis is not common practice in horses 
(or pigs) (Schumacher, et al., 2000).  Rather, the clinical diagnosis is corroborated with non-
invasive tests such as serology, PCR analysis on fecal material, or both (Lavoie, et al., 2000; 
Schumacher, et al., 2000; Sampieri, et al., 2006).  Today 3 main types of laboratory diagnostics 
are used to diagnose PPE/EPE in live animals: serology, immunochemical-staining on tissues 
and polymerase chain reaction (PCR) on fecal samples (Lawson & Gebhart, 2000).  Serology 
provides information about historical exposure to L. intracellularis; histology (through 
immunoperoxidase – IPX; or immunohistochemistry – IHC) demonstrates the presence of 
bacterial antigen; and PCR analysis determines if the presence of bacterial DNA in feces (fecal 
shedding), or tissues, is a source of disease propagation, even during treatment (Guedes, et al., 
2002a). 
 
2.2.2. Serology    
 
Serology is a relatively inexpensive and universally applied tool, used to investigate 
“disease status” and epidemiology of L. intracellularis, among other infectious agents 
(Holyoake, et al., 1994; Knittel, et al., 1998; Guedes, et al., 2002a; Guedes, et al., 2002b).  For 
PPE, the presence of detectable antibodies against L. intracellularis correlated closely to the 
presence of lesions, and not always to mere exposure to infection (Lawson, et al., 1988; Guedes, 
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et al., 2002a).  In an attempt to achieve optimal results, several techniques (Enzyme-linked 
immunosorbent assay, ELISA; indirect fluorescent antibody technique, IFAT; 
immunoperoxidase monolayer assay, IPMA) were developed over the years and a chronological 
description of serology techniques is listed in Table 2.1 (Serology techniques), whereas their 
diagnostic value is briefly discussed below. 
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Table 2.1 Serology Techniques 
Table 2.1. Serological techniques used for diagnosis of proliferative enteropathy exposure in 
porcine (PPE) equine (EPE) and lapine species (rabbits). 
Technique Species Antigen  Country Year Reference 
ELISA PPE Percoll-gradient purified-PPE antigen from 
intestines of naturally infected pigs                                
Australia 1994 (Holyoake, et al., 1994) 
IFAT PPE Pure cell-culture of L. intracellularis  Ames, IA, 
USA 
1998 (Knittel, et al., 1998) 
IFAT PPE Pure cell-culture of L. intracellularis St. Paul, 
MN, USA 
2002 (Guedes, et al., 2002a) 
IMPA PPE  
EPE 
Pure monolayer cell culture  
L. intracellularis  
St. Paul, 
MN, USA 
2002 (Guedes, et al., 2002c, 
Guedes, et al., 2002d) 
ELISA PPE 
rabbits 
Antiserum against synthetic peptides of  
L. intracellularis-surface 
Japan 2004 (Watarai, et al., 2004) 
ELISA PPE L. intracellularis lipopolysaccharide, and 
through percoll-purified antigen-coated 
plate 
Ames, IA 
USA 
2005 (Kroll, et al., 2005) 
ELISA PPE Sonicated pure culture of L. intracellularis St. Paul, 
MN, USA 
2008 (Wattanaphansak, et 
al., 2008) 
ELISA EPE Modified methodology from 
(Wattanaphansak, et al., 2008)  
Lexington, 
KY, USA 
2011 (Page, et al., 2011b) 
 
In the table, from left to right, are listed the serological techniques, the species targeted, the 
country, the year of publication and the bibliographic reference that first communicated the use 
of such a technique in regards of L.  intracellularis. 
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2.2.2.1. ELISA techniques.  
In the 1990s, an enzyme linked immuno-sorbent assay (ELISA) was used  with good 
results for IgG detection, but its specificity and sensitivity were not demonstrated, as the antigen 
used to coat the plates was harvested from naturally PPE-infected pigs, and the supply was 
limited (Holyoake, et al., 1994).  Interestingly, higher titers were obtained in pigs infected with 
unfiltered homogenates, confirming the requirements of a normal intestinal flora for PPE to 
develop successfully, but also leaving room for cross-contamination with other hypothetical 
pathogens (McOrist & Lawson, 1989; McOrist, et al., 1993; Holyoake, et al., 1994).  Lack of 
sensitivity and specificity information was obvious in evaluating a Japanese study, where the 
adaptation of an antiserum against synthetic peptides of L. intracellularis-surface, previously 
used in IHC analysis, was reported in L. intracellularis infected rabbits (Watarai, et al., 2004).  
In 2005, Kroll and colleagues finally shed light on these attributes of ELISA testing used for 
serology, showing a sensitivity and specificity of 88.7% and 93.7%, on the basis of L. 
intracellularis-lipopolysaccharide plates-coating (Kroll, et al., 2005). 
  In 2008, a further modification of the antigen coating for the plates (sonication, So-
ELISA), was utilized to provide an even more accurate estimate of sensitivity and specificity  in 
PPE infection, finding that on 332 samples from naturally and experimentally infected animals 
(compared to 350 uninfected control samples) the diagnostic value was 89.8% and 99.4%, 
respectively (Wattanaphansak, et al., 2008). An adaptation of this So-ELISA technique was later 
studied (2011) to explore EPE’s seroprevalence in Thoroughbred farms of central Kentucky, but 
sensitivity or specificity were not considered (Page, et al., 2011).  
2.2.2.2. IFA technique.  
An indirect fluorescent antibody test was reported first in 1998 (Knittel, et al., 1998), and 
over the years it has been used not only on serum, but also on feces and tissues (See below, 
subheadings 2.2.3 and 2.2.4).  This assay positively detected the infection with the bacterium 3-4 
weeks post inoculation in 90% of experimentally infected pigs. Unfortunately, the IFA technique 
showed 2 main methodology limitations: 1) the need to maintain L. intracellularis in vitro to 
provide a source of antigen (only a few laboratories worldwide have access to established in 
vitro pure cell-cultures); and 2) the need to store acetone-fixed cultures of L. intracellularis in 
96-well-plates, at -20°C conditions until use (Knittel, et al., 1998).  Although specificity data 
were not available, IFA was considered analytically very accurate, as no cross-reactivity of 
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hyperimmune sera of pigs experimentally infected with different enteropathogenic bacteria was 
detected (Knittel, et al., 1998).  A different study, comparing IFA serology tests versus PCR 
analyses in fecal samples, showed that IFA had higher sensitivity for detection of experimentally 
infected pigs, but, assuming a virtual PCR specificity of 100%, the drawback was its diagnostic 
sensitivity, as the reported sensitivities were 90% - 91% versus 39% - 67% for serology and for 
PCR in feces, respectively (Jones, et al., 1993b; Knittel, et al., 1998).  In 2002, Guedes and 
colleagues, reproduced the technique with a modified preparation (Guedes, et al., 2002a), as the 
study compared a tissue-IFA test to a glass-slide IFA test, along with other diagnostics’ 
comparisons.  The IFA serology positive results matched the presence of PPE lesions with a 78% 
and 83% agreement, for the tissue IFA and the glass-slide IFA, respectively (Guedes, et al., 
2002a).  The advantage of the glass-slide IFA was an easier transport, record keeping, and 
commercialization, as glass-slides coated with pure L. intracellularis can be fixed, dried and 
stored without a freezer.  However, IFA still holds the disadvantages of a complicated antigen 
preparation method and the necessity of a highly experienced fluorescence test-reader (Guedes, 
et al., 2002a).   
2.2.2.3. IPMA technique.  
In 2002, IPMA was developed as a potentially more practical approach to infection 
detection (Guedes, et al., 2002b; Guedes, et al., 2002c; Guedes, et al., 2002d). IPMA had similar 
sensitivity to IFA for PPE screening and showed undeniable advantages over IFA that could 
expedite and simplify analysis, such as: 1) did not require the use of a fluorescent microscope; 2) 
it was easier to interpret; and 3) it maintained stable color reactions for months (easier record 
keeping for extended time) (Guedes, et al., 2002b).  A large cohort comparison of PPE-infected 
pigs and control pigs demonstrated that the sensitivity of IPMA was only 88% with 100% 
specificity.  Thus, the test could be used for screening purposes, but not for definitive testing 
(Knittel, et al., 1998; Guedes, et al., 2002a; Guedes, et al., 2002b; Guedes, et al., 2002c).  
Negative IPMA results were confirmed through PCR analysis, and positive IPMA results were 
confirmed by PCR and IHC analysis (Guedes, et al., 2002c).  Also, with the aim of improving 
the results of IPMA and IHC diagnostics in pigs, the same authors investigated the production of 
mono- and polyclonal antibodies to apply to those techniques (Guedes & Gebhart, 2003c).      
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Serologic studies in foals started much more recently, as initially the techniques utilized 
for pigs were simply “adopted” for diagnostic purposes, on the basis of their availability, and 
regardless of the expected diagnostic value (Lavoie, et al., 2000; Schumacher, et al., 2000; 
Sampieri, et al., 2006).  Specific validation processes have just started due to the rising interests 
in a vaccine production (Page, et al., 2011a; Page, et al., 2011b).  However, also for EPE, 
serology (regardless of the specific technique) appears more sensitive than PCR on fecal material 
(Lavoie, et al., 2000; McClintock & Collins, 2004).  Positive seroconversion may be observed in 
foals a couple weeks after experimental inoculation, suggesting that serological evaluation could 
be a useful screening tool for EPE (Pusterla, et al., 2010a).  Furthermore, a serological response 
can occur in naïve foals, in contact with experimentally inoculated foals, and serum antibodies 
can persist for up to 2 months, whereas in naturally infected foals antibodies can be found for up 
to 6 months (Pusterla, et al., 2010a).  Today in North America, IPMA is widely and reliably 
utilized to screen or compare for anti-L. intracellularis antibodies in horses and pigs (Sampieri, 
et al., 2006; Frazer, 2008; Pusterla, et al., 2010a; Page, et al., 2011a). In the rest of the world, it 
is more common to observe the use of indirect IFA or ELISA testing, depending on the 
availability of L. intracellularis cell-cultures (Boesen, et al., 2005; Nathues & Beilage, 2008; 
Guimarães-Ladeira, et al., 2009; Boutrup, et al., 2010a).   
 
2.2.3. Fecal smears analysis: from immunology tests to PCR analysis  
 
In the late 1980s, fecal material from PPE-affected pigs was analyzed with an indirect 
immunofluorescence technique (IFA) and monoclonal L. intracellularis-specific antibodies, 
showing that clinically affected animals usually shed the pathogen in feces (McOrist, et al., 
1987). Since then several techniques (indirect fluorescent antibody technique, IFAT; 
immunoperoxidase IPX; Polymerase chain reaction, PCR) were developed over the years and a 
chronological description of the techniques is listed in Table 2.2 (Diagnostic techniques for 
fecal samples), whereas their diagnostic value is briefly discussed below. 
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Table 2.2. Diagnostic techniques in fecal samples. 
Table 2.2. Diagnostic techniques utilized to detect L. intracellularis in fecal or tissue samples in 
the porcine (PPE), equine (EPE) or other species. 
 
Technique Species Antigen Country Year Reference 
IFA PPE  
(tissue/ 
feces) 
Bacterial smears stained with homologous 
antisera 
St. Paul, 
MN, USA 
1984 (Chang, et al., 
 1984) 
IFA PPE  
(feces) 
Bacterial smears stained with homologous 
antisera 
 
United 
Kingdom 
1987 (McOrist, et al., 
1987) 
IPX PPE  
(feces) 
Monoclonal antibody L. intracellularis-
specific and  
red chromogen aminoethyl-carbazole 
 
St. Paul, 
MN, USA 
2002 (Guedes, et al., 
2002a) 
Conventional 
PCR 
PPE  
(feces) 
375-base pair (bp) segment of a 
DNA fragment from L. intracellularis     
DNA clone p78 
 
St. Paul, 
MN, USA 
1993 (Jones, et al., 
1993b) 
Nested PCR PPE  
(tissue/ 
feces) 
375-base pair (bp) segment of a 
DNA fragment from L. intracellularis     
DNA clone 
p78 DNA-DNA hybridization (for 
amplification) 
 
United 
Kingdom 
1994 (McOrist, et al., 
1994c) 
Multiplex 
PCR 
PPE Purified DNA from pure cultures of L. 
intracellularis, Serpulina hyodysenteriae, 
Salmonella spp.  Can detect DNAs from a 
number of different intestinal pathogens 
concurrently, in the one test sample. 
 
Lincoln,  
NE, USA  
1997 (Elder, et al., 
1997) 
PCR enzyme-
linked 
oligosorbent 
assay (PCR-
ELOSA) 
PPE Involved procedures of labeling PCR 
products with biotin, hybridization with an 
amine-modified internal oligonucleotide 
probe, addition of peroxidase–streptavidin 
complex, and measurement of 
spectrophotometric signal (results reported as 
optical density values). 
 
St. Paul, 
MN, USA 
2000 (Zhang, et al., 
2000) 
Real time 
PCR 
PPE 
EPE  
wildlife 
A specific oligonucleotide probe labeled with 
2 fluorescent dyes, allowing amplification 
and detection of an emission signal to occur 
simultaneously (Lindecrona, et al., 2002). 
Davis, 
CA, USA 
2002 
2008 
2009 
(Pusterla, et al., 
2008;  
Nathues, et al., 
2009;  
Pusterla, et al., 
2009a; 
Wattanaphansak 
et al., 2010)  
 
In the table, from left to right, are listed the techniques used for feces and tissues, the species 
targeted, the country, the year of publication and the bibliographic reference(s) that first 
communicated the use of such a technique in regards of L.  intracellularis. 
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2.2.3.1. IFA technique.  
Used and described formerly as a serology diagnostic, initially this technique was used to 
stain tissues and fecal smears, although a better result was claimed on the debris rather than the 
cells (Chang, et al., 1984; McOrist, et al., 1987).  However, the advent of PCR techniques 
replaced this diagnostic almost worldwide (see below). 
 
2.2.3.2. IPX technique.  
In 2002, IPX testing of fecal smears showed sensitivity close to 90% at the peak of the 
disease, 21 days post inoculation (PI), but needed clarification with regards to specificity.    In 
comparison to IFA, IPX reduces background scatter and affords clear visualization of the bright 
red antigen-labeled L. intracellularis, although the limitation of a non-specific background 
remains, as it is unavoidable with fecal smears, and can increase the number of false positives 
(Guedes, et al., 2002).  Even in this case, as PCR reagents are more widely available, IPX has 
been somewhat replaced in the past 10 years (see below). 
 
2.2.3.3. PCR technique.  
The specificity offered by the emerging and newly developed PCR techniques in 1983, 
did not go unnoticed among the L. intracellularis investigators. Even though the immunologic 
tests held the advantage of not being hampered by those same inhibiting factors,  that can hinder 
DNA amplification within fecal specimens, as demonstrated in a human Rotavirus study, the 
new technique had soon a lot of appeal (Wilde, et al., 1990).  Thus, a few years after the initial 
PCR studies, 2 joined research groups claimed that as few as 10 L. intracellularis bacteria could 
be detected by PCR technique in DNA extracted from infected mucosal filtrate and feces (Jones, 
et al., 1993b; McOrist, et al., 1994c).  In PPE samples, different PCR techniques have provided, 
either in feces and tissues or in feces only, variable sensitivities (36 - 100%) and specificities (50 
- 100%) (Pedersen, et al., 2010), depending on  the diagnostics used as terms of comparison (i.e., 
IHC rather than IFAT or Warthin-Starry staining) or the time of sampling in relation to the peak 
of disease, for example 3 vs. 3.5, or 4 weeks PI (Knittel, et al., 1998; Guedes, et al., 2002a).  
However, Guedes and coworkers in 2002, reported a PCR sensitivity higher than previously 
published on 2 weeks PI (71.05%) and 3 weeks DPI (60.5%), although it decreased (37.5%) by 4 
weeks PI (end of experiment).  A further explanation for the diagnostics differences has been 
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ascribed to the different infection model used by Guedes (ileal mucosal scrapings homogenate 
from PPE affected pigs) versus the one used by Knittel (pure cell-culture) (Knittel, et al., 1998; 
Guedes et al., 2002a).  Reportedly, animals infected with mucosal homogenates develop more 
severe clinical signs and gross lesions, than the ones challenged with pure cell-culture, with the 
amount of bacterial DNA shed in feces closely related to the severity/extension of intestinal 
lesions (Guedes, et al., 2002).  A better test sensitivity was advocated, in part due to the necessity 
of assessing the degree of fecal shedding without results being hampered by false-negatives; in 
part because PCR’s specificity for detecting L. intracellularis fecal shedding is virtually close to 
100% (Jones, et al., 1993; McOrist, et al., 1994c).  To date, PCR is not used as a sole diagnostic 
tool for PE diagnosis (Knittel, et al., 1998; Lavoie, et al., 2000; Zhang, et al., 2000; Guedes, et 
al., 2002, Guedes & Gebhart, 2003a; Jacobson, et al., 2004; McOrist & Smits, 2007; Guimarães-
Ladeira, et al. 2009; Merlo, et al., 2009; Pusterla, et al., 2009a; Pusterla, et al., 2009b; Pusterla & 
Gebhart, 2009; Pusterla, et al., 2010a; Pusterla, et al., 2010b; Page, et al., 2011b), particularly if 
samples are collected after the start of AM therapy, as L. intracellularis fecal shedding 
apparently decreases or stops (Dauvillier, et al., 2006; Nathues & Beilage, 2008). 
In 2003, an internal standard, called “mimic”, was developed to use along with L. 
intracellularis PCR technique, the “mimic” differed in size from the target template, but used the 
same primer recognition sites, hence affording the mimicking action through PCR amplification 
(Jacobson, et al., 2003). The goal of using the “mimic” is based on demonstration of PCR-
inhibitory factors in fecal samples and facilitating the differentiation between false-negative and 
real-negative results, thus overcoming the main limitation of background “noise” on fecal 
samples  (Jacobson, et al., 2004).  In such study, 10
2 
mimic molecules per 0.1 gram of feces were 
elected as a detection cut-off by nested-PCR (which uses a second set of primers – re-amplifying 
the reaction of the conventional PCR), also considering that L. intracellularis fecal shedding is 
estimated as equal to 10
8
/g. Through this PCR technique, DNA detection was sufficiently 
accurate to confirm PPE disease or exposure, but not lack of exposure (Jones, et al., 1993b; 
Jacobson, et al., 2003). 
Lately, a quantitative real time PCR (or qPCR) has been prompted for the use on both 
equine and porcine tissues (embedded and fresh) and feces (Pusterla, et al., 2008a; Pusterla, et 
al., 2009a; Drozd, et al., 2010; Richter, et al., 2010; Wattanaphansak, et al., 2010), with a 
sensitivity surpassing previous PCR methodologies.  Richter and colleagues reported an ability 
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of detection of L. intracellularis up to 4 amplicons/well in fresh and formalin-fixed-paraffin-
embedded tissues, versus the 18 amplicons/well in fecal material, as the inhibitory factors in 
feces remain a diagnostic hamper (Richter, et al., 2010).  Today, qPCR (SYBR Green principle) 
is applied successfully on quantitation procedures of experimental infectious inocula 
(Wattanaphansak, et al., 2010), and more recently real-time PCR (TAqMan principle) in the 
equine field, was utilized to confirm fecal shedding in animal modeling (Pusterla, et al., 2010a), 
as well as epidemiology investigations on horses and wildlife in stud farms (Pusterla, et al., 
2008b; Pusterla, et al., 2009a; Pusterla, et al., 2009c; Pusterla, et al., 2010b; Pusterla, et al., 
2010c).  Real-time PCR is utilized today, in porcine research, to investigate infection, or co-
infection, “status” involving L. intracellularis, among other bacteria (Molbak, et al., 2008; 
Willems & Reiner, 2010; Collins, et al., 2011).   
Interestingly, a systematic review by Pedersen and coworkers (2010) examined the 
diagnostic value of PCR analyses for L. intracellularis on porcine fecal samples (Pedersen, et al., 
2010).  Inclusion criteria were multifactorial, as they varied from the PCR principle and type of 
primer used, to the type and number of samples tested. The study examined the statistical 
analysis provided in over 21 studies, and attempted to provide a uniform predictive value (from 
15 to 90%) for all the PCR tests proposed in the last 20 years.  Seven different sets of primers 
were reported, with five different PCR principles applied (See table 2.2).  The most sensitive 
method was the nested PCR, but the complicated methodology reduces its applicability for 
clinical needs (Jacobson, et al., 2004). Pedersen distinguished elegantly the concepts of 
diagnostic and analytical sensitivity and specificity for PCR tests applied to feces: analytically, 
PCR tests were able to discern L. intracellularis from a list of enteric and non-enteric pathogens 
with an almost perfect specificity and a sensitivity (or limits of detection) that detected 10
2
-10
5 
bacteria/g of feces.  Epidemiologically, we appreciate the attempt to extrapolate sensitivity and 
specificity available for different sample sizes to a unique similar scale.  This is said despite the 
challenge of relating to a single interpretation studies conducted by different groups, in different 
time-frames and different settings. The report showed that the 3 PCR tests with diagnostic 
specificity <100% and higher chance of reporting false-positive results were preferable to the 4 
PCR tests with diagnostic sensitivity <100% (3 <50%), as they had higher chance of reporting 
false-negatives, despite having histological lesions validated by IHC (Pedersen, et al., 2010).  To 
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date, a similar report on PCR assays’ diagnostic specificity and sensitivity in EPE cases is not 
available.   
2.2.4. Immunohistochemistry: achieving the gold standard. 
 
Several histologic techniques have been described in the literature: staining with 
haematoxylin and eosin (H&E) (Rowland & Hutchings, 1978), Warthin–Starry (WS) silver stain 
and modified Ziehl–Nielsen (ZN) stain (Pedersen, et al., 2010), in situ hybridization (ISH) 
(Gebhart, et al., 1994), and immunohistochemistry (IHC) (McOrist, et al., 1987), but until 10 
years ago no technique could be considered the “gold standard” diagnostic method for L. 
intracellularis-infected animals. Firm diagnosis of PPE infected and non-infected animals 
requires a combination of tests, such as a positive fecal PCR test and a positive result by IHC in 
ileum sections (Guedes, et al., 2002a; Guedes, et al., 2002c).  This combination was elected on 
the basis of their high specificity (100%) (McOrist, et al., 1987; Jones, et al., 1993c). 
On post-mortem examination, histological diagnostics are necessary to confirm both EPE 
and PPE beyond doubt, despite the presence of typical intestinal lesions.  Moderate to severe 
lesions are readily detected on H&E preparations, as enterocytes’ proliferation is obvious; but 
detection of milder (or subclinical) cases is unreliable.  In the first cases of EPE, organisms were 
feebly visualized with Manovelian – Levaditi and then better detected with Steiner or WS 
methods, the latter becoming quickly the tissue staining of choice (Duhamel & Wheeldon, 1982, 
McOrist, et al., 1995a; Schumacher, et al., 2000).  Unfortunately WS is not specific for L. 
intracellularis and not very sensitive when applied to autolysed or necrotic tissues (Jensen, et al., 
1997). 
Immunohistochemistry (IHC) techniques, with murine monoclonal anti-L. intracellularis 
antibodies, have been used successfully to diagnose PPE since 1987, when results were first 
published about the utility of monoclonal antibodies for diagnosis of porcine ileitis (McOrist, et 
al., 1987). According to comparison studies, WS staining and IHC detected similarly L. 
intracellularis infection in severely affected tissues (macroscopically visible), with 95% and 
98% detection, respectively, but they differed profoundly when lesions were not macroscopically 
evident (Jensen, et al., 1997).  Further comparisons between WS and H&E techniques, and IHC 
labeling on 3 adjacent sections in 38 PPE-positive pigs showed that H&E had the lower 
sensitivity, followed by WS staining, compared to IHC (33 positive compared to 14 (H&E) and 
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19 (WS)) (Guedes, et al., 2002a).  The higher sensitivity of IHC is due to the specific binding of 
the monoclonal antibody to the outer membrane protein of L. intracellularis, and such bond is 
neither affected by severe necrosis, or autolysis, nor in the phase of recovery, when the bacterial 
antigen is found only in the cytoplasm of mononuclear cells in the lamina propria.  Thus, 
detection of positive antigen labeling and presence of PPE macroscopic lesions were in 
agreement (82.5%) even during remission or resolution (28 days PI) (Guedes, et al., 2002a).     
Veterinary diagnostic laboratories typically use H&E and WS stains for histology, as they 
are readily available, and corroborate the findings with a fecal PCR analysis (or on fresh 
intestine).  Ideally the high specificity of IHC and fecal IPX make these highly desirable tests. 
However, their need for the monoclonal antibody against L. intracellularis, limits their 
widespread use, although IHC has the ability to detect antigen labeling in tissues even at the end 
of the clinical phase (28 days PI), when fecal shedding falls below the limits of detection of the 
best technique used, IPX or PCR (Guedes, et al., 2002a). 
Today, IHC is acclaimed as the “golden standard” diagnostic test on available tissues.  
Most laboratories have a dichotomous classification system - either positive or negative.  In 
2003, a classification system was published, with lesions categorized on a scale from 0 to 4, 
where 0 equals no IHC labeling (or no infection) and 4 corresponds to 100% of IHC labeled 
enterocytes in the crypts (Guedes & Gebhart, 2003b).   
 To conclude, it is worth mentioning an in-situ hybridization (ISH) technique, studied for 
PPE detection even in absence of specific monoclonal antibodies (Ladinig, et al., 2009).  The 
first study (1994) that reported the use of ISH for L. intracellularis diagnostic purposes was 
conducted in the USA (Gebhart, et al., 1994).  Later, a Danish research group reported their 
fluorescent ISH (or FISH), targeting 16S ribosomal RNA, on formalin-fixed-paraffin-embedded 
tissues of 15 PPE-affected pigs (and 10 negative controls).  The oligonucleotide probe utilized 
was specific for histological detection of L. intracellularis (Boye, et al., 1998).  In 2007, a ISH 
digoxigenin-labeled oligonucleotide-probe was used in PPE cases, comparing the ISH technique 
to PCR and WS staining, but not IHC.  Results were highly favorable (71% agreement with 
PCR) for ISH, so that it was recommended as the second best test, after IHC (Weissenböck, et 
al., 2007).  Several studies followed, within the same European research groups, utilizing FISH 
and ISH as an ancillary diagnostic, along with q-PCR or RT-qPCR in the context of infection 
modeling experiments (Molbak, et al., 2008; Ladinig, et al., 2009, Boutrup, et al., 2010b; Jensen, 
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et al., 2010, Richter, et al., 2010).  Particularly 2 studies compared ISH and FISH diagnostic 
specificity and sensitivity to other techniques.  The first one, showed a lower sensitivity, but a 
higher specificity than PCR analysis on feces, because of a high possibility of false-positives.  
However, when compared to IHC for routine diagnosis, 66% sensitivity and 99% specificity and 
54%, sensitivity and 100% specificity were found, for IHC and ISH respectively (Ladinig, et al., 
2009). The second study was a comparison between FISH and IFA, which yielded 91% 
sensitivity for FISH, and 100% for IFA, although both methods had 100% specificity.  
Furthermore, IFA was much less susceptible than FISH to the effects of autolysis and 
cryopreservation (Jensen, et al., 2010). 
 
“Pincipiis obsta; sero medicina paratur , cum mala per longas convaluere moras. 
Stop it at the start, it’s late for medicine to be prepared when the disease has grown strong through long 
delays.”                                                                                                                   Ovid 
2.3. Current therapeutic approaches and EPE management in horses 
 
In the first cases ascribed to L. intracellularis, either non-specified or no AM treatment 
was implemented (Duhamel & Wheeldon, 1982, Williams, et al., 1996, Frank, et al., 1998).  
Foals either received supportive intravenous fluid-therapy and nonsteroidal anti-inflammatory 
treatment (Duhamel & Wheeldon, 1982), or corticosteroids (Frank, et al., 1998).  In all cases, the 
foals died shortly after institution of therapy.  Although corticosteroids initially improved fecal 
consistency and the apparent clinical condition of the foal, therapy-induced immunosuppression 
obviously inhibited long-term recovery. It was thus confirmed that administration of 
dexamethasone prior, or concurrently, to inoculation with L. intracellularis increased infectivity, 
or complicated recovery with secondary infections, as detected through experimental 
investigation in pigs (Holyoake, et al., 1994; Frank, et al., 1998) and hamsters (e.g., C. difficile 
overgrowth) (Drs. Vannucci and Gebhart, University of Minnesota, personal communications).  
Interestingly, in a recent study where EPE presentations were investigated in a foal model, the 
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authors did not demonstrate any worsening effect, after injectable dexamethasone was used to 
mimic stress (Page, et al., 2011c). 
Recently, 3 distinct forms of EPE have been described in foals and yearlings on the basis 
of the symptomatology and pathological lesions: classic, acute and subclinical, although, 
previously, only 1 clinical presentation was recognized (Page, et al., 2011c).  This is similar to 
the distinction in 4 clinical PPE presentations: 1) porcine intestinal adenomatosis (PIA); 2) 
necrotic enteritis; 3) regional ileitis and 4) proliferative hemorrhagic enteropathy (or PHE).  
Other authors divide PPE into 2 major clinical presentations: acute hemorrhagic diarrhea and 
death in young adult pigs; or chronic diarrhea and reduced growth performance in growing pigs 
(Lawson & Rowland, 1974; Rowland, 1975; Lawson, et al., 1979; Lawson & McOrist, 1993; 
Cooper & Gebhart, 1998; Lawson & Gebhart, 2000).  Over the years, the various manifestations 
of PPE in pigs have controversially been considered self-limiting at herd level, but in regards to 
EPE, where the single animal is the focus of production, the current perception is that AM 
administration should be recommended, and provided early in the course of disease (Cooper & 
Gebhart, 1998; Lavoie, et al., 2000).  Nonetheless, the economic impact of EPE is not only 
related to the clinical infection, but also due to costs of the prolonged recovery.  Horses surviving 
EPE have lower ability to absorb nutrients and poorer growth rates, when compared to breed 
averages, for several months after clinical disease (Frazer, 2008; Lavoie & Drolet, 2009; Merlo, 
et al., 2009, Wong, et al., 2009).  An example of the economic impact of L. intracellularis 
infection is clearly depicted in an age-matched comparison, where prolonged convalescence and 
unthrifty appearance, due to EPE, translated into lower sale prices (68%) for Thoroughbred 
yearlings in Kentucky (Frazer, 2008).   
Regardless of the drug, AM therapy for EPE usually lasts several weeks and is often 
accompanied by intense, and sometimes lengthy, hospitalization and care. Starting with Lavoie’s 
report of the first outbreak (2000), hospitalized foals were administered oral cimetidine or 
sucralfate, intravenous plasma transfusion or colloid solution infusions, along with parenteral 
nutrition and balanced polyionic solution therapy (Lavoie, et al., 2000). Moreover, close 
monitoring, through repeated blood work and diagnostic tests, was used to assess the response to 
therapy.  In some cases, diet was also enriched with vegetable oil and multivitamin supplements 
(Lavoie, et al., 2000; Sampieri, et al., 2006; Frazer, 2008).   
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When treatment was directed to EPE and other concurrent enteric infections (e.g., 
salmonellosis), and clinical disease was more severe, treatment was more challenging, with 
further prolonged hospitalization and recovery, poorer prognosis and higher expenses at 
discharge (Frazer, 2008).  Occasionally, changes in AM therapy are required, to successfully 
complete EPE treatment, suggesting that L. intracellularis may become more susceptible to 
certain drugs or may develop AM resistance, although neither is clearly demonstrated (Sampieri, 
et al., 2006; Frazer, 2008). 
 
2.3.1. Current antimicrobial therapy in EPE affected foals. 
 
On the basis of the results presented by the only in vitro work available at the time, the 
advantage of the intracellular “sanctuary-like” location of L. intracellularis (McOrist et al., 
1995a; McOrist, et al., 1995c) appeared successfully overcome by the treatment with 
erythromycin during the first EPE outbreak, so that the drug became immediately the treatment 
of choice (Lavoie, et al., 2000).  In that report, it was clinically demonstrated that oral 
erythromycin estolate (15–25 mg/kg BW q. 6–8 h), alone or in combination with oral rifampin 
(7–10 mg/kg BW, q. 12 h), rapidly improved foals’ clinical condition (i.e., attitude, weight gain, 
reduction in colic signs or diarrhea) (Lavoie, et al., 2000).  Despite the appropriate AM therapy, 
complete recovery and normalization of plasma protein levels was later proven to take months 
(Wong, et al., 2009). In Lavoie’s report, only 2 foals were switched to chloramphenicol (50 
mg/kg BW q. 6 h), due to the recurrence of diarrhea and the desire to avoid C. difficile 
overgrowth, underlining the possible limitations to a successful erythromycin therapy, as already 
feared in treatment of R. equi (Baverud, et al., 1998, Lavoie, et al., 2000).   
Nonetheless, in another case report, a filly underwent colic surgery because of 
unrelenting pain.  Neither the perioperative parenteral procaine penicillin G (22000 IU/kg BW 
IM, q12 h) and gentamicin sulfate (5 mg/kg BW, IV q. 24 h) treatment, or the 5 days of 
postoperative oral trimethoprim-sulfametoxazole (15 mg/kg BW q. 12 h) resolved her abdominal 
discomfort.  Following the histopathology diagnosis of L. intracellularis infection, AM treatment 
was successfully changed to oral erythromycin stearate (25 mg/kg BW, q. 6 h) and continued for 
6 weeks leading to rapid improvement and full recovery in 2 months (Schumacher, et al., 2000).  
Due to its almost infallible success, the AM combination of erythromycin (estolate or stearate) 
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and rifampin was considered the only resolutive treatment, even though expensive, for EPE for 
several years (Bihr, 2003; McClintock & Collins, 2004; Dauvillier, et al., 2006; Feary & Hassel, 
2006).   
A clinical case review by Sampieri and colleagues (2006) demonstrated the efficacy of 
intravenous oxytetracycline (6.6 mg/kg BW q. 12 h) during the hospitalization phase of 
treatment, followed by oral doxycycline (10 mg/kg BW q. 12 h) during the convalescence phase 
at home (Sampieri, et al., 2006).  Such a combination was chosen on the basis of publications 
regarding in vitro studies and the success obtained with tetracycline compounds in pigs, both in 
USA and Europe (Collins, et al., 1999; Kyriakis, et al., 2002).  To date, macrolides, rifampin and 
tetracycline are the most frequently used antimicrobial classes in weanling or yearling horses 
affected by EPE, although newer macrolides (oral clarithromycin, 7.5 mg/kg BW q. 12 h) or 
azalides (oral azithromycin,10 mg/kg BW q. 24 h) often in association with rifampin (5 mg/kg 
BW per os q. 12 h) also have been documented (Feary, et al., 2007; Frazer, 2008; Lavoie & 
Drolet, 2009; van den Wollenberg, et al., 2011).  
Recently, the veterinary community has expressed increasing concern that L. 
intracellularis infection seems to have extended its morbidity spectrum to adult horses, which 
are otherwise debilitated, or concurrently affected by other enteric pathogens (e.g., Salmonella 
spp., R. equi) or ailments (e.g., digestive tract lymphoma) (Dr. C. Gebhart, personal 
communication).  A case of EPE in a 26-month-old Thoroughbred colt in Japan, showed that the 
combination of R. equi and L. intracellularis was indeed fatal (Shimizu, et al., 2010).  In such 
cases, attending veterinarians resort, sometimes fruitlessly, to AMs such as fluoroquinolones, 
metronidazole (combined with tetracycline, in 16/46 cases, at an oral dose of 10 – 15 mg/kg BW 
q. 8 -12 h) and chloramphenicol (44 mg/kg per os q. 6-8 h).  This has been reported in affected 
foals in Kentucky, between 2005 and 2007 (Frazer, 2008).  Such reports leave room for debate, 
regarding L. intracellularis treatment, as to whether bacteria are developing AM resistance or 
have varying susceptibility.   
 
2.3.2. Experimental background to the clinical therapy 
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As the bacteria eluded every attempt at growing on agar plates (Roberts, et al., 1977; 
Lawson, et al., 1993; McOrist, et al., 1993), AM susceptibility investigations based on Kirby-
Bauer method were not applicable, thus initially, PPE treatment was empirical and variably 
successful (Greenwood, 1981, McOrist, et al., 1995c).  Also, limited information was available, 
in general, for intracellular treatment of pathogens (e.g., Chlamydia pneumoniae, Rickettsia spp., 
Bartonella spp. and Anaplasma phagocytophylum), until Minimum Inhibitory Concentrations 
(MIC) studies were established through complicated cell-culture systems (Gnarpe, et al., 1996; 
Ives, et al., 2000; Horowitz, et al., 2001).   
In the 1980s, when L. intracellularis taxonomy was still unclear, 2 studies showed the 
effectiveness of tetracycline (and its derivatives) against PPE, one being a controlled field trial in 
affected pigs, and the other a comparison between tetracycline hydrochloride, neomycin and 
dimetridazole in a hamster infection model (La Regina, et al., 1980). Both trials showed that 
tetracycline was effective at inhibiting L. intracellularis (La Regina, et al., 1980), and over the 
years, the efficacy of tetracycline against several intracellular bacteria was demonstrated, 
although obligate intracellular bacteria should be considered as a separate group altogether 
(Moulder, 1985). 
Several years later (1995), an in vitro study successfully tested more AMs against porcine 
L. intracellularis, applying the MIC method to cell cultures (McOrist, et al., 1995c).  In the 
1990s, not only the bacterium’s taxonomy was clarified, but also cell-culture methodologies 
were consistently standardized; moreover the bacteria produced in vitro were proven to be 
virulent for live hosts (pigs) (Lawson, et al., 1993; McOrist, et al., 1993; McOrist, et al., 1994a; 
Lawson, et al. 1995; McOrist, et al., 1995a; McOrist, et al., 1995c).  Thus, because of the 
difficulties encountered in understanding L. intracellularis, clearly McOrist’s in vitro work 
(1995) became a stepping stone in understanding unexpected treatment failures, or successes, in 
PPE cases in the field (McOrist, et al., 1995c).  
In order to determine appropriate concentrations for extracellular and intracellular AM 
activity, L. intracellularis cultures were incubated for 5 days, either in the presence or absence of 
various AMs’ concentrations, in order to afford unequivocal detection of inhibition of bacterial 
growth.  Each AM’s MIC was defined as the lowest concentration consistently inhibiting growth 
(equal to 0.1% of the growth of controls) and considered evidence of bacteriostatic activity only, 
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as Minimum Bactericidal Concentration (MBC) would have required testing in vivo (McOrist, et 
al., 1995c).  Penicillin, erythromycin, chlortetracycline, along with difloxacin and virginiamycin, 
were the most active AMs against L. intracellularis with a MICs ≤1 g/ml; tilmicosin and 
tiamulin had a MICs ≤ 4 g/ml; lincomycin and tylosin had a MIC ≥ 32 or 64 g/ml; and 
bacitracin-zinc, avoparcin, and all aminoglycoside, or aminocyclitol, had MIC >128 g/ml 
(McOrist, et al., 1995c).  Importantly, it was recognized that in vivo responses could have 
differed, due to specific drugs’ pharmacokinetics and pharmacodynamics. A candidate drug 
requires for efficacy the ability of killing/inhibiting a Gram-negative intracellular bacterium 
located in the lower bowel, where the oxygen concentration is very low, yet constitutes a thriving 
condition for L. intracellularis (Lawson, et al., 1993; Wattanaphansak, et al., 2009a).  Truthfully 
some drugs are simply unable to penetrate into enteric cells, or they only target inadequate 
cellular locations (Easmon & Crane, 1984).   
In regards to clinical EPE therapeutic approach, no novel information has been reported 
since 2008, when suspected resistant cases, also called “slow burners”, were treated with a 
plethora of AM (from metronidazole to chloramphenicol), in addition to the macrolides and 
rifampin combination, or the tetracycline class (Frazer, 2008).  Also these same drugs have 
proven useless in a fulminant form of EPE recently reported (Page, et al., 2012).  Thus, in the 
quest for an alternative solution, in vitro experiments are explored, although they are few and yet 
not specific for EPE.  
Two conceptually similar studies showed MIC investigations on multiple porcine L. 
intracellularis isolates, obtained from North American, European and Asian strains 
(Wattanaphansak, et al., 2009a; Yeh, et al., 2011).   The Asian study is the first publication on 
AM susceptibility of Asian isolates, wherein the MIC of 16 AM drugs were assessed for 2 
isolates recovered in South Korea: one from a finisher pig affected by PHE; the other from a 
grower pig affected by porcine intestinal adenomatosis (PIA).  Tylosin and tilmicosin were the 
most active AMs both intracellularly (MIC, 0.25 -0.5 g/ml and 0.125 g/ml, respectively); and 
extracellularly (MIC, 0.25 -0.5 g/ml and 1 g/ml), depending on the type of isolate (Yeh, et al., 
2011).   
However, the study conducted in North America, to date, is the most complete in vitro 
evaluation of AM susceptibility for L. intracellularis (Wattanaphansak, et al., 2009a).  Carbadox, 
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chlortetracycline hydrochloride, lincomycin hydrochloride, tylosin tartrate, tiamulin hydrogen 
fumarate and valnemulin hydrochloride were tested against 10 PPE L. intracellularis field 
isolates, collected between 1983 and 2006 in North America (6 strains), United Kingdom (3) and 
Denmark (1).  All strains were grown in murine fibroblast-like McCoy cells, new/clinical (or low 
passage) and well-established (or high passage) isolates alike, as intracellular bacteria cultured 
for extended time become “immortalized”, hence able to survive indefinitely, but potentially 
unable to react “normally” to AMs, due to the genomic mutations developed overtime 
(Drancourt & Raoult, 1993; Wattanaphansak, et al., 2009a).  Again, MIC was expressed for both 
intracellular and extracellular AM activities.  For the intracellular MIC assessment, a bacterial 
suspension was inoculated onto one-day-old McCoy cells 24 h prior to AM exposure, providing 
L. intracellularis a sufficient time-frame to invade the host-cells, and then maintained for 3 days, 
in optimal culture conditions (McOrist, et al., 1995; Guedes & Gebhart, 2003a; Wattanaphansak, 
et al., 2009a).  The extracellular MIC assessment was designed to mimic the AM effects on L. 
intracellularis, when bacteria are free in the gut lumen, before infecting the intestinal cells.  
Therefore the incubation with AM solutions was conducted on cell-cultures, at body temperature 
(37.8 C), in optimal PPE growth conditions (8.0% O2, 8.8% CO2, and 83.2% N2 atmosphere), 
only for 24 h.  After that, the bacterial suspension was transferred to infect one-day-old McCoy 
cells, but the medium was replaced with a new, blank, culture medium, to underline in this case 
that AM exposure occurs only in the gut lumen, but not within the cells (McOrist, et al., 1995c; 
Wattanaphansak, et al., 2009a).  Results showed that in vitro carbadox, tiamulin and valnemulin 
are most active, chlortetracycline and tylosin are intermediately active, and lincomycin is the 
least active, although different L. intracellularis isolates express a variety of AM sensitivity 
patterns. Specifically, North American isolates showed higher AMs MIC (intra- and 
extracellular), than the European ones.  Obviously additional PPE and EPE isolates should be 
tested before making any speculations about geographic differences and AM sensitivities 
changing over time, but those results could serve as a guideline for the range of AM responses.  
Clinically, in fact, it would be unlikely to isolate and test an L. intracellularis strain during an 
ongoing PE outbreak, regardless of the species affected (Wattanaphansak, et al., 2009a).   
Again the pharmacodynamic and pharmacokinetic limitations of an in vitro study were 
underlined, but until 2009, no AMs’ MIC breakpoints for intracellular organisms in cell-culture 
were available, thus the understanding of the full implications of those results has been 
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complicated (Wattanaphansak, et al., 2009a). Although in vitro sensitivity is helpful, the 
limitations of its different set-up need to be considered in comparison to an in vivo (or a field) 
study, before proclaiming a verdict of efficacy.  In an in vitro study, researchers have the ability 
of focusing on one question at the time, such as whether the AM concentration at the infection 
site is the determining factor for strain susceptibility, without concerns of other in vivo variables, 
even though it is currently unknown whether AMs would target differently extracellular or 
intracellular L. intracellularis (Wattanaphansak, et al., 2009a).  For example, it could be 
arguable that intracellular carbadox might be appropriate for all isolates, as no difference was 
detected in activity levels at its lower concentrations; or that chlortetracycline’s intracellular 
MICs large range indicates that some L. intracellularis isolates may be less susceptible, or that 
therapeutic difficulties, or even failures, should be easily expected.  Interestingly, the novel 
approach at evaluating AMs’ MICs showed that for all drugs extracellular MICs were higher 
than the correspondent intracellular ones, as the study accounted for the shorter contact time 
allowed for extracellular bacteria (1 day versus 3 days).  Such a conceptual difference may be 
difficult to quantify in vivo, beyond the reaching of a steady state condition in the cell-culture 
system (Wattanaphansak, et al., 2009a).  However, the main conclusion was that on the basis of 
the extracellular AM exposure, a single extracellular treatment (equal to a single-dose treatment) 
could be insufficient to inhibit bacterial growth long enough to resolve the infection. Also the 
lower intracellular MICs could be due to AM accumulation within the cells, thus enhancing the 
chemotherapeutic activity, showing that most AMs tested can bind to internalized L. 
intracellularis sufficiently to exert their action (Wattanaphansak, et al., 2009a). 
 
2.3.3. Current use of immunization 
 
EPE’s epidemiology is not yet completely clarified and no specific measures have been 
established for preventing the disease in horses.  In pigs, the current prevention strategy is 
achieved mostly using AMs in feed (prophylactic chemotherapy) and a commercially available 
L. intracellularis modified-live vaccine (prophylactic immunization).  In horses, single case 
treatments and metaphylactic chemotherapy (clinical treatment) usually lead to a cure, but is 
occasionally unsuccessful (Lavoie, et al., 2000; Sampieri, et al., 2006; Frazer, 2008; Pusterla & 
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Gebhart, 2009; Page, et al., 2012).  However, if the example to follow is PPE, whose exposure 
incidence is purported to be 97% worldwide, the many difficulties in controlling its effects and 
sequelae, through therapy and vaccinal prophylaxis, point to a need for early immunization 
(Lawson & Gebhart, 2000; Kroll, et al., 2004; Almond & Bilkei, 2006; McOrist & Smits, 2007).  
Initial investigations of the impact of L. intracellularis vaccination in weanling foals have 
shown detectable antibody titers, following oral or rectal administration of the modified-live L. 
intracellularis vaccine commercially available for pigs, Enterisol Ileitis (Boehringer Ingelheim 
Vetmedica, Inc., St. Joseph, USA) (Guedes, et al., 2002c; Pusterla, et al., 2009b).  The vaccine 
was a frozen avirulent live L. intracellularis, administered twice intra-rectally, as 50 mL vaccine, 
regardless of age and weight.  Later, this formulation was compared in foals to a lyophilized 
avirulent live vaccine, leading to comparable findings of safety, onset and duration of fecal 
shedding and serological response (IgG), even with a smaller (30 mL) dosing volume (Pusterla, 
et al., 2009b; Pusterla, et al., 2009c; Pusterla, et al., 2010b) 
In the first experimental evaluation of the vaccine, 3 groups of naïve foals, aged 4-6 
months, underwent 2 administrations, 3 weeks apart: 1) oral immunization, following 
omeprazole pre-medication; 2) intra-rectal immunization; and 3) oral immunization, without 
omeprazole pre-medication. No foal had detectable adverse effects due to the vaccine, regardless 
of the route of administration. In foals vaccinated intra-gastrically with omeprazole pre-
medication, no L. intracellularis’ DNA was detected at any point in the entire study. PCR 
analysis of serial rectal swabs demonstrated fecal shedding, starting at 11–15 days following the 
first intra-rectal vaccine administration.  It lasted for 1–12 days thereafter, whereas in foals 
vaccinated intra-gastrically, without omeprazole pre-medication, L. intracellularis’ DNA was 
detected only for the first 2 days following the first vaccination (Pusterla, et al., 2009b; Pusterla, 
et al., 2009c).  All the foals vaccinated intra-rectally seroconverted after the first vaccine, 
whereas the intra-gastrically vaccinated foals demonstrated seroconversion only after 
omeprazole pre-medication, with an earlier, and stronger, detectable humoral response.  The non-
pre-medicated foals never seroconverted (Pusterla, et al., 2009b).   
Subsequently, a study investigating the humoral response and the duration of fecal 
shedding was conducted in a group of EPE-naïve, healthy, pregnant broodmares, to determine 
whether specific maternal anti-L. intracellularis antibodies could be passively transferred to foals 
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through the colostrum (Pusterla, et al., 2009c).  Mares were divided in 2 groups, a vaccinated 
group (8 mares), and sentinel group (4).  The first group was  immunized intra-rectally, 3 to 5 
weeks ahead of the expected due date, with the protocol previously used in foals, as it produced 
the strongest seroconversion response, whereas sentinel mares were just “housed” together with 
vaccinated mares (Pusterla, et al., 2009b).  All mares were monitored for the 12 weeks following 
vaccination. After foaling, dam’s colostrum and foal’s serum were collected before and after 
nursing, to determine antibody titres in foals, and thereafter their titers increments were 
monitored for 8 weeks (Pusterla, et al., 2009c).  Vaccination against L. intracellularis in mares 
was safe, and fecal shedding was documented in only 3 vaccinated mares, with a pattern similar 
to the first study, but a lower magnitude and shorter duration (2 – 3 days) (Pusterla, et al., 2009b; 
Pusterla, et al., 2009c).  Fecal dilution may explain the lower detection rates in brood mares 
(adult horses produce a larger volume of fecal material relative to foals), but fecal shedding of L. 
intracellularis DNA, within a couple of weeks from vaccination, suggests active mucosal 
replication of the organism. 
Sentinel mares never seroconverted, whereas vaccinated mares seroconverted 2 to 4 
weeks after immunization, with the highest titres between 1:120 to 1:240 and L. intracellularis 
antibodies detectable for 6 to 10 weeks (Pusterla, et al., 2009c).  However, colostral antibodies 
(with titres of 1:240) were detected only in 25% of the seropositive mares that seroconverted 
before parturition.  Another 25% of mares had no detectable serum antibodies before parturition 
(1 mare seroconverted post-foaling; 1 mare, on the day of foaling).  The remaining 50% did not 
have measurable colostral antibodies, despite seroconversion occurring between 4 and 17 days 
before foaling (Pusterla, et al., 2009c).   
All foals’ transfer of passive colostral antibodies was adequate (IgG ≥800 mg/dl).  
Passive transfer of immunity against L intracellularis was documented in 6 foals (titres between 
1:60 and 1:120), and were detectable for 1.5 to 8 weeks.  The reasons for the lack of detectable 
antibodies in the dam’s serum, and the lack of transferred antibodies in foals, were not clear.  
Potentially, broodmares with undetectable serum antibodies may have colostral antibodies below 
the assay’s limits of detection, as a foal born from a sero-negative mare had measurable L. 
intracellularis antibodies for 8 weeks after birth.   
In 1 case, it is arguable that the mare had not the chance of mounting a proper peripheral 
immune response, as the foaling occurred less than 2 weeks after vaccination, but in the other, 
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the foal was born from a mare with high serum and colostrum titres.  Thus, it was hypothesized 
that, despite an adequate transfer of passive immunity for all foals, individual variability in 
ingestion, or absorption (or both) of specific colostral antibodies played a role.  In other words, 
although IgG transfer was normal, L. intracellularis specific IgG may have not been significant, 
and protection against EPE could have been conferred by mucosal IgA, together with the cell-
mediated immune response, which apparently can be associated with satisfactory protection 
against L. intracellularis infection (Metzger, et al., 2006; Pusterla, et al., 2009c). 
The results of the EPE immunization studies are in agreement with a body of work 
determining the immune response in pigs challenged with an attenuated L. intracellularis 
vaccine strain. A cautioning opinion was expressed in a few studies versus considering, or 
expecting, the anti-L. intracellularis-IgG in serum to be protective against a disease located 
within the intestinal wall. Mucosal IgA levels and cell-mediated immune responses could have a 
more probable role in protection against infection (Guedes, et al., 2002a).  The larger role of IgA 
against PE is ascribed to the ability of IgA to survive digestion more effectively, and to its larger 
concentration on a mucosal surface.  This concept has been supported for years, although a 
complete demonstration still has to be determined (Holyoake, et al., 1994; Pusterla, et al., 2010c; 
Page, et al., 2011c).  
One study demonstrated improved growing and finishing performance in addition to a 
strong humoral response in vaccinated piglets (Almond & Bilkei, 2006) and another study 
conducted on sows naturally exposed to L. intracellularis, documented that gilts developed a 
high serum immune response, for up to 3 months after the original exposure, thus corroborating 
the potential usefulness of mares’ vaccination (Guedes, et al., 2002d; Guedes & Gebhart, 2003a; 
Pusterla, et al., 2009b), although in piglets, the transfer of maternally derived antibodies against 
L. intracellularis had low titres that lasted for only 3 weeks. (Holyoake, et al., 1994; Guedes, et 
al., 2002d) 
Vaccine protection against L. intracellularis in foals definitely warrants more research, to 
both determine the presence of different classes of colostral antibodies (IgG and IgA) for L. 
intracellularis in seropositive mares; and to correlate those findings with immunity in foals.  To 
conclude, it is interesting that the sentinel mares did not show a humoral response.  In adult 
horses it could be due to the absence of exposure, as vaccinated herd-mates did not constitute a 
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risk of contamination for the environment, differently than foals, due to their longer fecal 
shedding and different behaviour (e.g., some degree of coprophagy is typical of young foals).  
Also, the controlled environment of an experimental setting differs from the normal foal rearing 
conditions, in a pasture.  In fact, not only were the vaccinated mares “shedders”, and allowed to 
commingle with the sentinel mares, but also all the other sources of contamination were kept 
under control, such as exposure to other animals and wildlife and uncontrolled and potentially 
contaminated feed (Pusterla, et al., 2008b; Pusterla, et al., 2009b). 
 
“A  desperate disease requires a dangerous remedy”  
                                                 G. Fawkes 
2.4. Pharmacokinetics and pharmacodynamics of AM drugs potentially useful 
against EPE 
 
Today, with the enhanced knowledge of L. intracellularis biology and the new 
methodologies available for research, it is simpler to understand successes, or failures, of past 
treatments for PPE or EPE infections. Coupling that understanding to the knowledge of 
pharmacokinetic and pharmacodynamic principles at the cellular level of the major AM classes 
against obligate (and facultative) intracellular bacteria, allows a more rational discussion and 
selection of the therapeutic choices available (Carryn, et al., 2003).  
2.4.1. Pharmacokinetic considerations 
 
The pharmacokinetic characteristics exhibited by an AM drug once administered to the 
affected pig, rodent or foal need to be considered to assess the appropriate therapy regimens, as 
each AM standard dose could only provide a cautious estimate of the likelihood of achieving a 
useful MIC in vivo (McOrist, et al., 1995c).  Interestingly, erythromycin, tetracycline, and 
penicillin, AM drugs of choice to treat cell-dependent micro-aerobic organisms, are the same 
drugs that were successful against L. intracellularis in the 1995 in vitro study.  Their adequacy to 
treat pathogens such as Treponema pallidum, Rickettsia spp. and Chlamydia spp., for example, 
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was confirmed by in vitro cell-culture systems, and their clinical application in human medicine, 
although initially challenging, has been standardized for several years now (Norris & 
Edmondson, 1988; Hammerschlag, 1994).  For L. intracellularis, instead, the current successful 
treatments have been achieved mostly through clinical experience and very limited in vitro 
investigation.  Thus exploring potential alternative AM therapy for this bacterium, may require 
some evaluation of past studies, along with new compounds.  In the attempt to summarize the 
relevant literature regarding AM pharmacokinetics at the cellular level, the -lactam class will be 
the first one described, as it is the more commonly used AMs in equine medicine (F. Sampieri et 
al., unpublished data).   
2.4.1.1. -lactams.  
Beta-lactams are unable to accumulate intracellularly, in phagocytic or non-phagocytic 
cells alike, and, at equilibrium, intracellular concentrations are much lower than extracellular 
levels (Prokesch & Hand, 1982; Nix, et al., 1991; Carryn, et al., 2002).  All -lactams display a 
free carboxylic functional group (or an equivalent proton donor-group), essential to exert their 
activity.  A low intracellular concentration was ascribed to their inability to cross cell membranes 
and penetrate within cells, but that is probably an incorrect perception as, through modeling 
studies of trans-membrane distribution, most -lactam drugs cross biologic membranes 
reasonably well (Tipper & Strominger, 1965; Carryn, et al., 2002).  Moreover, cephalosporins 
and penicillins are known today to be substrates of the transporter OCTN2, the same transporter 
of carnitine and acylcarnitine, 2 zwitterions that require a Na
+
-dependent transport within cells 
for function.  This mechanism may facilitate the -lactams transport within cells of the tubular 
system in kidneys and in enterocytes, pointing to the fact that several mechanisms of intracellular 
absorption may be related, and conditioned, not only by the genetics of the patient, but also by 
the presence of specific co-substrates (Ganapathy, et al., 2000).   
The -lactams are weak organic acids: because the intracellular milieu is slightly more 
acidic than the extracellular one, -lactam accumulation within cells, according to some authors, 
is prevented by an issue of pH balance, rather than their ability to cross cell membranes (Renard, 
et al., 1987), and masking the free carboxylic group with a basic moiety, would be all it takes to 
allow intracellular accumulation (Renard, et al., 1987).  Such a theory could be a possibility in 
macrophages (i.e., they have a lower pH), although it may be different in relation to different 
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cells. The newer generation cephalosporins and zwitterionic -lactams (e.g., ampicillin) are 
unable to accumulate within cells for the same reasons.  Furthermore, the presence of antibiotic 
efflux pumps, able to actively extrude -lactams from the cells, may explain the low intracellular 
concentration of -lactams (Van Bambeke, et al., 2003).   
2.4.1.2. Aminoglycosides.  
Aminoglycosides are thought to localize within membrane-bound portions of exposed 
cells and, normally, are inactive against obligate anaerobic bacteria, due to their need for aerobic 
transport of the AM into bacterial membranes.  Probably the best example of such a limitation is 
the variable success of clinical therapy with aminoglycosides for intracellular Listeria 
monocytogenes, despite it being active against the bacterium in vitro (Mates, et al., 1983; 
Tulkens, 1991; Carryn, et al., 2002).  Prolonged incubation (i.e., days) of macrophages and 
fibroblasts with aminoglycoside solutions have shown that such cells can achieve a ratio between 
intracellular to extracellular concentrations equal to 2:4 (Tulkens & Trouet, 1978), leaving the 
question open about whether or not such a ratio is sufficient to kill intracellular bacteria.  Also, 
aminoglycosides are found almost exclusively in the lysosomes, explaining their slow rate of 
accumulation and why it is incorrect to believe that they lack ability to penetrate within cells 
(Tulkens & Trouet, 1978; Ford, et al., 1994).   
2.4.1.3. Macrolides.  
Typically macrolides accumulate within all types of cells, with a few exceptions (Carryn, 
et al., 2002; Carryn, et al., 2003). As weak organic bases, these compounds accumulate within 
intracellular acidic environments (2/3 in lysosomes and phagosomes, and 1/3 in cytosol) at the 
site of infection, mainly due to their pH drive, with chemical structure differences between 
derivatives, being lower for erythromycin and much higher for those macrolides that carry more 
than 1 basic function.  Both the uptake and efflux of macrolides are usually rapid, with the 
exception of azithromycin, as its binding to cellular structures (e.g., phospholipids) may play a 
critical role (Van Bambeke, et al., 1998; Montenez, et al., 1999).  Studies on clarithromycin 
uptake by fibroblasts showed that intracellular steady state is reached within 15 minutes (Chou & 
Walters, 2008).  This said, once the pH drive is satisfied accumulation stops and macrolide drugs 
distribute from cytosol to lysosomes (more neutral pH) (Mandell & Coleman, 2001; Carryn, et 
al., 2002; Perletti, et al., 2011).  Recent studies (one of which in foals) showed the ability of 
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clarithromycin, azithromycin and gamithromycin to accumulate with ranges of over 10 to 100-
fold higher in the intracellular space of neutrophils and pulmonary macrophages, compared to 
the epithelial lining fluid and to plasma, respectively (Togami, et al., 2011, Berghaus, et al., 
2012).  Also, a study on erythromycin and its metabolites showed that intracellular accumulation 
to inhibitory and sub-inhibitory levels is much higher than plasma concentration (up to 40-fold) 
and tissue distribution and equilibration is delayed, likely due to cell uptake and accumulation 
processes (Krasniqi, et al., 2012).  Drug transporters linked to Ca
2+ 
or Ca
2+
-channel-operated 
mechanisms may be involved in macrolide uptake, although it appears limited to certain cell 
types.  Also an efflux transporter, modulating macrolide accumulation at equilibrium has been 
evidenced in rats’ macrophages, but it seems related only to erythromycin and azithromycin 
(Carryn, et al., 2003).   
2.4.1.4. Fluoroquinolones.   
Fluoroquinolones are known to rapidly accumulate in the cytosol up to 4- to 10-fold 
higher than the extracellular concentration (Carryn, et al., 2002).  In veterinary research, 
enrofloxacin improved the potency of pulmonary neutrophils against a battery of porcine 
pulmonary pathogens.  As well, enrofloxacin and marbofloxacin accumulated easily in canine 
neutrophils and in alveolar macrophages, respectively, suggesting that these AM’s may have 
improved treatment outcomes in cases of canine systemic inflammation and lung infection 
(Schoevers, et al., 1999; Boothe, et al., 2005; Boothe, et al., 2009). Although the mechanisms for 
such accumulation are not completely defined, a specific transport pathway (phorbol myristate 
acetate activated transporter) may be involved and uptake may require activation of protein 
kinase C and even simple diffusion processes (Cao, et al., 1993; Walters, et al., 1999; Hotta, et 
al., 2002).   
Cell maturation was believed to play a role in fluoroquinolone uptake by human 
monocytes and macrophages, but a French study demonstrated that cell activation due to 
inflammation, rather than maturation, was responsible (Dorian, et al., 2001).  Cell-associated 
fluoroquinolones have been consistently detected in the final supernatant of cell fractionation 
studies. Such findings suggest a rapid efflux of fluoroquinolones from a sub-cellular 
compartment, or that fluoroquinolones, which generally localize in the cytosol, easily diffuse to 
various sub-cellular components (Carlier, et al., 1990; Seral, et al., 2003a).  
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2.4.1.5. Tetracycline.   
The pharmacokinetics of tetracylines at the cellular level is still largely uncharacterized, 
aside from an indirect, or partial, evidence of their ability to penetrate cell membranes and 
accumulate within cells (Najar, et al., 1984).  Initially it was believed that tetracycline penetrated 
cells, bacterial or otherwise, through a passive diffusion mechanism. However, recent studies 
with cell-associated fluorescence clarified that tetracycline, and its derivatives, enter cells rapidly 
using a Na
+
-dependent active transport mechanism, with further regulation of intracellular levels 
by efflux pumps, such that intracellular drug concentrations exceed extracellular levels up to 40-
fold, particularly if the drug contains lipophilic moieties (Katiyar & Edlind, 1991; Schnappinger 
& Hillen, 1996; Brayton, et al., 2002; Walters, 2006).  Within neutrophils, tetracycline can be 
observed in the nucleus within 1 h of addition to the cell-culture medium, and the intracellular 
concentration appears unaffected by 2 pH unit variation and by cell activation with phorbol 
mirystate acetate (Kirkwood, et al., 2004; Walters, 2006).  The rate limiting step is transport 
across the plasma membrane, as equilibration within cytoplasm and liposomes is achieved in less 
than 1 h for tetracycline and their derivatives not displaying the carboxamide group (Sigler, et 
al., 2000).  Interestingly, reductions in extracellular levels trigger efflux pumps to extrude 
intracellular tetracycline (Walters, 2006).   
2.4.1.6. Other antimicrobials.  
In regard to other AM drugs pharmacokinetic activity at intracellular level, the 
information available is fairly limited. For lincosamides, lincomycin exhibits poor intracellular 
accumulation (thus explaining Wattanaphansak et al., 2009a’s in vitro findings), but clindamycin 
extensively accumulates within cells due to its basic nature (similar mechanism described for 
macrolides) and to the involvement of a nucleoside transporter (Hand & King-Thompson, 1982; 
Prokesch & Hand, 1982; Easmon & Crane, 1984).   
Among ansamycins, rifampin accumulates intracellularly, up to 2- to 10-fold according 
to the available literature, whereas other compounds of the same class may accumulate for up to 
60-80 fold (rifapentine).  Unfortunately, even for this class the accumulation mechanism is 
unknown (Johnson, et al., 1980; Hand, et al., 1984; Pascual, et al., 1987).   
For glycopeptides and polypetides (e.g., vancomycin and bacitracin), which are not 
active against Gram-negative bacteria, because of their actions against peptidoglycans, 
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intracellular kinetics studies have been limited too.  Vancomycin shows typically a slow and 
modest uptake in macrophages (up to only 8-folds in 24 h period) and, supposedly, accumulates 
within lysosomes, but those results are based on a study in vivo (Beauchamp, et al., 1992).  
Recent studies in regards of a novel lipoglycopeptide, confirmed in vitro a low accumulation of 
this class of AM drugs at the lysosomal level (Barcia-Macay, et al., 2008). 
2.4.2. Pharmacodynamic considerations 
 
From the standpoint of pharmacodynamic activity, clinical studies are particularly 
difficult yet extremely important, because they ultimately provide one overall global answer, to 
what is affected by the combination of complex extracellular and intracellular pharmacokinetic 
variables.  The equally large array of microbial and host-response variables and the simultaneous 
presence of infection, both in intracellular and extracellular foci, should be examined; 
furthermore, one must keep into account the dose, dosing interval and duration of therapy.  Such 
points are exemplified with studies on rifamycin activities, and, to a broader extent, about AM 
therapy against Mycobacteria (Burman, 1997; Burman, et al., 2001).  A recent comparison of 
several AM from different classes against intracellular S. aureus showed that dicloxacillin, 
cefuroxime, gentamicin, azithromycin, and rifampin (rifampicin), were tested in a new in vivo 
sepsis murine model, to distinguish between their extra- and intracellular effects. The 
intracellular effects of the AMs could be ranked as the mean change in the log(10) number of 
CFU/ml (Delta log(10) CFU/ml), between treated and untreated mice, after 4 h of treatment: the 
higher ranked CFU was dicloxacillin (with 3.70 Delta log(10) CFU/ml) and the lower was 
azithromycin (0.21 Delta log(10) CFU/ml), with cefuroxime, rifampin and gentamicin, 
respectively, in between (Sandberg, et al., 2009).  As stated above, factors such as size, number 
and frequency of doses; time of exposure and timing of treatment initiation, during testing of 
intracellular activity in vivo are determinants for therapeutic success, as intrinsically a poor 
correlation between the intracellular accumulation of AMs and the actual intracellular effect was 
detected (Sandberg, et al., 2009). 
These factors explain why it is difficult to delineate precisely the pharmacodynamic 
properties where the specific intracellular AM activity is concerned and why discussions on this 
purpose generally lead to conflicting opinions between researchers. Some prefer to rely on 
predictions made through intracellular pharmacokinetics of an AM and its MICs, where some 
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other researchers focus on the results of in vivo models (Cappelletty, 2007; Sandberg, et al., 
2009).  Moreover, a few studies aiming to compare in vitro and in vivo results of AM 
intracellular activity (particularly for active drugs such as fluoroquinolones and ansamycins) 
often are complicated by unexpected outcomes, further obfuscating an unclear clinical perception 
(Shandil, et al., 2007; Vallet, et al., 2011).  
Despite continuous improvement and standardization of better methodologies, the 
assessment of pharmacokinetic–pharmacodynamic properties in the context of intracellular 
infections (e.g., Myc. tuberculosis, Staph. aureus, Str. pneumonia, etc.) are greatly lacking when 
compared to studies and assessments about extracellularly localized diseases (Carryn, et al., 
2003).  Nevertheless, a generalized consensus about macrolides, fluoroquinolones, tetracyclines 
and ansamycins is their ability to exert their action against intracellular bacteria, as these drugs 
were used repeatedly and successfully to treat such infections, whether generated by obligate, or 
facultative intracellular bacteria. A key question is whether this activity is optimal or sub-
optimal, and whether cellular accumulation and sub-cellular disposition are related to the level of 
activity (Carryn, et al., 2003).   
However, there is agreement about -lactams and aminoglycosides showing poor 
intracellular activity, although once again, an attentive analysis of the studies reporting such 
results should be prompted. Often the exposure of the microorganism to the drug has only been 
for a short-term treatment (Carryn, et al., 2003).  Pharmacodynamically, the mechanism of action 
of such drugs differs by class. The aminoglycosides and fluoroquinolones are considered 
concentration-dependent at the intracellular level too, whereas -lactams, which exhibit time-
dependent and concentration-independent bactericidal activity on an extracellular level, should 
be considered equally active intracellularly, in a time-dependent fashion (Craig & Ebert, 1992; 
Carryn, et al., 2002).  Thus, the main pharmacodynamic tenets for those classes of AM still hold 
valid, although it is puzzling to find certain paradoxes, or contradictions, reported in the 
literature, regarding treatment successes or failures, particularly in regards of human infections 
with Staphylococcus aureus, Chlamydia spp., Listeria monocytogenes and Legionella spp. The 
most interesting examples being listeriosis and penicillin and tuberculosis and gentamicin 
(Carryn, et al., 2003).   
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Possibly, certain episodes of fluoroquinolone failure could be ascribed to suboptimal 
action toward intracellular bacteria despite high intracellular concentrations, whereas the failure 
of macrolide therapy could be due to their bacteriostatic properties, rather than to inadequate 
intracellular accumulation (Craig & Ebert, 1992; Carryn, et al., 2002).  Furthermore, the time-
dependent -lactams showed that in vitro failures depended mainly on a short exposure times, 
rather than on inadequate drug potency, hence explaining why repeated, and frequent, treatments 
reported clinical cure in diseases considered “off limits” for the “good old-fashioned” penicillin 
G (Carryn, et al., 2003).  The multiple and frequent administrations allowed achievement of an 
intracellular critical concentration condition for effective therapeutic outcomes with these AMs 
(Michelet, et al., 1994; Michelet, et al., 1997; Kutlin, et al., 1999; Somani, et al., 2000; Paillard, 
et al., 2002; Seral, et al., 2003b).   
 In this context, the pharmacokinetic and pharmacodynamic characteristics and the results 
obtained in vitro by McOrist’s (1995), explains the lack of in vivo efficacy of the 
aminoglycosides, bacitracin or vancomycin, as the AM’s oxygen demand is far higher than the 
microaerophilic environment, wherein L. intracellularis thrives (Lawson, et al., 1993).  
Moreover, it should be considered that -lactams, aminoglycosides and lincomycin accumulate 
intracellularly, but with difficulty (Carryn, et al., 2002; Carryn, et al., 2003; Wattanaphansak, et 
al., 2009a).  In contrast, macrolides, tetracyclines, pleuromulins, and virginiamycin localize in 
the cytosol of exposed cells, wherein L. intracellularis resides, and act by selectively blocking 
protein synthesis in ribosomes, a process that is independent of oxygen concentration (Cocito, 
1979; Tulkens, 1991). Particularly, in regards to tetracycline’s mechanism of action, its 
definition is becoming more multifaceted. Tetracyclines are bacteriostatic and inhibit bacterial 
protein synthesis, which destroys bacterial membranes, but these compounds also inhibit matrix 
metallo-proteinases and cause apoptosis in a variety of cells, which renders these drugs 
potentially helpful in other therapeutic fields (e.g., cardiovascular therapy) (Schnappinger & 
Hillen, 1996; Sagar, et al., 2010; Castro, et al., 2011).    
 
2.4.3. An alternative antimicrobial prospect: gallium maltolate  
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Having reviewed the mechanism of action of the available drugs against Gram-negative 
bacteria, the therapeutic options explored empirically for L. intracellularis over the years appear 
appropriate.  However, lately EPE was unresponsive to treatment, or was suspected to have a 
variable susceptibility to AMs, in a few cases across North America (Sampieri, et al., 2006; 
Frazer, 2008; Page, et al., 2012).  In usual EPE cases the disease and its management costs are 
dreaded, as much as its financial impact on the industry, especially in the areas where the disease 
is endemic and the concentration of horses is high (Lavoie, et al., 2000; Frazer, 2008; Pusterla, et 
al., 2009a). Thus, in the context of this dissertation project, EPE was exposed to a completely 
different compound with an hypothesized AM activity: the novel gallium-based molecule, 
gallium maltolate (Bernstein, et al., 2000).   
2.4.3.1. Gallium compounds available 
Gallium (Ga(III)) is a post-transition metal belonging to the group IIIA of the periodic 
table.  Chemically it is similar to ferric iron (Fe(III)), aluminium (Al), zinc (Zn) and indium (In) 
but its chemical behavior is particularly close to the one of Fe (III), in terms of electric charge, 
ionic radius, valence and electronic configuration (Collery, et al., 2002).  Unlike iron, Ga (III) is 
unable to attain a divalent state (e.g., ferrous iron - Fe(II)) under physiologic conditions, and it 
cannot participate in redox reactions, or enter mammalian Fe(II) binding molecules (e.g., heme) 
(Logan, et al., 1981; Bernstein, 1998), although  it apparently has a strong affinity for transferrin 
(an iron transporter, or siderophore – see below) (Vallabhajosula, et al., 1980; Rudnev, et al., 
2006; Chikh, et al., 2007), binding to it slowly, but tightly (Harris & Pecoraro, 1983).  It was 
estimated that in humans administered a Ga(III) product, the total gallium in plasma could be 
99.9% transferrin-bound.  
In human medicine, gallium salts have been studied and employed for years to normalise 
bone metabolism through down-regulation of osteoclastic degranulation, and the pertinent 
research has been abundant.  Suffice to say that gallium was found capable of inhibiting osteoclast 
reabsorption, when added to the culture medium at concentrations equal to, or higher than 0.39 
M (Hall & Chambers, 1990); also, it reversibly inhibited osteolysis induced by parathormone 
and tumor necrosis factor in a dose-dependent manner, when added in a culture of viable 
osteoclasts (Bockman, 1991). Its main effects were believed to be on mature osteoclasts (Blair, et 
al., 1992), due to inhibition of enzymatic synthesis and degranulation (starting from 1 M and 
increasing concentrations), but recent studies showed that gallium dose-dependently (0-100 M) 
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inhibited the in vitro reabsorption activity of RBC and induced a significant decrease in the 
expression level of transcripts coding for osteoclastic markers, as it affects the regulatory gene 
transcription (at concentrations at least equal to 2.5 M). Furthermore, it dramatically reduced the 
formation of TRAP-positive multinucleated cells. The dose-dependent down-regulation was clear 
for the expression of the transcription factor NFATc1, a master regulator of RANK-induced 
osteoclastic differentiation, but did not affect the viability or activity of primary and MC3T3-E1 
osteoblasts (Verron, et al., 2010). 
Gallium salts (particularly chloride and nitrate) dissociate easily in aqueous solution, 
becoming often unsuitable for oral or parenteral administration, but due to one of the dissociation 
by-product, gallium hydroxide, which is insoluble and severely limits the bioavailability in the 
intestines (Bernstein, 1998).  Thus far, only an injectable solution of sodium citrate-chelated 
gallium nitrate (Ganite
R
) is approved in the United States for the treatment of human cancer-
related hypercalcemia, and it is administered as continuous IV infusion once diluted in saline or 
dextrose solution, to avoid the nephrotoxic effects reported with IV bolus (Martens, et al., 2007a). 
This injectable gallium nitrate solution is able to acutely normalise calcemia (at concentrations of 
0.92 g/ml) in human patients affected by paraneoplastic hypercalcemia (Warrell, et al., 1986).   
Several studies on gallium compounds, in both veterinary species and humans, show a 
fairly long elimination kinetics, which varied depending on the species.  It is claimed to be 
potentially due to the slow absorption (Harrington, et al., 2006; Martens, et al., 2007a; Fecteau, et 
al., 2011; Pollina, et al., 2012), although several studies did not implement intravenous 
administration.  Probably, the main factors impacting the slow absorption are the high 
precipitation rate of by-products, gallates, (Ga(OH)4
-
), which are rapidly excreted by the kidneys; 
and the slow, but almost complete, binding to transferrin (Harris & Pecoraro 1983).  Furthermore, 
in early studies of gallium based compounds (Bruner, et al., 1953a; Bruner, et al., 1953b), 
elimination was shown to occur mainly by renal excretion within the first 24 h post-treatment, or 
by intestinal excretion, in the following days, as by then it mostly exists in plasma as transferrin-
bound gallium. However, the main reason of our interest is that, regardless of the specific 
compound vectoring it, Ga(III) binds to siderophores in vitro and is able to compete with Fe (III) 
for bacterial uptake, Gram-negative and Gram-positive alike. 
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2.4.3.2 Gallium maltolate   
Gallium maltolate (GaM), as visible in Figure 2.1, is a coordinated complex consisting 
of a Ga (III) ion surrounded by 3 maltol ligands, and different from other compounds, it is 
deemed safe when orally administered to humans, mice, rats, dogs, foals (Bernstein, et al., 2000; 
Martens, et al., 2010), and guinea pigs (L.R. Bernstein, personal communication), making it 
suitable for treating ambulatory patients.  Thus far, no nephrotoxic effects of GaM are known, 
likely because all the Ga(III) from GaM administered orally becomes protein bound in blood 
(Bernstein, et al., 2000).  Although the characteristics of the replication pathways specific for L. 
intracellularis are still incompletely known, we assume that GaM, should adequately convey 
Ga(III) in proximity of the bacteria, particularly the ones located in the enterocytes’ brush border 
(Bernstein, 1998).  
 
Figure 2.1. Gallium maltolate chemical structure. 
 
 
 
 
 
 
 
 
Figure 2.1. Gallium maltolate structure. Depiction of the chemical structure of the trivalent 
gallium (at the center), with the 3 maltol ligand molecules connected in a triangular shape. 
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In regards to its use in foals, GaM was first tested in vitro and in vivo (mice) against 
another equine intracellular pathogen, Rhodococcus equi (R. equi), with encouraging results 
(Harrington, et al., 2006).  Subsequently, GaM pharmacokinetics was investigated in foals, as a 
novel AM approach to treat rhodococcal pneumonia, particularly because the achieved serum 
concentrations exceeded the MIC determined in vitro (Harrington,  et al., 2006; Martens, et al., 
2007a, Martens, et al., 2007b, Martens, et al., 2010), both with single and multiple oral 
administration, via water solution and gel suspension (Chaffin, et al., 2010).  R. equi (gram-
positive) and L. intracellularis (gram-negative) are structurally and genetically different bacteria, 
but both are successfully treated with macrolides, or azalides, and rifampin or doxycycline 
(Jacks, et al., 2003; Giguere, et al., 2004; Womble, et al., 2007; Chaffin, et al., 2008).  Despite 
these differences, its use against L. intracellularis shows promise, as also this bacterium shares 
common intracellular bacteria characteristics, in that proliferation and virulence depends on the 
iron concentration in the host cell environment.   
Normal biological function of proteins containing Fe(III) depends on the reduction of the 
metal, and when Fe(III) is replaced by Ga(III), reduction cannot occur and this is hypothesized to 
disable the proteins, disrupting cellular metabolism and causing cell death.  A key study in vitro 
ascribed beyond doubt the efficacy of the Ga(III) moiety in impairing Mycobacteria replication 
and survival, clarifying the role of both moieties (Olakanmi, et al., 2000).  An even stronger 
demonstration of the iron mimicking strategy (also called “Trojan horse” mechanism) behind the 
gallium compounds was obvious when organic moieties (i.e. using a siderophore) compounds 
were used.  Recently gallium desferrioxamine topical applications were implemented against a 
Pseudomonas spp. infection in a rabbit uveitis model.  The desferrioxamine moiety vectored, 
better than others, Ga(III) to success, likely because many iron-dependent mechanisms, 
potentially too slow to access for Ga(III), were bypassed by the desferrioxamine (Banin, et al., 
2008).  An additional favorable pharmacologic feature of Ga(III) is its apparent accumulation at 
sites of inflammation, which underlies its use as a diagnostic imaging agent (Berry, et al., 1984; 
Bernstein, 1998), but it could be useful as a chemotactic feature to the site of infection.  
 2.4.3.3. The rationale for using an iron mimicking compound  
The body needs iron for multiple functions, the most known being the role of heme and 
hemoglobin for oxygen transport. Iron also plays a fundamental role in several transport proteins, 
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cell membrane transporters, metallo-enzymes, DNA replication processes and xenobiotic 
metabolism.  It is transported into cells by transferrin-mediated endocytosis, but other absorption 
mechanisms likely exist as the transport proteins (e.g., apotransferrin) are insufficient to fully 
account for dietary iron absorption (Gunshin, et al., 1997).  In monogastrates, the iron balance is 
dependent almost entirely on dietary intake, as it is absorbed in the intestinal tract and 
internalized by enterocytes as ionic ferrous iron (Fe(II)) (Ma, et al., 2002; Ma, et al., 2006; Chua, 
et al., 2007; Kolachala, et al., 2007) (See sub-chapter 2.5).  
Iron is essential not only for mammalian functions, but it is also required for a variety of 
metabolic processes in virtually all microorganisms. Its ability to cycle between Fe(II) and 
Fe(III) represents one of the limiting steps of metallo-mediated functions in mammalian 
physiology, whereas bacteria preferentially uptake Fe(III). Now in an aerobic, neutral pH 
environment the concentration of free Fe(III) is limited to 10
-18
M by the insolubility of Fe(OH), 
which is well below the required concentration for cells survival (Girijavallabhan & Miller, 
2004).  However, the concentration of Fe(III) available for bacteria is even lower, as mammalian 
sequester and bind Fe(III) through serum proteins, such as transferrin and lactoferrin (Raymond 
& Dertz, 2004), thus many bacteria circumvent the Fe(III) nutritional limitation by producing the 
“siderophores”.  These are chelating low-molecular-weight agents, secreted under iron-limited 
conditions, which strongly and specifically bind, solubilize and deliver Fe(III) to bacterial cells 
through specific cell surface receptors (Raymond & Dertz, 2004). The virulence of certain 
intracellular bacteria (e.g., E. coli, Shigella spp. and Salmonella spp.), is coupled with the 
siderophores production (Reigstad, et al., 2007; DeLeon, et al., 2009).  Some bacteria produce 
only 1 siderophore, while others have many, thus increasing the chances to utilize available 
Fe(III). For example, E.coli siderophore-system has been extensively studied and it is 
paradigmatic for bacterial siderophore–dependent iron uptake (Earhart, 2004).  Iron assimilation 
in E.coli occurs by means of the “enterobactin-system”, which is also typical of most enteric 
Gram-negative and intracellular bacteria, such as L. intracellularis (Payne & Mey, 2004).  In 
latently infected epithelial cells iron uptake systems are expressed up to a 100-fold more than in 
normal or early infected cells.   
Thus, targeting bacterial iron uptake mechanisms and their metabolism could constitute good 
targets for novel AMs compounds.  By a larger definition, siderophores can be indicated as those 
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molecular structures, or proteins, that literally “carry” or transport iron. These latter are currently 
investigated as therapeutic aids in different medical branches, to either vector antimicrobial 
drugs within bacteria, or, as, for example, desferrioxamine mesylate, used to reduce iron 
availability in cases of patients with thalassemia, or subjected to multiple transfusions 
(Girijavallabhan & Miller, 2004).  Regardless of the carrier that Ga(III) can use to interact with 
the Fe(III) pathway, its ability to bind to transferrin (and the likes) has been documented and 
becomes of great pharmacokinetic relevance in our study. Transferrin receptors are present on 
many epithelial cells, including epithelial cells of small and large intestine and intestinal crypt 
cells (Jeffrey, 1996), as that gains a route of entry into enterocytes for Ga(III); moreover its 
accumulation in lysosomes (mature endosomes) of neoplastic tissues, renal tubular cells and 
macrophages has been reported too, providing other routes to convey it to the site of infection 
(Berry, et al., 1984, Bernstein, 1998; Bernstein, et al., 2000). 
 
“Il faut manger pour vivre et non pas vivre pour manger” 
“One should eat to live, and not live to eat.” 
                                                      Molière 
2.5 Gastrointestinal function. 
 
A brief review of the GIT absorption processes follows, as L. intracellularis infection can 
be a useful model for alimentary tract diseases, due to the typical pathogenetic “malabsorption” 
traits.  In humans, malabsorption defines altered, or deficient, structure or function (or both) of 
the small intestine, alone or together with disturbances of liver, biliary ducts and pancreas.  In 
equine medicine, it defines malfunction of both small and large intestine (Roberts, 2004).  Its 
diagnosis is complicated and, regardless of the affected site, malabsorption often exhibits 
diarrhea as a feature, not as a cause (Roberts, 2004), as absorption disturbances in the small 
intestine lead to altered microflora and fermentation products in the large intestine, predisposing 
the horse to maldigestion, diarrhea (see below) and weight loss, or more complex disturbances, 
such as colic, the leading cause of mortality in horses (Dyer, et al., 2002).   
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The most important function of the gastrointestinal tract (GIT) is to transform orally 
ingested food into absorbable substrates and energy sources for the body functions.  The key 
point is in the ability of absorbing and transporting substances through the mucosal barrier of 
enterocytes to the lymphatic system and the blood.  To these ends, the GIT transforms diet’s 
contents, mainly represented by polymers (e.g., cellulose, starches, proteins and triglycerides), 
into monomers or specially reconstituted polymers (e.g., chylomicrons), in the only form of 
utilizable and transportable substrate, in order to vector it to the blood stream, and from there, 
wherever necessary (Caspary, 1992).  
2.5.1. Physiology of intestinal absorption 
 
Nutrient absorption occurs both in the small and large intestine. The large intestine 
absorption mechanisms are briefly approached first, as the small intestinal absorptive function is 
more detailed (and pertinent to the dissertation’s subject) and will be addressed more in detail. 
For this section the main body of literature cited is constituted by GIT physiology reviews and  
GIT physiology book chapters, although, where appropriate, original research papers were 
consulted for novel or specific details.  
 The horse large intestinal functions consist mainly of: 1) absorbing (and reabsorbing) 
water (up to 95%) from the chyme originating from the ileum and the large intestinal secretions; 
2) absorbing electrolytes; and 3) providing a site of slower transit for microbial digestion 
(Argenzio, et al., 1974a). Specifically to compensate their incomplete colonic functions, younger 
foals, rabbits and other rodents resort to coprophagy, the former often ingesting the dam’s feces 
to expedite the large intestine bacterial colonization (Crowell-Davis & Houpt, 1985; Crowell-
Davis,1986); the others ingesting their own feces to compensate the partial absorption obtained 
through the stationary haustral contractions and retrograde propulsion, as one-pass only is 
insufficient to absorb the microbial digestion by-products (e.g., vitamin B complex) (Pickard & 
Stevens, 1972).   
In a series of studies conducted in ponies, a considerably slower transit through the large 
colon was demonstrated with radio-marked particles (chromium radioisotopes) injected at the 
level of stomach, cecum and large colon (Argenzio, et al., 1974a; Argenzio, et al., 1974b; 
Argenzio & Stevens, 1975).  Digesta were observed to move very quickly from the stomach to 
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the cecum, and then to the proximal colon.  While the cecum absorbs large quantities of water, 
especially between meals, the large colon sees large water volumes exchanged through the 
colonic mucosa, through cyclic periods of net influx and efflux.  Such a conspicuous exchange 
between digesta and plasma content apparently is associated primarily with cyclic changes in 
osmolality, resulting from a cyclic microbial digestion (Argenzio, et al., 1974a). Resident 
microorganisms’ digestion not only affects the digesta’s electrolyte contents, but also the 
fermentation of vegetable fiber.  The result is the formation of short chain fatty acids, which 
provides a large portion of the horse’s energy requirements.  Thus, variations of the fermentation 
pattern lead to osmotic imbalances, and to osmotic diarrhea.   
Today’s horses’ nutrition regimens contain much more concentrate feed than they did 50-
60 years ago and the absorption of such high levels of starches (i.e., grain) is managed by the 
small intestine, providing a substantial fraction of energy for metabolism (Alexander, 1955; 
Argenzio & Hintz, 1972; Dyer, et al., 2002).  The small intestine of non-ruminant herbivores, 
such non-suckling horses, absorbs large amounts of carbohydrates, and proportionally less, 
proteins, lipids, electrolytes and water, due to the driving force that sodium ions (Na
+
) exert on 
the small intestinal uptake of other electrolytes and substances.  Enterocytes can absorb Na
+
 
through 3 major processes.   
1) The first process is active absorption through a “conductance pathway”, which is 
electrogenic, though uncoupled with other substance’s uptake, as Na+ initiates an inward 
electrochemical gradient between extracellular and intracellular spaces. The gradient is 
maintained  in exchange of energy, as it requires catalysation of ATP, via hydrolysis, by the Na
+
-
K
+
-ATP-ase “pump” located on the enterocyte’s basolateral membrane.  The “pump” exchanges 
Na
+
 “out” for potassium ions (K+) “in”, thus establishing the steep electrochemical gradient that 
leads to Na
+
 absorption from the lumen.  Under these conditions, particularly in the duodenum 
and ileum, chloride ion (Cl
-
) absorption accompanies Na
+
 in its inward transition.  Supposedly it 
occurs through a paracellular mechanism, and marginally, by the transcellular route.  This is not 
the only mode of entry for Na
+
 and Cl
-
, although the uncoupled absorption of Na
+
 is perhaps the 
major route of Na
+
 entry in the mammalian colon (Fondacaro, 1986).  One should note that 
throughout the whole intestine, water follows the so-constituted electrolyte gradient and is 
59 
 
absorbed almost entirely by diffusion through the intestinal wall, obeying classical osmosis laws.  
(Guyton & Hall, 2005a).   
2) The second process of Na
+
 mucosal absorption is through a coupling to other organic 
solutes, as Na
+
 is required for, and is co-transported with, the absorption of glucose, amino-acids, 
bile acids (in the ileum), water and water-soluble vitamins. The driving force, even in the face of 
uphill movement, is the electrochemical gradient discussed above, created at the level of the 
baso-lateral membrane (Fondacaro, 1986).  
3) The last process is a neutral, carrier-mediated, electrically silent one-for-one Na-Cl co-
transport system, at the level of the villous brush border, in the small intestine.  This process, 
energized by the inwardly directed Na
+
-dependent electrochemical gradient, provides the bulk of 
absorbed Na
+
 and Cl
-
 in the mammalian small intestine.  More importantly, this coupled entry 
seems not to be an unidirectional co-transport, or “symport”, but involves coupling of Na+-H- 
and Cl
-
-HCO3
-
, or Cl
-
-OH
-
 exchange (Liedtke & Hopfer, 1982a; Liedtke & Hopfer, 1982b; 
Gunther & Wright, 1983, Knickelbein, et al., 1983, Fondacaro 1986).  The exchange of Cl
-
 for 
HCO3
-
 is an equally active process.  In the duodenum and jejunum, a high HCO3
- 
concentration 
occurs as a result of bile and intestinal and pancreatic secretions.  The HCO3
-
 absorption process 
is more complicated than an electric gradient absorption, as it implies an exchange of H
+
 for Na
+ 
(Guyton & Hall, 2005a).   
Calcium ions (Ca
++
) are absorbed through active transport mechanisms into the blood, 
especially in the duodenum, and the absorbed amount of Ca
++
 is closely regulated by a finely 
tuned interaction of parathyroid hormones and vitamin D (Caspary, 1992).  K
+
, magnesium 
(Mg
++
) and phosphate (P
-
) ions, are absorbed through the small intestinal mucosa, following the 
general rule that, monovalent ions are easily absorbed in great quantities, whereas bivalent ions 
are normally absorbed in smaller amounts (e.g., Ca
++
 in humans is absorbed at a ratio of 1:50 
compared to Na
+
) (Caspary, 1992; Guyton & Hall, 2005). 
2.5.1.1. Carbohydrate absorption 
The detailed explanation of the role of Na
+
 in absorption clarifies that virtually no 
carbohydrate could be absorbed in absence of Na
+
 co-transport.  In non-ruminant species, 
digestible carbohydrates are hydrolysed within the lumen by pancreatic -amylase and 
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disaccharidases of the brush-border membrane, such as sucrase, maltase and lactase, to the 3 
main monosaccharides: D-glucose, D-fructose and D-galactose.  These are vectored through the 
brush-border membrane by specific monosaccharides transporters (Shirazi-Beechey, 1995).  The 
expression of sucrase, maltase and lactase in the brush-border membrane and the Na
+
-glucose 
transporters’ distribution in the small intestine of mature grass-fed horses (< 4 years of age) was 
elegantly illustrated by Dyer and coworkers (2002).  Dyer evaluated the digestive and absorptive 
ability of duodenum, jejunum and ileum both at cellular and molecular levels, in terms of 
abundance and level of activity of transporters and enzymes. Sucrase apparently is highly 
concentrated in the proximal small intestine, whereas maltase is expressed all along the small 
intestinal brush border membrane, with the findings in horses much higher than in other non-
ruminant species (1 M/min/mg protein in horses vs. 0.013-0.054 M/min/mg protein in man) 
(Dyer, et al., 2002).  Opposite to the general belief of the mid 1970’s, lactase is expressed also in 
mature horses, at higher concentrations in duodenal and jejunal brush-border than the ileal one, 
confirming that non-nursing animals can still digest the disaccharide lactose (Roberts, 1975).   
A similar pattern of expression was reported for the Na
+
-dependent-D-glucose-transport 
protein (SGLT), which is a bifunctional carrier and works optimally when both sites - one for 
monosaccharides (both glucose and galactose are accepted) and one for Na
+
 - are occupied 
(Caspary, 1992; Dyer, et al., 2002).  Its kinetics was investigated in tissues, testing increasing D-
glucose concentrations (0.01-2.5 mM), with the result that the D-glucose uptake conformed to 
Michaelis-Menten kinetics, with Km (0.49 ± 0.06 mM) similar in the 3 small intestine sections, 
but with a significantly higher Vmax in duodenum (1312 ± 141.9 pM/s/mg protein) (Dyer, et al., 
2002).  As inhibitors selectivity (and aminoacid sequence) is similar to the one of other species, 
the equine SGLT co-transporter, is believed to be the isoform 1 (Wright, 1993; Dyer, et al., 
2002).  As a note of interest for the purpose of animal modeling and comparisons (see chapter 
2.6), the Equine SGLT1 shares the same hypervariable regions as SGLT1 in other species, 
although it’s the only one together with the rabbit, showing a lower number (662) of constituting 
amino acids  and 2 amino acid deletions at positions 592-593 (Dyer, et al., 2002).   
Once in the intracellular space, glucose, and almost identically galactose, is facilitated 
through the baso-lateral membrane towards the bloodstream.  Differently, fructose never uses the 
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Na
+
-co-transport mechanism, as it is absorbed by facilitated diffusion along the whole intestine. 
(Caspary, 1992). 
2.5.1.2 Protein absorption 
The ingested proteins first undergo denaturation by pepsins in the acid gastric 
environment, although a large amount of polypeptides still enters the duodenum (Caspary, 1992).  
In the intestinal lumen, those polypeptides are hydrolyzed as di-peptides, tri-peptides and few 
free amino-acids, so that they can be absorbed through the enterocytes’ luminal membrane 
(Guyton & Hall, 2005a; Guyton & Hall, 2005b).   
The assimilation of peptides occurs mainly in the proximal jejunum, and to a lesser extent 
in the distal jejunum and proximal ileum, which is a key in understanding the reasons behind the 
protein-losing aspect of EPE, as in the majority of cases affects terminal jejunum and ileum.  The 
final phase of the proteins absorption follows 2 energy mediated mechanisms: one is the active 
Na
+
-co-transport, which takes care of absorbing di- and tri-peptides. The other is the process 
managing the larger peptides, cleaved at the level of the brush border membrane and 
subsequently trans-located through specific carrier-mediated transport-systems for neutral, basic 
and acidic amino acids (Caspary, 1992).  Only a few free amino-acids are transported inside the 
cells through facilitated diffusion, similarly to fructose (Guyton & Hall, 2005a; Guyton & Hall, 
2005b). 
2.5.1.3. Lipid absorption 
The absorption of fats consists of 2 phases: a luminal and a mucosal phase.  In the 
luminal phase the complex food lipid aggregates are solubilized as “micellar” dispersions of 
monomeric lipids, by the interactions of several mechanical and emulsifying agents. The 
emulsification process takes place partially in the stomach, thanks to the contribution of salivary 
lipase, although this is a minor step in the complex of reactions of emulsification.  Subsequently, 
enzymatic hydrolysis of lipid esters ensues by pancreatic lipase in the duodenum, preparing the 
lipid substrate for the last step of the conversion of lipolytic products from insoluble to 
hydrosoluble status, so enterocytes can absorb it through the membrane.   
In the duodenum, the low pH triggers the release of secretin, which triggers the release of 
HCO3
- 
, as a chain reaction, and due to the rise in pH, fat droplets rise to surface and perform a 
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more efficient emulsification. The release of cholecystokinin–pancreozymin substances triggers 
biliary and pancreatic enzyme secretion.  
Bile’s main constituents are bile salts and bile lipids (phospholipids), which as micelles, 
act on the basis of their detergents properties and increase the surface area of the fat droplets.  A 
large surface area is a requirement for fat digestion: the hydrolytic steps of pancreatic 
lipase/colipase system and the interaction of esterases, phospholipase-A2 and cholesterolase.  
The obtained mixed micelles have a very small size (3-6 nm), are highly charged and form an 
aqueous suspension which is easily absorbed by the mucosal cells (Carey, et al., 1983; 
Caspary,1992). The mucosal phase is the actual absorption step in which fatty acids, 
monoglycerids, cholesterol and lipid-soluble vitamins are transported from jejunum to blood.  
The bile micelles constitute the key step for intestinal absorption of fats (with bile micelles about 
97% of fat is absorbed, without bile micelles only 40-50% is absorbed) (Guyton & Hall, 2005a;  
Guyton & Hall, 2005c), as their absorption depends solely on the rate of penetration through 2 
barriers: 1) the unstirred water layer, at the surface of mucosal cells membranes; and 2) the lipid 
membrane into the mucosal cell.   
Fat absorption starts in the distal duodenum and it is complete by the proximal part of the 
jejunum, whereas the bile salts are reabsorbed in the terminal ileum (entero-hepatic recirculation 
of bile salts) (Caspary, 1992).  However, in horses, the absorption of short-chain fatty acids 
derived by resident microfloral fermentation is reported to occur in the large intestine, 
particularly in animals whose nutrition is grass-based (Alexander, 1955; Argenzio & Hintz, 
1972).  Permeation of fatty acids through the brush border membrane occurs through a specific 
carrier-mediated Na
+
-co-transport, which is energy dependent.  Once in the intracellular space, 
short-chain fatty acids are absorbed with more ease than long-chain ones, although micelles are 
disassembled and the fatty acids are re-synthesized at the level of SER and Golgi apparatus 
where are packaged in low-density lipo-protein and chylomicrons, and then released again in the 
cytoplasm to migrate in the systemic bloodstream, via the lymphatic system, as lipids are pushed 
in through the villi’s pumping contractions (Guyton & Hall, 2005a; Guyton & Hall, 2005c).   
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2.5.2. Pathogenesis of malabsorption. 
 
After the brief review of principal nutrient groups’ absorption, it is clear that a diagnosis 
of malabsorption is complicated and, in horses, it is often a diagnosis of exclusion, particularly in 
those cases that present for chronic weight loss and wasting.  If the lesions are located in the 
small intestine (e.g., EPE lesions), the absorption of carbohydrates, proteins, fats, oligominerals 
and vitamins is profoundly changed, whereas the changes in absorption of electrolytes and water 
are marginal. However, the chyme presenting to the large intestine is substantially altered, 
containing larger amount of unabsorbed substrates, which change the pH altogether. These 
changes subsequently complicate the chyme’s fermentation in the large intestine, impacting 
abnormally both caecal and colonic microflora, the cardinal point of equine digestion.  
The reason why it is difficult to accurately diagnose malabsorption in horses, is due to 
their herbivorous condition, with an eminent role of the large intestine and a limited exocrine 
pancreatic activity (i.e., compared to humans or small animals). Nonetheless, maldigestion and 
malabsorption can undoubtedly contribute to chronic weight loss, which is significant during 
severe infiltrative disease of the small intestine, with partial or total villous atrophy (Roberts, 
2004).  In foals, such an impaired digestive process may exacerbate diarrhea, wherein bile salts 
concentration may be reduced because of chyme dilution, hepatic or ileal dysfunction.  
 
2.5.3. Tests to evaluate intestinal integrity and absorption ability. 
 
In the last 35 years, several testing methodologies were investigated and are now 
routinely available, allowing us to evaluate the function and potentially the integrity, the 
structural appearance and mobility of the intestine, so as to improve the therapeutic approach 
without resorting to exploratory celiotomy (Schumacher, et al., 2000).  Until recently, suspected 
malabsorption was confirmed upon histopathology examination of tissues, whether obtained 
surgically, or necroscopically, regardless of the causal dysfunction (Kemper, et al., 2000).   
Through ultrasonographic examination, wall-thickening lesions (> 3 mm) and changes in 
architectural structure of the intestine can be discerned, this is not a specific diagnostic for 
malabsorption, as thickening of the intestinal wall is typical not only for EPE (Schumacher, et 
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al., 2000), but also for other infiltrative/inflammatory disorders (PE in general), or even of 
strangulating accidents leading to edema or blood stasis (Alderton, et al., 1992; Kemper, et al., 
2000; van den Wollenberg, et al., 2011).  In EPE affected foals, the jejunal and ileal walls are 
grossly thickened and corrugated. Typically intestinal loops have a “doughnut-like” appearance 
when detected transversally through ultrasonographic examination, as their thickness is often in 
the range of 0.5-0.8 cm, or larger, compared to the normal intestinal thickness of < 0.3 cm. 
Today such intestinal wall thickening and its ultrasonographic appearance are considered a 
pathognomonic EPE clinical sign (Schumacher, et al., 2000; Sampieri, et al., 2006; Frazer, 
2008), yet not specific enough to justify therapy initiation on their own (Page, et al., 2011a).   
Thus far, the best tests to assess for suspected intestinal malabsorption mechanisms are 
the D-glucose test and the D-xylose test (Roberts & Hill, 1973; Roberts, 1974, Roberts & 
Norman, 1979; Mair, et al., 1991; Brown, 1992), and in younger foals, it can be helpful to utilize 
the lactose tolerance test as well (Sweeney, 1987).  The D-xylose test technique is typical of 
research settings, although both D-xylose and D-glucose tests have similar protocols, yet 
different analytical objectives (glucose versus xylose).  The protocols use, after an overnight 
fasting, the oral administration of either glucose (or dextrose) at 0.5 -1 g/Kg BW in a 20% water 
solution, for the oral glucose absorption test (OGAT); or D-xylose at 0.5 -1 g/Kg BW in a 20% 
water solution, with the smaller dose suggested for ponies (Roberts & Hill, 1973, Brown 1992). 
Either test provides information on the intestinal ability to digest and absorb nutrients, with the 
monosaccharides easier to test.  Samples are taken q 30 minutes, from time 0 to 6 h after 
administration (Roberts & Hill, 1973; Mair, et al., 1991).  
2.5.3.1. Oral glucose absorption test (OGAT).   
OGAT is a valid test for small intestinal absorption capacity, hepatic glucose uptake and 
endocrine pancreatic function (Sweeney, 1987; Mair, et al., 1991; Firshman & Valberg, 2007).  
In healthy horses it consists of 2 phases: the first one sees the blood glucose concentration 
peaking by 120 minutes after oral administration; the second one sees the return to baseline 
glycaemia in 4-6 h from administration (Roberts & Hill, 1973; Mair, et al., 1991). A modified, 
faster and cheaper, version is reported with only 2 blood samples, 1 as a baseline, and 1 120 
minutes later (Murphy, et al., 1997).  However, most reports use, or suggest, the 6 hours 
sampling time-frame (Mair, et al., 1991; Kemper, et al., 2000; Firshman & Valberg, 2007) for 
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better results.  The results of the OGAT test define complete malabsorption if the blood glucose 
peak is <15% above the resting levels by 120 minutes after glucose administration; whereas 
partial malabsorption is defined by a peak between 15 and 85% above the resting level at 120 
minutes (Roberts & Hill, 1973; Mair, et al., 1991).  OGAT is a sensitive, but non-specific test, as 
it identified correctly complete malabsorption in horses, but it was accurate in identifying the 
partial condition in only 72% of horses with a structural small intestinal disorder; or only in 75% 
of horses that suffered lymphocytic-plasmacytic enterocolitis, as per microscopic diagnosis 
(Roberts & Hill, 1973; Mair, et al., 1991; Kemper, et al., 2000).  Gastric emptying, intestinal 
transit time and length of fasting can affect cellular uptake of glucose, as well as metabolism and 
endocrine function (i.e., insulin release) (Freeman, et al., 1989; Mair, et al., 1991).  
OGAT was performed in 4 EPE affected foals (Wong, et al., 2009). Three of them were 
tested at presentation, and then repeated OGATs were performed to follow-up their recovery.  
The fourth case was not tested prior to treatment, due to the profound debilitation and the critical 
conditions on arrival (i.e., recumbency), requiring immediate initiation of total parenteral 
nutrition (Wong, et al., 2009).  As weight loss continued (40 Kg) through the first month of 
treatment/convalescence, the OGAT at that stage confirmed a complete condition of 
malabsorption. The clinical observations on those foals reported 3 out of 4 animals with 
complete malabsorption, as the glucose curves were flattened (normal glucose range: 4.5 -10.9 
mM/L) (Bauer, et al., 1984), whereas one foal showed partial malabsorption.  During recovery 
samples were taken at different time points, but only 2 foals showed a return to normal OGAT 
conditions within 3 months from admission, whereas the other 2 only showed partial 
improvement from complete to partial malabsorption, in the same time frame.  To confirm it, 
serum total protein (TP) and albumin (ALB) concentrations were still far below normal range 
(TP: 50-61 g/L; ALB: 26 – 32 g/L, in foals 1-6 month-old) for the duration of the follow-up 
(Lumsden, et al., 1980; Wong, et al., 2009).  This report  was the first one to assess directly the 
degree of impaired intestinal absorption, as previous clinical series assessed the suspicion of 
malabsorption based on clinical signs and blood-work abnormalities (hypoproteinemia and 
anemia) (Lavoie, et al., 2000; Bihr, 2003; Dauvillier, et al., 2006).  Wong’s observations (2009) 
clarified why the complete recovery is so prolonged in EPE affected foals and why, even after 
several months, the disease effects on growth rate are still compromising the weanlings/yearlings 
general appearance (Frazer, 2008). 
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2.5.3.2.  D-xylose absorption test.   
The D xylose test has some advantages over OGAT, because xylose is not metabolized in 
the small intestine, and its absorption is not affected by insulin. Identically to D-glucose, D-
xylose is affected by GIT motility, length of fasting (i.e., the longer the fasting, the flatter the 
curves) and intestinal bacterial overgrowth, but it is also affected by renal function, as it is 
cleared by the kidneys (Freeman, et al., 1989; Brown, 1992). Normal D-xylose absorption test 
results should peak between 20 and 25 mg/dl at 60 and 120 minutes after dosing (Brown, 1992).  
Decreased D-xylose absorption has been observed in cases of extensive small intestinal resection 
and any cause of villous atrophy, along with the causes for low OGAT results. 
2.5.3.3  Other tests 
Another test to evaluate the common event of maldigestion in foals with diarrhea, or 
recovering from diarrhea, is D-lactose test, to evaluate the ability to tolerate the lactose 
contained in the mare’s milk.  D-lactose, dosed naso-gastrically at 1g/kg BW, in normal cases 
should lead to doubling of blood glucose level by 60 minutes after dosing and in intolerant 
animals it should detrimentally induce osmotic diarrhea (Roberts, 1975).  However, lactose 
intolerance seems more typical of young nursing foals affected by Clostridium spp., Rotaviruses 
and Coronaviruses, rather than others infectious agents.  Also, opposite to OGAT and D-xylose 
tests, the lactose test has not been proved to increase disorder and recovery information in EPE 
foals and weanlings (Wong, et al., 2009). 
       
2.5.4 Iron absorption.  
 
For the purposes of this dissertation objectives, it is important to emphasize the small 
intestine’s active transport mechanism in absorbing iron ions, Fe(II) and Fe(III).  Mammalian 
organisms need iron for multiple functions, the primary being oxygen transport in blood (i.e., 
heme and hemoglobin), but other roles are not less important, such as the catalysis reactions of 
multiple metallo-enzymes and cytochromes, DNA replication processes and transport proteins, 
needed both for generating energy and drug metabolism (Guyton & Hall, 2005a; Naigamwalla, 
et al., 2012).   
As described by many textbooks and thoroughly summarized in a recent review by 
Naigamwalla (2012), functional iron is chiefly found in hemoglobin (heme), and to a smaller 
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extent in myoglobin and cytochromes (Naigamwalla, et al., 2012).  Non-functional iron is 
largely stored in the liver, wherein iron transport proteins are produced, as ferritin, the primary 
iron storage protein, ubiquitous and soluble; and hemosiderin, that has a similar structure, but is 
insoluble, with more iron component relative to the protein one.  Also the reticulo-endothelial 
cells of bone marrow (with the exception of cats) and spleen are storage locations as well.  
Mammalian cells are capable of utilizing iron red-ox functions (i.e., donation or acceptance of an 
electron to/from the surrounding elements), in a uniquely advantageous manner for transport 
across membranes, as iron exists as a reduced ferrous (Fe(II)), or an oxidative ferric state 
(Fe(III)).  
Iron is transported into cells by transferrin-mediated endocytosis, and absorbed and 
internalized by cells as Fe(II) (Ma, et al., 2006; Chua, et al., 2007; Kolachala, et al., 2007). 
However, other absorption mechanisms likely exist, as the transport proteins (e.g., 
apotransferrin) are insufficient to fully account for dietary iron absorption (Gunshin, et al., 
1997).  The mechanism of iron absorption and homeostasis in humans has generated copious 
research in murine models, as dietary imbalances, intoxications, and genetic disorders are 
frequent and severe (Andrews,  2000; Pietrangelo, 2010).  This absorption process is mediated 
by the divalent metal transporter-1 (DMT1/SLC11A2) across the apical membrane of 
enterocytes and it is regulated by several enzyme and protein complexes (Gunshin, et al., 2005; 
Thompson, et al., 2007). The complete role and function of the DMT1/SLC11A2 transporter is 
currently under investigation with radioactive iron and IHC techniques, and age differences, in 
absorption of non-heme iron, are becoming better defined (Thompson, et al., 2007).   
In monogastrics, the iron balance is dependent almost entirely on diet, as the non-heme 
iron is absorbed by the body solely through diet. It is absorbed in the intestinal tract with 
duodenum playing a primary role in it (Ma, et al., 2002; Ma, et al., 2006; Chua, et al., 2007, 
Kolachala, et al., 2007).  Iron is then transported across the enterocytes apical membrane by 
DMT-1. According to recent publications (Harvey, 2008; Crichton, 2009), iron is then 
transferred across the enterocyte to the basolateral membrane through a yet unknown 
mechanism, but it is exported across the enterocyte’s basolateral membrane by ferroportin, to 
be subsequently bound to transferrin in the plasma and then vectored in target organs and/or 
storage (Naigamwalla, et al., 2012). 
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The total body iron stores are finely tuned and their regulation is strict, to provide an 
adequate availability of iron for cellular needs, yet preventing excess and toxicity.  Excess of 
iron storage, in human hepatocytes, leads to escalating pathological lesions, such as 
hemochromatosis, cirrhosis and fibrosis (Harvey, 2008; Weiss, 2010; Naigamwalla, et al., 2012).  
Thus, iron homeostasis is tightly controlled to limit intestinal iron uptake, through an impaired 
efflux from enterocytes, as the body is not provided of an efficient mechanism for excretion of 
iron excess.  Recently, the hormone regulating iron efflux was discovered, and named hepcidin.  
When iron stores are adequate to high, hepatocytes release hepcidin, which binds intestinal 
ferroportin, causing its internalization and destruction. A reduced availability of ferroportin, 
induces the storage of absorbed dietary iron within the enterocyte, where it is lost with the 
enterocyte by the time this latter sheds out (in normal conditions, 3-4 days).  However, if or 
when iron stores are low, hepcidin production and secretion are suppressed, thus allowing the 
ferroportin system to proceed with the facilitation of the increased iron efflux from enterocytes to 
the blood.  In other words, whereas the down-regulation of iron absorption is complex if not 
impossible, despite a very limited capability of the duodenum of absorbing dietary iron; the up-
regulation of iron absorption is feasible in situations of iron deficiency and depletion of body 
iron stores.   
Two cytoplasmic homologous iron regulatory proteins, IRP-1 and IRP-2, are found in 
liver and duodenal cells, where they can be “switched on” to the uptake function by iron 
responsive elements (IREs) of ferritin and transferrin receptors (Schumann, et al., 2004; 
Starzynski, et al., 2004).  Electrophoretic mobility shift assay (EMSA) showed IREs and IRP-1 
presence in murine duodenal mucosa, and confirmed it within hepatocytes of rabbits, cattle, 
goats, and pigs (Schumann, et al., 2004; Starzynski, et al., 2004).  This is important because one 
should not plan on restoring adequate iron homeostasis after chronic blood loss and subsequent 
iron deficiency only counting on up-regulation of iron absorption, because it may be 
inappropriate.  
Iron deficiency can be the result of either inappropriate dietary intake, when intestinal 
absorption or feed iron content does not meet the body’s requirements, or in case of a chronic 
non-resorptive blood loss (e.g., severe ectoparasites infestation or a chronic bleeding in the 
lumen of the GIT).  The dietary iron requirement for adult dogs and cats is estimated at 80 mg/kg 
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dry matter, in horses is 300 mg/day, regardless of being at rest or in exercise (note that it is 
higher in young animals, due to their rapid growth (Dzanis, 1994, Rooney, 2004)). Inadequate 
intake is rare in animals, except in nursing ones, due to the low concentration of iron in milk 
(300-350 mg in foals and 350-450 mg in weanlings) (Weiss, 2010; Naigamwalla, et al., 2012). 
High iron content is found in meat products (obviously not relevant to horses feeding), but also 
in brewer’s yeast, wheat germ, and some fruits; furthermore green-leaf vegetables, cereals, have 
an intermediate amount of iron, whereas, similarly to milk, most non-green vegetables contain 
low iron (Harvey, 2000; Naigamwalla, et al., 2012). 
However, little research focus specifically on iron absorption patterns of monogastrate 
herbivores, such as horses and rabbits.  Disorders and fatalities related to iron deficiency or 
toxicity are reported in large animals, but the knowledge of potential interaction of dietary iron 
with orally administered drugs, or the extent of iron absorption during gastrointestinal disease, is 
limited, or extrapolated from other species, particularly murine models and findings in humans 
(Somers, 1947; Ruhr, et al., 1983; Mullaney & Brown, 1988). 
Leaving aside the diseases leading to chronic blood loss that can onset iron deficiency 
derived disorders, such as anemia, one should mention that such disorders don’t usually start 
from, or during, acute blood loss, because body iron stores are generally sufficient to restore 
erythropoiesis activity. Nursing animals are particularly prone to developing iron deficiency 
anemia, not only because of the low iron content of a milk based diet, but because of lower body 
iron stores and larger requirements due to growth (Stockholm & Scott, 2002; Abrams-Ogg, 
2010; Naigamwalla, et al., 2012). Quite intuitively, surgical resection of the entire duodenum 
will result in iron malabsorption, and it is worth mentioning that iatrogenically induced iron 
deficiency anemia is possible, through excessive phlebotomies of blood donor animals, 
considering that a regular blood donation of 450 mL removes approximately 200 mg of iron 
from the body (Giger, 2005). Similarly, particular care should be taken in bleeding smaller 
animals, as iron deficiency limits can be reached with harvested blood volume in excess of 1% of 
the animal’s body weight per week (Diehl, et al., 2001; Giger, 2005; Naigamwalla, et al., 2012).  
It is worth mentioning that rare genetic defects in ferroportin and hepcidin regulation have been 
reported to cause iron refractory iron deficiency anemia in humans, but these have not been 
reported in animals, aside from a single case of iron-refractory-iron-deficiency-anemia in a 
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cocker spaniel recently mentioned, yet unpublished, by Naigamwalla and colleagues, which was 
identified as a defect in the hepcidin regulator, Tmprss6 (Naigamwalla, et al., 2012). 
 
“All animals are equal , but some animals are more equal than others”.  
                                                                                                                                                                      G. Orwell  
2.6 Animal models. 
 
An elegant way to introduce the concept of using animal models for research could be a 
quotation by R. Virchow (1821-1902) "Between animal and human medicine there is no dividing 
line — nor should there be. The object is different, but the experience obtained constitutes the 
basis of all medicine" (Klauder, 1958). 
Today many organizations and charity funds have formed to protect research animals, 
insure the quality of scientific projects, and the quality of life offered to experimental animals, 
ultimately determining whether using live animals in a variety of biomedical fields is necessary.  
In Canada the supervising role of such institutions is covered by the Canadian Council of Animal 
Care (CCAC).  Correspondent regulatory organs are found in many Western countries.  Not 
every country in the world adopts the same beliefs and stands by the same rules, and that is 
recognizable in the research allowances of studies conducted in some countries, but not in others.  
The role of CCAC, among others, is to bridge the needs of research, yet maintaining animal 
wellbeing, care and respect as a priority.  To fulfill that priority, in 1989, the fundamental Policy 
Statement on the Ethics of Animal Investigation was approved and the Fund for Replacement of 
Animals in Medical Experiments promoted the use of the “Three Rs” tenet: replacement, 
reduction and refinement of animal use (Fenwick, et al., 2009; Greek & Shanks, 2009; Shanks, et 
al., 2009).  The CCAC adopted the program and has been recommending it for the multiple 
branches of biomedical research that use animal models: from orthopaedic surgery to 
neuropsychiatry, to every branch of internal medicine, in subjects of various ages, gender and 
genetic background.  More importantly, biomedical research had, and still has, the need for live 
animal studies in fields such as pharmacology, toxicology or infectious diseases.  A reviewed 
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analysis of the “Three R’s” tenet, and the programs to which it is applicable, has been recently 
published, showing the commitment to improve the practical aspects of it and the applicability of 
the concepts to provide ethical support to well-structured research, so as to protect animals and 
yet to not completely hamper researchers (Fenwick, et al., 2009; Griffin, 2009).  Currently, 
neither the reduction or replacement concepts apply to the financial aspect of research.  For 
example, replacing an animal species with another for the purpose of veterinary experimentation 
is not considered a true fulfilling of the tenet, as it is perceived as driven only by economic 
rationales (Fenwick, et al., 2009). Admittedly, although very useful in supporting the concept of 
research on animals, the current program needs perfecting for all branches of research (Fenwick, 
et al., 2009).  
In countries such as Canada and the USA the thoughts about biomedical research on 
animals divides the public understanding, regardless of engaging into such a debate with well-
informed scientists or the general public. In other western countries (e.g., Italy, United Kingdom 
and Switzerland), the drive to ban research on animals is rising frantically, in the attempt to 
please the masses (Drs. D. Panzani and A. Rota, School of Veterinary Medicine, University of 
Pisa, Italy; Dr. K.J. Smith, University of Cambridge, United Kingdom; and Dr. C.C. 
Schwartzwald, Universität Zürich Vetsuisse-Fakultät, personal communications).  
However, sustainers of the “One medicine: One health” concept support the research on 
animal models as they see it useful to develop basic science knowledge prior to its application to 
clinical trials, not only in human medicine, but also in veterinary species (Sundberg & Schofield, 
2009; Sundberg, et al., 2009).  For example, the laboratory mouse has been the species of choice 
for many animal models of human diseases and for basic research areas.  It is due not only to the 
low cost of the subjects, but most importantly because of the long-standing genetic resources 
available for that species.  Moreover, today, the development of powerful new techniques for 
generating mutations, analysis of complex traits, and high through-put data-gathering render 
mice the preeminent animal model (Schofield, et al., 2004; Rosenthal & Brown, 2007).  In 
parallel, there is the increasing demand for laboratory animal specialists and “mouse 
pathologists”, with either veterinary or medical training, who can interpret the histopathologic 
changes (so-called phenotyping) that occur primarily in genetically engineered inbred strains of 
mice (Cardiff, et al., 2008), as well as specialists that can deal with cloned animal clinical 
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presentations (Fecteau, et al., 2005). Animal models more pertinent to this dissertation will be 
addressed below.  
The counterpart opposing to animal research, however, seems further divided. Several 
associations have risen, besides the extreme violent outbursts of some anti-vivisectionists 
movements (e.g., PETA), several national associations are active in North America to those ends 
(e.g., National Anti-Vivisection Society etc.) (Shanks, et al., 2009).  However, not all the 
opponents operate on the mere principle of “ostracism” to animal model research.  Some groups, 
Americans for Medical Advancement (AFMA) for example, are interested in improving the 
availability of therapeutics, in particular, for human diseases and they mainly refute the concept 
of prediction extendable from animal models to humans, with somewhat reasonable scientific 
arguments (Greek & Shanks, 2009; Shanks, et al., 2009).  They advocate the use of animal 
models only as “heuristic devices”, rather than predictive models where findings can be 
extrapolated to higher species, specifically humans. Their critique is based on the alleged 
misinterpretation of the word “prediction”, and its statistical meaning, in the scientific literature, 
as according to them not even animals of the same species could fulfill such a requirement, as 
shown by different studies in humans, and monozygotic twins in particular (Knight, et al., 2006a; 
Bruder, et al., 2008; Weiss, et al., 2008).  According to AFMA, animals and humans are 
complex systems evolved along separate lineages over time.  Thus, the very mechanisms and 
outcomes of evolution are precisely why animals cannot be used to predict human responses. 
Their assertion is that, as in genetics, context of expression is everything, organisms belonging to 
different species, or even different strains of the same species, may show different responses to 
the same stimuli because of differences, with respect to: 1) the genes present and the versions 
(alleles) of those genes; 2) mutations in individual genes, gene expression and gene regulation; 
3) proteins and protein activity and protein-protein interactions; 4) genetic networks (e.g., 
robustness and pleiotropy); 5) environmental exposures and evolutionary histories (Knight, et al., 
2006; Wall & Shani, 2008; Shanks, et al., 2009).  
Among other referenced pharmacology or toxicology studies, the lack of risk 
demonstration in the use of thalidomide in pregnant women is widely used by the AFMA 
activists, proving that even with all the studies “after the fact” such a teratogenic disaster could 
not have been prevented (Runner, 1967).  Approximately 10 strains of rats, 15 strains of mice, 11 
breeds of rabbits, 2 breeds of dogs, 3 strains of hamsters, 8 species of primates, and in other such 
73 
 
varied species as cats, armadillos, guinea pigs, swine and ferrets thalidomide was tested and, 
teratogenic effects have been induced only occasionally (Staples & Holtkamp, 1963; Shardein, 
J., 1976, “Drugs as teratogens” cited in Shanks, et al., 2009).  More than one example is used in 
their argumentations, among others: 1) troglitazone (Rezulin™), withdrawn for 1% incidence of 
liver failure (unnoticed in animal models); 2) rofecoxib (Vioxx™), withdrawn because it caused 
< 1% incidence of heart attack, or stroke (unnoticed in animal models); and 3) an open critique to 
the work of Olson on multiple pharmaceutical companies toxicity controls (Olson, et al., 2000; 
Topol, 2004; Masubuchi, 2006), to prove that the animal model testing would not have been 
accurate enough for society's standards. “Medical practice”, they stated, “does not tolerate risks 
that are instead acceptable for laboratory experiments”, since “getting the answer wrong in 
medical practice has consequences; people die” (sic) (Shanks, et al., 2009).  
However, the AFMA manifest’s conclusions, published on the web (http://www.afma-
curedisease.org) or on scientific journals (Greek & Shanks, 2009; Shanks, et al., 2009), leave a 
disheartening feeling in a knowledgeable readership. Partially, because they are biased in 
addressing only a portion of the experiments currently in process (i.e., excerpts wisely chosen of 
pharmaceutical and toxicological research, only); partially, because they are confuting the value 
of experiments on models. However, they don’t support fully the in vitro, ex vivo and in silico 
studies either, prospecting no specific solution, but to use “intraspecific rather than interspecific 
studies”, almost advocating for self-experimentation and micro-dosing experiments for 
toxicology studies in humans (Shanks, et al., 2009).   
In summary, the conclusions, or lack thereof, of the groups opposed to the use of animal 
models in modern biomedical science, bring us back to the fact that specific clinical problems 
require a deeper understanding in vivo.  As exposing people to un-trialed experiments is ethically 
unacceptable, the judicious use of animal models (often on mammalians) is, to this point, the 
only reasonable answer, before clinical trials can be condoned, and undertaken, with a margin of 
safety. 
 
2.6.1. The beginnings of the research on animal models.      
 
The first study that can thoroughly document a certain type of “modeling” is likely the 
collection of observations of the cow-pox (or better, horse-pox) vaccine for human small-pox, 
74 
 
which Dr. Jenner carefully compiled in 1798 (Jenner, 1798).  His experiments were based on 
clinical situations, as he was trying to understand the disease without compromising, or 
threatening, further human lives.  Jenner observed that passing the unknown etiologic agent from 
horse’s greasy heels (he defined it horse-pox) to cattle’s udder (cow-pox) caused the typical 
lesions, when the horse attendants were employed in the cattle barn (e.g. in the busier times of 
the year) (Jenner, 1798).  He described vividly his results, reporting all what he deemed 
important about the enrolled volunteers.  Men and women alike, often desperate, choose to test 
the scarification technique on themselves, or their children, hoping for protection from the 
disease.  At the time, he used no privacy statements (aside of some name omission) or informed 
consent to enroll “experimental” subjects. Careful annotations about probable previous exposure, 
and an apparent healthy physical condition were the only objective criteria in order to proceed 
with the scarification.   
The success of small-pox vaccination is an historical milestone in medicine, and many 
are examples followed. Particularly the studies conducted by L. Pasteur, and his collaborators, on 
fowl cholera, the anthrax vaccine, and, most prominently, the rabies vaccine, opened the route to 
the understanding of immunology and microbiology, validating the use of animal models in 
research (Campbell, 1915). During his work on the bacteria responsible for the fowl cholera in 
chickens, Pasteur and Chamberland found that the culture used to experimentally infect chickens 
had spoiled. Thus it failed to induce the overt disease, although mild clinical signs and short term 
recovery, without fatalities, were noticed (Sternberg, 1901).  Upon re-using the same healthy 
chickens, Pasteur discovered he could not infect them, even with fresh bacteria, as chickens 
developed a “sort of immunity” (Sternberg,1901; Walsh, 1913; Ullmann, 2007).  Similar results 
were obtained in cattle treated with a “vaccine” consisting of oxygen inactivated (via potassium 
dichromate) bacilli, following the initial steps taken by Dr. Toussaint, a veterinarian from 
Toulouse.  In the 1870s, Pasteur applied this immunization method to cattle, and the success 
aroused interest in combating other diseases (Sternberg, 1901).  However, it is the rabies vaccine, 
initially created by Dr. Roux, Pasteur’s colleague, who had the French scientist hailed as a hero.  
The killed vaccine was produced by desiccating the spinal cords of infected rabbits and, when 
Pasteur utilized successfully the vaccine on a 9-year old boy, mauled by a rabid dog, it had been 
tested only on 11 dogs (Walsh, 1913; Campbell, 1915).  The boy survived, Pasteur’s place in 
history became assured.    
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Although several types of research progressed on animal models across the world, a few 
dilemmas were encountered in those studies, for which either the transmission route or the 
pathogen itself could not be recognized, as in the case of Yellow Fever, which brought several 
expeditions from Europe and North America to their knees. Christopher Columbus’s second 
expedition appears to be the 1
st
 report; the decimation of Napoleon’s contingent sent to Louisiana 
and Mississippi, USA, at the beginning of the 1800, is another historical example; and, at the 
turn of the 20
th
 century, the majority of US Army troops sent to Cuba suffered the same fate 
(Pierce, 2011). While the physician “in charge” of the experimentation, MAJ (Dr.) Walter Reed, 
was struggling to use a guinea pig model, to reproduce the disease from mosquitoes fed onto 
diseased soldiers; Dr. Lazear, one of his collaborators, proceeded to infect directly a volunteer 
and himself. Although in Lazear’s laboratory book every change observed in the “guinea pigs” 
was annotated, MAJ Reed understood that there were no animals involved, but rather Lazear was 
writing about his self-inflicted disease.  In that study, started against military orders, the soldier 
recovered, but Dr. Lazear died, demonstrating that Yellow Fever needed several days’ 
“extrinsic” incubation within the mosquitoes, before being contagious for men. A volunteer-
based research started shortly after, utilizing for the first time: 1) an informed consent, 2) a 
privacy statement, and 3) a monetary retribution, as the concept of experimentation on people 
was already considered inappropriate and unwelcome to the public (Pierce, 2011).  Fortunately, 
the precautions against mosquitoes derived from Reed’s experiments impacted significantly both 
Yellow Fever’s morbidity and mortality, to be praised beyond the coasts of US and Cuba (e.g., 
Panama) within 6 months, even though Flaviviridae (the Yellow Fever viral agent) were not  
identified for another 30 years (Pierce, 2011). 
This brief historical introduction describes where the western biomedical science and 
research community started, and today still stands, considering the use of animals for research a 
privilege to use with ethic deontology, respect and appropriate statistics, to maximize its value. 
Unfortunately there are branches of biomedical research that cannot rely on systems (in vitro, in 
silico, or ex vivo) other than in vivo animal modeling.  
 
2.6.2. Rabbits and hamsters as animal models. 
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The volume of literature retrievable, thanks to computerized search engines, in regard to 
“rabbits” or “hamsters” used as animal models is enormous, with 26379 hits for rabbits animal 
models in general, and 2906 hits for rabbit infection animal models specifically 
(http://www.ncbi.nlm.nih.gov/pubmed?term=rabbit%);  9894 hits for hamster animal models in 
general, and 963 hits for hamster infection animal models specifically  
(http://www.ncbi.nlm.nih.gov/pubmed?term=hamster%).   
For this dissertation’s purpose, the focus will be on the above mentioned animal species 
used as infection models. It should not be disregarded that both species have long been used, 
alone or “in tandem” with other species, in every type of research, from pharmacology 
(Chambers ,2006; Moon, et al., 2006), to cancer pathogenesis studies (Vanderhyden, et al., 2003; 
Brandsma, 2005; Chen & Lin 2010), to, even, infant sudden unexplained death investigations 
(Blood-Siegfried & Shelton, 2004) and the literature cited are just recent limited examples of 
specific studies or reviews of standardized models.  Experimental infection models have the 
distinct advantages of controlling: 1) the unpredictability of naturally occurring infection; 2) 
external non-interventional factors (i.e., age, sex, feeding and housing); and 3) host 
characteristics which would require a large number of animals to separate the interventional 
effect from the natural chance in the disease/treatment (intervention) progression.  
For several human diseases (e.g., tuberculosis, cryptococcosis, anthrax etc.) multiple 
excellent infection models exist, and rabbits have been used often, depending on the infection’s 
aspect that the model is intended to clarify (Carroll, et al., 2007; Yee, et al., 2010; Jassal, et al., 
2011). Depending on the infection, rabbits showed a good correlation between their response to 
treatment and the human disease outcomes (Carroll, et al., 2007; Yee, et al., 2010).  Each model-
host species confers specific advantages, and limitations, for modeling disease in another species 
(e.g., from humans). Often, starting with a species naturally susceptible to the disease may be 
advantageous, for therapy research, or even more relevant for vaccine development (Carroll, et 
al., 2007), or, as of lately, to prevent bioterrorism (Chapman, et al., 2010; Yee, et al., 2010), 
even though bioterrorism is not a novel warfare method. For example, ignoring those 
Orthopoxvirus disease’s (and immunity’s) details, known and studied today in Rabbitpox 
infection models (Chapman, et al., 2010; Rice, et al., 2011), in 1763 did not stop soldiers from 
decimating Native American populations, by distributing smallpox-contaminated blankets, 
during the French and Indian wars (Henderson, et al., 1999).  Thus, in the development of a new 
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rabbit infection model for EPE, it is important to know that rabbits are naturally susceptible to L. 
intracellularis infection, as observed since before the pathogen was defined in 1995 (Moon, et 
al., 1974; Schoeb & Fox, 1990; Watarai, et al., 2004; Horiuchi, et al., 2008; Watarai, et al., 
2008).   
On the other hand, choosing a species naturally resistant to the infection (e.g., rabbits and 
cryptococcosis), may be needed for different reasons (e.g., epidemiology), although it is 
undeniable that immune-suppression is mandatory (Carroll, et al., 2007).  Also, a model-host 
species may be targeted to develop a type of symptomatology (or a treatment to the disease), 
rather than others, although it may need previous preparation (e.g., bacterial sensitization) 
(Jassal, et al., 2011). For example, a large size animal, such as the rabbit, can be useful in 
meningo-encephalitis infections because the size and accessibility of the brain; whereas a mouse-
model might be a better fit for a lung study, as more of its genomic needs and characteristics are 
known with respect to pulmonary pathophysiology (Carroll, et al., 2007).     
Regardless of the chosen model host, its role in the study of complex-host pathogen 
interactions may vary, depending on the study’s objective (Basaraba, 2008). We can distinguish 
research approaches as “host-centric” and as “microbe-centric”.  The former approach focuses on 
the immune-response and the inflammatory contributions typical of that species when challenged 
with a standardized microbial load, or inoculum (Casadevall, 2005).  The latter, is typically 
oriented at investigating the disease-causing factors related to the pathogen in a uniform model 
host system (Carroll, et al., 2007).  Such concepts may merge in the future, depending on the 
level of manipulation achieved, not only on model hosts (e.g., the transgenic mice), but also and 
more specifically on the infectious agents utilized for modeling.  
 
2.6.2.1. Rabbits.  
Probably the first claim to fame for rabbits used in an infection model was their use to 
produce the rabies vaccine that Roux and Pasteur discovered (Walsh, 1913).  Today several 
species of rabbits are used in a variety of infection models, depending on the specific research 
needs. The rabbits used in animal models are breeds belonging to the Oryctolagus cuniculi 
species, specifically the New Zealand white, the Dutch Belted, and the Old English (less 
commonly used today).  Old English rabbits appeared to have the highest immune-response, in 
comparison to other breeds, (i.e., increase for up to 46 days of E-type prostaglandins, total 
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leucocyte counts and free acid phosphatase activity) when challenged identically at the level of 
the knee joint, as it was reported in an older study on prostaglandins and arthritic inflammation 
(Blackham, et al., 1974).   
Rabbits have been long known to: 1) develop quickly an appropriately high immune-
response, whether it is needed for the production of diagnostics based on antibodies (e.g., 
monoclonal and polyclonal antibodies for plate coatings) (Guedes & Gebhart, 2003c); 2) 
construct allergy-based (asthma) laboratory models (Keir & Page, 2008); or 3) for the need to 
mount an immune (Breau, et al., 2012; Spaulding, et al., 2012) or autoimmune response (Dvorak 
& Waksman, 1962; Zhu, et al., 2003; Wei, et al., 2012). 
With the focus on the infection models that have used, and still use, rabbits, a few points 
should be underlined, as those are the characteristics to emulate when aiming to build a new 
infection model.  From the practical side, all rabbits (unless neonates are used) have a fairly large 
body weight (i.e., 2 - 3 kg) and usually a fairly high body temperature (39 - 39.5C) (Bergman, 
1966), with a few variations due to age and breed.  A number of routes of infection are easily 
accessible aside of the oral and parenteral routes: retinal, and ocular in general, via carotid artery 
(Fujita, et al., 1983); intra-cisternal (Perfect, et al., 1980); intra-tracheal (Nessa, et al., 1997), 
intra-testicular (Bergman, 1966), being utilized for those infectious agents requiring a slightly 
lower body temperature.  Their large body size allows repeated body fluid sampling (i.e., blood, 
but also CSF) and drug administration (Zak & Sande,1999), although they also require large 
doses of corticosteroids for immunosuppression (similarly to humans) (Zak & Sande, 1999), and 
depending on the route of infection, large inocula (Perfect, et al., 1980).  Thus far, their genetic 
information is incomplete (Zak & Sande,1999), but their purchase and maintenance costs are 
elevated, compared to other rodents (Bonner, et al., 1976) and (http://www.criver.com/en-
S/ProdServ/ByType/ResModOver/ResMod/Pages/NZWRabbit.aspx). Rabbits today are utilized 
commonly for ophthalmology infection studies (Altmann, et al., 2011), as a disease model for 
humans and veterinary species (Schulz, et al., 2001; Campo, 2002; Hayashi, et al., 2002; An, et 
al., 2006; Clemons, et al., 2007; Stanford, et al., 2007; Mitchell & Taggart, 2009; Ramirez-
Iglesias, et al., 2011); for the production of vaccines (Nalca & Nichols 2011; Breau, et al., 
2012); and for the observation of preclinical, or basic, development of specific lesions (Basaraba, 
2008), along with research in drug development, either for antimicrobial or anti-neoplastic 
therapy (Banin, et al., 2008; Kohno, et al., 2008; Zhou, et al., 2011).  
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2.6.2.1. Hamsters  
The species more commonly used is the Mesocricetus auratus, and the breed is the 
Syrian golden hamster.  Hamsters usually are of small size with body weight between 100 and 
150 g (depending on the breeding colony), although pet breeds can be larger (or smaller).  The 
approved routes of drug administration and sampling in hamster are the oral, intraperitoneal, sub 
cutis and intravenous routes.  The latter is suggested through the saphenous vein and, in 
anesthetized animals, the sublingual vein, the tip of the tail and the retrobulbar plexus, similarly 
to mouse and rat (Diehl, et al., 2001).  However, the use of the retrobulbar plexus is not 
supported any longer by the CCAC guidelines, as much as the bleeding through cardiocentesis is 
not advised for repeated sampling, but only for terminal blood collection, due to the incidence of 
fatalities (Diehl, et al., 2001). 
The use of hamsters has been more limited than other rodents, dogs or minipigs.  In the 
past, hamsters were more widely used for evaluation of carcinogenicity, in part to understand the 
original cause and the similarity with human adenocaricinomata (Jonas, et al., 1965), but 
particularly because diethylstilbesterol administration to hamsters resulted in neoplasms of the 
reproductive tract (both in males and females), liver and kidney (Jacobs 2006), which rendered 
them a very reliable model.  Today, hamsters are scarcely used for drug carcinogenicity studies, 
although they can be appropriate when species-specific effects arise in other rodent species, and 
their use is approved by Center for Drug Evaluation and Research (CDER)/FDA (Chen & Lin, 
2010).   
In general studies in hamster are recommended for evaluation of oral cavity 
pharmaceuticals, as their buccal cavity and cheek pouches are a good model for studies on non-
keratinized skin (http://www.fda.gov/cder/guidelines.htm 2005; Chen & Lin, 2010).  Hamsters 
may be used as models for effects of inhaled particles or administered intratracheally.  For some 
drugs, hamsters have been preferred because of higher bioavailability compared to rats (>10-
times greater in hamsters) (Jacobs, 2006).  Model-host studies in hamsters may be useful to 
evaluate not only a variety of drug administrations, but also infectious disease models (Haake, 
2006; Moon, et al., 2006; Nambiar, et al., 2006; Zuerner, et al., 2011) and diabetes investigation 
(Morand, et al., 2005).  Several parasitic diseases have been successfully modeled in hamsters 
and gerbils (Fenoy, et al., 2001), as mice are resistant to Entoamoeba spp. infection (Tsutsumi & 
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Shibayama, 2006), along with other human (Fox, et al., 2009; Reuter & Schneider-Schaulies, 
2010), and animal infectious diseases (Garg & Dube, 2006; Flisser, et al., 2010). 
In our specific case, hamster have been long reported as models for L. intracellularis 
infection, as they are naturally and experimentally susceptible to the PE agent, usually known as 
“wet tail” (Jacoby, et al., 1975; Amend, et al., 1976; Frisk & Wagner, 1977; Jacoby, 1978; 
Cooper, et al., 1997), with typical lesions of the ileum, from mild to severe and hyperplastic, and 
explains why the almost neoplastic appearance was initially confused with adenocarcinomatosis 
and compared to the human ileal neoplasia (Jonas, et al., 1965; Boothe & Cheville, 1967). 
 
2.6.3. Animal models for Lawsonia intracellularis  
 
Although L. intracellularis is an obligate intracellular bacterium, it is apparently not host-
restricted and it is able to produce infection in animals different than the species of origin, as it 
was detected in multiple species: horse, hamster, deer, dog, fox, rabbit, macaque, ostrich, emus 
and a giraffe (Drolet, et al., 1996; Hotchkiss, et al., 1996; Cooper, et al., 1997; Lemarchand, et 
al., 1997; Klein, et al., 1999; Herbst, et al., 2003; Pusterla, et al., 2008b).  
The first trials in reproducing the disease in pigs were published in 1977, with ileal 
mucosa scrapings from diseased subjects, as the etiological agent was still unclear and it could 
not be isolated on bacteriology plates (Roberts, et al., 1977).  In the following years a few 
pathogenesis characteristics were understood through in vivo modeling, as the disease failed to 
reproduce successfully in pathogen free piglets challenged with pure cell culture, although the 
reproduction was successful in gnotobiotic pigs, with both ileal scrapings and pure cell culture 
(McCartney, et al., 1984; McOrist & Lawson, 1989; McOrist, et al., 1993).  Yet again a full 
understanding of the bacterium characteristic remained out of grasp for a few more years 
(Gebhart, et al., 1991; Gebhart et al., 1993; Lawson & McOrist, 1993; McOrist, et al., 1995a).  
The bacterium was revealed to be very complicated to maintain in vitro and absolutely unable to 
grow on traditional bacteriology plates (Lawson, et al., 1993).  Since its classification was 
determined, multiple studies were conducted for L. intracellularis in vivo (McOrist, et al., 1994a; 
Guedes & Gebhart, 2003b; Guedes, et al., 2003; Jordan, et al., 2004), to determine the impact of 
pure cell culture-induced disease versus mucosal-scrapings-induced disease, along with the 
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presence, or absence, of a normal bacterial flora; the impact of the inoculum dose on infection; or 
the effect of a seeder sentinel pig in a herd.  Also, research was conducted on ex vivo ileal loops 
explanted from pigs (Collins, et al., 2000; McOrist, et al., 2006; Boutrup, et al., 2010a; Boutrup, 
et al., 2010b), contributing to a better understanding of its behavior, both for the requirements of 
diagnostics and vaccine development. Lately, studies investigating the level of naturally-acquired 
immunity were performed, serologically testing or re-challenging pigs exposed to infection in the 
past (Guedes, et al., 2002; Collins & Love, 2007).  
For epidemiology interest, the L. intracellularis infection has been reproduced in mice 
starting with isolates obtained from pigs and rabbits, although lesions are not detectable for long, 
so the species cannot be employed as an in vivo model (Murakata, et al., 2008).  Similar results 
have been achieved in rats and chickens (Collins, et al., 1999).   
Among rodents, probably the best cross-infection model for pigs in vivo is represented by 
the hamster, as its disease was noted early in the 1960’s (see above) and connected to the porcine 
clinical disease in the early research years (1970-1980s) (Frisk & Wagner, 1977; Johnson & 
Jacoby, 1978; Lawson, et al., 1985; McOrist & Lawson, 1987; McOrist, et al., 1989).  The first 
successful hamster species-specific model was reported around 1991 (also including the study on 
a cultured Chlamydia spp. by mistake) (Stills, et al., 1987; Stills & Hook, 1989; Stills, 1991; 
Stills, et al., 1991).  From the porcine strain, a cross infection model was obtained, only a few 
years later, with a reduced symptomatology if it was caused by pure cell culture rather than 
mucosal scrapings (Jasni, et al., 1994a; Jasni, et al., 1994b).  To this day, the only hamster 
models that produce severe clinical signs are the ones obtained with ileal mucosal scrapings, 
wherein the small intestine absorption and histo-morphometry are markedly abnormal 
(Vannucci, et al., 2010). 
Among rabbits and hares, the disease was found naturally (see above) or their fecal 
shedding was detected in horse farm surroundings (Pusterla, et al., 2008b; Pusterla, et al., 
2012a), but no rabbit has ever been used to reproduce the disease, either from other species or 
from species-specific infectious material (Duhamel, et al., 1998).  
In horses the only autologous model that has been published is the one by Pusterla and 
collaborators in 2010 (Pusterla, et al., 2010a), and reproduced by the group at University of 
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Kentucky (Page, et al., 2011c).  To this day, such a model is the only one available for EPE and 
may have serious clinical manifestations that render it risky for the animals (C. Gebhart, 
University of Minnesota, personal communication).  It is currently utilized for the investigations 
in process about developing a vaccine for EPE at University of California-Davis (See chapter 
2.3).  
With the intention of bearing in mind every possible alternative, before embarking on a 
new animal model validation, consideration was given to the ex vivo “Ussing chambers” already 
used for studies on equine intestinal tissues permeability and drug absorption (Davis, et al., 
2006). However, with the difficulties in maintaining the bacteria alive in the tissue harvested 
(Lawson, et al., 1993), the risk is that the model may lack validity before starting the tests on 
drug absorption, as bacteria may die regardless of treatment. 
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CHAPTER 3  
OBJECTIVE AND HYPOTHESES 
“Is the nature of an hypothesis,, when once a man has conceived it,  
that it assimilates everything to itself ,as proper nourishment” 
                                                                                   L. Sterne 
 
OBJECTIVE: To demonstrate that gallium maltolate is an appropriate metal based 
antimicrobial therapeutic to treat Equine Proliferative Enteropathy (EPE) in a laboratory animal 
infection model. 
3.1 Animal Model Validation – Hypotheses (H) 
 
Rationale: L. intracellularis is the obligate intra-cytoplasmic agent of EPE, Porcine 
Proliferative Enteropathy (PPE) complex and enteropathies in various animal species.  Its 
replication and maintenance in vitro are easily challenged by minimal variations in oxygen 
tension and carbon dioxide concentration, and the necessity of inducing disease in animal models 
has been demonstrated since the initial phases of its investigation.  L. intracellularis has a 98% 
genomic similarity (16s rDNA sequencing) between species’ isolates (horse, pig, hamster and 
deer).  Infection has been transmitted experimentally from pigs to hamsters since 1991 and it is 
suspected to cross infect to horses.  
3.1.1 - H1) Cross-infection of juvenile rabbits, with a pure cell culture of equine strain of 
L. intracellularis, will lead to mild to moderate clinical signs of disease and intestinal lesions, 
together with fecal shedding of bacteria and serologic immune-response, detectable by gold 
standard diagnostics (i.e., immuno-histochemistry on tissues, quantitative PCR on feces and 
immuno-peroxidase monolayer assay on serum). 
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3.1.2 - H2) Cross-infection of weanling hamsters, with a pure cell culture of equine strain 
of L. intracellularis, will lead - similarly to what is reported in hamsters infected with PPE - to 
mild clinical signs, but typical intestinal lesions, together with fecal shedding of bacterial DNA 
and serologic immune response. 
3.1.3 - H3) Cross-infection of juvenile rabbits, with a pure cell culture of PPE L. 
intracellularis will lead to mild to moderate clinical signs of disease, typical intestinal lesions - 
as the ones published in PPE-infected hamsters – together with fecal shedding and serologic 
immune-response. 
3.2 Therapeutic hypotheses 
 
Rationale: As a novel antimicrobial candidate, gallium maltolate (GaM), is the core of 
our research projects.  It is claimed to: be “highly” bioavailable; easily administered per os; able 
to release elemental gallium (Ga(III)) for absorption within cells.  The novelty of this idea rests 
with the iron-mimicry abilities of Ga(III) compared to ferric iron (Fe(III)), as Ga(III) has the 
same chemical radius and “footprint” of Fe(III), although incapable of undergoing a red-ox 
reaction. This phenomenon, known as “Trojan horse mechanism”, is selectively safe for 
mammalian versus protozoan cells, as bacteria preferentially uptake iron as Fe(III) (ferric iron), 
whereas mammalian cells prefer Fe(II) (ferrous iron). Due to the incapability of red-ox reacting 
with the bacterial organelles, gallium maltolate treatment should lead to the destruction of L. 
intracellularis, or to the inhibition of its replication, hence accomplishing its antimicrobial goal. 
3.2.1. - H1) After oral administration Ga(III) will be detected both in healthy and EPE-
infected rabbits intestinal tissues through hard x-ray fluorescence (VESPERS beamline at the 
Canadian Light Source), demonstrating its presence within the target tissues. 
3.2.2. – H2) After oral administration in healthy rabbits, Ga(III) will be detectable in 
serum, for pharmacokinetic evaluation, and within intestinal tissues both at 24 h and at the 
completion of a full pharmacokinetic study, lasting at least 3 estimated half-lives.  
3.2.3. - H3) After oral administration in EPE-infected rabbits, elemental gallium will be 
detectable in serum, for pharmacokinetic evaluation, and within intestinal tissues at 24 h and at 
completion of the full pharmacokinetic study, lasting at least 3 estimated half-lives.  
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3.2.4. - H4) The comparison between the healthy and EPE-infected rabbits will show a 
marked reduction in concentration of gallium and iron, both in blood and in intestinal tissues of 
the latter group, due to absorption difficulties of infected animals. 
3.2.5. - H5) The concentration of Ga(III) in serum and tissue in infected hamsters will be 
sufficient to exert antimicrobial activity, which is hypothesized to be superior to current clinical 
therapeutic treatments for EPE.  
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CHAPTER 4 
THE RABBIT AS AN INFECTION MODEL FOR EQUINE PROLIFERATIVE 
ENTEROPATHY.* 
 
 
Relationship of this study to the dissertation objectives. 
In this chapter, the results of a preliminary study on a rabbit infection model for EPE are 
reported. Rabbits had never been utilized as a modeling-host for Lawsonia intracellularis 
infection, although they are naturally susceptible to the infection.  The development of the model 
was a necessary step-stone in this entire research project. Thus, prior to investigation of the 
pharmacokinetics of gallium maltolate in this lagomorph species, the infection model was tested 
after inoculation with EPE bacteria cultured in vitro.  The success of this modeling experiment 
was of fundamental importance for the comparison between the pharmacokinetics of the 
compound of interest in healthy and EPE-diseased animals.   
 
 
 
* This material is to be published as: Sampieri, F., Allen, A.L., Pusterla, N., Vannucci, F.A., 
Antonopoulos, A.J., Ball, K.R., Thompson, J., Dowling, P.M., Hamilton, D.L. & Gebhart C.J. 
(2013). The rabbit as an infection model for equine proliferative enteropathy. Canadian Journal 
of Veterinary Research 77: 000-000. In press. 
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4.1. Abstract 
 
This study demonstrates the susceptibility of rabbits to Lawsonia intracellularis obtained 
from a clinical equine proliferative enteropathy (EPE) case, and thus provides a potential animal 
model for investigations on pathogenesis and therapy of this disease in horses.  Nine does were 
equally assigned to 3 groups.  Animals in 2 groups (Group 1 and Group 2) were orally inoculated 
with different doses of cell-cultured L. intracellularis.  Controls (Group 3) were sham inoculated.  
Feces and blood were collected prior to infection and at 7, 14, 21 days post infection (DPI).  
Serum IgG titers were measured using an immuno-peroxidase monolayer assay (IPMA) and 
fecal samples were analyzed with quantitative PCR (qPCR). A doe from each group was 
euthanized at 7, 14, 21 DPI for collection and evaluation of intestinal samples.  Tissues were 
stained by routine H&E and immunohistochemistry (IHC) with L. intracellularis-specific mouse 
monoclonal antibody.  Serologic responses were detected beginning at 14 DPI in both infected 
groups, which maintained high titers through 21 DPI.  On 7 DPI, L. intracellularis DNA was 
detected in the feces of Group 2 and on 14 DPI was detected in both infected groups.  Gross 
lesions were apparent in Group 1 and Group 2 on 14 DPI.  IHC confirmed L. intracellularis 
antigen within cells of Group 1 and Group 2 rabbits on 7, 14, 21 DPI.  No lesions, serologic 
response, shedding or IHC labeling were found in Group 3 rabbits.  This study describes an EPE 
rabbit model that simulates natural infection, as typical lesions, immune response, and fecal 
shedding were present. 
4.2. Introduction 
 
Lawsonia intracellularis is a Gram-negative, obligate intracellular bacterium affecting a 
wide range of domestic, wildlife, avian and laboratory animal species (McOrist, et al., 1995a; 
Hotchkiss, et al., 1996; Cooper, et al., 1997b; Lawson & Gebhart, 2000; Pusterla, et al., 2008b).  
Principally, L. intracellularis is known as the etiologic agent of porcine proliferative enteropathy 
(PPE) and equine proliferative enteropathy (EPE), with approximately 98% 16S rDNA gene 
similarities reported between strains (Cooper, et al., 1997a; Lawson & Gebhart, 2000; Pusterla & 
Gebhart, 2009).  Associated with L. intracellularis intra-cytoplasmic replication is the patent 
proliferation induced in the host’s enterocytes of either the small or large intestine, which 
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reduces nutrient absorption, resulting in malabsorption, diarrhea, depression, weight loss, 
abdominal pain, and even death (Wong, et al., 2009; Vannucci et al., 2010).  Typically, EPE 
affects the enterocytes of the distal portion of the jejunum and ileum of weanling foals.  Several 
individual, isolated cases of EPE were reported before 1999 (Duhamel & Wheeldon, 1982; 
Williams, et al., 1996; Brees, et al., 1999; Schumacher, et al., 2000).  The first large outbreaks in 
foals occurred in Quebec and Ontario, Canada, in 1999, and since then clinical EPE has acquired 
growing worldwide importance (Lavoie, et al., 2000; Frazer, 2008; Pusterla & Gebhart, 2009).   
L. intracellularis is a challenging organism to isolate and maintain in vitro, as its growth 
requires an intracellular environment and a specific microaerophilic atmosphere (Lawson, et al., 
1993).  Thus, multiple studies about L. intracellularis susceptibility in pigs targeted not only 
bacterial culture in vitro, but also experimental reproduction of PPE in animal models.  Hamsters 
are the main laboratory species that can be naturally affected by L. intracellularis, and the 
disease in this species is commonly and non-specifically addressed as “wet tail” (Lawson & 
Gebhart, 2000; Vannucci, et al., 2010).  Hamsters were the first model species in which 
information about lesion progression was experimentally gained, as disease was induced through 
laborious filtration of porcine infected ileal tissue scrapings (Jasni, et al., 1994b).  Since the early 
1990’s hamsters, more than mice, have been considered a potentially advantageous model for 
PPE because they afforded lower cost and larger statistical power of experiments (Stills, et al., 
1987; Stills & Hook, 1989; Stills, 1991; Stills, et al., 1991; Murakata, et al., 2008).  
Reproduction of the disease in laboratory species using intestinal mucosa homogenate or pure 
cell cultures has been traditionally limited to pigs or hamsters, either infected (from strains 
collected from animals of the same species) or cross-infected (from strains collected from 
different animal species) (Stills, 1991; Boutrup, et al., 2010a; Boutrup, et al., 2010b).  Thus, 
although a few investigators have successfully produced typical lesions of PE in mice, hamsters 
continue to provide a reliable infection model to investigate PPE using porcine ileal scraping 
homogenates as inocula (Jasni, et al., 1994a; Murakata, et al., 2008; Vannucci, et al., 2010).   
In foals, EPE has only been experimentally reproduced after oral inoculation of an equine 
strain of L. intracellularis, originating from the intestine of an affected foal that succumbed to 
EPE (Pusterla, et al., 2010a).  However, there are no published reports of EPE reproduced in a 
different species and the question arises about the susceptibility of other animals to the equine L. 
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intracellularis strain.  Two preliminary infection trials in hamsters with a virulent pure cell 
culture equine L. intracellularis strain did not yield EPE lesions.  However, classical microscopic 
lesions were clearly observed in positive control hamsters infected with a pure cell culture 
porcine L. intracellularis strain (Chapter 5).  
Interestingly, natural L. intracellularis infection is also recognized in rabbits, although 
less frequently than in hamsters.  Clinical signs are similar to the ones noted in other species, 
although the intestinal lesions are also commonly found in the cecum and large colon (Schoeb & 
Fox 1990; Horiuchi, et al., 2008; Murakata, et al., 2008; Watarai, et al., 2008).  Furthermore, 
fecal shedding has been observed through quantitative polymerase chain reaction (qPCR) of 
fecal material recovered from wild rabbits which were populating the grounds of equine stud 
farms, wherein EPE was endemic (Pusterla, et al., 2008b).   
This present study aimed to reproduce EPE lesions in rabbits due to the anatomical and 
physiological similarities of their gastrointestinal systems to the horse (Harcourt-Brown, 2002a).  
This is the first report of experimental infection in rabbits with a pure cell culture of L. 
intracellularis derived from an EPE clinical case, and it represents a valuable preliminary step in 
developing a rabbit infection model for studying EPE in horses. 
4.3. Materials and Methods 
 
4.3.1 Animals 
 
Nine, 7- to 8-wk-old female New Zealand white rabbits (Charles River Canada, Pointe 
Claire, QC, Canada) were used (spp. Oryctolagus cuniculus, strain -052). They originated from 
colonies tested, at regular intervals, for absence (VAF) of Reovirus, Rotavirus, L. 
intracellularis, Helicobacter spp., CAR Bacillus, Salmonella spp., Pasteurella spp., P. 
aeruginosa, Treponema Helmints spp., C. piliforme, Eimeria spp. amongst other viral, bacterial 
and parasitic diseases.  Upon arrival to the Animal Care Unit facilities at the University of 
Saskatchewan’s Western College of Veterinary Medicine, the 9 does were mandatorily 
acclimated to the room facilities for 1 week.  At the beginning of the experimental trial they 
were weighed (range: 1.8 to 2.3 kg), examined and tattooed on the right ear after local 
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anesthetic treatment (EMLA Cream, Astra Zeneca Canada Inc., Missisauga, ON, Canada).  
Rabbits were randomly assigned to 3 groups of 3 animals each (Group 1, Group 2 and Group 3), 
group-housed in isolated pens in a Containment Level 2 Room, fed rabbit pellets (Co-op Whole 
Earth* Rabbit Ration, Federated Co-op. Ltd. Saskatoon, SK, Canada) ad libitum and maintained 
using standard husbandry conditions (12/12 h light – dark cycle, and 20 ± 2oC room 
temperature).  All groups were housed, within the same room, but managed separately, with 
particular care to assess Group 3 (uninfected controls) first.  Animals were bedded on ventilated 
shavings. The base of the pen was separated and isolated from other pens by PVC 
compartments (40-50 cm tall), whereas a stainless steel mesh was used at the top, impeding 
direct contact between rabbits of adjacent pens’ and the mixing of bedding. Cleaning and 
disinfection procedures were standardized for the facilities and a peroxide-based disinfectant 
(Peroxigard, Bayer Healthcare, Animal Health Division, Bayer Inc., Toronto, ON Canada) was 
used. This study was approved by the Animal Research Ethics Board of the University of 
Saskatchewan and conducted according to Canadian Council on Animal Care (CCAC) 
guidelines.  
4.3.2. Inoculum preparation 
 
L. intracellularis inocula were prepared as previously described (Pusterla, et al., 2010a).  
The infectious material was harvested during necropsy of a foal diagnosed with EPE, wherein 
clinical signs were confirmed by histopathology and IHC findings.  Subsequently, the L. 
intracellularis harvested from the ileal mucosa were cultured on McCoy cells (ATCC CRL 
1696), as previously described (Lawson, et al., 1993; Guedes & Gebhart, 2003b).  Two different 
doses of inocula were prepared and each was suspended in 3 mL of buffered 
sucrose/phosphate/glutamate (SPG) medium, to be administered to Group 1 and Group 2 rabbits 
(Guedes, et al., 2003).  Sham treatment (SPG medium only) was administered to Group 3 
(controls).  A SYBR Green-based PCR quantitation assay was used to determine the bacterial 
concentration of the inocula.  This assay targets the aspartate ammonia lyase gene (aspA gene), 
which is represented just once on the L. intracellularis chromosome, so that each aspA gene 
copy corresponds to one organism (Wattanaphansak, et al., 2010).  Since a lower culture passage 
appears related to higher L. intracellularis virulence, passage cultures lower than 20 (passages 9 
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and 10, for Group 1 and Group 2, respectively) were used to infect the rabbits, but with different 
doses, to potentially compensate for the difference in passage. Thus, Group 1 received a dose 
equivalent to 1.3×10
8 
bacteria/rabbit; and Group 2 received a dose equivalent to 2.5×10
8 
bacteria/rabbit. These infecting doses, obtained from the same equine infected isolate previously 
utilized in the foal model, are approximately 150-200 times smaller than the doses used to infect 
foals; and 6-10 times larger than the dose used to infect hamsters (Pusterla, et al., 2010a; Chapter 
5).   
4.3.3. Inoculation procedures 
 
Rabbit inoculation with L. intracellularis was performed on the first day after the 
acclimation period (a week from arrival).  Prior to the infection, pooled fecal samples were 
collected from each separate pen, each rabbit was weighed and its general health was assessed, 
and a blood sample was collected from the left ear’s central artery, which was previously 
prepped with a local anesthetic cream (EMLA Cream, Astra Zeneca Canada Inc., Missisauga, 
ON, Canada).  A local lidocaine gel block (Xylocaine Gel 2%,  Astra Zeneca Canada Inc., 
Missisauga, ON, Canada) was applied inside the right nostril; and a 5 Fr. wide, 40 cm long 
feeding tube (Kendall Sovereign, Tyco Health Care Group LP, Mansfield, MA, USA) was 
inserted via the nose into the stomach.  Each rabbit received naso-gastrically either a 3 mL L. 
intracellularis inoculum or a 3 mL SPG medium-only treatment.    
4.3.4. Collection of samples 
 
Body weight changes were monitored daily throughout the study (21 days).  Demeanor, 
gross appearance, fecal consistency and quality, appetite, and self and mutual grooming were 
monitored twice daily with a 4 step grading system, a score of 0 corresponding to normal and 3 
to severely abnormal findings.  All rabbits readily adapted to handling and their interest could be 
easily stimulated with carrots and apples (treats).  Treats were offered twice daily to check 
appetite, as in the group-housing setting it is difficult to assess each individual’s food intake.  
Lack of interest in treats was considered a sign of decreased well-being (Johnson-Delaney, 
2006).  
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Blood samples for serology were collected from the central artery of the left or right ear 
of each rabbit once weekly and at the time of euthanasia.  Also, pooled fecal samples were 
collected from each separate pen once weekly, and individual fecal samples were collected at the 
time of euthanasia.  One doe per week per group was randomly selected and humanely 
euthanized with an intravenous overdose (720 mg/rabbit) of pentobarbital (Euthanyl, Bimeda 
MTC, Animal Health Inc., Cambridge, ON, Canada).  Necropsies were performed to observe 
evidence of gross lesions and to collect multiple intestinal tract samples (1.25 to 2.5 cm long) for 
microscopic examination.  Samples were immediately placed in phosphate buffered 10% 
formalin solution.  
4.3.5. Sample analysis  
 
4.3.5.1. Macroscopic examination.  
The abdominal cavity was opened shortly after euthanasia, the mesentery and mesocolon 
were dissected, and the organs were examined visually, from stomach to rectum.  Changes in 
thickness, discoloration or content of the intestinal tract were observed.  The sample of 
duodenum was collected 2.5 cm distal to the pylorus; one jejunal sample was collected at an 
approximate mid-distance between the end of duodenum and the beginning of ileum, whereas the 
terminal jejunal sample was collected proximal to the last jejunal Peyer’s patch. The ileal sample 
was collected proximal and adjacent to the ileal Peyer’s patch, approximately 5 cm proximal to 
the ileocecal valve.  The ileocecal valve was also collected in its entirety, including the ampulla 
coli and sacculus rotundus.  The sample of cecum was collected in the transitional area between 
cecum and appendix ceci, and the terminal portion of the appendix ceci was also collected.  The 
sample of large colon was collected adjacent and distal to the cecum, whereas the sample of 
terminal colon was collected at a mid-distance between the end of the large colon and the 
rectum. 
4.3.5.2. Histology and immunohistochemistry.  
Two adjacent formalin-fixed paraffin-embedded sections per sample were cut and stained 
by haematoxylin-eosin method (H&E) and streptavidin method, using anti-L. intracellularis-
specific murine monoclonal antibody (IHC), to observe for typical proliferative lesions of the 
intestinal epithelium and for the presence of the antigen within the cells (Guedes & Gebhart, 
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2003b; Guedes & Gebhart 2003c).  The L. intracellularis-specific antigen in the enterocytes was 
blindly evaluated with a 5 grade IHC scoring system, as follows: grade 0, for no antigen labeling 
in the tissue; grade 1, for up to 25% of the crypts labeled; grade 2, for 26 - 50% crypts labeled; 
grade 3, for 51-75% crypts labeled; and grade 4, for 76-100% crypts labeled (Guedes & Gebhart, 
2003b). For each rabbit, the negative control for each tissue section consisted of a correspondent 
tissue section IHC-labeled, except for the primary antibody. Furthermore, pig ileal tissues, 
known to be negative and positive for L. intracellularis infection, were labeled with the murine 
anti-L. intracellularis monoclonal antibody to confirm the antibody's specificity and sensitivity, 
respectively. 
4.3.5.3. Serology analysis.  
In serum, anti–L. intracellularis–specific IgG concentration was measured by an immuno 
peroxidase monolayer assay (IPMA), as reported previously (Guedes, et al., 2002c).  Positive 
serum samples were end-point titrated starting with a dilution of 1:30 up to 1:1920.  Control 
samples consisted of serum from a rabbit prior to (negative control) and after (positive control) 
hyperimmunization with L. intracellularis, purified from cell culture. Also, serum total protein 
concentration was measured with the refractometer method to investigate if changes in serum 
total protein concentration were comparable to the values reported in foals naturally and 
experimentally infected with EPE (Pusterla, et al., 2010a).  
4.3.5.4. Quantitative PCR Analysis.  
Quantitative PCR (qPCR) analysis was conducted on fecal samples, as previously reported 
(Pusterla, et al., 2010a).  The purified DNA was analyzed by qPCR for presence of L. 
intracellularis aspA gene copies (Pusterla, et al., 2008b; Pusterla, et al., 2009a).  For each target 
gene, two primers and an internal, fluorescent labeled TaqMan probe (5´end, reporter dye FAM 
(6-carboxyflourescein), 3´end, quencher dye TAMRA (6-carboxytetramethylrhodamine)) was 
designed using Primer Express software (Applied Biosystems, Foster City, CA, USA)
 
(Table 1). 
TaqMan PCR systems were validated using 2-fold dilutions of gDNA testing positive for the 
target genes.  Dilutions were analyzed in triplicate and a standard curve was plotted against the 
dilutions.  The slope of the standard curve was used to calculate amplification efficiencies using 
the formula E = 10 
1/-s
-1.  Each system needed to be greater than 95% efficiency to be 
considered.  The detection limit for “L.intra system” is between 5-10 copies/l DNA (determined 
with plasmid DNA).  The “L.intra system” detects all L. intracellularis, regardless of the host 
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species.  Known positive controls and no template controls were run on every plate, and met 
previously standardized values.  DNA quality was determined by the “PanBacteria system”, with 
a control value under 30, to pass quality control (Leutenegger, et al., 1999).   
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Table 4.1 PCR analysis details 
  
System 
Forward primer Reverse primer Probe target Accession 
number 
Efficiency 
L.intra 
 
bcL.intra-114f 
CACTTGCAAA
CAATAAACTT
GGTCTTC 
bcL.intra-263r 
CATTCATATTTGT
ACTTGTCCCTGCA 
bcL.intra-201p 
TCCTTGATCAATTTGT
TGTGGATTGTATTCAA
GG 
Aspartate 
ammonia 
lyase 
EU127293.
1 
95.6% 
Pan- 
bacteria 
 
PB.283f 
GGATGATCA
GCCACACTGG
A 
PB.352r 
CCAATATTCCTCA
CTGCTGCC 
PB.305 
CCCGTAGGAGTCTGG
ACCGTGTCTCA 
16S rRNA Multi 
sequence 
alignment 
98.2% 
 
Table 4.1: Specific forward and reverse primers sequences, along with probe, target gene and 
accession numbers for the technique of PCR utilized in the diagnosis of L. intracellularis fecal 
shedding in rabbits, after infectious challenge with pure cell bacteria. In the last column of the 
table, note the rate of efficiency. 
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4.3.5.5. RT-reaction and real-time TaqMan PCR.  
Each PCR reaction contained 20x primer and probes for the respective TaqMan system 
with a final concentration of 400 nM for each primer and 80 nM for the TaqMan probe and 
commercially available PCR Mastermix (TaqMan Universal PCR Mastermix, Applied 
Biosystems, Foster City, CA, USA), containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mM 
MgCl2, 2.5 mM deoxynucleotide triphosphates, 0.625 U AmpliTaq Gold DNA polymerase per 
reaction; 0.25 U AmpErase UNG per reaction; and 1 l of the DNA sample in a final volume of 
12 l.  The samples were placed in 384 well plates and amplified in an automated fluorometer 
(ABI PRISM 7900 HTA FAST, ABI).  ABI’s standard amplification conditions were used: 2 
min at 50°C, 10 min at 95°C, 40 cycles of 15 s at 95°C and 60 s at 60°C. Fluorescent signals 
were collected during the annealing temperature and CT values extracted with a threshold of 0.1 
and baseline values of 3-12 for all samples using SDS 2.2.1 (Applied Biosystems, Foster City, 
CA, USA). Absolute quantitation was calculated by a standard curve and expressed as copy 
numbers of the L. intracellularis aspA gene per gram of feces. 
 
4.3.6. Statistics 
 
In general, only descriptive statistics were used in this study, as sample numbers were 
insufficient for statistical analysis.  However, bodyweight and serum total protein concentration 
were analyzed with a Kruskal-Wallis non-parametric test and Dunn post-hoc testing for multiple 
comparisons between groups. Commercial software (GraphPad Prism 5.4 Software, CA, USA) 
was used, with p–value set at ≤ 0.05. 
4.4. Results 
 
4.4.1. Clinical signs.  
 
During the entire duration of this study, no evidence of diarrhea, overt signs of pain (e.g., 
bruxism), or prostration were detected in the rabbits. Minor details of incomplete grooming 
around the tail region were noted in rabbits of all groups, but these were observed sporadically 
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and deemed not relevant.  No remarkable changes were noted in any group during the first 7 
DPI, aside from a transient (1 day’s duration only) weight loss, or a weight gain smaller than half 
the individual’s average daily gain. This weight loss affected control and infected rabbits alike 
on 1 DPI and was ascribed to the stressful procedures on the day of infection (day 0).  As the 
rabbits were still growing, their bodyweight gain should have ranged between 100 to 200 g/week 
(or 14.2 to 28.5 g/day), as per the provider’s indications (Charles River Canada, Pointe Claire, 
QC, Canada).  All rabbits’ averaged daily weight gains were within limits, with 2 rabbits well 
above that range (52 g and 49.1 g for Group 1 and Group 2, respectively).  Negative weight 
changes were not statistically significant (p–value = 0.87) in any of the groups throughout the 21 
DPI (Figure 1).  However, between 12 to 17 DPI in Group 1 and Group 2, infected rabbits’ 
weight losses, or gains smaller than half the individual’s average daily gain, were noted.  The 
only animal that showed depression and dullness between 12 (rated 1) and 14 (rated 2) DPI was 
the Group 1 doe euthanized at 14 DPI, which showed marked progressive weight loss and lack of 
appetite.  Additionally, although general self-grooming appeared normal, the normal residues of 
cecotrophes on the perineum of this doe were not cleaned (abnormal behavior). 
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Figure 4.1. 
 
Figure 4.1: Bodyweight (in Kg) changes in Rabbits infected with L. intracellularis.  
Graphical representation of the weight gains during the whole duration of the experiment (21 
DPI). In the 2 infected groups a trend to reduced weight gain and marginal weight loss can be 
noted, although these were statistically not different than the control weight gains (p=0.87). 
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4.4.2. Necropsy findings. 
  
Gross lesions were not evident in any of the rabbits examined on 7 DPI, but on 14 DPI, 
Group 1 and Group 2 infected rabbits showed hyperemia and edematous corrugation of the 
serosal surface of the jejunum (such as a “cobblestone-like” appearance) (Figure 2a) compared 
to controls (Figures 2b and 2d).  Additionally, typical PE lesions were observed in the mucosal 
surface (Figure 2c).  The ileum showed a similar “cobblestone-like” appearance, particularly 
close to the ileocecal valve.  These gross changes were consistent with proliferative enteropathy 
lesions, as described in rabbits, pigs and horses (Lavoie, et al., 2000; Lawson & Gebhart, 2000; 
Horiuchi, et al., 2008).  The cecum of the Group 1 infected rabbit appeared generally hyperemic 
once opened, and it was deemed non-specific for EPE.  Hyperemia was not noticeable in the 
cecum of Group 2 or Group 3 does. 
By 14 DPI, the Group 1 rabbit that was euthanized had lost over 200g in 3 days.  In 
contrast, the rabbits in Group 2 and Group 3 gained marginal or no weight but did not lose 
weight.  Also, the Group 1 rabbit’s terminal colon and rectum were mostly empty, although 
cecum and colon content did not differ from the control doe.   
By 21 DPI, only mild, non-specific changes were noted on gross pathology at necropsy. 
These changes included hyperemia and mild wall thickening (edema) of the serosal surface of 
the jejunum of both Group 1 and Group 2 rabbits, and were more pronounced in Group 1.
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Figure 4.2.1. 
 
Figure 4.2.2.  
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Figure 4.2.3. 
 
Figure 4.2.4. 
 
Figure 4.2: Comparisons of infected and uninfected jejunum in a rabbit model for L. 
intracellularis infection. Scale bar, 1 cm. Description: Figure 4.2.1: Serosal surface of the mid-
jejunum from an infected rabbit (Group 1 inoculum) at 14 DPI.  Note the cobblestone-like 
appearance of the serosal surface.  A round jejunal Peyer’s patch is notable on the left side 
(arrow).  Figure 4.2.2.: Serosal surface of a mid-jejunum section of a control rabbit.  Figure 
4.2.3.: Luminal surface of the mid-jejunum from an infected rabbit (Group 1 inoculum) at 14 
DPI.  Note the rugae of the mucosa. Figure 4.2.4: Luminal surface of the mid-jejunum from a 
control uninfected rabbit.  Note the smooth surface. 
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  4.4.3. Histology and immunohistochemistry. 
  
Typical histological lesions characterized by hyperplasia of immature enterocytes and 
absence of goblet cells were observed by H&E staining, but no inflammation was detected. 
These proliferative changes were consistently associated with the presence of intracellular 
bacteria identified by IHC (Figure 4.3.1. and 4.3.2.).  Detailed results of IHC analysis on 
intestinal sections are summarized in Table 4.2. 
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Table 4.2. Immunohistochemistry (IHC) results in L. intracellularis orally inoculated 
rabbits. 
Section Group 3  Rabbits (Control ) Group 1 Rabbits Group 2 Rabbits 
 7 days 14 days 21 days 7 days 14 days 21 days 7 days 14 days 21 days 
Duodenum 0 0 0 0 0 0 0 0 0 
Mid jejunum 0 0 0 0 +3 0 +1 +1 0 
End jejunum 0 0 0 +1 +1 0 +2 +2 0 
Ileum 0 0 0 0 +1 0 +2 +1 0 
Cecum 0 0 0 +2 +2 +1 +2 +1 0 
Appendix 
ceci 
0 0 0 0 +1 0 +1 +1 0 
Ileocecal 
valve 
0 0 0 0 +1 0 +2 +1 0 
Colon 0 0 0 +1 +2 0 +2 +2 0 
Terminal 
colon 
0 0 0 0 0 0 0 0 0 
Rectum 0 0 0 0 0 0 0 0 0 
 
Table 4.2: Results are separated by group and by DPI (7, 14, and 21). Numbers in the table refer 
to IHC grading from 0 to 4, grade 0 is no antigen labeling detected (no shading), grade +1 (light 
gray shading) equivalent to 25% antigen labeled, grade +2 (gray shading) equivalent to 50%, 
grade +3 (dark gray shading) to 75%, and grade +4 (very dark gray shading) equivalent to 100% 
antigen labeled.  The groups consisted of 3 rabbits each, which were euthanized once weekly, 
one per group. Group 1 was infected orally with 1.3 x 10
8 
bacteria/rabbit and Group 2 with 2.5 x 
10
8 
bacteria/rabbit. Group 3 was inoculated with medium only. Bacterial virulence of inocula 
was verified by challenge of natural host (4 foals) with the same lot of bacteria in different 
studies (Pusterla, et al., 2010a; Pusterla, et al., 2012a). 
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  IHC analysis was conducted on intestinal sections from duodenum to rectum at 7, 14, 
and 21 DPI.  At 7 DPI, L. intracellularis antigen was found as multifocal (mild to diffuse) 
labeling in the apical cytoplasm of enterocytes in the jejunum, caecal tip and colon of the Group 
1 infected rabbits, and in the jejunum, ileum, cecum and colon of the Group 2 infected rabbit 
(Figure 4.3.1.).  The labeled antigen in caecal epithelium is shown in Figure 4.3.2.  At 7 DPI, 
all stained antigen was in the enterocytes and no L. intracellularis antigen was detectable in the 
lamina propria of any of the intestinal sections.   
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Figure 4.3.1. 
 
Figure 4.3.2.    
 
Figure 4.3: Immunochemistry stains of infected rabbit intestine. L. intracellularis antigen-
specific staining with AEC substrate-chromogen and counterstained with Mayer’s haematoxylin. 
Figure 4.3.1: note ileal crypts of an experimentally infected rabbit (14 DPI).  Note the 
hyperplasia of immature enterocytes associated with bacterial infection (apical membrane).  
Scale bar, 10 µm.  Figure 4.3.2: note the caecal mucosa of an experimentally infected rabbit 
(14DPI), showing labeled antigen in the superficial epithelium. Scale bar, 100 µm. 
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At 14 DPI, the antigen was found in epithelium and lamina propria as focal to multifocal 
and diffuse labeling, and the extent of the microscopic lesions previously observed in the H&E 
staining was associated with the increased IHC grading (grades 2 or 3).  In the Group 2 infected 
rabbit, L. intracellularis antigen was not found in the lamina propria of terminal jejunum, 
appendix ceci or colon samples, but the grading was higher due to the higher frequency of 
antigen detection in the epithelium.   
At 21 DPI, IHC analysis showed no detectable antigen in any of the infected groups 
except a focally labeled area noted in the lamina propria of the caecal tip of the Group 1 infected 
rabbit.  Thus, IHC labeling and histologic analysis demonstrated that the rabbits had lesions from 
about 7 through 21 DPI, with highest severity noted at 14 DPI.  No presence of labeled L. 
intracellularis antigen was detected in the duodenum, terminal colon, or rectum of any groups, 
nor was antigen detected in the intestinal tract of Group 3 (control rabbits) at any point in the 
experiment.  
 
4.4.4. Serum analyses.  
 
As displayed in Figure 4, serologic responses were detectable by IPMA analyses in the 
infected groups at 14 DPI.  L. intracellularis infection generated a high serologic response in 
both infected groups, coinciding with the severity of lesions. With regards to total protein 
concentrations in sera, no significant differences (p = 0.72) were found between groups.  
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Figure 4.4. Serologic response in L. intracellularis infected rabbits  
 
Figure 4.4: Serologic response detected in experimentally infected and uninfected control rabbits 
after oral challenge with an equine strain of Lawsonia intracellularis.  The rabbits were infected 
with a strain proven virulent in foals and did not show any circulating antibody until 14 DPI, 
showing that the immune response requires a minimum time to show and does not manifest 
equally in every individual (note the different titers in different animals). 
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4.4.5. Quantitative PCR. 
  
The results of the qPCR analysis are displayed in Figure 5.  L. intracellularis was detected 
in feces of Group 2 infected rabbits at 7 DPI and was detected in both Group 1 and Group 2 
rabbits at 14 DPI, becoming undetectable at 21 DPI.  In Group 3 rabbits (controls), L. 
intracellularis organisms were never shed in feces throughout the experiment.  
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Figure 4.5 
 
Figure 4.5: Quantitative PCR results. Quantitative PCR results (represented by L. 
intracellularis DNA gene copies/g feces) in rabbits experimentally infected with equine strain of 
Lawsonia intracellularis and in uninfected controls.  Note that the represented fecal shedding 
was obtained for each group not for each individual.  From these preliminary results the fecal 
shedding of L. intracellularis after cross infection from horses to rabbits, can be noted as early as 
7 DPI, but apparently resolves by 21 DPI.  
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4.5. Discussion 
 
This study describes the initial development of a rabbit infection model to investigate 
EPE in horses.  Results show that there is merit in substituting rabbits for horses in infection 
model studies for EPE, as infection in juvenile rabbits was achieved after inoculation with a pure 
cell culture equine strain of L. intracellularis.  Such findings provide a basis for pathogenesis 
studies, as this EPE infection model can be obtained within a relatively short incubation period 
and lesions can resolve quickly without subjecting animals to excessive discomfort.  The equine 
strain of L. intracellularis, although purified through growth in cell culture, was pathogenic for 
rabbits.  The infection did not cause marked clinical illness, but macroscopic and microscopic 
lesions were detected and confirmed by histopathology and IHC. Such findings were comparable 
to the ones observed in foals naturally and experimentally infected with EPE (Pusterla & 
Gebhart, 2009; Pusterla, et al., 2010a).  Similarly, in the infected rabbits, fecal qPCR findings 
and IPMA serology showed fecal shedding consistent with bacterial active replication and 
marked immune response, respectively.   
A trend of reduced growth performance was noted in Group 1 and Group 2 rabbits 
around 12 and 17 DPI, which approximately corresponded with the time of the infection’s peak 
(14 DPI) as lesions appeared more severe on gross pathology and IHC labeling at that time.  
Moderate weight loss and dullness, along with decreased appetite, were the most remarkable 
clinical signs noted.  Overall, the clinical signs observed were mild; likely, the rabbits 
experimentally infected in this model could survive through the acute phase of the infection.  
Diarrhea was never noted, contrary to what is reported in both naturally infected rabbits and 
naturally and experimentally infected foals (Horiuchi, et al., 2008; Pusterla, et al., 2010a).  In 
this study, the clinical condition of infected does appeared normal on 21 DPI, although the 
surviving Group 1 rabbit (the most clinically-affected group) did not appear to gain weight at the 
rate exhibited prior to the peak of disease (or less than half the average daily weight gain).  Even 
with no clinical support, recovery appeared to occur by 21 DPI, as evidenced by improved 
weight gain and the absence of major IHC labeling.  Mild IHC labeling (grade 1) in the cecum of 
the Group 1 rabbit could be consistent with ongoing recovery.  This differs from reports about 
rabbits exhibiting clinical disease, after natural exposure, wherein clinical signs consist of 
marked diarrhea, weight loss and dehydration; or from sub-clinically affected rabbits, as they are 
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commonly reported to be exposed to the disease (Duhamel, et al., 1998; Horiuchi, et al., 2008; 
Pusterla, et al. 2008b; Watarai, et al., 2008).     
Previous reports and personal communications regarding hamsters’ infection with 
porcine strain L. intracellularis grown in cell culture noted that clinical signs are usually subtle 
or absent, yet characteristic histopathology lesions were present (Jasni, et al., 1994a; Vannucci, 
et al., 2010).  In the rabbits of this study, in spite of mild clinical signs, gross lesions typical of 
EPE extended from the mid-jejunum to the terminal ileum (Lavoie, et al., 2000; Schumacher, et 
al., 2000; Pusterla & Gebhart, 2009).  Characteristically, L. intracellularis is found free within 
the apical cytoplasm of small intestinal crypt cells, particularly in the distal jejunum and ileum, 
in both horses and pigs, as previously reviewed (Lawson & Gebhart, 2000).  Caecal hyperemia 
was noted in the Group 1 rabbit, at the disease’s peak, and deemed a non-specific change, 
although caecal and colonic proliferative lesions can typically be found in naturally infected 
rabbits (Schoeb & Fox, 1990).  Possibly, in this cross-infection model, lesion location may be 
related to the bacterial isolate involved, rather than the animal species affected.  In other words, 
EPE lesions, even in rabbits, appear preferentially located in those sites typical for horses, such 
as jejunum and ileum, whereas only mild, non-specific lesions are found in sites observed only in 
overtly diseased rabbits, such as cecum and colon (Duhamel, et al., 1998; Horiuchi, et al., 2008).  
However, further studies are warranted to confirm this suspicion.   
Lesions were confirmed through IHC labeling starting at 7 DPI, and their severity 
increased at 14 DPI, but decreased dramatically by 21 DPI.  Such a finding is quite novel, as the 
incubation period is longer in experimentally infected horses and pigs (Lawson & Gebhart, 2000; 
Pusterla, et al., 2010a). Furthermore, presence of antigen in the lamina propria was noted, 
particularly in the Group 1 infected rabbit, suggesting an infection at an advanced stage or, later 
on (21 DPI), resolution of the lesions, as antigen was observed in the macrophages in the lamina 
propria (Jensen, et al., 1997). 
The dose of bacterial challenge, administered orally as it is the natural infection route, 
differed slightly in the 2 infected groups, but this did not seem to have a major impact on results, 
as infection was obtained in both groups.  For both inocula, the bacterial virulence was verified 
by challenge of natural host (4 foals) with the same lot of L. intracellularis, in a different study, 
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in which foals developed clinical EPE, with severe manifestations (3 out of 4) and demise (1 out 
of 4) (Vannucci, et al., 2012).  
On gross inspection the passage 9 inocula (Group 1) caused marked lesions and 
temporary weight loss, whereas the passage 10 inocula (Group 2) caused milder lesions and even 
milder clinical signs. Although studies in pig models show that increased (10-fold) 
concentrations of inoculum are related to increased severity of clinical signs, different virulence 
did not appear related to a 2-fold increase in concentration in the rabbit model (Guedes, et al., 
2003).  Moreover, severity of clinical appearance in this model could be related to a low passage 
isolate, which somehow compensated for a lower concentration of the inoculum. At this stage, 
further investigation is needed, but it is clear that a low passage isolate can cause lesions in 
rabbits.   
This L. intracellularis cross infection study shows fecal shedding in infected rabbits 
starting at 7 DPI and increasing by 14 DPI.  TaqMan PCR technique detects the presence of 
genetic material regardless of whether it is viable or inactivated, and so it is of interest that in 
rabbits, fecal shedding appears limited to the presence of active infection (based on IHC lesions).  
Shedding was not detectable at 21 DPI, when clinical signs had already subsided and IHC 
labeling was drastically reduced.  In the foal infection model the fecal shedding is reported to last 
longer than 21 DPI, but a specific relation between duration of fecal shedding, presence of 
lesions and IHC labeling in the equine model is not available, as the foals were enrolled in a 
survival study (Pusterla, et al., 2010a).  The information gathered about serologic conversion is 
limited, in this initial experiment, due to the short experimental timeline.  Rabbits manifested a 
high serologic response 14 DPI, and even higher responses (>1920) in both diseased groups, by 
the final week.  Such a high immune response showed that this EPE infection model in rabbits 
could be considered a “time-compressed” course of infection, in comparison to the equine EPE 
infection model, as such high titers were achieved in foals only by 28 or 35 DPI (Pusterla et al., 
2010a).  Contrary to what is found in foals, a clinically significant hypoproteinemia was not 
found in the rabbits of our model, nor was edema of the limbs or abdomen ever detected, though 
these sequelae would normally occur after 21 DPI.  Further investigations with larger numbers of 
rabbits and throughout a longer time period are needed to investigate the onset of 
hypoproteinemia and hypoalbuminemia in this rabbit model.  
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In conclusion, on the basis of clinical, diagnostic, gross pathology and IHC findings, the 
incubation period in rabbits infected with an equine L. intracellularis isolate appears to be 
shorter than it is for pigs and hamsters challenged with a pig isolate or for the EPE infection 
model (Lawson & Gebhart 2000; Pusterla et al., 2010a; Vannucci, et al., 2010).  Moreover, 
intestinal lesions appeared to resolve by 21 DPI.  These time factors could constitute an 
experimental advantage for the model in rabbits.  Furthermore, infection is reproducible with no 
discomfort or overt disease.  In pharmacology research, such a finding would represent an 
optimal model for drug preclinical testing.  Further, rabbits, like horses, are hindgut fermenters, 
and unlike laboratory rodents offer the advantages of a larger bodyweight and blood volume, and 
accessible blood vessels for collection of multiple blood samples.  Further studies with this 
infection model could be used for pathogenesis and epidemiology studies, particularly when 
associated with such a remarkable serologic response.  In fact, the ability to overcome infection 
quickly, and without overt disease, can represent an epidemiologic risk, or may explain the 
limited success of prevention measures, if the equine L. intracellularis strain can be carried sub-
clinically by rabbits populating the horse farm grounds (Pusterla, et al., 2008b).  Finally, the 
success of this cross-infection experiment and the failure to generate infection in hamsters, which 
were previously the animal model of choice for proliferative enteropathies, suggest a selective, 
secondary host adaptation of a given L. intracellularis strain.  Further studies are now necessary 
to define the details of such a discovery and its multiple implications.  
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CHAPTER 5 
SPECIES-SPECIFICITY OF EQUINE AND PORCINE L. INTRACELLULARIS 
ISOLATES IN LABORATORY ANIMALS*. 
 
 
Relationship of this study to the dissertation objectives. 
In this chapter the results of a preliminary study on a hamster infection model for EPE are 
reported. As hamsters have been considered the model-host for excellence, with regards to 
Lawsonia intracellularis infection, the fact that the first trial failed to confirm infection, 
generated a few question marks in the structure of the whole research and in the species 
specificity of a bacterium that was considered equally pathogenic for multiple animal species, 
mammalian and avian. However, with the success of rabbit as a model-host for EPE and the 
future of the project secured, we explored a few microbiology concepts that brought us well 
beyond the expectations of this Doctoral dissertation. Through our initial failures and the 
repetition of cross-infection of the 2 known strains of L. intracellularis (EPE and PPE) we 
demonstrated that an unsuspected secondary species-specificity restriction for each strain exist in 
laboratory animals, as it does in pigs and horses.  
 
*This material is to be published as: Sampieri, F., Vannucci, F.A., Allen, A.L., Pusterla, N., 
Antonopoulos, A.J., Ball, K.R., Thompson, J., Dowling, P.M., Hamilton, D.L. & Gebhart, C.J. 
(2013). Species-specificity of equine and porcine L. intracellularis isolates in laboratory animals. 
Canadian Journal of Veterinary Research. In press. 
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5.1. Abstract 
 
L. intracellularis infection causes proliferative enteropathies in many mammalian species, the 
porcine (PPE) and equine (EPE) ones being known worldwide.  Hamsters are a well-published 
animal model for PPE infection studies in pigs.  There is no laboratory animal model, currently, 
for EPE infection studies and it is unknown whether there is species-specificity for equine or 
porcine isolates of L. intracellularis in animal models.  In 2 separate trials, 4-wk-old and 3-wk-
old weanling golden Syrian hamsters were challenged with EPE strains and compared to 
uninfected (both trials) and PPE infected controls (trial 2 only).  Concurrently, 6 female New 
Zealand white juvenile rabbits were infected with PPE strain and observed concomitantly to 8 
similar rabbits infected with EPE strain (for a different experiment requirement).  Hamsters and 
rabbits were observed for 21 to 24 days post-infection (DPI), depending on the experiment.  
Neither infected species developed clinical signs. Presence of disease was assessed with 
diagnostic techniques classically used for pigs and horses: immune-peroxidase monolayer assay 
on sera; quantitative PCR detection of molecular DNA in feces; haematoxylin-eosin stain and 
immunohistochemistry (IHC) on intestinal tissues. Our results showed that EPE-challenged 
hamsters do not develop infection when compared with PPE controls (IHC p 0.009; qPCR p 
0.0003). Conversely, PPE-challenged rabbits do not develop typical intestinal lesions in 
comparison to EPE-challenged rabbits, with serological response at 14 DPI being significantly 
lower (p 0.0023). In conclusion, PPE and EPE strains appear to have different host-specificities 
for hamsters and rabbits, respectively. 
5.2. Introduction 
 
Lawsonia intracellularis is a Gram-negative, obligate intracellular bacterium infecting 
the enterocytes of large or small intestines of a wide range of domestic, wildlife, avian and 
laboratory animal species (McOrist, et al., 1995a; Hotchkiss, et al., 1996; Lavoie, et al., 2000; 
Lawson & Gebhart, 2000; Pusterla, et al., 2008b).  An intense proliferation is induced by L. 
intracellularis intra-cytoplasmic replication in the host’s enterocytes, principally in the jejunum 
and ileum, wherein the hyperplasic activity corresponds to loss of function.  Such lesions cause a 
variety of clinical signs, acute and chronic, in affected individuals ranging from malabsorption, 
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diarrhea, depression, weight loss, abdominal pain and even death (Pusterla & Gebhart, 2009; 
Wong, et al., 2009; Vannucci, et al., 2010).  L. intracellularis is known to cause porcine and 
equine proliferative enteropathies (PPE and EPE, respectively): the former represented a 
challenge for the swine industry for over 50 years; the latter emerged more recently, and is now 
diffused worldwide, after sporadic and isolated beginnings (Gebhart, et al., 1993; Lawson & 
Gebhart, 2000; Frazer, 2008; Pusterla & Gebhart, 2009).  Proliferative enteropathies reflect 
negatively on both the porcine and equine industries, as their impact goes beyond the presence of 
challenging clinical signs, as slow and long recoveries, or severely reduced growth performance 
are common consequences (Lavoie, et al., 2000; Frazer, 2008; Pusterla & Gebhart, 2009).   
Proliferative enteropathy has been studied experimentally in pigs for years, either 
utilizing porcine L. intracellularis isolates grown in vitro or porcine tissues (Guedes & Gebhart, 
2003a; Boutrup, et al., 2010b).  Similarly, amongst laboratory animals, hamsters are known to be 
naturally, and experimentally, affected by the disease, since long before L. intracellularis was 
defined and named in 1995 (Stills, et al., 1987).  Naturally affected hamsters undergo diarrhea 
(also known as “wet-tail”) and weight loss, with severe hyperplasia of the ileal segment in the 
small intestine, similar to lesions observed in pigs (Stills, 1991).  Thus, hamsters have been used 
as an animal model for PPE studies, whether infection is produced through ileal homogenates, 
harvested from naturally-diseased pigs, or bacteria grown in pure cell culture (McOrist, et al., 
1989; Stills & Hook, 1989; Stills, 1991; Jasni, et al., 1994a; Jasni, et al., 1994b; Cooper, et al., 
1997a; Vannucci, et al., 2010).  A few researchers attempted, with variable success, infection on 
other rodents (mice and rats) and chickens (Collins, et al., 1999; Murakata, et al., 2008; Collins, 
et al., 2011).  Contrarily to PPE studies, the research on EPE animal models is limited to a 
recently established foal model and to the preliminary results of a rabbit model, both obtained 
from the same virulent EPE strain (Pusterla, et al., 2010a; Vannucci, et al., 2012; Chapter 4).  
Due to the increasing costs of research for the main species affected - horses and pigs-, 
replacing the large animal species with laboratory animal models could be useful to reduce the 
expenses, yet obtaining standardized welfare conditions, and maximising environmental and 
infection control over larger populations at one time, thus potentiating the statistical value of 
results.  Although the Canadian Council for Animal Care (CCAC) “3R’s” tenet (replacement, 
reduction and refinement) is not aimed to reduce experimental costs, but to responsibly control 
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animals use in research, animal models are advocated when in vitro models have great 
limitations, as in the case of L. intracellularis (Lawson, et al., 1993; Fenwick, et al., 2009).  The 
studies here described were part of a larger project investigating EPE in relation to a novel 
pharmaceutical compound, which contains the post-transition metal gallium, whose 
environmental impact, after excretion, has not been clarified  (Fecteau, et al., 2011).  To that end, 
modeling EPE on smaller surrogate animals, was considered liberally in agreement with the 
“3R’s” tenet.   
Our interest was to verify whether L. intracellularis exhibits a species-restricted host-
susceptibility, or if one given strain could generate infection in multiple species (Lavoie, et al., 
2000; Pusterla, et al., 2008b).  Also, understanding the role of cross-infection in the pathogenesis 
of proliferative enteropathy would be epidemiologically useful to define which species may 
amplify the bacterial shedding in the environment.  Importantly, such an understanding could 
help in determining to what extent and for how long these species represent a challenge for 
horse, or pig, farms’ epidemiology boundaries.  Even more importantly, clarifying the ability of 
L. intracellularis to cross-infect, from one host-species to another, will help researchers to 
choose appropriate animal models, hence reducing costs, refining experimental methods and, 
ultimately, sparing animals.  The specific objectives of the present study were to determine 
whether it is possible to generate typical EPE lesions in hamsters, after inoculation with an 
equine strain of L. intracellularis (EPE strain), and whether it is comparatively possible to 
generate PPE lesions in rabbits, after inoculation with a porcine strain of L. intracellularis (PPE 
strain). 
5.3. Materials and methods 
 
All the studies described were approved by the Animal Research Ethics Board of the 
University of Saskatchewan and conducted according to CCAC guidelines.   
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5.3.1. Animals: Hamsters  
 
5.3.1.1. Trial 1.  
Twenty-nine pathogen-free golden Syrian hamster (Mesocricetus auratus) weanlings 
(Strain 049 - VAF Hamsters – Charles River Canada, Pointe Claire, QC, Canada)  were born at 
the Animal Care Unit - Western College of Veterinary Medicine - University of Saskatchewan.  
The hamsters originated from immuno-competent animal colonies monitored by serology, PCR, 
bacteriology, parasitology or gross pathology tests, for absence (pathogen free and virus antibody 
free, or VAF/Plus hamsters) of Reovirus, Sendai virus, Lymphocytic choriomeningitis virus, 
Bordetella bronchiseptica, Strep. pneumonia, Campylobacter jejuni, Cl. piliforme, 
Corynebacterium kutscheri, Encephalitozoon cuniculi, Helicobacter spp., Myc. pulmonis, 
Salmonella spp., -hemolytic Streptococcus spp. (serogroups A, B and G); all intestinal helmints 
(Syphacia spp., Hymenolepis spp. etc.) and protozoa species (Coccidia spp., Trichomonadaceae, 
Entamoeba spp., etc.); dermathophytosis and all arthropods ectoparasites spp. (Strain 049 - VAF 
Hamsters – Charles River Canada, Pointe Claire, QC, Canada).  They were housed, with their 
dams, in rodent cages in a Containment Level (CL)-1 Room until weaning (21 days from birth), 
bedded on dust free shavings, fed rodent chow pellets (5P00, Prolab RMH 3000, LabDiet - PMI 
Nutritional International, LLC, Brentwood, MO USA) and fresh water ad libitum and maintained 
in standard husbandry conditions (12/12 h light – dark cycle, and 20oC ± 2oC room temperature).  
Newborn hamsters were visually monitored once daily, for the first 5 days of life, and then twice 
daily until weaning.  At weaning, they were weighed, ear punched and randomly assigned to 2 
groups: uninfected controls (9 hamsters) and EPE-strain infected (20 hamsters).  At that time, 
hamsters were separated into pairs, or triplets, according to group (controls vs. EPE-infected) and 
sex.  Inoculation with L. intracellularis occurred 1 week after weaning.  After inoculation, 
hamsters were housed in rodent cages in a CL-2 Room, bedded on dust-free shavings in identical 
husbandry conditions and provided with the same feed and water sources, as described above.  
5.3.1.2. Trial 2.  
An additional 24 pathogen-free and VAF golden Syrian hamsters (Strain HsdHanTM 
AURA – Harlan Laboratories –, Indianapolis, IN, USA) were born at the same Animal Care Unit 
facility described for Trial 1. Both for experimental subjects and their dams, housing, husbandry 
and daily monitoring conditions were identical to that described for Trial 1. The health 
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monitoring of the immuno-competent originating hamster colonies included serology, gross 
pathology and microscopic analysis tests to verify the absence of pathogens and related 
antibodies for Reovirus, Sendai virus, Lymphocytic choriomeningitis virus, Simian Virus 5, 
Bordetella bronchiseptica, Cl. piliforme, Corynebacterium kutscheri, Salmonella spp., 
Campylobacter jejuni, L. intracellularis, Helicobacter spp., Klebsiella spp., Myc. pulmonis 
Proteus mirabilis, Pseudomonas aeruginosa, Pneumocystis spp., Pasteurella  pneumotropica,-
hemolytic Streptococcus spp., Strep. pneumonia, Staph. aureus; ectoparasites and endoparasites, 
Demodex spp., Encephalitozoon cuniculi (Strain HsdHanTM AURA – Harlan Laboratories –, 
Indianapolis, IN, USA).  On day 21, hamsters were weaned, ear punched, weighed and randomly 
assigned to 3 groups: controls - uninfected (6 hamsters); PPE-strain group – inoculated with a 
porcine strain of L. intracellularis (9 hamsters); and EPE-strain group – inoculated with an 
equine strain of L. intracellularis (9 hamsters).  Trial 2 hamsters were inoculated at weaning, to 
increase the impact of stress on disease reproduction.  
 
5.3.2. Animals: Rabbits. 
 
Similarly to what described in Chapter 4 for rabbits, 6 female, New Zealand white 
pathogen-free rabbits (Strain - 052 VAF Rabbits - Charles River Canada, Pointe Claire, QC, 
Canada) (Oryctolagus cuniculus) were used, differing from Chapter 4 does only in age, as they 
were 4- to 5- weeks old.  Animals originated from colonies tested regularly by serology, gross 
and histo- pathology, bacteriology and parasitology tests for absence of pathogen agents and 
related antibodies (VAF) (Lymphocytic choriomeningitis virus, Parainfluenza virus 1 and 2, 
Rabbit hemorrhagic disease virus, Reovirus, Rotavirus, Bordetella bronchiseptica, CAR-
Bacillus, Cl. piliforme, Campylobacter jejuni, Corynebacterium kutscheri, Helicobacter spp., 
Klebsiella spp., L. intracellularis, Myc. pulmonis P. mirabilis, Ps. aeruginosa, Pneumocystis 
spp., Past.  pneumotropica,Salmonella spp., -hemolytic Streptococcus spp., Strep. pneumonia, 
Staph. aureus, Encephalitozoon cuniculi, Giardia spp., Toxoplasma gondii, Treponema cuniculi, 
pinworms and several tests for typical rodent diseases, but used annually in rabbits by the 
provider for internal control purposes - Strain - 052 VAF Rabbits - Charles River Canada, Pointe 
Claire, QC, Canada), as described for the previous study on the L. intracellularis rabbit model 
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(Chapter 4).  Also, 8 further does of the same age, weight and origin (Strain - 052 VAF Rabbits - 
Charles River Canada, Pointe Claire, QC, Canada) were used as a comparative control to the 
PPE-strain study, as they were EPE-infected for a different experiment (Chapter 8).  The 2 
studies were purposefully conducted at the same time, to compare the lesions at the peak of 
infection (14 DPI), and no sham-challenged rabbits were used in this experiment, as unexposed 
rabbits have previously been shown to not develop infection (Chapter 4).  The receiving and 
identification procedures and the husbandry conditions in CL-2 Room were already described in 
detail in Chapter 4, as animals were group-housed in two separate and isolated pens.  Both EPE- 
and PPE-infected rabbits were inoculated concurrently and managed identically, with strict 
reverse isolation procedures maintained for the PPE-strain group.     
 
5.3.3. Inoculum preparation. 
 
Control inoculum (medium only) consisted of buffered sucrose/phosphate/glutamate 
(SPG) solution and was administered to the uninfected hamster groups in both trials (controls), 
but not to the rabbits.  
5.3.3.1. EPE strain.  
Hamsters in Trials 1 and 2 and the EPE-infected rabbits were challenged with the equine 
strain of L. intracellularis E40504, prepared as previously described (Pusterla, et al., 2010a; 
Vannucci, et al., 2012).  The L. intracellularis infectious material originated from ileal mucosal 
scrapings of a foal that succumbed to EPE.  It was subsequently cultured on McCoy cells (ATCC 
CRL 1696) in a defined environment (Lawson, et al., 1993; Guedes & Gebhart, 2003b).  
Infectious virulent isolate from low passage pure cell-cultures was prepared and suspended in 
buffered SPG medium for all the EPE infected animals, as previously described (Pusterla, et al., 
2010; Vannucci, et al., 2012).  In the hamster trials, inoculum concentration was between 4.5 x 
10
7 
bacteria/ml and 7.5 x10
7 
bacteria/ml (Guedes, et al., 2003).  For the positive control, EPE 
infected rabbits were inoculated at a dose of 5.5 ml/rabbit, to give a final inoculum  between 1.3 
and 2.5 x 10
8
 bacteria per rabbit (Chapter 4). 
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5.3.3.2. PPE strain.  
For the Trial 2 hamsters and PPE-infected rabbits, inocula were prepared from PPE 
lesions harvested from an infected pig’s ileal mucosa (PHE/MN1-00) and cultured on  McCoy 
cells (ATCC CRL 1696), in a defined environment (Lawson, et al., 1993; Guedes & Gebhart, 
2003b; Vannucci, et al., 2012).  Infectious inocula were prepared as described above, from low 
passage pure cell-culture isolate.  The main difference between hamster’s and rabbit’s inocula 
was the final concentration and the volume, which for hamster’s inocula was a concentration 
of 3.2 x 10
7 
bacteria/ml and a volume as close as possible to 1 mL (see below); whereas 
rabbits’ inocula were 8.5 mL per rabbit (target dose of inoculum was 4.25 x 108 bacteria per 
animal).   
For Trial 1 hamsters, a total dose of 0.45 mL/hamster (approx. 3.375 x 10
7 
bacteria\hamster), suspended in commercial fruit flavoured pudding (Jell-O, Kraft Foods, 
Canada) was administered to each animal once, on day 0.  In trial 2, an equal inoculum dose 
was given, but no palatable medium was added. Subjects were 1 week younger and of lighter 
body weight (BW), thus the total target volume (1 mL) was divided into 3 administrations over 
2 days (once on day 0, twice on day 1).  The dosing volume calculations were based on a 
maximum volume of 20 ml/kg BW and repeated inoculation was used to maximize exposure 
(Morton, et al., 2001).  All challenge material was stored in a -20
o
C freezer and thawed 
overnight at 4
o
C, 12 hours prior to the experiments.   
 
5.3.4. Inoculation procedures. 
 
5.3.4.1. Hamsters.  
Inoculation occurred by 2 different techniques.  In Trial 1, hamsters were fed the inocula 
through a syringe, because of the palatable medium added.  In trial 2, hamsters were inoculated 
via oral gavage, to ensure that the intended dose was entirely administered to the smaller 
animals.  
5.3.4.2. Rabbits.  
Rabbit inoculation occurred after a 1 week mandatory acclimation with identical 
procedures and husbandry protocols, as described in Chapter 4.  
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5.3.5. Collection of samples 
 
5.3.5.1. Hamsters.   
In Trial 1, BW changes were monitored daily for 21 DPI.  In Trial 2, BW changes were 
monitored daily for 24 DPI. In both trials, demeanor, gross appearance, fecal consistency and 
quality, as well as self and mutual grooming were monitored twice daily with a 4 step grading 
system, 0 corresponding to normal and 3 to severely abnormal findings (Table 5.1).   Treats 
(apples and small amounts of fruit flavored pudding - Jell-O, Kraft Foods, Canada) were used to 
check individual animals’ appetite and awareness, twice daily.  Lack of response to treats and to 
researchers’ voices was considered a sign of decreased well-being (Johnson-Delaney, 2006).  In 
both trials, pooled fecal samples from the cages were collected once weekly and on the 
predetermined days of euthanasia, when individual samples were collected from the sacrificed 
animals. 
Blood samples for serologic evaluation were collected at the time of euthanasia via 
intracardiac puncture.  In Trial 1, 4 EPE-infected hamsters were euthanized at 7, 11, 14, 17, 21 
DPI; 1 control was euthanized at 7, 11 and 21 DPI, and 3 controls were sacrificed at 14 and 17 
DPI.  In Trial 2, 8 hamsters (3 from EPE group; 3 from PPE group; and 2 controls) were 
euthanized at 17, 21 and 24 DPI.  In both trials, euthanasia was achieved with an inhalatory 
anesthetic overdose (isofluorane - Isoflurane, 99.9%, Halocarbon Products Corporation, River 
Edge, NJ, USA) in a glass chamber. Within each group, selection for euthanasia was 
randomized.  At necropsy, for evaluation of the presence of proliferative enteropathy lesions, 
sections of the ileum, jejunum, cecum and colon were harvested, prepared within histology 
cassettes and immediately placed in 10% phosphate buffered formalin solution, for 
histopathologic (haematoxylin & eosin – H&E) and immunohistochemical (IHC) examination 
(Vannucci, et al., 2010).  
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Table 5.1. Humane Intervention Monitoring Parameters for the hamster studies. 
EXPERIMENTAL DAY:                              DATE:                                   HAMSTER ID CODE: 
 Variable Individual score 
 
0 
1 
2 
3 
Daily Feed Intake 
Same or increased from previous day 
Slight decreased from previous day 
Marked decrease from previous day 
Complete anorexia 
Am 
 
 
Pm 
 
0 
1 
2 
3 
Daily Water Intake 
Same or increased from previous day 
Slight decreased from previous day 
Marked decrease from previous day 
No water taken in  
Am 
 
 
Pm 
 
 
0 
1 
2 
3 
Body Weight (average weight gain for young hamsters is 1-2g/day or 
≈10g/wk.) 
Increasing weight ~ 20%/wk. 
Increasing weight ~ 10% /wk. 
Maintaining weight, no weight gain 
Rapid weight loss (20-25%/wk.) or losing weight for more than 2 days 
Am 
 
 
(Calculated gain from 
last BW measure) 
 
0 
1 
2 
3 
Stool 
Normal feces 
Feces formed but softer than usual 
Feces not formed, but not liquid 
Liquid feces (for >2days) leading to emaciation 
Am 
 
 
Pm 
 
0 
1 
2 
3 
Physical Appearance 
Normal 
Lack of grooming 
Rough coat, nasal/ocular discharge,  
Very rough coat, abnormally hunched  posture, distended abdomen 
(>3days) 
Am 
 
 
Pm 
 
0 
1 
2 
3 
Behavior 
Normal, alert, playful, comes to front of cage 
Hyperactive, agitated 
Decreased activity, minor depression, unwilling to move  
Depressed, head turned to corner of cage, still moves when stimulated  
Am 
 
 
Pm 
 
Table 5.1: This “Humane Intervention Monitoring Parameters” format was used for the 
hamsters enrolled in the infection animal model for porcine and equine proliferative 
enteropathy, during phase of validation.  Each animal had this table as a daily monitoring 
spreadsheet, where twice daily clinical observations were recorded, except for BW (assessed 
only once daily).  
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5.3.5.2. Rabbits.  
BW changes were monitored daily. Demeanor, gross appearance, fecal consistency and 
quality, appetite, and self and mutual grooming were monitored twice daily with a 4 step grading 
system, 0 corresponding to normal and 3 to severely abnormal findings, as previously described 
(Table 5.2) (Chapter 4). Again, lack of interest in treats (apples and carrots, in this case) was 
considered a sign of decreased well-being (Johnson-Delaney, 2006).  
Blood samples (1 ml each) for serology were collected with a sterile needle and syringe 
once weekly and at the time of euthanasia, from the ear’s central artery, after a local block and 
disinfection were applied, as previously described (Chapter 4).  Also, pooled fecal samples were 
collected from the pen once weekly, and individual fecal samples were collected at the time of 
euthanasia.  Two PPE-infected rabbits per week were humanely euthanized with an intravenous 
overdose (720 mg/rabbit) of pentobarbital (Euthanyl, Bimeda MTC, Animal Health Inc., 
Cambridge, ON, Canada).  To observe for evidence of lesions, the same collection procedures 
and storage protocols were followed as described in Chapter 4.  
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Table 5.2. Humane Intervention Monitoring Parameters for the rabbit studies.  
EXPERIMENTAL DAY:                              DATE:                                           RABBIT ID CODE: 
 Variable Individual score 
 
0 
1 
2 
3 
Daily Feed Intake 
Same or increased from previous day 
Slight decreased from previous day 
Marked decrease from previous day 
Complete anorexia 
Am 
 
 
Pm 
 
0 
1 
2 
3 
Daily Water Intake 
Same or increased from previous day 
Slight decreased from previous day 
Marked decrease from previous day 
No water taken in  
Am 
 
 
Pm 
 
0 
1 
2 
3 
Body Weight (average weight gain for young rabbits is 200 
g/wk.) 
Increasing weight ~ 200 g/wk. 
Increasing weight ~ 100 g /wk. 
Maintaining weight, no weight gain - Losing weight for 
more than 2 days 
Am 
 
 
(Calculated gain from last BW 
measure) 
 
0 
1 
2 
3 
Stool 
Normal feces 
Feces formed but softer than usual 
Feces not formed, but not liquid 
Liquid feces 
Am 
 
 
Pm 
 
0 
1 
2 
3 
Physical Appearance 
Normal 
Lack of grooming 
Rough coat, nasal/ocular discharge,  
Very rough coat, abnormal posture, ears low 
Am 
 
 
Pm 
 
0 
1 
2 
3 
Behaviour 
Normal, alert, comes to front of cage 
Minor depression, but still moves when stimulated  
Grinding teeth, depressed, head turned to corner of cage  
Very depressed, almost unresponsive 
Am 
 
 
Pm 
 
Table 5.2: This “Humane Intervention Monitoring Parameters” format was used for the 
rabbits enrolled in the rabbit animal model for porcine (and equine) proliferative enteropathy, 
during phase of validation. Each animal had this table as a daily monitoring spreadsheet, 
where twice daily clinical observations were recorded, except for BW (assessed only once 
daily).  
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5.3.6. Sample analysis.  
 
5.3.6.1. Macroscopic examination.  
For both hamsters and rabbits, regardless of group and trial, shortly after euthanasia the 
alimentary tract was examined visually from stomach to rectum.  The sampling protocol for 
hamsters consisted of collection of the terminal jejunum, ileum, ileocecal valve, caecal ampulla 
and colon, as previously reported (Vannucci, et al., 2010).  Fecal pellets were collected from the 
terminal colon and rectum.  The sampling protocol for rabbits was identical to what described in 
a previous study (Chapter 4).   
5.3.6.2. Immunohistochemistry.  
Formalin-fixed sections were paraffin embedded, cut and stained by streptavidin method, 
including anti-L. intracellularis specific mouse monoclonal antibody (Guedes & Gebhart, 
2003c).  The positive labeled L. intracellularis-specific antigen in the crypts was evaluated with 
a 5 grade IHC scoring system, previously published (Guedes & Gebhart, 2003c; Vannucci, et al., 
2010).  For each animal, the negative control for each tissue section consisted of a correspondent 
tissue section IHC-labeled, but omitting the primary antibody. Furthermore, pig ileal tissues, 
known to be negative and positive for L. intracellularis infection, were labeled with the murine 
anti-L. intracellularis monoclonal antibody to confirm the antibody's specificity and sensitivity, 
respectively. 
5.3.6.3. Serology analysis.  
Anti–L. intracellularis–specific IgG in serum was measured by an immuno-peroxidase 
monolayer assay (IPMA), as reported previously (Guedes, et al., 2002c). Positive serum samples 
were end-point titrated from 1:30 up to 1:1920.  Control samples consisted of serum from a 
rabbit prior to (negative control) and after (positive control) hyperimmunization with L. 
intracellularis, purified from cell culture. Also, serum total protein concentration was measured, 
with the refractometer method, to investigate changes overtime. 
5.3.6.4. Quantitative PCR Analysis.   
Quantitative PCR analysis was conducted on fecal samples as previously reported 
(Pusterla, et al., 2010a). The purified DNA was analyzed by qPCR for presence of L. 
intracellularis aspA gene copies (Pusterla, et al., 2008b; Pusterla, et al., 2009a). For each target 
gene, two primers and an internal, fluorescent labeled TaqMan probe (5´end, reporter dye FAM 
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(6-carboxyflourescein), 3´end, quencher dye TAMRA (6-carboxytetramethylrhodamine)) was 
designed using Primer Express software (Applied Biosystems, Foster City, CA, USA).  The 
“L.intra system” forward primer and reverse primer were “bcL.intra-114f” 
(CACTTGCAAACAATAAACTTGGTCTTC) and “bcL.intra-263r” (CATTCATATTTGTACT 
TGTCCCTGCA), respectively, with the Aspartate Ammonia Lyase (AspA) gene as target, and 
“bcL.intra-201p” (TCCTTGATCAATTTGTTGTGGATTGTATTCAAGG) as probe.  The “Pan-
Bacteria system” forward primer and reverse primer were “PB.283f” 
(GGATGATCAGCCACACTGGA) and “PB.352r” (CCAATATTCCTCACTGCTGCC), 
respectively, with 16S rRNA as a target, and “PB.305” 
(CCCGTAGGAGTCTGGACCGTGTCTCA) as a probe.   TaqMan PCR systems were validated 
using 2-fold dilutions of gDNA testing positive for the target genes.  Dilutions were analyzed in 
triplicate and a standard curve was plotted against the dilutions.  The slope of the standard curve 
was used to calculate amplification efficiencies using the formula E =10 
1/-s
-1.  Each system 
needed to be greater than 95% efficiency to be considered.  The detection limit for “L.intra 
system” is between 5-10 copies/l DNA (determined with plasmid DNA).  The “L.intra system” 
detects all L. intracellularis, regardless of the host species.  Known positive controls and no 
template controls were run on every plate, and met previously standardization values.  DNA 
quality was determined by the “PanBacteria system”, with a control value under 30, to pass 
quality control (Leutenegger, et al., 1999).  A real-time PCR assay targeting a universal sequence 
of the bacterial 16S rRNA gene was used as quality control (i.e., efficiency of DNA purification 
and amplification) and as indicator of fecal inhibition (Mapes, et al., 2007). 
5.3.6.5. RT-reaction and real-time TaqMan PCR.  
Each PCR reaction contained 20x primer and probes for the respective TaqMan system 
with a final concentration of 400 nM for each primer and 80 nM for the TaqMan probe and 
commercially available PCR Mastermix (TaqMan Universal PCR Mastermix, Applied 
Biosystems, Foster City, CA, USA), containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mM 
MgCl2, 2.5 mM deoxynucleotide triphosphates, 0.625 U AmpliTaq Gold DNA polymerase per 
reaction; 0.25 U AmpErase UNG per reaction; and 1 l of the DNA sample in a final volume of 
12 l.  The samples were placed in 384 well plate and amplified in an automated fluorometer 
(ABI PRISM 7900 HTA FAST, ABI).  ABI’s standard amplification conditions were used: 2 
min at 50°C, 10 min at 95°C, 40 cycles of 15 s at 95°C and 60 s at 60°C. Fluorescent signals 
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were collected during the annealing temperature and CT values extracted with a threshold of 0.1 
and baseline values of 3-12 for all samples using SDS 2.2.1 (Applied Biosystems, Foster City, 
CA, USA). Absolute quantitation was calculated by a standard curve and expressed as copy 
numbers of the L. intracellularis aspA gene/g of feces.  
 
5.3.7. Statistics. 
 
5.3.7.1. Hamster trials.  
BW findings were analyzed through a Mann-Whitney test, as Trial 1 had 2 uneven 
groups; and Kruskal-Wallis test with Dunn`s post hoc testing, as Trial 2 had 3 uneven groups.  
IHC results were analyzed through contingency tables with Fisher Exact Test, to compare the 2 
categorical outcomes (lesions versus no lesions) and to estimate odds ratio and relative risks.  For 
qPCR results analyses, a one-way ANOVA, with Bonferroni’s post hoc testing was used.   
5.3.7.2. Rabbit trial.  
For PPE-infected rabbits only descriptive statistics were used, as the sample number was 
insufficient for statistical analysis; however, where the comparison was applicable to the EPE-
infected animals, Mann Whitney, Kruskal-Wallis and unpaired t- tests were used (BW and serum 
total protein concentration).  For all statistical analyses in hamsters and rabbits, a commercial 
software (GraphPad Prism 5.4 Software, CA, USA) was used, and alpha was set at 5%. 
5.4. Results 
 
5.4.1. Clinical appearance. 
   
5.4.1.1.  Hamsters.  
No hamster showed sign of diarrhea, throughout either trial, and their enthusiastic interest 
in treats was never diminished (Johnson-Delaney, 2006).  The only behavioural change was a 
mild to moderate hyperactivity, noted after 14 DPI, as some PPE-infected animals rearranged the 
entire cage`s content within a few hours, in the daylight hours, suggesting abnormal behaviour.  
In regards to daily BW gains, there was no difference between infected and uninfected hamsters 
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in either trial (p: 0.12 for Trial 1; 0.88 for Trial 2).  Comparisons between 3- and 4-wk-old 
hamsters showed no difference (p: 0.14), due to age (3 versus 4 weeks old) or breeding colony 
(comparison of Trial 1 hamsters (Strain 049 - VAF Hamsters – Charles River Canada, Pointe 
Claire, QC, Canada) versus Trial 2 hamsters (Strain HsdHanTM AURA – Harlan Laboratories –, 
Indianapolis, IN, USA) providers), in infected and uninfected hamsters (p: for EPE group: 0.77; 
and for EPE and PPE combined group: 0.6). 
5.4.1.2. Rabbits.  
For the PPE-infected rabbits, no clinical abnormalities were noted during the study. Signs 
of aggression toward other pen-mates were noted in 2 does: 1 improved over time, 1 developed it 
toward the end of the trial. No significant depression, nor BW gain suppression, was noted in any 
PPE-infected rabbit, not even around 14 DPI (peak of disease), as observed in EPE-infected 
rabbits (Chapter 4).  Three PPE-infected rabbits had negative BW gains at different stages, 
unrelated to each other and quickly compensated (within 1 day) as the total BW gain of PPE-
infected rabbits (7 DPI: 171 – 309g; 14 DPI: 506 – 667g; 21 DPI: 781 - 871g) was above the 
average recommended by the provider (200g/week) (Strain - 052 VAF Rabbits - Charles River 
Canada, Pointe Claire, QC, Canada).  A comparison between daily BW gain averages in the EPE 
and PPE groups at 14 DPI (Figure 1) showed that EPE-does had a BW gain suppression (p 
0.036).   
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Figure 5.1. 
 
Figure 5.1: Comparison of bodyweight changes in infected rabbits. Comparison between 
infection with the EPE-strain and the PPE-strain of L. intracellularis in 5-wk-old rabbits.  The 
PPE-infected rabbits gained overall more weight than the EPE-infected counterparts by 14 DPI 
(p 0.04). The mean in the boxplot is represented by a cross hair, whereas the whiskers represent 
the 5 – 95 percentile interval.  One should note that the preliminary phases of the EPE-strain of 
L. intracellularis infection model in rabbits show a trend of reduced growth performance around 
the infection peak (approximately 14 DPI), not matched by the PPE-infected rabbits.  
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5.4.2. Gross pathology. 
  
5.4.2.1.  Hamsters.  
In either trial there were no gross lesions in the intestines.  A larger amount of abdominal 
fat was noted in older animals (Trial 1).  Intestinal content appeared adequate for the tracts 
examined and, upon measurement of the diameter of the intestinal sections, trial 1 controls had 
smaller ilea (p 0.0011) than EPE-infected hamsters, at the level of the ileocecal valve (1.5 -2.5 
mm vs. 2-3 mm).  However, in Trial 2, hamsters, jejunum and ileum diameters were not different 
in EPE-, PPE- and control-groups (p 0.9 and 0.26, respectively).  
5.4.2.2.  Rabbits.  
In PPE-infected rabbits, mild edematous changes of the serosal layer of the terminal 
portion of jejunum and ileum were noted and were comparable to EPE-infected rabbits serosal 
findings (Figure 5.2).  However, no rugae were observed in the mucosa and by 14 DPI, only the 
serosal and mucosal edema was apparently increased.  
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Figure 5.2.  
 
Figure 5.2: Infected rabbit jejunum. Example of the macroscopic appearance of a tract of 
jejunum, approximately 3.5 cm in length (bar’s size: 1 cm), in rabbits infected with L. 
intracellularis PPE-strain.  Note that the serosal edema and “cobble-stone” appearance on the 
anti-mesenteric aspect of the sample is reminiscent of the macroscopic lesions of the EPE 
infection model in rabbits, however such serosal appearance was not related to mucosal lesions 
in the PPE-infected rabbits.  
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5.4.3. Immunohistochemistry. 
 
5.4.3.1. Hamsters.  
In Trial 1, only 1 out of the 20 EPE-infected hamsters showed mild (grade 1) IHC 
labeling, which statistically was not different (p 1.0) from controls.  The odds ratio showed 2.586 
higher chances of getting a hamster infected when challenged with the inoculum versus an 
uninfected control.  In Trial 2, a statistical difference (p 0.013) was noted between the infected 
and uninfected hamsters, with greatly reduced (0.04) odds ratios of having PE lesions in 
uninfected animals.  However, comparing the presence of IHC labelled lesions between PPE-
infected hamsters and uninfected controls increased the statistical significance (p 0.0003), 
whereas the comparison of PPE-strain and EPE-strain groups showed that the PPE-strain had 
higher ability than EPE-strain to infect hamsters (p 0.009) (Figure 5.3.1. and Figure 5.3.2.). The 
relative risk of inducing IHC detectable lesions in hamsters after PPE-strain inoculation was 3 
times higher than after EPE-strain inoculation, with an odds ratio of 35.29 in favor of PPE-strain 
infection.  The results of the challenge in Trial 2 are represented in figure 4.  
One last observation about EPE-strain is that there was no difference (p 0.28) found in 
either trial regarding age (3-wk-old versus 4-wk-old), level of stress (inoculated a week after 
weaning versus inoculated at weaning) or method of inoculation (oral feeding versus oral 
gavage), even though the relative risk appears 3.3 times higher in younger, stressed hamsters.  
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Figure 5.3.1.  
 
 
Figure 5.3. Immunohistochemistry (IHC) results in hamsters. Comparison of IHC labelling 
in the EPE-strain and the PPE-strain infected hamsters. Staining: streptavidin method, including 
anti-L. intracellularis specific mouse monoclonal antibody, with 3-amino-9-ethylcarbazol (AEC) 
substrate-chromogen and counterstained with Mayer’s haematoxylin to observe for the presence 
of the antigen within the cells.  Figure 5.3.1: IHC of the ileum of an EPE-infected hamster.  
Note that distribution of antigen (red dots) in the mucosal enterocytes of ileal villi is very limited 
and no antigen is detectable within the enteric crypts. Scale bar, 100µm.  
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Figure 5.3.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.2: IHC of the ileum of a PPE-infected hamster. Note the much larger distribution 
of detectable antigen in the mucosal enterocytes. Scale bar, 100µm.  
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Figure 5.4.  
 
Figure 5.4.: Comparison between strains infection in hamsters. In this graph of Trial 2, the 
predominance of infection obtained in hamsters inoculated with the PPE-strain of L. 
intracellularis versus the EPE-strain and uninfected controls is shown. Note that all the PPE-
challenged hamsters were showing IHC detectable antigen in typical lesion sites (enteric crypts 
and mucosal enterocytes), whereas only 3 out of 9 hamsters showed mild EPE lesions (not in the  
intestinal crypts) after the EPE-strain challenge. 
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5.4.3.2. Rabbits.  
In the PPE-infected rabbit experiment, no characteristic lesions were detected through 
IHC labeling, at any stage of the study.  Only fragments of reactive DNA at the level of the 
lamina propria were noted (figures 5.5.1 and 5.5.2).  In the EPE-infected rabbits, euthanized at 
the same time, IHC detectable lesions were found in several rabbits in at least 2 GIT sections 
(jejunum and ileum) (Chapter 8), mirroring the initial model development results (Chapter 4).  
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Figure 5.5.1 
 
Figure 5.5: Comparison of IHC labelling in EPE- and PPE-infected rabbits. Staining: 
streptavidin method, including anti-L. intracellularis specific mouse monoclonal antibody, with 
3-amino-9-ethylcarbazol (AEC) substrate-chromogen; counterstained with Mayer’s 
haematoxylin to observe for typical proliferative lesions of the intestinal epithelium, and for the 
presence of the antigen within the cells. Figure 5.5.1: EPE-infected rabbit, example of ileum 
at 14 DPI. Note the wide distribution of IHC detectable antigen in the mucosal enterocytes over 
ileal villi and within enteric crypts. Scale bar, 100 µm.  
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Figure 5.5.2  
 
Figure 5.5.1: PPE-infected rabbit, example of cecum at 14 DPI. Scale bar, 100 µm.  An ileal 
tissue counterpart for the PPE strain was unavailable as no antigen was detected anywhere, 
except in the cecum.  Note that not only the distribution of detectable antigen in the mucosal 
enterocytes is minimal to none, but also the antigenic material appears scattered at the level of 
the lamina propria, wherein it is destroyed after being engulfed and processed by macrophages.  
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5.4.4. Serology. 
  
Control samples for the IPMA procedure consisted of serum from a rabbit prior to 
(negative control) and after (positive control) hyperimmunization with L. intracellularis, purified 
from cell culture.  No IPMA serology results consistent with immune response, were noted in 
hamsters in either trial, whether they were terminated at 21 or 24 DPI.   
For the PPE infected rabbits, no antibody titers were evident until 14 DPI.  The IgG titers 
at that time (Figure 6) appeared significantly lower (p .0023) in PPE-infected rabbits (range: 60 - 
960) than the EPE-infected group (range: 480 - 1920) of rabbits of same age, sex, litter and 
housing.  Serum total protein concentration was measured to investigate changes, as decreased 
values are reported in foals naturally and experimentally affected by EPE (Lavoie, et al., 2000; 
Pusterla, et al., 2010a).  No statistical difference was noted overtime (p 0.88, as it ranged from 
49 - 60 g/L on day 0; 45 – 53 g/L at 7 DPI; 40.5 – 49 g/L at 14 DPI and 47.5-53.2 g/L on 21 
DPI) in PPE infected rabbits, although around 14 DPI, a decreased concentration in at least 4 
rabbits was noted, soon to be recovered by the 2 survivor rabbits by 21 DPI.  
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Figure 5.6 
 
Figure 5.6: Serology results. Immuno-peroxidase monolayer assay (IPMA) findings indicating 
antibody response in EPE-strain and PPE-strain infected rabbits 14 DPI with L. intracellularis. 
The serological response at 14 DPI in EPE-infected rabbits is visibly different (p 0.0023) 
compared to PPE-infected ones.  The bars’ whiskers indicate standard deviations. 
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5.4.5. Quantitative PCR. 
 
5.4.5.1. Hamsters.  
On Trial 1, on day 0: 5 hamsters from the EPE-infected group showed positive fecal 
qPCR - one being quite high (693609.1 aspA gene copies/g feces - see day 0 column on Figure 
5.7.1.).  For Trial 1, qPCR results showed no difference (p 0.051) over time, when compared to 
the “day 0” group, although at the limits of significance (Figure 5.7.1).  However, by 21 DPI, 3 
out of 4 infected hamsters were still shedding L. intracellularis.  After infection with EPE-strain 
L.intracellularis, a comparison between 3 and 4-week-old hamsters, showed that younger 
hamsters have a higher likelihood of shedding L. intracellularis in feces (p <0.0001).   
Conversely, in Trial 2 (Figure 5.7.2), despite an initial higher fecal shedding of L. 
intracellularis for EPE-infected hamsters by 7 DPI, the overall comparison of the EPE-strain and 
PPE-strain over time, from day 0 to 24 DPI, showed higher shedding in the PPE-strain group (p 
0.0003) related to both time and infection factors (Figure 5.7.3).  
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Figure 5.7.1. 
 
Figure 5.7. Detection of L. intracellularis DNA gene copies (aspA gene) through qPCR 
analysis in feces (grams) of experimentally infected weanling hamsters.  For all 3 graphs, the 
bars’ whiskers indicate the standard deviations.  In figure 5.7.1. fecal shedding for EPE-strain 
L. intracellularis in hamsters, in the course of Trial 1, shown from day 0 to 21 DPI. On day 0 
some unexplained technical contamination occurred while feeding orally the infectious inocula 
and its responsible for the measurable AspA gene in the material collected on inoculation day.  
The shedding was minimal at 7 DPI and then increased over time. Because of the technical 
contamination observed, the method of inoculation was changed for Trial 2.  Note that the 
concentration of the aspA gene is barely in the range 10
5
-10
6
, particularly when compared to the 
PPE-infected hamsters (10
7-
10
8
 range).  
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Figure 5.7.2.  
 
Figure 5.7.2. Fecal shedding in hamsters, for EPE-strain and PPE-strain L.intracellularis in 
the course of Trial 2, shown from day 0 to 24 DPI. While the PPE-strain fecal shedding increases 
exponentially over time, the EPE-strain fecal shedding is highest 14 DPI and then decreases 
significantly over time (p 0.003) to the end of the experiment (24 DPI).   
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Figure 5.7.3. 
 
In figure 5.7.3. Overall comparison between strain group in hamsters (uninfected controls, 
EPE and PPE). The different amounts of shedding amongst groups are visible (p 0.033). 
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5.4.5.2. Rabbits.  
A comparison between the detection of PPE-strain versus EPE-strain L. intracellularis is 
shown in figure 5.8., where higher fecal shedding is noted in the EPE-infected rabbits (p 
0.0089). 
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Figure 5.8. 
 
Figure 5.8. qPCR results in rabbits. Comparison of L. intracellularis aspA gene copies/g of 
feces obtained through qPCR between EPE-infected versus PPE-infected rabbits (p 0.0089).  The 
bars’ whiskers indicate the standard deviation. Note that the concentration of the aspA gene in 
EPE-infected rabbits’ feces is so high that the PPE-strain infected group values don’t appear in 
the graph, as they remained several orders of magnitude lower (10
6
 or 10
7
, at the most).   
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5.6. Discussion 
 
 
These studies show that L. intracellularis cross-infection in laboratory animals can occur, 
but not with ease.  The goal was to reproduce PE disease, or lesions, from equine and porcine 
strain isolates, so to individuate a surrogate species small enough to be cost effective, yet 
sufficiently large to endure humane research procedures, as, for example, repeated blood 
samples. 
The PPE infection model in hamsters was considered the term of comparison of our 
hamsters’ studies. Replication of infection in hamster weanlings, from a pure cell culture of PPE-
strain of L. intracellularis, isolated from naturally diseased pigs, was in agreement with previous 
publications, as inoculation of hamsters yielded a typical PE infection (Stills, 1991; Jasni, et al., 
1994a; Jasni, et al., 1994b; Vannucci, et al., 2010).  In the infected hamsters of these studies, no 
clinical signs were noted, as is commonly reported with pure cell culture inoculation, both in 
hamsters and pigs (Jasni, et al., 1994b; Guedes & Gebhart, 2003b; Vannucci, et al., 2010).  The 
only exception was some degree of hyperactivity during daylight hours, atypical for hamsters, as 
they are nocturnal animals.  In addition, intestinal lesions were detected by H&E and confirmed 
with IHC labelling.  Quantitative PCR showed that L. intracellularis DNA was shed in feces in 
exponentially increasing concentrations throughout the study (24 DPI), demonstrating active 
replication of the bacteria in the host’s intestine (McOrist, et al., 1989; Stills, 1991; Cooper, et 
al., 1997a; Cooper, et al., 1997b; Vannucci, et al., 2010).   
The leading hypothesis supporting the idea of the EPE-strain of L. intracellularis being 
capable of infecting hamsters was based not only on the similarities of the bacterial genomic 
characteristics (98% between PPE and EPE strains), but also on how easily the PPE-strain can 
cross-infect from pigs to hamsters (Jasni, et al., 1994b; Cooper, et al., 1997a; Cooper, et al., 
1997b; Vannucci, et al., 2010).  Furthermore, GIT similarities between hamsters, rabbits and 
horses, such as hind-gut fermentation and a proportionally large cecum, were considered 
advantageous, even in the absence of evolutionary correlations (Argenzio, 1984).  The cross-
infection of hamsters with the EPE-strain, starting from a pure cell culture isolate, virulent for 
both horses and rabbits, was attempted in Trial 1 in young susceptible animals (4-week-old) and, 
since it failed to generate detectable IHC lesions, was tried again on younger and potentially 
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more vulnerable subjects (3-week-old) (Pusterla, et al., 2012a; and Chapter 4).  One should note 
that in Trial 1, a contamination of the fecal material on day 0 appeared evident in 5 of the 20 
inoculated hamsters (see figure 5.7.1., day 0), despite having followed rigorous experimental 
procedures in handling each subject.  Although such an outcome was unexpected, potential 
contamination of the feces with fresh inoculum was a plausible explanation.  Interestingly, 
L.intracellularis DNA material reached values higher than the ones detected in the first 11 DPI, 
with maximum values in the range of 2.0x 10
5
 AspA gene/g.  In the whole experiment, the DNA 
concentration never rose above the order of magnitude of 10
5
, in contrast to the concentrations 
detected in PPE infected hamsters (largely over 2 orders of magnitude higher at weeks 2 and 3 
PI).   
In Trial 2, the component of stress (carefully avoided in Trial 1) as well as young age, 
was added as hamsters were infected immediately after weaning.  Despite 2 attempts, EPE-strain 
cross-infection of hamsters was unsuccessful, aside from a mild and inconsistent fecal shedding, 
which, even at its maximum value, was never as high as the PPE-infected hamsters’ shedding (at 
disease peak between 17 and 24 DPI). This is particularly striking in comparison to the textbook-
like development of fecal shedding and lesions in PPE-infected hamsters.  Although our results 
originated from a small population, the fact that PPE-challenged hamsters have over 35 times 
more chances to develop lesions than the EPE-challenged ones is an obvious limitation.  It 
should discourage the further use of hamsters to replace horses in EPE infection models.  On a 
wider perspective, these results constitute evidence to reconsider the ability of the EPE-strain of 
L. intracellularis to cross-infect and cause lesions into other rodents, contrarily to what was seen 
for the PPE-strain, whether it depends on their resistance to infection, or on specific bacterial 
tropism for specific hosts (Murakata, et al., 2008; Vannucci, et al., 2010).   
As no serologic response was noted in either hamster trials, it is arguable that hamsters 
may need a longer time to develop a detectable immune response to L. intracellularis infection: 
partially, due to the L. intracellularis privileged location, remote from processing, opsonizing 
and exposing units of the reticulo-endothelial system; partially, because weanling hamsters may 
not be as immuno-competent as adults are.  Older subjects, in other infection models, have been 
shown to develop an IgG response in a much more timely fashion (1 week PI) (Zuerner, et al., 
2011).  Based on lack of seroconversion and of limited fecal shedding, the question now is 
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whether EPE-challenged rodents can become healthy short-term carriers for the disease, and in 
what capacity they contribute to the amplification of infection.   
In this context, failing to reproduce a viable PPE-infection in rabbits is significant, as no 
clinical signs (even as reduced growth performance), nor IHC lesions were observed in our PPE-
challenged rabbits (Chapter 4).  A transient IHC labelling was noted in the lamina propria of 
only 1 sample out of 6 whole GIT sets of samples (42 samples total), consistent with destruction 
of the bacteria, but not with typical active lesions, which should be located at the apex of 
enterocytes, in the intestinal crypts.  This shows that the PPE-strain L. intracellularis is 
eliminated swiftly by rabbits, despite inoculation with almost twice the dose used in the EPE-
challenged rabbits (Chapter 4).   
A recent publication showed that the EPE-strain L. intracellularis is unable to cross-
infect age-susceptible pigs and the PPE-strain is unable to cross-infect age-susceptible foals, thus 
the results of this study on laboratory animals acquire even more relevance (Vannucci, et al., 
2012).  The incapability of the EPE-strain to cause demonstrable infection in hamsters mirrors 
the results of cross-infection onto pigs, although it is clearly capable of infecting and inducing 
clinical disease and lesions in young horses, as well as cross-infecting rabbits, with mild clinical 
discomfort, typical intestinal lesions, limited fecal shedding and high serologic response 
(Vannucci, et al., 2012; and Chapter 4).  On the contrary, the PPE-strain L. intracellularis is 
capable of infecting and causing overt (in some case) disease in pigs and hamsters, but does not 
cause infection in rabbits nor horses, although in rabbits a limited immune-response and fecal 
shedding were detected as well, reminiscent of some exposure results in sentinel rabbits used in 
piggeries (Duhamel, et al., 1998; Guedes & Gebhart, 2003b; Vannucci, et al., 2010).  Perhaps a 
secondary host-adaptation, or species-specificity, exists for different L. intracellularis strains 
(Friedman, et al., 2008; Vannucci, et al., 2012; and Chapter 4).  In hamsters cross-infected with 
PPE-strain, the most severe clinical signs were caused by inoculation with homogenates of 
porcine mucosal ileal scrapings (Stills, et al., 1989; Jasni, et al., 1994a; Jasni, et al., 1994b; 
Vannucci, et al., 2010).  Thus, future studies may determine whether the role of cell culture 
passages of the infectious material through cell cultures hampers the virulence in EPE-strains 
too, as we know that higher passages of PPE-strain in cell cultures definitely immortalize L. 
intracellularis, but reduce its virulence.  
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In conclusion, although using only a small number of animals, our investigations help 
clarify whether different strains of L. intracellularis have different secondary host-specificities.  
Such findings should help to exclude hamsters from modeling EPE-strain infection and rabbits 
from modeling PPE-strain infection.  However, as EPE modeling has been achieved in rabbits, 2 
important concepts may be extrapolated from our results: first, studying the infection caused by 
L. intracellularis may necessitate more than one animal model; and, second, different wildlife 
species, potentially, could be a connecting link between differently adapted infectious strains 
(Pusterla, et al., 2008b).  
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CHAPTER 6:  
PROTECTING SHORT-TERM EAR CATHETERS IN HEALTHY RABBITS. 
 
 
Relationship of this study to the dissertation objectives. 
In this chapter the results of a technique’s refinement study are presented. When the 
pharmacokinetic study (Chapter 7) was started, several difficulties in maintaining auricular 
catheters in rabbits were noted, hindering the timeliness and the feasibility of sample collection. 
As the subjects in the study, albeit infected, were not sick or depressed, and behaved not at all 
differently than healthy rabbits, the catheter’s bandaging, usually appropriate for sick animals, 
proved to be inadequate. The bandaging technique described in this chapter not only secured the 
catheter to the ear and allowed repeated and timely samples for the pharmacokinetic study; but 
also allowed us to release the rabbits in their pen between samplings, promoting normal behavior 
and decreasing stress.   
 
 
 
This material has been published as: Sampieri, F., Orchard, R.N., Antonopoulos, A.J. & 
Hamilton, D.L. (2012). Protecting short-term intravascular ear catheters in healthy rabbits. Lab 
Animal, 41, 44-48. 
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6.1. Abstract 
 
Often in rabbits used for research, the catheterization of the ear’s vessels is chosen, 
because it requires minimal restraint.  Healthy rabbits are challenging with regards to 
maintaining indwelling catheters in their ears, as they tend to scratch catheters out or cause large 
hematomas that impair blood sampling.  This case study was generated by the necessity of 
collecting, for 12-hour terms, multiple blood samples in rabbits enrolled in a pharmacokinetics 
study.  Nine juvenile does, divided in 3 groups of 3, had an intra-arterial short-term catheter 
placed in the ear. The novel aspect of this technique consisted of protecting the indwelling 
catheter, by covering it with a section of moleskin, in the same shape as the ear.  Catheters 
remained patent for repeated sampling in 5 rabbits for 12 hours; in 2 rabbits for 8 hours, 1 rabbit 
for 6 hours, and 1 rabbit for 4 hours.  This method, using a lightweight bandage, resulted in 
minimal interference to the rabbits. 
6.2. Introduction 
 
Healthy rabbits, more commonly as research subjects than patients, might need an 
intravascular catheter for a short period of time, so that repeated blood samplings can be 
performed with minimal restraint and distress.  The common target of indwelling catheters in 
rabbits, for both clinicians and researchers, is to preserve the patency of the main blood vessels 
(arteries or veins) and to avoid trauma, but the necessary approach is perceived in a dichotomous 
way.  
The recommendation of clinicians is to collect blood through venipuncture of either the 
jugular or the saphenous veins, leaving the cephalic vein as a privileged site for potential 
insertion of an intravenous indwelling catheter (Graham, 2006).  Other authors indicate that, for 
a slow rate administration of drugs or intravenous fluids, the ear’s marginal vein is the easiest to 
approach, particularly in sick and critical patients (Harcourt-Brown, 2002b).  However, 
commonly it is suggested not to use the ear’s central artery and marginal vein, as there is a high 
incidence of hematomas, potential arterial damage and subsequent skin sloughing at the ear’s tip 
(Harcourt-Brown, 2002b; Graham, 2006).  Undoubtedly, it is better for the clinician facing a 
critical patient, to attempt blood sampling from a large vessel, rather than trying to obtain a 
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significant amount of blood from small vessels on the ear’s delicate surface (Paul-Murphy, 
2007).  However, blood sampling from the ideal sites listed above requires the presence of a 
technician, or an experienced handler. Appropriate restraint is the main limiting factor to a 
careful sampling procedure, in critical patients to minimize their stress; and in healthy research 
subjects, to limit their normal grooming and scratching reactions (Graham, 2006). 
The researchers working with rabbits target the ear’s marginal vein and ear’s central 
artery, as such approach requires minimal restraint and causes less stress, and are therefore 
commonly accepted as sampling sites (Diehl, et al., 2001).  In research, it is necessary to satisfy 
many experimental needs, not least, the fact that samplings often need to be feasible without 
assistance (e.g., night sampling).  Research rabbits usually are not sick and depressed, as clinical 
patients can be. They get accustomed over time to mechanical restraint devices and are 
comfortable when so kept, for short periods of time (Suchow & Douglas, 1997).  In other studies, 
restraint jackets are utilized with multiple functions, beside restraint, such as protection for 
bandages, or carriers for drug administering pumps (Clifford, et al., 2003).  In these rabbits the 
main challenge is to maintain an indwelling catheter, regardless of the period’s length, because 
they are mostly healthy and behave accordingly.  Rabbits usually resist indwelling catheters and 
their protections, by scratching or biting them.  Thus, they often have to wear Elizabethan 
collars, which are a notable source of stress for the rabbits, as shown by the changes in their 
glycaemia (Knudtzon, 1984).  Furthermore the presence of an Elizabethan collar, as it limits both 
regular feeding and cecotrophy, can lead to inappetence and anorexia, unless rabbits are 
acclimated to wear it, before the experiments begin (Harcourt-Brown, 2002b; Clifford, et al., 
2003; Graham, 2006). 
During the initial phase of a pharmacokinetic study, while working with 3 healthy 
rabbits, this research team encountered many difficulties in maintaining working catheters, 
preventing trauma to the ears and bandaging ears and catheters in a scratch-proof manner.  In the 
experiments, multiple, small volume (1 ml), blood samples were needed at specific time-points, 
initially concentrated within a 12-hour time-frame.  Thus, this study aimed to improve the 
management of ear catheters in the short term, catheterizing the animals only once and 
preventing multiple punctures of the vessels.  This method was sought to provide rabbits with 
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their customary freedom of movement and to allow researchers the peace of mind of a working 
catheter. 
6.3. Materials and methods 
 
6.3.1. Animals. 
 
Nine New Zealand White female rabbits (Charles River Canada, Pointe Claire, QC, 
Canada), 8 to 10 weeks of age, body weight range of 2.1 - 2.8 kg, were enrolled in this research 
case study. The catheterization study was conducted on 3 groups of 3 does, each equally handled 
and treated, which participated in a pharmacokinetic study (same does of the experiments 
described in Chapter 7).   
 
 
6.3.2. Ear Preparation. 
 
After cleaning and drying the outside aspect of the ear’s pinna, a topical anesthetic cream 
(EMLA Cream Astra Zeneca Canada Inc., Mississauga, ON, L4Y 1M4 Canada) was applied in 
the area above the ear’s central artery, for two thirds of its length, excluding the tip, as the 
catheter was placed in the rostral portion of the artery.  A 30-45 minute interval was allowed to 
obtain appropriate anesthetic effects.   
The proper placement of an arterial catheter requires typical animal restraint, to minimize 
the chances of damaging the artery.  A mechanical restraint device (visible in Figures 6.1 to 6.5) 
was used.  The ear selected for catheterization was gently directed laterally from the rabbit’s 
head, to allow full access to the artery.  The fur on the pinna’s outer surface was shaved with 
clippers (blade #40 - Oster Golden A5,J. Tarnow Company Ltd., Toronto, ON, M6A 2X5 
Canada), assuring that no hair was left on the ear’s portion to be covered by the catheter 
protection (visible in Figure 6.1.1.).  
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Figure 6.1.1.  
 
 
 
 
 
 
 
 
 
 
Figure 6.1.1. Ear’s preparation. Once the rabbit is properly restrained and the ear’s skin above 
the artery has been locally anesthetized, the fur can be shaved off. 
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6.3.3. Preparation of supplies 
 
Moleskin (Dr. Scholl’s Extra Soft Moleskin. Imported by Schering Canada Inc., Pointe 
Claire, QC, H9R 1B4 Canada): It was chosen to cover the catheter and the catheter’s insertion 
site, with the idea of somehow simulating a “skin-embedded” injection port.  The moleskin 
coverage was used as it holds and protects the catheter, while still allowing the rabbit free, 
unhindered movement of the ear.  The size of the moleskin section was pre-measured and pre-cut 
in the shape of the ear (Figures 6.1.2. and 6.1.3.), so that the moleskin’s edges did not extend 
beyond the ear’s margins.  The moleskin covered from the base of the ear, to 2 – 3 cm from the 
tip.  
Catheter (BD Insyte - Becton Dickinson Infusion Therapy Systems Inc. Sandy, UT, 
84070 USA): After opening the package and ensuring that the catheter moved freely from its 
stylet, the catheter was pre-flushed with heparinized saline.  
Tissue glue (3M Vetbond - 3M Animal Care Products, St. Paul, MN, 55144 USA):  
Although the underside of Dr Scholl’s moleskin is prepared with an adhesive layer, tissue glue 
was used to reinforce sealing and adhesion of the cover to the skin. In the absence of tissue 
adhesive, Krazy Glue (Instant Krazy Glue - Imported by Elmer’s Products Canada Corp., 
Toronto, ON, M1P 28B Canada) can be used, although a greater thermal reaction would be 
expected. 
 
 
  
158 
 
Figure 6.1.2. 
 
 
 
 
 
 
 
 
Figure 6.1.2. Preparation of the moleskin: Step 1. The moleskin width is measured to the 
breadth of the rabbit’s auricular pinna.  
 
Figure 6.1.3. 
 
 
 
 
 
 
 
Figure 6.1.3. Preparation of the moleskin: Step 2. Measure the moleskin length to the desired 
length on the rabbit’s auricular pinna. Paper scissors are more appropriate for this initial 
preparation step.  
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6.3.4. Placement of the catheter and protection cover 
  
The entire procedure is illustrated in Figures 6.2.1 through 6.2.6.  The catheter was 
aligned directly with the artery, near the ear’s midpoint, taking care of not placing it too far close 
to the tip of the ear, as the weight of the catheter could contribute to the ear flopping.  As the skin 
must be dry for the moleskin to adhere, the catheter was inserted using gauzes to catch any blood 
spills, before the placement of the injection port.  Keeping the catheter in line with the artery, the 
catheter’s hub was glued to the ear with tissue glue.   
The pre-cut moleskin was placed near the ear’s base, after covering the adhesive side 
with tissue glue, which was applied to the rest of the moleskin’s adhesive surface, particularly 
near the edges.  It was then laid over the entire catheter’s hub and injection port (Intermittent 
Infusion Plug - Kendall Argyle TYCO Healthcare Group LP. USA) (Figures 6.3.1. to 6.3.2.) and 
all the moleskin edges were pressed down.  Careful not to perforate the injection port or the ear 
below the moleskin, a small hole was cut in the moleskin, with a #11 scalpel blade, to allow the 
injection port to “peep” out, for the purpose of sampling.  Thus, the effect of “skin embedding” 
was obtained. 
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Figure 6.2.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2.1. Catheter insertion: Step 1.  An arterial catheter is inserted after the skin over the 
ear’s central artery has been locally anesthetized, shaved and scrubbed.  Prior to insertion, the 
catheter is filled with sterile heparinized saline. 
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Figure 6.2.2. 
 
 
 
 
 
 
 
 
Figure 6.2.3. 
 
 
 
 
 
 
 
 
 
Figures 6.2.2. and 6.2.3. Catheter insertion: steps 2 and 3. As soon as blood is noted in the 
hub of the catheter, gauze is used to prevent the area surrounding the catheter from getting wet. 
A key point of this technique is to have the ear’s skin clean and dry throughout the procedure. 
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Figure 6.2.4. 
 
 
 
 
 
 
 
 
Figure 6.2.5 
 
 
 
 
 
 
 
 
Figures 6.2.4. and 6.2.5. Catheter insertion: Steps 4 and 5. The catheter is capped with a 
temporary cap.   
 
 
163 
 
Figure 6.2.6. 
 
 
 
 
 
 
 
 
 
Figure 6.2.6. Catheter insertion: Step 6. After changing the gauze to a clean (and dry) one, a 
screw-on injection port is attached to the catheter (2f). 
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Figure 6.3.1. 
 
 
 
 
 
 
 
 
 
Figure 6.3.1. Securing the catheter and the moleskin: Step 1. Tissue glue is distributed around 
the catheter’s hub and crown, so it stays in place. 
 
Figure 6.3.2. 
 
 
 
 
 
 
 
 
Figure 6.3.2.  Securing the moleskin: Step 2. The moleskin paper protection is removed and 
the moleskin is placed appropriately on the rabbit’s auricular pavilion.  Tissue glue is distributed 
on the sticky surface of the moleskin, in particular close to the edges. 
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Figure 6.3.3. 
 
 
 
 
 
 
 
 
 
Figure 6.3.3. Moleskin in place. This illustrates the final appearance of the moleskin coverage 
on the catheter. 
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Figure 6.4.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4. Troubleshooting.  Removing the paper protection of the moleskin as it gets attached 
to the ear is not convenient, because it can get hung on the catheter’s hub. The risk is moving or 
offsetting the catheter. 
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6.3.5. Maintenance of the Catheter: repeated sampling. 
 
After catheter placement or sample collection, a small volume of heparinized saline                                                                                                                                                                                                                                                                                                             
(3000 IU of sodium heparin in 500 ml of 0.9% sodium chloride solution) was injected to 
maintain the patency of the catheter (Figure 6.5).  The heparinized catheter’s “lock” (a small 
amount of heparinized saline to maintain the catheter’s hub clear and patent and prevent clotting) 
was achieved by flushing the catheter after sampling, with 0.3-0.5 ml of heparinized solution.  At 
the time of collection, the “lock” was removed and discarded, along with a small amount of 
blood.  A new syringe and needle were used for each sample collection. 
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Figure 6.5. 
                             
 
 
 
 
 
 
Figure 6.5. Catheter Flush. Flushing of the catheter, which is completely embedded under the 
moleskin. 
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6.3.6. Removal of the catheter and recovery of the ear 
 
The moleskin protective cover was soaked with a biological adhesive remover (Remove* 
- Imported by Smith and Nephew Inc. St Laurent, QC H4R 2P9 Canada) and gently peeled off at 
the end of the 12-hour period, or at the time of catheter’s failure (Figure 6.6.1. to 6.6.3.).  The 
catheter was removed and compression was applied on the puncture site of the vessel for up to 5 
minutes, to avoid arterial bleeding and hematomas.  The remaining adhesive, in many cases, 
were easily peeled off, after removing the protection cover and the catheter.  Smaller residual 
areas peeled off over time, once dried.  Ears were cleaned with alcohol and dried gently to not 
remove the recently formed clot.  Antiseptic cream (Hibitane –Wyeth Santé Animale – Division 
de Wyeth Canada, Guelph, ON, N1K 1E4 Canada) was applied over the ear, after the removal of 
the catheter (Figure 6.7.2.) and, thereafter daily after cleaning the area, until hematomas or signs 
of skin irritation were resolved.  
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Figure 6.6.1. 
 
 
 
 
 
 
 
 
Figure 6.6.1. Removal of the moleskin: Step 1. The moleskin is carefully soaked, so to not wet 
the rabbit’s head (and eyes) with adhesive remover.  
 
Figure 6.6.2. 
 
 
 
 
 
 
 
 
Figure 6.6.2: Removal of the moleskin: Step 2. The edges of the protective cover are lifted 
carefully. 
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Figure 6.6.3.  
 
 
 
 
 
 
 
 
 
Figure 6.6.3.: Removal of the moleskin: Step 3. The moleskin is carefully removed to maintain 
hemostasis, paying attention to not pull the catheter and induce bleeding and subcutaneous 
hematomas. 
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Figure 6.7.1. 
 
 
 
 
 
 
 
 
Figure 6.7.1. Appearance of the catheterized ear after removal of the catheter.  Appearance 
of the auricular pinna in the rabbit, after removing the moleskin and the catheter utilized for 
repeated sampling within 12 hours. 
 
Figure 6.7.2. 
 
 
 
 
 
 
 
 
Figure 6.7.2. Aftercare of the rabbit’s ear, after the ear has been cleaned and dried. Antiseptic 
cream is applied daily on the area previously covered with the protective moleskin.  
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6.4. Results 
 
Out of 9 placed catheters, multiple samples were collected successfully for 12 hours in 5 
animals.  Of the remaining 4 catheters inserted, 2 failed to yield successful samples after 8 hours 
from insertion, 1 failed after 6 hours and 1 failed after 4 hours.  This technique was perfected 
over time and a better catheter’s performance was obtained in the last 6 rabbits, particularly 
when heparinized solution flushes were applied every 2 hours, regardless of sample collection. 
As the technique improved, the length of aftercare decreased.  This simple technique allowed 
precision and timeliness in the collection of samples for the pharmacokinetic study, compared to 
conventional methods used for catheterization and bandaging techniques.  
Three rabbits could be caught, prepared for sampling in the restraint devices, sampled 
and released in less than 10 minutes, accounting for an average handling time of 3 minutes per 
rabbit. Between samples, the rabbits were released in their pens; free to eat and drink at libitum 
and able to interact normally with their pen mates (Figure 6.8.).   
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Figure 6.8. 
 
Figure 6.8. Rabbits with catheter and moleskin protection cover. They are released with their 
peers in their pen. On the rabbit on right, the light tan color of the moleskin is visible on the ear’s 
outer surface; the edges of the moleskin protection cover are visible on the rabbit on the left, 
whereas in the rabbit in the center of the picture, the moleskin protection cover is perceivable 
from the front as a dark shape. It could look like a big ear bruise from the inner aspect of the ear! 
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Pictures of the outcome after removing the moleskin after 12-hours sampling are 
illustrated in Figure 6.7.1 (shown on page 21), as well as pictures of recovery, after 3 and 7 
days, following catheterization (Figures 6.9.1, 6.9.2. and 6.10).  The ear’s central artery and the 
surrounding skin successfully recovered from the catheterization and the application of the 
glued-on protective moleskin.  
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Figure 6.9.1. 
 
 
 
 
 
 
 
 
Figure 6.9.1: Ear’s recovery 3 days after the catheter and the moleskin protective cover was 
removed. Small residues of dried tissue glue are visible, but little irritation is detectable. 
 
Figure 6.9.2. 
 
 
 
 
 
 
 
Figure 6.9.2. Ear’s recovery 3 days after catheter removal. Another ear’s recovery 3 days 
after the catheter and moleskin were removed. Small residues of dried tissue glue are visible, as 
well as a small hematoma over the insertion site. 
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 Figure 6.10. 
 
Figure 6.10: Ear’s recovery 7 days after the catheter and moleskin were removed. The 
artery is clear and the growing hair is noticeable.  
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6.5. Discussion 
 
The results of this case study demonstrate a very simple approach to maintaining a short 
term intra-arterial catheter, for multiple blood samples in research rabbits. The novelty consists 
in the application of the protective moleskin over the catheter site and the ear, rather than the 
catheterization itself.  The full coverage of the catheter and the light weight of the moleskin 
cover are key-points to the technique, as this ear shaped moleskin provides protection from 
scratching and improves stability of the catheter, yet it allows the rabbit to move the ear freely 
and to carry it in a normal position.  As the base of the pinna is thicker, the moleskin functioned 
as a semi-rigid splint to the ear itself.  The tissue glue reinforced the splinting effect, ensuring an 
all-around better seal.  Had the moleskin been placed only near the ear’s tip, it would have 
caused the ear to flop and would have been irritating to the rabbit.   
The tissue glue dried quickly and caused minor thermal and chemical irritation to the 
rabbits’ ears.  In absence of tissue glue, Krazy glue has been used, although it appears to develop 
more of a thermal reaction, hence irritating the rabbits’ ears more than tissue glue.  The use of 
superglue to stabilize a butterfly needle that is inserted in the ear’s marginal vein, was previously 
reported, this technique was advised for critical, or moribund, patients, as they probably would 
not attempt to scratch their catheters (Harcourt-Brown, 2002b).  In comparison to the previously 
suggested superglue method, our technique can be applied safely to healthy and normally active 
animals.  Some irritation would be expected during the 12-hour period, but the rabbits were 
observed to not scratch the catheterized ear with a higher frequency than the bare ear.  During 
grooming, the rabbits’ paws, glided swiftly over the protective moleskin, more so when the 
injection port “peeped” halfway through the moleskin, than when it was at the end of the 
protective cover, as the surface exposed to snagging and scratching was minimized.    
One of the advantages of this method is the ability, without assistance, for a veterinarian 
or a technician to take repeated blood samples, provided that the rabbit is adequately restrained 
in a mechanical device; the material is pre-organized; and that the operator is experienced at 
inserting small arterial catheters.  Having said that, a “bunny-wrap” method of restraint can also 
be used, but such a technique would require an assistant, to hold the wrap. 
179 
 
Although the results of this protective cover were encouraging, and the catheter failures 
decreased with experience, some flaws were also observed.  First, the catheters’ patency was at 
times dependent on its position within the vessel, as the angle at which the ear was catheterized, 
at the time of stylet insertion, needed to be exactly repeated to obtain blood flow through the 
catheter, at the time of blood collection.  The reason could be due to the tip of the catheter being 
too close against the vascular wall, or the decreased pressure surrounding the catheter itself.  A 
second flaw was the incapability of inspecting the catheter directly, throughout the experiment; 
and finally, the inaccessibility of the injection port for cleaning and disinfection.  These are the 
main reasons why such a technique is not ideal for long term repeated sampling, as 
contamination of the catheter can occur and initiate arterial damage or infection.   
Despite the few limitations listed, this protected catheterization technique provided an 
easy access for short term repeated blood sampling and was followed by a quick recovery of the 
catheterized ear’s arteries and skin.  Moreover, the appealing aspect consisted in being able to 
utilize the same artery for repeated sampling within a few days from catheterization.  In 
conclusion, this protective technique could be a valuable procedure to bear in mind for both 
pharmacokinetics and endocrinology studies on rabbits, both as research animals and as patients.  
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CHAPTER 7 
 PHARMACOKINETICS OF GALLIUM MALTOLATE IN LAWSONIA 
INTRACELLULARIS-INFECTED AND UNINFECTED RABBITS. 
 
Relationship of this project to the dissertation objectives. 
In this chapter the methodologies and the results of a pharmacokinetic study regarding the 
compound Gallium maltolate are reported. The pharmacokinetic analysis of this novel compound 
was one of the main goals of this doctoral project. For this purpose the rabbit infection model 
was validated, to investigate the impact of gastrointestinal disease on the total body exposure to 
the drug administered at 50 mg/kg BW orally once. The results of this study were utilized to 
calculate a dosing interval for the other main goal of the project, the evaluation of efficacy of the 
compound against gastrointestinal infection. 
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7.1 Abstract 
 
Oral gallium maltolate (GaM) pharmacokinetics (PK) and intestinal tissue (IT) 
concentrations of elemental gallium ([Ga]) and iron ([Fe]) were investigated in a rabbit model of 
equine proliferative enteropathy (EPE).  New Zealand white does (uninfected controls and EPE-
infected, n=6/group) were given a single oral GaM dose (50 mg/kg).  Serial blood samples were 
collected from 0–216 h post-treatment (PT) and IT samples after euthanasia.  Serology, qPCR 
and immunohistochemistry confirmed, or excluded, EPE.  Blood and IT [Ga] and [Fe] were 
determined using inductively coupled plasma–mass spectrometry. PK parameters were estimated 
through non-compartmental approaches. For all [Ga] and [Fe] statistical comparisons were set at 
=5%. The Ga log-linear terminal phase rate constant was lower in EPE-rabbits versus 
uninfected controls (0.0116 ±0.004 (SD) vs. 0.0171 ±0.0028 h
-1
) (p=0.03); but half-life (59.4 ± 
24.0 vs. 39.4 ± 10.8 h) (p=0.12); Cmax (0.50 ±0.21 vs. 0.59 ±0.42 µg/mL) (p=0.45); tmax (1.75 
±0.41 vs. 0.9 ± 0.37 h) (p=0.20); and oral clearance (6.743 ± 1.887 vs. 7.208 ± 2.565 L/h) 
(p=0.74) were not.   IT’s [Ga] and [Fe] were higher (p<0.0001) in controls.  In conclusion, a 48 h 
GaM dosing interval is appropriate for multi-dose studies in EPE-rabbits, wherein both IT [Ga] 
and [Fe] are reduced.   
7.2 Introduction 
 
Equine proliferative enteropathy (EPE) is an emerging disease in weanling horses caused 
by Lawsonia intracellularis, an obligate intracellular gram-negative bacterium (McOrist, et al., 
1995a; Pusterla & Gebhart, 2009).  The disease causes hyperplasia of enterocytes and enteric 
crypts, primarily in the distal jejunum and ileum, and occasionally in the cecum and colon, 
affecting the intestinal ability to absorb nutrients in multiple domestic and wildlife animal 
species (Herbst, et al., 2003; Horiuchi, et al., 2008; Pusterla & Gebhart, 2009; Wong, et al., 
2009).  In weanling foals, EPE’s clinical signs range in severity and chronicity from generalized 
wasting, pronounced ventral edema (along with hypoproteinemia), to profuse diarrhea, fever, 
colic, acute shock and death (Lavoie, et al., 2000; Pusterla & Gebhart, 2009; Page, et al., 2012).  
Similarly to its impact on the swine production industry worldwide, L. intracellularis infection in 
weanling horses is a significant economic and welfare burden for the equestrian industry, with 
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economic losses due to animal mortality, poor growth rates, and costly therapeutic interventions. 
Moreover, EPE typically long convalescence and recovery constitute a sale-price drawback, up 
to a year after clinical manifestation (Guedes, et al., 2002d; Frazer, 2008).   
L. intracellularis infections pose a challenge for antimicrobial drug (AMs) therapy due to 
the bacteria’s privileged intracellular location within enterocytes.  This “sanctuary-like” location 
protects the bacteria from the host defenses and from the common first-line AMs adopted by 
equine clinicians.  Currently, the therapeutic management of EPE relies on the oral employment 
of macrolides or azalides, often combined with rifampin, or the tetracycline class, either through 
parenteral or oral administration (Lavoie, et al., 2000; Schumacher, et al., 2000; Sampieri, et al., 
2006, Feary, et al., 2007; Frazer, 2008).  No new alternative AMs have been proposed for EPE 
therapy since 2006.  A few reported cases of treatment failures suggest a need for alternative 
therapeutic approaches, but the potential for L. intracellularis to develop a specific susceptibility 
pattern, or even an AM resistance, although currently unknown, provides increasing motivation 
to identify other AM treatments (Frazer, 2008).  Strain susceptibility studies in vitro have not yet 
been conducted on the EPE strain.  For the porcine proliferative enteropathy (PPE) strains, the 
limited number of studies conducted thus far suggests a potential for geographical strain 
differentiation (McOrist, et al., 1995c: Wattanaphansak, et al., 2009a).  Interestingly, most 
therapeutic knowledge has been achieved through clinical experiences, rather than laboratory 
trials, due to intrinsic difficulties in maintaining L. intracellularis in a pure cell-culture 
environment (Lawson, et al., 1993).  A few studies involving exposure of cultured bacteria in 
vitro to a variety of AMs and disinfectants showed the clear technical limitations of in vitro 
research for intracellular organisms (Wattanaphansak, et al., 2009a; Wattanaphansak, et al., 
2009b).  To overcome these limitations, in the present study the use of a rabbit infection model 
was elected (Chapter 4), to obtain a valuable preclinical characterization of the drug during 
disease, for the needs of EPE therapy.  
A potential alternative AM therapy for EPE is the novel, gallium-based compound, 
gallium maltolate (GaM). It is hypothesized that gallium may reach intracellular bacteria through 
typical mechanisms of oligo-element absorption (specifically iron, zinc and aluminum) in the 
small intestine (Gunther & Wright, 1983; Caspary, 1992).  Given its similarity in electric charge, 
ionic radius, valence and electronic footprint to ferric iron (Fe(III)), elemental gallium (Ga(III)) 
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may function through a “Trojan horse” mechanism replacing ferric iron (Fe(III)), a metabolically 
essential element to most pathogens’ survival, and thereby reduce the risk for development of 
AM resistance (Bernstein, 1998; Collery, et al. 2002).  Gallium is predominantly detected in 
plasma bound to Fe(III)-sites of transferrin.  It is preferentially taken up by phagocytic cells 
during the inflammation process entering such cells through mechanisms dependent and 
independent of transferrin (Tsan, 1986; Chitambar & Zivkovic, 1987).  Selectivity must occur 
because bacteria take up ferric iron, while healthy mammalian cells tend to heavily recycle iron 
locally or, in the case of erythropoietic cells, take up ferrous iron (Fe(II)), which subsequently 
undergoes intracellular redox reactions (Logan, et al., 1981; Bernstein, 1998).  In the presence of 
sufficiently high Ga(III) concentration, then, bacteria may take up large amounts of Ga(III), 
altering the first step of the bacterial ferric metabolism (Olakanmi, et al., 2000).  Unlike iron, 
gallium is unable to complete a redox-cycling reaction (from valence III to valence II) and thus 
cannot be incorporated or function in many iron metabolic pathways and enzymes (e.g. 
ribonucleotide reductase) necessary for DNA replication and cell function (Bernstein, 1998).  
The ability of Ga(III) to block these iron-dependent metabolic steps has been demonstrated in 
Mycobacteria and hypothesized in R. equi, and it has been clearly ascribed to the gallium moiety, 
not to the particular salt or ligand utilized in the formulation (i.e. nitrate, chloride or maltolate) 
(Olakanmi, et al., 2000; Harrington, et al., 2006).  Inhibition of bacterial iron metabolism may 
lead to AM effects, as it may ultimately reduce bacterial survival and replication (Bernstein, 
1998).    
The AM activity of several gallium-based compounds has been explored for a few 
intracellular bacteria in veterinary medicine (Harrington, et al., 2006; Martens, et al., 2007a; 
Fecteau, et al., 2011).  Only an injectable solution of citrate-chelated gallium nitrate is approved 
in United States for the treatment of human cancer-related hypercalcemia, and is administered as 
a continuous IV infusion, to avoid the nephrotoxic effects reported with IV bolus (Martens, et 
al., 2007).  GaM is deemed safe when orally administered to humans, mice, rats, dogs and foals 
(Bernstein, et al., 2000; Martens, et al., 2010).  Unlike with gallium salts (i.e. gallium chloride or 
nitrate) there are no reports of GaM nephrotoxicity, as it is apparently highly protein-bound in 
the bloodstream; it is thus expected to convey Ga(III) to the bacteria located in the intestinal 
brush border membrane (Collery, et al., 1989; Bernstein, et al., 2000).  
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In the present study, the potential differences induced by EPE on GaM pharmacokinetics 
(PK) parameters were investigated in rabbits, prior to exposing foals affected by L. 
intracellularis to treatment.  Using a bolus dose (50 mg/kg BW once intra-gastrically) previously 
utilized in a mouse model for R. equi, for a preclinical trial (Harrington, et al., 2006; Martens, et 
al., 2010; Chaffin, et al., 2011), the present study aimed to obtain sufficient information on the 
PK characteristics of this novel compound to determine the feasibility of a multiple oral dose 
GaM efficacy study in a rabbit infection model.  
7.3 Material and Methods 
 
This work was approved by the University of Saskatchewan’s Animal Research Ethics 
Board, and it adhered to the Canadian Council on Animal Care guidelines for humane animal 
use. 
7.3.1. Animals 
 
Eighteen, 8 to 9-week-old, 2.01 - 3.07 kg BW, New Zealand white female rabbits
 
(Charles River Canada, Pointe Claire, QC, Canada) were used. The infected does were managed, 
fed and housed as described in Chapter 4; the uninfected controls were treated equally but, as 
they were not infected, they were housed in the Animal Care Unit facilities in a Containment 
Level (CL)-1 room. Experiments started after a mandatory week of acclimation.  Treats (apples 
and carrots) were offered to promote socialization, facilitate handling, and monitor individual 
appetite, alertness and brightness, particularly in group-housing conditions (Johnson-Delaney, 
2006; Chapter 4).  The rabbits monitoring followed daily or more often (in the case of multiple 
samples in a day) the protocol previously reported (Chapters 4 and 5).  
7.3.2. L. intracellularis rabbit infection model 
 
The protocol described for inducing equine strain L. intracellularis lesions in juvenile 
rabbits was followed to achieve infection in the EPE-infected group (Chapter 4).  Each rabbit 
was inoculated via nasogastric intubation with a low passage pure cell-culture inoculum of 
E04504 L. intracellularis harvested after isolating the bacteria from a deceased foal’s ileal 
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mucosa.  Inocula were prepared and suspended in 3 mL of buffered sucrose/phosphate/glutamate 
medium, for a total inoculating dose of 2.5 x 10
8 
bacteria/rabbit (Chapter 4), administered with a 
chasing volume of 3 mL of distilled water.  A SYBR Green-based PCR quantitation assay was 
used to determine the bacterial concentration of the infectious material, as previously published 
(Wattanaphansak, et al., 2010).  Onset of infection, or its absence in the controls, was detected 
ante mortem through diagnostics used currently in clinical practice for EPE, such as immune-
peroxidase monolayer assay (IPMA) serology and TaqMan qPCR on fecal material (Guedes, et 
al., 2002c; Chapter 4).  The post mortem assessment was based on gross pathology examination, 
haematoxylin-eosin (H&E) staining, and immunohistochemistry (IHC) labeling of specific 
lesions based on murine anti-L. intracellularis antibody on samples fixed in 10% buffered 
formalin at collection time (Guedes, et al., 2002a).   
7.3.3. Study design 
 
Rabbits were divided into 2 groups of 9 animals each: the uninfected control group 
(controls) and EPE-infected group (EPE-infected).  In each group, 3 does were randomly 
selected for a pilot – limit of detection – experiment.  Those rabbits underwent euthanasia and 
full necropsy 24 h post-treatment (PT).   
The remaining 6 rabbits of both groups were enrolled in the PK study: the uninfected 
control and the EPE-infected groups were studied in 2 phases a few days apart, so that only 3 
animals at a time were treated, sampled and euthanized, to maximize accuracy in sample 
collection and animal monitoring, throughout the experiment.   
Gallium maltolate (provided by LRB, Terrametrix, Menlo Park, CA, USA) was dissolved 
in sterile double-distilled water, immediately prior to administration, achieving a concentration 
of 8 mg/mL, with a solution’s final pH = 5.8 - 6 (Harrington, et al., 2006).  Rabbits were 
administered a single intragastric dose of GaM solution, 50 mg/kg BW, on day 0 for the controls 
and on day 7 post infection (PI) for the EPE-infected rabbits.  Such timing was elected to 
evaluate the ability of small intestine to absorb the solution when the EPE lesions start to appear, 
as the disease peak in the rabbit model is reported to be around 12-14 days PI.    
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A nasogastric tube was used for intragastric administration of GaM, due to the relatively 
large administered volume.  Briefly, an anesthetic gel (Xylocaine Gel 2%, Astra Zeneca Canada 
Inc., Mississauga, ON, Canada) was applied medially on both nostrils.  Approximately 30 to 45 
minutes later, a 5 Fr. wide, 40 cm long feeding tube (Kendall Sovereign, Tyco Health Care 
Group LP, Mansfield, MA, USA) was inserted via the nose into the stomach.  Serial blood 
samples were taken from a catheter in the ear central artery.  Briefly, a local skin block above the 
ear’s central artery was achieved with a minute amount of local anesthetic cream (EMLA Cream, 
Astra Zeneca Canada Inc., Missisauga, ON, Canada).  The rabbits were placed within restraint 
cages and the catheterization of the ear’s central artery was performed following a previously 
published protocol (Chapter 6) with an indwelling sterile catheter (BD Insyte - Becton Dickinson 
Infusion Therapy Systems Inc. Sandy, UT, USA) affixed to an injection port (Intermittent 
Infusion Plug - Kendall Argyle TYCO Healthcare Group LP. USA).  The injection port, along 
with the catheter hub, was glued temporarily to the skin with tissue glue (3M Vetbond - 3M 
Animal Care Products, St. Paul, MN, USA).  Subsequently, the whole ear was bandaged with 
moleskin (Dr. Scholl’s Extra Soft Moleskin, imported Schering Canada Inc., Pointe Claire, QC, 
Canada) in such a way that the bandage mimicked a skin embedded port, affording timely 
repeated samples (Chapter 6).  
7.3.4. Sample collection .  
 
7.3.4.1. Blood.  
Arterial blood was collected (1 mL/sample) from time 0 h (tfirst), immediately after GaM 
administration, and then at time 0.5, 1, 1.5, 2, 4, 6, 8, 12, 24, 36, 48 h, and subsequently every 24 
h, until time 216 h (9 days PT, tlast).  The first 9 samples were collected through the injection port 
bandaged in place, as described above.  Starting with the sample at 24 h PT to the tlast sample, 
blood was collected off the needle, after local anesthesia was applied on the skin over the ear’s 
central artery. 
7.3.4.2. Tissue samples.  
A full necropsy examination was conducted in all 18 rabbits.  A published, sampling 
protocol (Chapter 4) was followed for visual examination of the organs, from stomach to rectum, 
for thickness, discoloration or type of content as L. intracellularis lesions are not located in any 
other organ.  Samples of duodenum, mid-jejunum and terminal jejunum, ileum, ileocecal valve 
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(including ampulla coli and sacculus rotundus), cecum (transitional area between cecum and 
caecal appendix), terminal portion of the caecal appendix, large colon (proximal to the fusum 
coli), terminal colon and rectum were collected  (Chapter 4). 
7.3.5. Verification of infection. 
 
7.3.5.1. Histology and immunohistochemistry.  
Two adjacent, formalin-fixed and paraffin-embedded sections per sample were cut and 
stained by H&E and IHC with streptavidin method using murine anti-L. intracellularis-specific 
monoclonal antibody to detect proliferative lesions of the intestinal epithelium and the presence 
of the antigen within the cells (Guedes & Gebhart, 2003c).  The L. intracellularis-specific 
antigen in the enterocytes was blindly evaluated with a 5 grade IHC scoring system, as 
previously reported (Guedes & Gebhart, 2003b).  For each rabbit, the negative control for each 
tissue section consisted of a correspondent IHC-labeled tissue section, except for the primary 
antibody.  Furthermore, pig ileal tissues known to be negative and positive for L. intracellularis 
infection were labeled with the murine anti-L. intracellularis monoclonal antibody to confirm the 
antibody's specificity and sensitivity, respectively. 
7.3.5.2. Serology.  
In serum, anti–L. intracellularis–specific IgG concentration was measured by an IPMA 
as reported previously (Guedes, et al., 2002c) and in Chapters 4 and 5.   
7.3.5.3. Quantitative PCR Analysis.  
Quantitative PCR analysis was conducted on fecal samples as previously reported, 
including a general bacteriology 16 sRNA for quality control (Pusterla, et al., 2010a; Chapter 4).  
The purified DNA was analyzed by qPCR for presence of L. intracellularis aspA gene copies 
(Pusterla, et al., 2008; Pusterla, et al., 2009).  
7.3.6. Elemental Iron and Gallium tissue concentration 
 
Serum and intestinal tissue (IT) concentrations of elemental gallium ([Ga]) and iron 
([Fe]) were determined through Inductively Coupled Plasma - Mass Spectrometry (ICP-MS).  
The maltol portion of the initial compound was not detectable due to its rapid metabolism, hence 
the tissue analysis focused on elemental metal concentrations (Bernstein, et al., 2000).  The 
188 
 
methodology was titrated prior to each batch of sample testing with rabbit blank serum, standard 
samples spiked with known [Ga] and [Fe], and verified on a batch of test tissues (liver).  
Analysis was repeated in duplicate.  
7.3.7. Pharmacokinetic analysis.  
 
Serum [Ga], or Cs, versus time data was analyzed using the non-compartmental approach 
(NCA), and the analysis was carried out using GraphPad Prism 5.4 Software (GraphPad 
Software, Inc., La Jolla, CA, USA).  The NCA was used to provide robust estimates of area 
under the curve from time 0 to time 216 h (AUC0→ 216), area under the curve extrapolated to 
infinity (AUC0→∞), elimination rate constant (), mean residence time (MRT), terminal half-life 
(t1/2), and oral clearance (Clo).  The observed maximum plasma concentration (Cmax) and 
observed time to maximum concentration (tmax) were determined by visual inspection of the 
serum concentration versus time profiles.  The AUC was determined using the trapezoidal rule 
with the extrapolated area calculated from the ratio of the last calculated concentration and   
Oral clearance (Clo) was calculated from the ratio of oral dose and AUC extrapolated to infinity 
(AUC0→∞); MRT was calculated as the ratio of the area under the first moment curve 
(AUMC0→∞) to the AUC0→∞; and half-life was obtained from the product of 0.693 and MRT. 
 
7.3.8. Statistics.  
 
Descriptive statistics (average and standard deviation, among others) were calculated for 
each NCA derived parameter.  For comparison of the PK parameters, a Student t-test was used.  
For the [Ga] and [Fe] in intestinal tissues a one-way ANOVA was used; whereas a two-way 
ANOVA for repeated measures was used for PCR comparisons in relation to GaM treatment.  
For both ANOVAs, a Bonferroni post-hoc test was implemented. When it was more appropriate 
not to assume a Gaussian distribution (uneven groups), a Kruskal Wallis analysis with Dunn’s 
post-hoc test was used.  Alpha was set at 5% for all the comparisons.  
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7.4. Results 
7.4.1. Clinical appearance.  
 
All rabbits tolerated well the single oral GaM dose.  During the 24 h pilot study, no 
abnormalities were detected in either uninfected control or EPE-infected rabbits. In the 
pharmacokinetic studies, no change was evident in either group, for the duration of the 
experiments for appetite, fecal consistency, self or mutual grooming, and behavior.  Only a 
marginal weight loss was observed on day 1 PT due to blood sampling loss and stress associated 
with multiple blood sampling (9 samples in 12 h).  In all cases, BW rapidly recovered within a 
day (Figures 7.1.1. and 7.1.2.).  A decrease in BW gain trend (indicating a clear weight loss, or 
a BW gain smaller than half the average daily BW gain observed throughout the experiment) 
was observed in EPE-infected rabbits (visible in Figure 7.1.2.) on or around 12 days PI, 
although not statistically significant (p=0.97).   
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Figure 7.1.1. 
  
Figure 7.1.1. Body weight changes in uninfected rabbits administered gallium maltolate. 
Body weight (Kg) changes in 6 uninfected controls rabbit (PK study only) administered a single 
oral dose of gallium maltolate (50 mg/Kg) on day 0, with serial blood sampling until day 9 post 
treatment (PT).  BW loss on day 1 PT is ascribed to the stress of dosing and blood sampling on 
day 1 PT.    
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Figure 7.1.2. 
 
Figure 7.1.2. Body weight changes in infected rabbits administered gallium maltolate. Body 
weight (Kg) changes in 6 EPE-infected rabbits (PK study only) inoculated with L. intracellularis 
on day 0 and administered a single oral dose of gallium maltolate (50 mg/Kg) on day 7 post 
infection (PI).  Rabbits underwent blood sampling until day 9 PT, or 16 PI. Note that the BW 
loss on day 8 PT is ascribed to the stress of dosing and serial blood sampling, but a trend towards 
BW gain suppression is noted around day 12 PI and is consistent with EPE infection.  
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7.4.2. Pharmacokinetics.  
 
Gallium was rapidly absorbed, with a minimal to nonexistent lag phase (Figures 7.2.1 
and 7.2.2.). The mean of the first detected Cs immediately after nasogastric administration was 
57.3 g/L in controls and 110.2 g/L in EPE-infected rabbits, increasing to 389.5g/L and to 
533.75 g/L, respectively, within 30 minutes.  In control does, Cmax ranged between 248 g/L 
and 849.5 g/L (mean 500.43 ± 214.07 g/L), and it peaked with tmax in 1-12 h (mean 3.41 ± 
4.22 (SD) h).  In EPE-infected rabbits, Cmax ranged between 238 g/L to 1415 g/L (590.7 ± 
416.07 g/L), and tmax had a range of 0.5 - 1.5 h (0.9 ± 0.37 h).  
Elemental gallium half-life in rabbits (uninfected controls and EPE-infected alike) is 
prolonged, particularly in the EPE-infected rabbits. The elimination rate constants,  were 
0.0171 ± 0.0028 h
-1
 and 0.0116 ± 0.004 h
-1
, elimination half-lives of 39.38 ± 10.78 h and 59.36 ± 
24.02 h; and oral clearance of 6.743 ± 1.887 L/h and 7.208 ± 2.565 L/h, respectively, in 
uninfected controls and EPE-infected rabbits. In both groups, the slope calculations were verified 
through the fitting of the line calculations and the evaluation of residuals, which showed a 
random distribution and close proximity to the fitted line.  
The total body exposure to the drug showed a mean AUC extrapolated to infinity 
(AUC0→∞) of 21069.47 ± 6263.01 [(g/L) x h] and 19146.35 ± 9403.13 [(g/L) x h], 
respectively, in uninfected controls and EPE–infected rabbits.  Averaged and detailed Cs values 
from each rabbit are reported in Table 7.1 for control and Table 7.2 for EPE-infected rabbits. 
The only statistically significant parameter between the healthy and EPE-infected rabbits was the 
elimination rate constant  (p=0.03), whereas no parameter differences were found within the 2 
groups, as indicated in Table 7.2.  Individual log-linear Cs versus time curves are represented 
in Figures 7.2.1. and 7.2.2. for healthy and EPE-infected rabbits, respectively.  In several cases, 
cecotrophes ingestion, typical of normally behaving rabbits, could not be prevented, despite 
close monitoring, and it is clearly visible in the figures.    
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Figure 7.2.1. 
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Figure 7.2.1. Concentration versus time curves for uninfected rabbits administered  
gallium maltolate. Representation on log-linear scale of gallium serum concentrations in 6 
uninfected rabbits, treated orally once with gallium maltolate (50 mg/kg).  Blood sampling lasted 
for 9 days (216 h) PT. 
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Figure 7.2.2. 
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Figure 7.2.2. Concentration versus time curves for the infected rabbits administered 
gallium maltolate. Representation on log-linear scale of gallium serum concentrations in 6 
rabbits infected with L. intracellularis and treated orally once with gallium maltolate (50 mg/kg). 
Blood sampling lasted for 9 days (216 h) PT.  Note in both graphs that in the first 24 h 
cecotrophy was not completely prevented in all rabbits; hence, a second peak in the curves is 
noticeable. 
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Table 7.1. Pharmacokinetic parameters in uninfected control rabbits.  
 Rabbits   
PK 
parameters  
(units) 
2A 2B 2E 2G 2H 2I Mean SD 
Cmax (μg/L) 557 519 525 849 302 248 500.4 214 
tmax  (h) 2 2 1.5 2 12 1 1.7 0.4 
 (h-1) 0.0168 0.0188 0.0178 0.0155 0.021 0.0127 0.0171 0.0028 
AUC (0 → ∞) 
(μg·h /L) 
24419.2 19816.1 18318.4 31480.9 13047.0 19335.0 21069.4 6263 
AUMC(0 - ∞) 
(μg·h2/L) 
1170142 979910 1033179 2098963 532047 1616948 1238532 547063 
Clo (L/h) 5.5 6.4 8.2 4.0 9.9 6.3 6.7 1.8 
MRT (h) 47 49 56 66 40 83 56.8 15.5 
t ½  (h) 32.5 33.9 38.8 45.7 27.7 57.5 39.3 10.7 
 
Table 7.1. Pharmacokinetic parameter estimates for healthy uninfected rabbits after a single oral 
bolus of gallium maltolate (50 mg/kg BW). The individual values, mean and SD are reported. 
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Table 7.2. Pharmacokinetic parameters in EPE-infected rabbits 
 Rabbits    
PK 
parameter  
(units) 
4A 4B 4C 4D 4F 4I Mean SD p-
value 
Cmax (μg/L) 393 468 477 1415 549 238 590.4 417 0.45 
tmax  (h) 1 0.5 1.5 0.5 1 1 0.9 0.3 0.20 
(h-1) 0.0059 0.0087 0.0139 0.0168 0.014 0.0105 0.0116 0.004 0.03 
AUC (0 - ∞) 
(μg·h /L) 
13382.6 10664.3 20949.6 36990.6 17023.5 15867.2 19146.3 9403 0.53 
AUMC(0 - 
∞) (μg·h
2
/L) 
1965962 980040 1467763 2039778 922321 1564630 1490082 472689 0.13 
Clo (L/h) 10.1 10.4 5.8 2.8 6.6 7.4 7.2 2.5 0.74 
MRT (h) 146 91 70 55 54 98 85.6 34.6 0.12 
t ½  (h) 101.1 63 48.5 38.1 37.4 67.9 59.3 24.0 0.12 
 
Table 7.2. Pharmacokinetic parameter estimates for 6 EPE-infected rabbits after a single oral 
bolus dose of gallium maltolate (50 mg/kg BW). The individual values, mean and SD are 
reported. In the last column the p-value derived from t-test comparison between uninfected 
controls and EPE-infected rabbits are reported indicating the level of significance. Significantly 
different parameters are shaded in grey in the table. 
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Our estimates of the AUC0→∞ were considered reliable; in the control group the tail 
region estimate was always below 20% and in 3 rabbits was below 5%, whereas, in the EPE-
infected group, all but one doe (4A) had a tail region estimate below 20%, of which 2 does (4D 
and 4F) were below 5%.  
7.4.3. Gross pathology.   
 
 In the limit of detection pilot study, rabbits were euthanized 1 day PT (8 days PT in 
EPE-infected rabbits).  In the PK study, euthanasia was performed 9 days PT (16 days PI in 
EPE-infected rabbits), after collection of the last blood sample.  No abnormalities were observed 
in the gastrointestinal tract (GIT) and in any other organ in the uninfected control rabbits.  
Lesions consistent with L. intracellularis infection, as described in Chapter 4, were noted in the 
GIT of EPE-infected rabbits, but no other gross abnormalities were detected in any other organ. 
7.4.4. Intestinal tissue Fe(III) and Ga(III) concentrations.  
 
A three order of magnitude of difference between [Fe] and [Ga] was detected in intestinal 
tissues with [Fe] detected in ppm (mg/kg) and [Ga] in ppb (g/kg).  In healthy rabbits euthanized 
1 day PT (pilot study), no significant difference was observed between the six different GIT 
sections collected for [Ga] (p=0.26) or [Fe] (p=0.58).   In uninfected control rabbits, euthanized 9 
days PT, a significant difference in [Ga] and [Fe] (p <0.0001, for both) was observed between 
the 6 different GIT regions collected.  For [Ga] the greatest concentration was determined in the 
caecal appendix and lowest in mid-jejunum, cecum, and colon.  Similarly, for [Fe] the greatest 
concentration was found in the caecal appendix.  A comparison between uninfected control 
rabbits sacrificed 1 day PT versus 9 days PT indicates a significantly lower [Ga] and [Fe] in GIT 
sections of subjects euthanized 9 days PT (p<0.0001 and p=0.0011, respectively) with the 
comparisons between the 2 sets of ceca and cola showing the greater differences for [Ga], but no 
specific differences for [Fe].  
Among the EPE-infected rabbits euthanized 1 day PT, significant differences were 
observed between the six different GIT sections collected for [Ga] (p =0.031) and [Fe] (p 
=0.015), with greater concentrations in the cecum and colon and lower concentrations in the 
caecal appendix for both metals (Figures 7.3.1 and 7.3.2, respectively for gallium and iron).  
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Among the EPE-infected rabbits euthanized 9 days PT, a significant difference in [Ga] and [Fe] 
(p <0.0001, for both) was observed between the 6 different GIT regions collected, with the 
greatest concentration in the caecal appendix and the lowest in the colon for [Ga], but the highest 
in the cecum and lowest in the caecal appendix for [Fe].  In the comparison of the uninfected and 
EPE-infected rabbits, euthanized 9 days PT, [Ga] and [Fe] were significantly different in the 2 
groups (p <0.0001, for both) with the greatest differences observed in the end-jejunum, ileum 
and caecal appendix for [Ga] (Figure 7.4.1.), but only in the cecum for [Fe] (Figure 7.4.2.).  
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Figure 7.3.1
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Figure 7.3.1. Comparison of elemental gallium concentration in EPE-infected rabbits and 
uninfected controls at 24 h PT. Comparison of [Ga] (in g/kg) in sections of the small and 
large intestine of 3 uninfected controls and 3 EPE-infected rabbits, treated with a single oral dose 
of gallium maltolate (50 mg/kg) and sacrificed 1 day PT (8 days PI, for the EPE-infected 
subjects).  Each bar graph represents the averaged value of each intestinal section (n=3): a = mid 
jejunum; b = end jejunum; c = ileum; d = cecum; e = caecal appendix; f = colon. 
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Figure 7.3.2. 
Gastrointestinal tract sections
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Figure 7.3.2. Comparison of elemental iron concentration in EPE-infected rabbits and 
uninfected controls at 24 h PT. Comparison of [Fe]  (in mg/kg) in sections of the small and 
large intestine of  3 uninfected controls and 3 EPE-infected rabbits, treated with a single oral 
dose of gallium maltolate (50 mg/kg) and sacrificed 1 day PT (8 days PI, for the EPE-infected 
subjects).  Each bar graph represents the averaged value of each intestinal section (n=3): a = mid 
jejunum; b = end jejunum; c = ileum; d = cecum; e = caecal appendix; f = colon.  
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Figure 7.4.1.   
Gastrointestinal tract sections
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Figure 7.4.1. Comparison of elemental gallium concentration in EPE-infected rabbits and 
uninfected controls at 9 days PT. Comparison of intestinal tissue [Ga] (g/kg) in 6 uninfected 
controls and 6 EPE-infected rabbits after a single oral gallium maltolate dose (50 mg/kg BW). 
Samples collected 9 days PT (or 16 days PI).  In both graphs, each bar graph represents the 
averaged value of each intestinal section (n=6): a = mid jejunum; b = end jejunum; c = ileum; d 
= cecum; e = caecal appendix; f = colon. The asterisks indicate statistical significance ≥ 0.05.  
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Figure 7.4.2. 
Gastrointestinal tract sections
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Figure 7.4.2. Comparison of elemental iron concentration in EPE-infected rabbits and 
uninfected controls at 9 days PT. Comparison of intestinal tissue [Fe] (mg/kg) in 6 uninfected 
controls and 6 EPE-infected rabbits, after a single oral gallium maltolate dose (50 mg/kg BW). 
Samples collected 9 DPT (16 DPI). In both graphs, each bar graph represents the averaged value 
of each intestinal section (n=6): a = mid jejunum; b = end jejunum; c = ileum; d = cecum; e = 
caecal appendix; f = colon. The asterisks indicate statistical significance ≥ 0.05. 
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7.4.5. Serology.  
 
The uninfected control rabbits’ serology was negative for specific anti-L. intracellularis 
antibodies.  For EPE-infected rabbits, titers were negative at day 7 PI, started rising at day 14 PI, 
and increased even further by day 16 PI (9 days PT, and time of euthanasia), confirming 
presence of infection and reflecting data previously published (Chapters 4 and 5) . 
7.4.6. Histology and immunohistochemistry. 
  
In uninfected controls, no alterations of the intestinal structure were noted and no IHC 
labelling with specific murine anti-L. intracellularis antibodies was detected, in the prime areas 
usually infected by L. intracellularis (jejunum, ileum and cecum).  In EPE-infected rabbits the 
IHC labelling confirmed typical lesions in 7 out of 9 animals, with no statistical difference 
between lesions detected in 1 versus multiple tracts of the GIT (p =0.07), such as jejunum, ileum 
and cecum.  
7.4.7. PCR.  
 
A complete absence of L. intracellularis shedding was confirmed in feces of uninfected 
control rabbits (p<0.0001).  In the EPE-infected rabbits fecal shedding of L. intracellularis was 
confirmed (Figures 7.5.1 and 7.5.2) at around day 4 PI, in partial agreement with previous 
reports, as it started earlier than day 7 PI and lasted for the duration of the experiment (Chapter 
4).  No differences were noted with regards to comparisons between rabbits (p=0.53), between 
days (p=0.21) or between fecal and caecal content (at necropsy, p=0.7).  
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Figure 7.5.1. 
 
Figure 7.5.1. PCR results before and after gallium maltolate treatment in EPE-infected 
rabbits.  L. intracellularis DNA (AspA gene)/gram of feces following L. intracellularis qPCR 
analysis in feces of experimentally infected rabbits before and after a single oral dose of gallium 
maltolate (50 mg/kg). Each pair of bars represents an individual rabbit, in the days before and 
after the treatment. 
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Figure 7.5.2. 
 
Figure 7.5.2 PCR results indicating fecal shedding after EPE infection in rabbits: time of 
onset and subjects variability.  L. intracellularis DNA (AspA gene)/gram of feces following L. 
intracellularis  qPCR analysis in feces of experimentally infected rabbits treated with a single 
oral dose of gallium maltolate (50 mg/kg).  Superimposed bars represent each individual rabbit 
concentration and “Tx” indicates the day of treatment. 
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7.5. Discussion 
 
In this study a single oral bolus dose of GaM was readily tolerated by uninfected and 
EPE-infected rabbits.  However, EPE infection caused prolongation of the terminal half-life (t½) 
without alteration of other PK characteristics.  Given the long half-life, a GaM dosing interval of 
once every 48 h should lead to sufficient concentrations in rabbits for AM activity of GaM.  This 
dosing interval was deemed safe to test in an efficacy study, although the potential for elemental 
[Ga] accumulation and environmental impact requires further consideration (Fecteau, et al., 
2011). 
The in vitro susceptibility studies for L. intracellularis clarified that multiple AM dosing 
is necessary for therapy, due to the variable distribution and differentiation state of the infected 
cells in the enteric crypts (Wattanaphansak, et al., 2009a).  Furthermore, no clinical study has 
shown efficacious AM therapy against EPE following a single dose or short duration AM dosing 
regimen (Lavoie, et al., 2000; Sampieri, et al., 2006; Frazer, 2008).  The 48 h dosing interval 
was derived from estimates for the elimination half-life in EPE-infected rabbits, as half-life is the 
only factor determining the time to steady state concentrations. As well, assuming linear 
pharmacokinetics and according to the principle of superposition, our single GaM dose’s AUC 
estimate suggests that the 48 h dosing interval is adequate to assure appropriate exposure for AM 
therapy. These assumptions are necessary as multiple dosing studies of gallium-based 
compounds for PK purposes are not common in animals, with only one study for GaM reported 
in foals (Martens, et al., 2010), and a multiple dosing regimen estimated for gallium nitrate in 
adult horses based on a projected study in silico (Pollina, et al., 2012).  We did not administer an 
intravenous dose to rabbits, which precluded the calculation of absolute GaM’s bioavailability, 
but in healthy humans GaM is reported to provide a Ga(III) bioavailability of ≥ 25% to 57% and 
exhibits linear absorption and elimination kinetics (Bernstein, et al., 2000).  Presuming similar 
bioavailabilities of GaM in rabbits, such data also supported our decision of a 48 h dosing 
interval for GaM in EPE infected rabbits. 
Our study using the rabbit model is intended to be a preclinical study to help in 
determining the clinical GaM treatment of foals. An effective GaM therapy against L. 
intracellularis in an infection rabbit model of EPE might allow allometric scaling of a GaM dose 
for a clinical trial in weanling foals.  Also, despite the anatomical similarities between rabbits 
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and horses (e.g., herbivores, hind-gut fermenters with a small stomach and large cecum), we 
would still expect to observe significant interspecies variation and, hence, the need to conduct 
dose titration studies in foals (Bernstein, et al., 2000).  Certainly, the design of our rabbit study 
using a 9 day sampling period was premised on information available in humans (t½ ≈5 days), 
dogs (t½ ≈3 days), rather than foals (t½ ≈1.5 days), and a consideration of body-scaling in rabbits 
and the putative effect of EPE infection on GaM absorption and disposition characteristics 
(Bernstein, et al., 2000; Martens, et al., 2007a).   
It is relevant to compare our findings to what Martens and colleagues (2007) estimated in 
healthy neonatal foals where MRT was 39.5 ± 17.2 h, and t½  was 26.6 ± 11.6 h (Martens, et al. 
2007a).  The MRT and t½ in juvenile rabbits were much longer.  Interestingly, in 2010 the same 
researchers reported several differences in the PK parameters estimates of GaM administered to 
adult horses (Arnold, et al., 2010).  Sampling lasted 5 days and the main PK estimates were 
generally more fitting with the rabbits’ PK findings, being Cmax: 280 ± 90 µg/L, tmax: 3.09 ± 0.43 
h, lag-time: 0.26 ± 0.11 h, and apparent elimination t½:48.82 ± 5.63 h (Arnold, et al., 2010).  The 
differences in half-lives may relate to ontogenic differences in the degree of maturation of the 
drug clearance mechanisms between the neonate foal and the adult horse. Usually, drug 
clearance mechanisms are underdeveloped in neonatal stages resulting in longer half-lives 
relative to the adult. The study reported by Martens and coworkers utilized a 48 h blood 
sampling period, which may have been insufficient to adequately describe the terminal 
disposition rate constant, on the concentration versus time profiles of the foals in that study 
(Martens, et al., 2007a). Furthermore, our juvenile rabbits gave PK estimates compatible with 
results reported in mice treated with the same dose once daily for 10 days (Harrington, et al., 
2006), but the estimates were nearly 4 times lower than the canine ones, after a single dose 
(Bernstein, et al., 2000).   
In addition to identifying an appropriate dosing interval for GaM in rabbits, we wished to 
understand the influence of EPE infection on the PK of GaM. The EPE rabbit model 
demonstrated clearly the impact of GIT disease on [Ga] and [Fe] following a single dose of a 
metal-based compound.  In order to mimic a natural infection in foals (Lavoie, et al., 2000, 
Sampieri, et al., 2006; Frazer, 2008), the delay between the onset of infection (inoculation) and 
treatment was purposefully designed in our preclinical rabbit model and current diagnostics were 
utilized to confirm the status of disease.  It was expected that a single GaM dose would not affect 
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the fecal shedding of L. intracellularis DNA and the immune-response (Chapter 4); thus, 
serology, PCR analysis and IHC tests confirmed the EPE-infected status in rabbits.  In particular, 
IHC showed that only 2 out of 6 total EPE-infected does had no detectable lesions at disease 
peak (14 days PI) and the 3 EPE-infected rabbits euthanized at 8 days PI had confirmed lesions 
too, despite a typical EPE appearance of the serosal and mucosal layers of jejunum and ileum on 
gross pathology (Chapter 4).  Furthermore, without bacterial inoculation, no infection occurs 
(p=0.002), with an odds ratio of developing infection 57 times higher after exposure to L. 
intracellularis.   
It is difficult to determine if the apparently faster (day 16 PI) cell turnover/healing 
(usually noted at 20-21 days PI in the original infection model) was due to the natural evolution 
of the lesions  (Chapter 4) or GaM effects on macrophage activity, similar to the action of other 
gallium compounds on various cell-lines of the reticulo-endothelial system (Bockman, 1991).  
However, intracellular [Ga] in activated macrophages was not assessed in this lapine model, or in 
equine experiments described thus far (Martens, et al., 2007; Arnold, et al., 2010).  In the rabbit 
model, we assessed [Ga] and [Fe] in targeted GIT sections and not in macrophages for 2 reasons: 
to assess the impact of disease on the tissue content of these oligo-elements and because EPE is 
uncommonly associated with large inflammatory reactions.  In the equine studies, both foals and 
horses utilized were clinically normal (Martens, et al., 2007; Arnold, et al., 2010).   
In uninfected control rabbits, a single oral GaM administration did not cause major 
differences in tissue accumulation within a day PT.  However, in rabbits sacrificed 9 days PT, 
[Ga] and [Fe] in tissues tended to show reverse correspondence in specific GIT sections: gallium 
preferentially accumulated in the caecal appendix tissue, where reticulo-endothelial tissue is 
mostly concentrated, but this finding was true in reverse for [Fe]. Whether this phenomenon is 
dependent upon Ga(III) sequestration by macrophages is not known.   
Not surprisingly, EPE infection led to decreased tissue [Ga], particularly where lesions 
were more pronounced (i.e., terminal jejunum and ileum), as the intestinal absorption is severely 
impaired (Wong, et al., 2009).  Moreover, [Fe] was decreased throughout the entire GIT in the 
EPE-infected rabbits.  Reductions in [Fe] may be due to competition with GaM for tissue uptake 
and disruption in iron absorption due potentially to saturation of Fe(III) transporters (e.g., 
transferrin, siderophores).  It is important to note that [Fe] was decreased in the cecum, despite 
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the prolonged residence of digesta in that GIT section, and a single GaM dose can alter both iron 
absorption and catabolism equilibria, despite normal iron dietary levels.  
In conclusion, our study allowed the first evaluation of GaM PK in uninfected and in 
EPE-infected rabbits, along with an assessment of iron tissue contents achieved after a single 
GaM administration. A dosing interval of q 48 h was estimated to sufficiently maintain 
therapeutic concentrations during EPE infection in rabbits.  Nonetheless, dose titration studies 
and assessment of safety of such a dosing regimen (50 mg/kg q 48 h) should be carried out in 
foals, before employing this therapy in clinical patients.  Finally, it should be considered that 
EPE-related malabsorption may result in decreased Ga and Fe GIT tissue concentrations in EPE-
infected animals.  Thus, the use of GaM as AM alternative therapy warrants further assessment, 
not only for its ability to compete with the essential nutrient iron, but also for its impact on 
recovery from infection.  
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CHAPTER 8 
EFFICACY OF GALLIUM MALTOLATE AGAINST LAWSONIA 
INTRACELLULARIS INFECTION IN A RABBIT MODEL. 
 
 
Relationship of this study to the dissertation objectives. 
In this chapter we report the study and its results in regards of gallium maltolate efficacy in a 
rabbit infection model for EPE. This study was the ultimate goal of the doctoral project in an 
animal model phase, where the novel compound gallium maltolte was compared to the leading 
treatment (doxycycline) in equine medicine for EPE cases and a negative untreated control.  This 
study needed all of the research studies reported throughout the dissertation. In the future, it may 
be helpful in constructing further studies whether in animal models or in clinical trials.  
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8.1 Abstract 
 
Antimicrobial efficacy against Lawsonia intracellularis (LI) is difficult to evaluate in 
vitro, thus gallium maltolate’s (GaM) effects were investigated in a rabbit model for equine 
proliferative enteropathy (EPE).  Juvenile (5-6 week old) does were infected with 3.0 ×10
8
 
LI/rabbit and divided into 3 groups (n=8).  One week post-infection, one group was treated with 
GaM, 50 mg/kg; one, with doxycycline, 5 mg/kg; and one with a sham-treatment (control).  
Feces and blood were collected daily and weekly, respectively, to verify presence of LI fecal 
shedding using qPCR and seroconversion using immunoperoxidase monolayer assay.  Rabbits 
were sacrificed after one week of treatment to collect intestinal tissues (IT) with focus on EPE-
affected sections.  In IT, lesions were confirmed via immunohistochemistry (IHC) and gallium 
([Ga]) and iron ([Fe]) concentrations via inductively coupled plasma-mass spectrometry.  Chi-
square tests and one-way ANOVA were used (5%), respectively, for the comparison of 
lesions, the results of other diagnostics in the 3 groups, and for comparing [Ga] and [Fe] in IT.  
No difference was noted between treatments regarding EPE-lesions in jejunum (p=0.51), ileum 
(p=0.74), and cecum (p=0.35), or in LI fecal shedding (p=0.64).  GaM appears to be no more 
efficacious than doxycycline against EPE in infected rabbits, but multiple treatments led to 
higher [Ga] and [Fe] in the cecum (p=0.0064, <0.0001, respectively).  
 
8.2 Introduction 
 
The obligate intracellular gram-negative bacterium Lawsonia intracellularis is the 
etiological agent of proliferative enteritis, or enteropathy (PE), an emerging disease in weanling 
horses known as equine PE, or EPE (McOrist, et al., 1995a; Pusterla & Gebhart, 2009).  Among 
the multiple domestic and wildlife species affected, PE is of prime importance in pigs (porcine 
PE, or PPE) due to the significant economic and welfare losses incurred with this pathogen 
(Lawson & Gebhart, 2000).  L. intracellularis causes different degrees of enterocytic hyperplasia 
in the distal jejunum and ileum (occasionally cecum and colon), and affects the intestinal ability 
to absorb nutrients (Herbst, et al., 2003; Horiuchi, et al., 2008; Pusterla & Gebhart, 2009; Wong, 
et al., 2009).  In foals, EPE’s clinical signs range in severity and chronicity from generalized 
wasting and pronounced ventral edema (along with altered colloid-osmotic pressure and 
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hypoalbuminemia) to profuse diarrhea, fever, colic, acute shock and death (Pusterla & Gebhart, 
2009; Page, et al., 2012).  Thus, L. intracellularis infection is a significant burden for the 
equestrian and swine industries, with economic losses due to animal mortality, poor growth rates 
and costly therapeutic interventions, as well as lost revenue from recovered animals (Frazer, 
2008).   
The current antimicrobial (AM) treatment for EPE relies either on oral macrolides, or 
azalides, often combined with rifampin (Lavoie, et al., 2000; Schumacher, et al., 2000; Feary, et 
al., 2007), or on the parenteral or oral administration of tetracyclines, with no further alternative 
AMs proposed since 2006 (Sampieri, et al., 2006; Frazer, 2008).  Those AMs are lipophilic 
drugs, capable of permeating cell membranes to reach intracellular microorganisms that are 
otherwise inaccessible to the common water-soluble AM utilized in equine therapy (i.e., beta-
lactams and gentamicin) (Sampieri, et al., unpublished data).  L. intracellularis presents a 
challenge for AM therapy as these bacteria use the “sanctuary-like” location of enterocytes to 
avoid AM activity and the local and cellular host immune defenses. Although not specifically 
evaluated, treatment failures (Page, et al., 2012; Frazer, 2008), indicate the potential for L. 
intracellularis to develop a specific AM susceptibility pattern, or even resistance (Frazer, 2008).    
To date, antimicrobial susceptibility studies for EPE have not been conducted in vitro, 
but several studies were designed to evaluate PPE strain susceptibility to a variety of AMs.  
Although they attempted to plausibly mimic clinical conditions, these studies demonstrated clear 
technical limitations, possible geographical strain differentiation for the 10 PPE strains known 
today, and the intrinsic difficulty of maintaining L. intracellularis in pure cell-culture 
(Wattanaphansak, et al., 2009a; McOrist, et al., 1995c; Lawson, et al., 1993).  In the early years 
of PE research, two clinical studies showed the effectiveness of the tetracycline class in affected 
pigs and in a hamster PPE model (La Regina, et al., 1980).  Furthermore, tetracycline AMs 
demonstrated efficacy against several other intracellular bacteria (Moulder, 1985; McOrist, et al., 
1995c), but for EPE most therapeutic knowledge has been achieved through clinical experience. 
It is postulated that a novel, gallium-based compound, gallium maltolate (GaM), might be 
capable of reaching intracellular bacteria through the oligoelement absorption mechanism 
(specifically iron, zinc and aluminum) in the small intestine, without generating specific grounds 
for AM resistance (Gunther & Wright, 1983; Berry, et al., 1984; Caspary, 1992).  Elemental 
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gallium (Ga(III)), a post-transition metal belonging to the periodic table’s group IIIA, seems 
ideal for the so-called “Trojan horse” mechanism, as its electric charge, ionic radius, valence and 
electronic footprint are similar to ferric iron (Fe(III)), which is metabolically essential to 
pathogen survival (Bernstein, 1998; Collery, et al., 2002).  Gallium is preferentially absorbed by 
phagocytic cells during the inflammatory process and appears to copiously converge onto sites of 
infection, entering macrophages through mechanisms dependent and independent of the iron-
transporter transferrin (Tsan, 1986; Chitambar & Zivkovic, 1987). Bacteria take up Fe(III), 
whereas mammalian cells and structures (e.g., heme) use ferrous iron (Fe(II)) and subsequently 
process it through various red-ox reactions (Logan, et al., 1981; Bernstein, 1998).  Thus, at 
sufficiently high concentrations, Ga(III) can be absorbed by bacteria, altering the first step of the 
bacterial ferric metabolism (Olakanmi, et al., 2000).  Unlike iron, gallium is unable to complete a 
redox-cycling reaction in several iron metabolic pathways and enzymes (e.g., ribonucleotide 
reductase) necessary for DNA replication and cell functions (Bernstein, 1998).  The blockage of 
these iron-dependent metabolic steps has been clearly ascribed to elemental gallium, not its salt 
forms, in Mycobacteria, and it was hypothesized in R. equi (Olakanmi, et al., 2000; Harrington, 
et al., 2006).  Ga(III)’s activity appears sufficient to reduce bacterial survival and replication 
(Bernstein, 1998).  In the United States, gallium is used for treatment of human cancer-related 
hypercalcemia (citrate-chelated gallium nitrate) and for diagnostic imaging (as the radioisotope 
Ga
67
) (Chitambar, 2010).   
Recently, the AM activity of several gallium-based compounds, such as gallium 
maltolate and gallium nitrate, was explored for several other intracellular bacteria of veterinary 
interest (Harrington, et al., 2006; Fecteau, et al., 2011; Arnold, et al., 2012).  Gallium salts have 
poor solubility in aqueous solution, becoming often unsuitable for oral or parenteral 
administration due to the formation of insoluble by-products (e.g., gallium hydroxide, gallate), 
which limits enteral absorption and bioavailability or causes nephrotoxicity (Bernstein, 1998).  
On the contrary, GaM is safe when orally administered to humans, mice, rats, dogs and foals 
(Bernstein, et al., 2000; Martens, et al., 2007a; Martens, et al., 2010) and no nephrotoxic effects 
of GaM are reported to date (Bernstein, et al., 2000).  Although the replication pathway 
characteristics specific for L. intracellularis are still incompletely known, it can be assumed that 
GaM should convey Ga(III) in proximity of the bacteria, particularly the ones located at the 
intestinal brush border membrane (Bernstein, 1998).  
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In this study, the potential differences in efficacy between doxycycline (at 5 mg/kg), the 
current most common AM treatment in EPE, and GaM (50 mg/kg) relative to an untreated 
control were tested following a multiple oral dosing regimen in a rabbit EPE infection model 
(Chapter 4). The dosing regimens are based on our understanding of doxycycline 
pharmacokinetics in horses (2006) (Davis, et al., 2006) and GaM pharmacokinetics in healthy 
and EPE-infected rabbits (Chapter 7), as well as literature support for doxycycline efficacy 
against multiple intracellular bacteria (e.g., N. risticii and R. equi) (Womble, et al., 2007).  
8.3 Material and Methods 
 
This work was approved by the University of Saskatchewan’s Animal Research Ethics 
Board, and adhered to the Canadian Council on Animal Care guidelines for humane animal use. 
8.3.1 Animals. 
The same species and provider for rabbit was used (Oryctolagus cuniculi, Strain - 052 
VAF Rabbits; Charles River Canada, Pointe Claire, QC, Canada), as previously described for 
Chapter 4, 5 and 7. The main difference from the described protocol was the 24 does were 5 to 6-
week-old, 1.2–1.5 kg BW. The rabbits health status report, their identification procedure, the 
housing, the husbandry conditions, feeding, environmental enrichment and monitoring were 
identical to the ones previously described (Chapter 4).  The rabbits were allowed a one-week 
acclimatization period, during which time treats (apples and carrots) were offered to promote 
socialization, facilitate handling, and monitor individual appetite, alertness and brightness, and to 
help the animals to ingest the oral medication more willingly (e.g., bananas specifically in the 
doxycycline group). Does were group-housed in separate pens according to group (controls, 
GaM and doxycycline). 
8.3.2. L. intracellularis rabbit infection model. 
 
The protocol previously described for inducing lesions with the equine strain L. 
intracellularis in juvenile rabbits, was followed to achieve infection (Chapter 4). Onset of 
infection was detected ante mortem through current diagnostics used for EPE, such as 
immunoperoxidase monolayer assay (IPMA) serology and TaqMan qPCR on fecal material 
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(Guedes, et al., 2002c; Pusterla, et al., 2009a; Chapter 4). The post mortem assessment was 
based on gross pathology examination, haematoxylin-eosin (H&E) staining, and 
immunohistochemistry (IHC) labeling of L. intracellularis using murine anti-L.intracellularis-
antibody on samples previously fixed in 10% buffered formalin (Guedes, et al., 2002a).   
8.3.3. Study design. 
 
Gallium maltolate (provided by L.R.B., Terrametrix, Menlo Park, CA, USA) was 
dissolved in sterile double-distilled water until a clear solution was achieved immediately prior 
to administration at a concentration of 8 mg/mL and final pH = 5.8 - 6 (Harrington, et al., 2006). 
Rabbits were divided into 3 treatment groups of 8 animals: control group, doxycycline 
group and GaM group.  Drug treatments were started on day 7 post-infection (PI), a time when 
EPE lesions begin to appear, with a disease peak around 12-14 days PI in the rabbit model 
(Chapter 4).  The control group received a mixture, in 6 mL suspension volume, of water and 
Jell-O (Kraft Foods, Canada), administered orally q 48 h.  The doxycycline group received an 
oral suspension of doxycycline at 5 mg/kg q 24 h dose (10 mg/ml).  The GaM-group was 
administered the GaM solution via a nasogastric tube (5 Fr. wide, 40 cm long feeding tube 
(Kendall Sovereign, Tyco Health Care Group LP, Mansfield, MA, USA)), as previously 
described in Chapter 7. 
8.3.4. Sample collection.   
 
Pooled fecal samples were collected daily from each group and frozen at -20°C until 
analysis.  In all does, arterial blood (1 mL) was collected at the time of infection and then once 
weekly until the day of euthanasia (day 14 PI) to detect an immune response. For 
pharmacokinetic purposes the GaM group rabbits were sampled at time 0 h (tfirst), at 24 h post 
dose (peak), and at 48 h (trough), immediately before the next GaM administration.  Due to a 
need to examine L. intracellularis lesions at disease peak, euthanasia coincided with day 8 of 
treatment and GaM was therefore administered only 4 times. As the concentration achieved with 
4 administrations was not sufficient to expect steady-state, the data collected were not analyzed 
for PK parameters estimates (Riviere, 2011). Intestinal sections were collected from all rabbits. 
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One rabbit in the GaM-group died within less than 18 after dosing. Necropsy indicated that cause 
of death was aspiration pneumonia. 
8.3.5. Verification of infection 
 
8.3.5.1. Histology and immunohistochemistry.  
Two adjacent, formalin-fixed and paraffin-embedded sections per sample were cut and 
stained by H&E and IHC with streptavidin method, using murine anti-L. intracellularis-specific 
monoclonal antibody, to detect proliferative lesions of the intestinal epithelium and the presence 
of the antigen within the cells, respectively. The L. intracellularis-specific antigen in the 
enterocytes was blindly evaluated with a 5 grade IHC scoring system as previously reported 
(Guedes, et al., 2002a).  For each rabbit, a negative control for each intestinal section consisted 
of a corresponding IHC-labeled tissue section with the exclusion of the primary antibody.  
Furthermore, pig ileal tissues known to be negative and positive for L. intracellularis infection 
were labeled with the murine anti-L. intracellularis monoclonal antibody to confirm the 
antibody's specificity and sensitivity, respectively. 
8.3.5.2. Serology.  
In serum, anti–L. intracellularis–specific IgG titer was measured by an 
immunoperoxidase monolayer assay (IPMA), as reported previously (Guedes, et al., 2002c).  
Positive serum samples were end-point titrated starting with a dilution of 1:30 up to 1:1920.  
Control samples consisted of serum from a rabbit prior to (negative control) and after (positive 
control) hyperimmunization with L. intracellularis purified from cell-culture.  
8.3.5.3 Quantitative PCR Analysis.  
Quantitative PCR analysis was conducted on fecal samples, as previously reported 
(Pusterla, et al., 2010a; Chapter 4).  The purified DNA was analyzed by qPCR for presence of L. 
intracellularis aspA gene copies (Pusterla, et al., 2009a).  
8.3.5.4 Gallium and iron elemental analysis 
Serum and intestinal tissue (IT) concentrations of elemental gallium ([Ga]) and iron 
([Fe]) were determined through Inductively Couple Plasma - Mass Spectrometry (ICP-Mass 
Spec) as already described in Chapter 7.  The maltol portion of the initial compound was not 
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detectable, due to its rapid metabolism through the liver, hence the tissue analysis focused on 
metals’ concentrations (Bernstein, et al., 2000).   
 
8.3.6. Statistics  
 
Statistical analysis was conducted through a commercial software program (GraphPad 
Prism 5.4, GraphPad Software, Inc., Software, La Jolla, CA, USA).  Contingency tables with 
Chi-square tests were used for comparison of the IHC lesions in different IT sections and for 
trend.  For [Ga] and [Fe] in intestinal tissues, bodyweight gains, qPCR analysis and serology 
comparisons in relation to GaM treatment a one-way ANOVA with Bonferroni post-hoc test was 
implemented. Alpha was set at 5%.  
8.4 Results 
 
8.4.1. Clinical appearance.   
All rabbits tolerated the infection, the stress of handling and multiple GaM treatments 
well.  Rate of body weight gain decreased around 11 and 12 DPI (repeatedly observed in the 
replication of the rabbit EPE model), although this was not significant (p=0.98).  In all groups, 
no significant changes in food intake, fecal consistency, grooming, and behavior were noted for 
the duration of the experiments. A marginal decrease in body weight gain (a BW gain smaller 
than half the average daily BW gain observed throughout the experiment) in the GaM-group was 
observed on day 8, 10, 12, 14 PI and was attributed to the dosing volume (often >10 mL), as it 
was earlier observed during the PK experiments (Chapter 7) (Figures 8.1.1 and 8.1.2). This was 
attributed to the sensation of satiation and hunger suppression induced by the stomach distension, 
after administration of large amounts of fluid (GaM and water solution).  
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Figure 8.1.1. Bodyweight changes in EPE infected rabbits undergoing 3 different AM 
treatments. Mean ± SD body weight gain (kg) (n=8/group) of rabbits inoculated orally with L. 
intracellularis and treated with vehicle-only (controls) (6 mL every second day), doxycycline (5 
mg/kg once daily) or gallium maltolate (50 mg/kg every second day) by nasogastric tube 
beginning 7 DPI. No statistically significant difference was noted between the 3 groups. In all 
groups a reduction of BW gain was noted between day 8 and day 12 PI. The dashed vertical lines 
and “T” indicate gallium maltolate or control treatment.  
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Figure 8.1.2. 
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Figure 8.1.2. Daily variation in bodyweight in 3 groups of EPE-infected rabbits undergoing 
3 different AM treatments. Mean ± SD daily body weight changes (in grams) in rabbits 
(n=8/group) inoculated orally with L. intracellularis and treated with vehicle-only (controls) (6 
mL every second day), doxycycline (5 mg/kg once daily) or gallium maltolate (50 mg/kg every 
second day) by nasogastric tube beginning 7 DPI. Note the trend in suppression of BW gain 
between 8 and 12 DPI.     
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8.4.2. Gross pathology.  
 
Euthanasia was performed 14 days PI, after collection of the last blood sample.  Lesions 
consistent with L. intracellularis infection were visible in jejunum and ileum, but were less 
pronounced in the doxycycline group, with a notable return towards normal in the appearance of 
the lesions from proximal to distal jejunum. 
8.4.3 Serology.   
 
All IgG titers, except for 1 GaM treated rabbit, were negative at 7 DPI (low titer: 60). 
Seroconversion was demonstrated in all rabbits by 14 days PI (with reciprocal titers ranging 
between 480 to >1920 in the control group, 120 to >1920 in the doxycycline group, and 480 to 
>1920 in the GaM group), but no difference (p=0.56) was detected between groups, merely 
confirming presence of infection and immune-response, reflecting data previously published 
(Chapter 4).   
8.4.4. Histology and immunohistochemistry.  
 
Evaluation of IHC labeling with specific murine anti-L. intracellularis antibodies was 
performed by a blinded examiner on jejunum, ileum and cecum samples, the principal lesion 
sites of L. intracellularis infection (Chapter 4).  Typical lesions were confirmed in jejunum 
(controls: 2; doxycycline: 3; GaM: 1, respectively), ileum (controls: 1; doxycycline: 2; GaM: 1, 
respectively) and cecum (controls: 0; doxycycline: 0; GaM: 1, respectively) and no statistically 
significant differences were detected between the treatments, with p=0.51, for jejunum; p=0.74 
for ileum; and p=0.35 for cecum.  
8.4.5. PCR. 
  
Fecal shedding of L. intracellularis was noted by 5 DPI (although inconsistently 
observed starting at 2 DPI in 2/3 groups).  On daily assessments, no statistically significant 
differences were noted between groups (p=0.61) (Figure 8.2).  Shedding persisted for the entire 
experiment, as previously seen in Chapter 4. Also, no difference was noted in fecal shedding 
amongst the three treatment groups, considering the amount of L. intracellularis DNA detected 
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in the feces (p=0.64) (Figure 8.3) and in the caecal content (p=0.32) collected at the time of 
euthanasia (Figure 8.4).   
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Figure 8.2. 
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Figure 8.2. Daily progression of fecal shedding in EPE-infected rabbits undergoing 3 
different AM treatments. qPCR results reporting daily fecal L. intracellularis DNA levels, in 
rabbits inoculated orally with L. intracellularis and treated with vehicle-only (controls) (6 mL 
every second day), doxycycline (5 mg/kg once daily) or gallium maltolate (50 mg/kg every 
second day) by nasogastric tube beginning 7 DPI.  Fresh feces were collected as pooled samples 
for each group.  The dashed vertical lines and “T” indicate gallium maltolate or control 
treatment. 
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Figure 8.3. 
 
Figure 8.3: Comparison of L. intracellularis fecal shedding between groups (averaged 
values). Mean ± SD of qPCR results of fecal L. intracellularis DNA concentrations collected at 
necropsy in 3 groups of 8 rabbits each, after inoculation with L. intracellularis and 7 days 
treatment with vehicle-only (control) (6 mL every second day), doxycycline (5 mg/kg once 
daily) or gallium maltolate (50 mg/kg every second day) by nasogastric tube. Although not 
statistically different, fecal L. intracellularis DNA concentration for both doxycycline and 
control groups were lower than GaM, but still in the range 10
6
 to >10
7
.    
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Figure 8.4. 
 
Figure 8.4: Comparison of L. intracellularis caecal content between groups (averaged 
values on day of euthanasia). Mean ± SD of qPCR results of caecal content L. intracellularis 
DNA concentrations collected at necropsy in 3 groups of 8 rabbits each, after inoculation with L. 
intracellularis and 7 days treatment with vehicle-only (control) (6 mL every second day), 
doxycycline (5 mg/kg once daily) or gallium maltolate (50 mg/kg every second day) by 
nasogastric tube. Although not statistically different, caecal L. intracellularis DNA concentration 
for both doxycycline and GaM groups were lower than untreated controls, but still in the range 
10
5
 to >10
6
, showing that untreated animals may carry (and shed) live bacteria in their intestines 
contaminating the environment with low to undetectable amounts of bacteria for a long time.  
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8.4.6. Gallium and Iron elemental analysis. 
  
Similarly to the PK study conducted by our research group, [Ga] and [Fe] differed by an 
order of magnitude, [Fe] in ppm (g/g) and [Ga] in ppb (ng/g) (GaM-group only).  After 
repeated dosing, comparison between GIT sections of GaM-group rabbits demonstrated higher 
[Ga] in cecum vs. jejunum and caecal appendix (p=0.0064); whereas for [Fe], the same 
comparison yielded the highest values in cecum, but the lowest in the caecal appendix 
(p<0.0001). A comparison between experiments (Kruskall-Wallis test with Dunn’s post hoc test) 
of the data obtained from does treated once (limits of detection study) to the ones treated for 7 
days, demonstrated a [Ga] higher (p=0.0016) in cecum, caecal appendix and, colon in the latter 
ones.  However, in the same comparison [Fe] is significantly lower (p<0.0001) in every GIT 
section after multiple dosing.  Finally, a comparison of the data obtained from does treated once 
(PK study) to does treated for 7 days, demonstrated that, as expected, [Ga] is higher (p<0.0001) 
in the repeated treatment rabbits, but [Fe] is significantly lower in every GIT section, excluding 
caecal appendix and colon (p<0.0001) as visible in figures 8.5.1. and 8.5.2. 
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Figure 8.5.1. 
 
Figure 8.5.1. Accumulation of elemental gallium (in ppb = ng/g) in intestinal tract’s sections 
of EPE-infected rabbits, comparing one single oral GaM treatment (light gray bars) and 
multiple (n=4) oral GaM treatments (dark gray bars) 24 h after the last dose. The bars indicate 
the average values and the skewers represent the SD for each intestinal section: light gray bars 
indicate values in 3 rabbits, for the single oral treatment with gallium maltolate (described in 
Chapter 7); the dark gray bars indicate value in 8 rabbits treated multiple times.  
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Figure 8.5.2. 
 
Figure 8.5.2. Concentration of elemental iron (in ppm = g/g) in intestinal tract’s sections 
of EPE-infected rabbits, comparing one single oral GaM treatment (light gray bars) and 
multiple (n = 4) oral GaM treatments (dark gray bars) 24 h after the last dose.  The bars indicate 
the average values and the skewers the SD, for each intestinal section: light gray bars indicate 
values in 3 rabbits, for the single oral treatment with gallium maltolate (described in Chapter 7); 
the dark gray bars indicate value in 8 rabbits, treated multiple times. 
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8.5 Discussion 
 
This efficacy study is the first reported antimicrobial (AM) comparison for EPE treatment 
in an infection model. Multiple oral bolus doses of GaM were clinically well tolerated by EPE-
infected rabbits.  However, no difference was detected through several diagnostic methodologies 
between treatment outcomes, between GaM, doxycycline, and a vehicle-only control.  Our data 
in the EPE-infected rabbit model suggests GaM is no more efficacious than doxycycline against 
EPE. Also, an iron reduced tissue content was noted in several intestinal sections, confirming 
previous suspicions in regards of risks related to GaM oral administration (Chapter 7) and 
(Fecteau, et al., 2011). 
In the establishment of the EPE-infected rabbit model, we have repeatedly observed a 
suppression in BW gain on or around the 12
th
 day PI, a time that corresponds to peak infection 
(Chapter 4).  In the present study, we expected the added stress associated with the multiple 
dosing regimen (i.e., repeated nasogastric intubation and dosing) to affect BW gain more 
significantly (i.e., remaining well below ≈28.5 g/day in 5 to 6-week-old does (Charles River 
Canada, Pointe Claire, QC, Canada)), but this was not observed.  Furthermore, treatment with 
GaM or doxycycline failed to reverse this suppression in BW gain around the peak infection 
time, demonstrating that, regardless of treatment, EPE infected animals still lose body condition 
(Frazer, 2008; Wong, et al., 2009).   
We used the rabbit model to compare AM efficacy against EPE infection because the 
rabbit represents a “time-compressed” model, as specific IgG antibodies against L. 
intracellularis are typically detectable in rabbits within 2 weeks PI, and occasionally by day 7 PI 
(Chapters 4 and 5), unlike the foal EPE model (Pusterla, et al., 2010a). Unlike our previous 
work, the present study used younger rabbits (3 weeks younger than the rabbit model described 
in Chapter 4), as younger animals were hypothesized to develop more severe lesions, due to their 
immature gastrointestinal tract and lower immune-competence (Pakandl, et al., 2008).  More 
severe lesions, in turn, would have allowed more readily observable positive treatment outcomes.  
Once an immune-competent age is achieved, weaned rabbits are known to mount a sufficient 
immune response when challenged with infectious agents, although this depends on infection 
type and load (Guedes & Gebhart, 2003c; Pakandl, et al., 2008). Changes in immune-
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competence induced by age in suckling rabbits, in relation to L. intracellularis, though, are 
currently unknown. However, rabbits in all treatment groups developed a very high immune 
response (IgG) to L. intracellularis infection, with titers comparable, or higher, than the levels 
observed in the original EPE infection model rabbits (8-9 weeks old). This may explain the low 
incidence of severe lesions on pathological and immunohistochemical analysis. 
Similarly to the effect on serology, multiple GaM doses failed to decrease fecal shedding 
of L. intracellularis DNA (Figure 3).  For all groups the, fecal shedding rates were similar to 
rates identified in our original infection model (Chapter 4).   
Interestingly, DNA concentration in feces from untreated control rabbits was not 
significantly different than the treatment groups, although the GaM showed somewhat increased 
values. Quantitative PCR detects DNA material (live and dead bacteria alike), confirming the 
occurrence of bacterial replication within the intestine (concentrations range: 10
5
 to 10
7
) during 
AM therapy with varying concentrations in different intestinal sections (see the differences 
between feces and caecal contents).  Higher fecal shedding of DNA in AM treated rabbits may 
be related to faster bacterial inactivation and subsequent expulsion, following therapy.  However, 
this finding disagrees with the reported association of AM treatment and decreased bacterial 
fecal shedding, which prompts clinicians to diligently collect fecal samples before therapy 
initiation, so to increase diagnostic accuracy (Dauvillier, et al., 2006).  In rabbits, the higher 
caecal concentrations of L. intracellularis of untreated controls could be related to L. 
intracellularis colonization in the cecum as reported in the literature (Duhamel, et al., 1998; 
Horiuchi, et al., 2008), or it may depend on prolonged residence of digesta in the cecum relative 
to other sections of the intestinal tract. A better detailing of such differences between the rabbit 
model and horses would be useful to understand the true implications of therapeutic responses or 
lesion (and clinical signs) development. At present, a detailed understanding of differences in 
bacterial concentrations of the foal’s gastrointestinal tract sections is not available (Pusterla, et 
al., 2010a).  
In this study, lesion remission occurred more rapidly than our previous study (14 versus 
21 DPI). This observation may relate to the age difference of the rabbits used in each study. 
Possibly, younger rabbits exposed to EPE proceed more quickly from “onset” to “remission” 
than older does (9-10 weeks), showing fecal shedding and seroconversion as expected, but 
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“compressing” even further the timeframe of lesion appearance (Chapter 4).  This concept may 
have epidemiological relevance for the contamination of horse premises (Pusterla, et al., 2012b), 
but it is as an unwanted complication for our present study.  This required us to examine more 
closely the results obtained through the gold-standard IHC analysis (Guedes, et al., 2002), along 
with the above-discussed serology and PCR, in the context of the EPE model.   
Our statistical comparison of gut lesion counts (or the percentage of rabbits affected) 
between groups failed to identify significant differences between treatments or between 
treatments and untreated controls.  However, the location of the IHC-labeling within the gut 
mucosa should be discussed as well, in view of the further time-compression exerted by age on 
this infection model.  Lesion location, allows us to approximate the time of lesion appearance 
closer to either the time of onset, or the time of recovery.  This type of differences is not 
applicable to statistics, but underlines differences between the affected groups (Chapter 4). Only 
37.5% of control rabbits demonstrated observable lesions (counting all 3 sections with IHC 
positive lesions), but IHC labeling was detected at the level of the lamina propria, where 
bacteria are processed and destroyed.  This suggests that rabbits were in the recovery phase, 
which is typically observed around week 3 PI, in the original model using 9 - 10 weeks old 
rabbits.  In the doxycycline and the GaM treatment groups, rabbits demonstrated observable 
IHC-labeled lesions in clusters, in 62.5% and 37.5% of cases, respectively. Lesions were 
principally located in the mucosa and still progressing toward the lamina propria. These 
observations suggest an important delay in lesion development and progression, ascribable to 
AM therapy.  This may explain the enhanced L. intracellularis fecal shedding in the GaM group 
at time of euthanasia, as active lesions remained present in the gut, unlike with untreated 
controls. In our model, timing of euthanasia with duration of treatment is a significant 
consideration in the study design and in understanding lesion progression and fecal shedding of 
L. intracellularis, after the initiation of AM therapy. 
An additional consideration is the age of the animal.  The variability observed between 
our previously reported EPE model and the present study may suggest a potential difference 
between the maturation of the IgG system versus the intestinal mucosal immunoglobulin systems 
(A and E) and the way it affects the response to infectious insults in recently weaned rabbits.  
Undoubtedly, such a consideration warrants further research (not only in rabbits), as similar 
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findings were obtained with AM treatments in porcine models of PPE used in efficacy studies 
(personal communication of Dr. C.J. Gebhart - University of Minnesota).  Interestingly, gross 
pathological examination of the intestines suggested that doxycycline-treated rabbits appeared to 
show a faster return to normal of the affected digestive tract.  Gross reductions of serosal edema 
and wall thickness were observed moving progressively from proximal to distal locations within 
the small intestine, and this effect of doxycycline should be further investigated. 
Our comparative AM analysis in an EPE model calls into question the use of GaM as a 
potential AM treatment for EPE.  Recent studies on GaM’s efficacy against R. equi infection 
showed its failure to prevent disease, after a prophylactic treatment prior to experimental 
infection at a dose capable of achieving the minimum inhibitory concentration (MIC) necessary 
to inhibit rhodococcal growth (Harrington, et al., 2006; Coleman, et al., 2010; Chaffin, et al., 
2011).  For L. intracellularis, where in vitro susceptibility studies are very difficult (Lawson, et 
al., 1993), our use of a rabbit model of EPE clearly indicated a delay in lesion development with 
GaM therapy suggesting that any expectation for obtaining a better result with a GaM 
prophylactic treatment are low, unlike the expectations associated with GaM research on R. equi 
affected foals (Chaffin, et al., 2011).  Until in vitro studies clearly demonstrate L. intracellularis 
sensitivity to GaM, we suggest that further studies in vivo are not warranted and would conflict 
with the ‘Three Rs’ tenet of animal experimentation (Fenwick, et al., 2009).   
Furthermore, multiple GaM doses in EPE-rabbits, expectedly, led to increased IT [Ga], 
when compared to a single dose, but also caused a decreased [Fe] in IT, except in caecal 
appendix and colon (where Fe absorption is reduced, as per normal physiology).  Interestingly, 
multiple GaM dosing highlighted a preferential location for this transitional metal, similarly to 
the findings of the rabbits examined 9 days PT in the PK study (Chapter 7), as Ga(III) tends to 
accumulate in the caecal appendix, mostly constituted by reticulo-endothelial tissue, and to affect 
negatively [Fe] in the same tissue.  At this stage, it can only be hypothesized that the low [Fe] 
could depend on Ga(III) sequestration in macrophages. Regardless of the reason, these findings 
confirm that GaM hinders iron absorption, competing for the same absorption pathways and 
transporters (i.e., transferrin and siderophores).  The impact of this process, and the altered 
regulation of iron absorption (demonstrated by reduced tissue content), appears to complicate the 
already fine equilibrium of oligo-elements in a diseased intestine. This is hypothesized as due to 
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the further absorption competition created by the presence of Ga(III), particularly in spite of a 
normal dietary iron concentration.  Overall, our model sets a valid mimicry situation of an 
impaired intestinal absorption.  In fact it demonstrates that if the effects of GaM may reduce 
considerably the ability of the intestine to absorb iron, the results are not only that it would limit 
the bacterial metabolism, for which it was advocated initially, but also that it may contribute to 
defects in host’s iron metabolism, if treatment is sufficiently protracted (Wong, et al., 2009).   
In conclusion, multiple dosing of GaM, at 50 mg/kg (2.5 times the dose used in foals), 
although clinically safe, is not a valid alternative to the current AM therapy employed in EPE-
affected animals. Although our rabbit model represents a mild form of EPE-infection, no 
treatment advantage was observed with GaM.  We conclude that our study offered no evidence 
to support the use of multiple dosing of GaM, at 50 mg/kg (2.5 times the dose used in foals) as 
an alternative treatment to current AM therapy employed in EPE-affected animals. Given the 
lack of supportive evidence in a preclinical model of EPE, further investigations with GaM in 
foals infected with EPE is not warranted at this time.  In vitro MIC studies may demonstrate a 
need to re-evaluate GaM in vivo in the foal, but until such studies are completed we recommend 
that EPE infected foals be treated with the current standard of care.  Moreover, prolonged 
treatment with GaM may become a hindrance into the normal iron metabolism in the host, 
potentially adding complications and prolonging either the appearance of disease, or the 
progression of recovery. 
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CHAPTER 9  
GENERAL DISCUSSION 
 “Be calm in arguing; for fierceness makes  
Error a fault and truth discourtesy.”  
                                                                                    G. Herbert  
This project was structured in 2 phases, and for clarity, the phases will be discussed in 
order: the animal modeling phase and the pharmacology phase.  The combined results of the 
animal modeling experiments changed the structure of the pharmacology experiments, but 
broadened the perspective for the future use of animal models in research involving L. 
intracellularis, the agent of equine and porcine proliferative enteropathy (EPE and PPE, 
respectively).  
9.1. Animal Modeling Phase 
 
9.1.1. Rabbit Model 
 
The first objective was to determine whether EPE infection can be achieved after 
challenging juvenile rabbits (Oryctolagus cuniculi) with an equine strain of L. intracellularis, as 
lagomorphs are naturally susceptible to infection (Duhamel, et al., 1998; Horiuchi, et al., 2008).  
As the infection route is typically fecal-oral, the rabbits were inoculated intragastrically with a 
pure low-passage cell-culture of E40504 L. intracellularis, harvested from a deceased foal 
(Pusterla, et al., 2010).  Results were consistent with a humane model.  EPE caused detectable 
lesions in jejunum and ileum (prime sites for EPE lesions), by gross pathology, histopathology 
and immunohistochemistry (IHC) (Guedes, et al., 2002a). Also, large fecal shedding of L. 
intracellularis DNA, closely connected with the presence of lesions, was detected, along with 
high serological response (high IgG concentration).  However, no overt disease (e.g., diarrhea) 
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was observed.  Clinically, we noted only what appeared to be a consistent trend in body weight 
(BW) gain suppression, although never statistically significant, both in the first (p = 0.87) and in 
all the subsequent experiments (total p = 0.23) involving EPE- infected rabbits.  Out of 42 
infected-rabbits in total, only one rabbit manifested overt depression, lack of appetite and weight 
loss, around 12-14 days post infection (DPI) (See Chapter 4).   
The rabbit infection model, established for the first time, permitted the planned 
pharmacokinetic study on Gallium maltolate (GaM) in rabbits, both in healthy and in EPE-
infected animals, as well as supplying a reliable alternative, when the experiments on hamsters 
failed to deliver the expected results (See Chapter 5). 
9.1.2. Hamster Model 
 
The second objective of this study was to reproduce EPE from an equine strain of L. 
intracellularis in weanling hamsters (Mesocricetus auratus), as they have been successfully 
utilized, for over 20 years, to model PPE and they are naturally susceptible to proliferative 
enteropathy (“wet tail”) (Jasni, et al., 1994a; Vannucci, et al., 2010).  The results in 2 groups of 
weanling hamsters, challenged again with the L. intracellularis E40504 strain, were consistent 
with this species being apparently resistant to developing detectable intestinal lesions, serological 
response, and clinical disease; despite a low and inconsistent level of fecal shedding of bacterial 
DNA, detected throughout the experiment (See Chapter 5).   
A few factors were discussed and evaluated while trying to understand why, during the 
experiments, the hamster appeared to be EPE-resistant:  breeding colony differences (i.e., tested 
from 2 different providers); BW and age at the time of inoculation (i.e., 3 vs. 4 weeks old at the 
time of exposure); and stress factors, as one group was infected after a post-weaning acclimation 
period, but the other one was infected right after weaning (i.e., same day). To test such difference 
during the second trial, along with the EPE infection, a concomitant infection with PPE strain 
(PHE-MN-01) was performed and used as a positive control. As per textbook description, PPE 
caused lesions and exponentially higher fecal shedding of DNA, although no seroconversion was 
demonstrated.  Such results confirmed that PPE strain adapts well to the Cricetinae species and 
that pure cell-culture-derived inoculum does not cause overt and severe clinical signs (i.e. 
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diarrhea and prostration), compared to ileal scrapings from diseased animals (Jasni, et al., 1994b; 
Vannucci, et al., 2010).   
On the other hand, a suspicion took shape that a secondary host-restriction, or species-
specificity of the strain (not the bacterium), could exist.  In order to pursue this concept, a small 
group of rabbits (n = 6) were infected with PPE strain and compared to the EPE-infected group. 
The results obtained in rabbits were opposite to the ones obtained in hamsters.  Rabbits 
developed the EPE-infection (as described above – See chapter 4), but not the PPE-one, even 
though transient low levels of fecal shedding and low titers of serological response were detected 
(See Chapter 5). 
9.1.3. Considerations and Discussion     
 
On the basis of these findings, multiple directions can be considered for future studies on 
L. intracellularis.  First and foremost the rabbit EPE model appears to be a “time-compressed” 
infection model when compared to experimentally infected foals. This has been observed both in 
terms of onset and duration of lesions (2 weeks versus 4-5 weeks), but also immune-response 
and fecal shedding, although these latter aspects can be considered from different viewpoints.  
The compressed lesion and shedding time in rabbits could allow a better focus, for a 
shorter time, on the research regarding EPE pathogenesis and the recovery pathophysiology. 
However, at this stage it is unknown how long the immune response could last, because of the 
short duration (only up to 3 weeks) of our experiments. In foals, the longer incubation, 
development of clinical signs and lesions is likely tightly related to the development of 
hypoproteinemia and hypoalbuminemia, 2 very important features in clinical treatment, but in 
the rabbit model that aspect could not be analyzed, as experiments were only 21 days long.  
Very importantly this model is more humane and self-limiting than the one achieved in 
foals, where a few horses may manifest low grade clinical signs, a few are completely 
subclinical, but others present the full-blown acute disease, which leaves no alternative but 
euthanasia, as the experimentally induced disease can be unresponsive to current therapeutic 
intervention (Page, et al., 2011c; Vannucci, et al., 2012).   
236 
 
The first source of future investigation could be a longitudinal study in rabbits, to 
understand how long they are really susceptible to infection, and to what extent their immune-
response may rise. The researchers (including extramural collaborators) involved in the modeling 
experiments are aware that laboratory experimental conditions differ from wildlife exposure and 
natural course of infection.  However, observing the whole course of disease and recovery may 
clarify several of the epidemiology steps that lead to the differences of cross-infection, behind 
such a peculiar secondary host-specificity.   
Dr. Vannucci (University of Minnesota), in his PhD thesis, is demonstrating that 
infection transfer from finisher pigs to weanling foals, and vice versa, can occur (also 
investigated subsequently to our hamster trials – see Chapter 5).  Although no clinical disease 
was obtained in both porcine and equine bacterial cross-specific challenges, increase in serology 
titers and fecal shedding were positive findings (Vannucci, et al., 2012).  Those results showed a 
partial host-adaptation, whereas ours showed a partial host-restriction: in summary both studies 
provided grounds to the hypothesis of several L. intracellularis subspecies.  Currently it is 
unknown how many subspecies exist and whether every subspecies is able to infect across 
species, but L. intracellularis genomics investigation is underway (F.A. Vannucci and C.J. 
Gebhart, University of Minnesota -- personal communication).   
 From the longitudinal study we could derive a better understanding of L. intracellularis 
survivability and infectivity, after being shed in the feces, as wild rabbits often populate the 
environment where horses live (i.e., pastures) and their feed is stored (i.e., haymows) (Pusterla, 
et al., 2008b; Pusterla, et al., 2012a).  Indeed, Dr. Pusterla (University of California-Davis) has 
reproduced L. intracellularis exposure in foals fed grain contaminated with EPE-infected rabbits’ 
feces, obtaining serological response and fecal shedding of the bacterium, although no overt 
clinical disease (Pusterla, et al., 2012c).  As EPE targets mainly young animals, a shorter and 
more intense (larger litters) reproductive cycle in rabbits and rodents than in horses, contributes 
to enhance the potential for sub-clinical carriers, for contamination of feed stuff and thereby 
transmission of the infection.  
Further uses of the rabbit model could be to investigate the clinico-pathological 
combination hypoalbuminemia/ hypoproteinemia, a natural EPE clinical feature in horses. As the 
rabbit model is “time-compressed”, additional clinical changes could be more focused within a 
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short time frame, to gain knowledge about the processes leading to EPE and also to understand 
the natural step to remission and recovery, which are apparently normal in rabbits. 
One question may arise regarding immune-competence and age as limiting factors for the 
EPE model in rabbits. A quicker lesion progression and resolution was unexpectedly observed 
during the efficacy experiment (See chapter 8). The study was conducted on does 4 weeks 
younger than the original model ones, as older subjects were not available at the time.  Immuno-
competence and age-dependent factors are not known specifically in relation to L. intracellularis 
infection in rabbits, regardless of the strain; thus, it could be questionable whether our subjects 
were appropriately immuno-competent, yet too young, for developing normally progressing 
lesions and that might have complicated the results of the study, not offering a solid term of 
comparison to infected treated rabbits investigated (Chapter 8).  Studies on parasitosis rabbit 
models, such as nematode or coccidiosis infections (for example), report differences in regards 
of the immune response and the onset of disease depending on age, and different models are 
established at different ages (suckling rabbits versus > 3 weeks rabbits, and versus juvenile/prae-
pubertal rabbits) targeting different responses.  My opinion is that infecting rabbits 8-9 weeks old 
was a good timeframe to get both immune response and lesions.  However, it is to consider in the 
future whether or not, similarly to those parasitosis rabbit models, infection in suckling rabbits 
does not lead to disease or immune-response; infection in weaned rabbits (around 3-4 weeks old) 
leads to very high immune-response with questionable development of lesions; and if infection 
in 2-3 months old subjects leads to a decent immune-response and disease manifestation 
(Pakandl, et al., 2008).  In the case of parasitology models the intervening immune-response 
factors may be different than bacterial infection, such as L. intracellularis, but such a 
consideration could clarify not only some use of the model, but also what could be the age 
categories to target in rabbits, in order to control the impact of EPE carriers on horse premises.  
Aside from epidemiological, bacterial genetics and potentially clinical benefits realized, 
further developments and use of the rabbit model could target the investigation of serological 
responses in challenged animals.  Rabbits are known to mount an intense, and in some cases, 
prolonged immune response, for which they have already been used in the production of 
polyclonal antibodies in diagnostic techniques for L. intracellularis research (Guedes & Gebhart, 
2003c).  The possibility of using this model to investigate future development of vaccinal 
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products could be of support, and benefit, to some of the studies already in progress in the foal 
model (Pusterla, et al., 2009b; Pusterla, et al., 2009c; Pusterla, et al., 2010a; Pusterla, et al., 
2012b; Pusterla, et al., 2012d). For example: 1. reduced purchase and husbandry costs compared 
to foals; 2. reduced starting inoculum dose (as reproducing sufficient material to inoculate rabbits 
is less time- and resource-consuming, than producing it for foals) (Pusterla, et al., 2010a); 3. 
reduced time necessary to detect immune-response (See Chapter 4).   
Finally, to try and conclude on the potential developments of this novel (and mild) 
infection model, it would be interesting to reproduce EPE in a rabbit model starting from equine 
ileal/ jejunal scrapings rather than from pure cell-culture, as, if we think of a parallel with the 
PPE strain, both in pigs and hamsters, there is the potential to obtain a more clinically aggressive 
model from the fresh “street-strain” than from the low-passage cultures (McOrist, et al., 1993; 
Jasni, et al., 1994a; Jasni, et al., 1994b; Guedes & Gebhart, 2003a; Guedes & Gebhart, 2003b; 
Vannucci, et al., 2010).  The interest tied to this type of study is derived from the initial 
experiments, as the higher concentration/lower cell-culture passage produced the only 
“somewhat” clinically affected rabbit (See Chapter 4).  Moreover, knowledge gained from the 
field experiments (Dr. C.J. Gebhart -- University of Minnesota -- personal communication) on 
vaccines, noted that lower-passage cultures provided a better immunity response, although those 
same cultures are harder to maintain in vitro, whereas the higher the passage in culture, the more 
immortalized they become.  Nonetheless, developing a more aggressive facet to the rabbit EPE 
model may provide better grounds both for the testing of vaccines and antimicrobial drugs. 
Last but not least, the infection modeling phase indicated also that the use of hamsters 
should be avoided for experimental EPE modeling, unless there is only the aim to account for the 
fecal shedding of infectious material into the environment.  Not only do they not develop clinical 
disease and intestinal lesions, but the serological response appears to be minimal to none when 
challenged either with EPE or PPE L. intracellularis (See Chapter 5). At this stage, is not clear 
and may warrant further investigation, whether the lack of a strong immune-response is related 
to the low immune-competence of weanling hamsters; or due to the effects of the intracellular 
location, where L. intracellularis is protected from the processing steps of the immune system, 
humoral or cellular.  It is arguable, however, that another and more challenge-responsive species, 
such as the rabbit model, may offer a better insight.     
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9.2. Pharmacology phase 
 
The pharmacology phase of this project involved the use of the EPE rabbit model in a 
pharmacokinetic (PK) study and in an efficacy study for the novel gallium-based compound 
gallium maltolate (GaM).  The EPE-infected rabbits were compared to healthy subjects in the PK 
study, to assess the possible effects of intestinal absorption impairment on subsequent plasma 
concentrations of elemental gallium.  Gallium and iron concentrations in intestinal tissues were 
compared between EPE-infected and healthy rabbits, both 24 h and 9 days after one single oral 
bolus.   
9.2.1. Ear catheterization and timely sample collection 
 
The first challenge encountered in this phase was merely technical, as healthy rabbits 
tend to scratch their ears and remove the indwelling catheters placed in the central artery, 
complicating blood sampling procedures. The problem was solved with a moleskin-glued 
bandage, in the shape of the ear, transforming the catheter hub and the injection port into a 
smooth surface, where rabbits’ paws could readily glide over. This skin-embedded-like injection-
port was utilized up to 9 times in 12 h, simplifying rabbit preparation and restraint, and keeping 
sampling timely (See Chapter 6). This technical contribution refined the project and reduced 
stress, both on the rabbits as well as the researchers. It can be easily applied to any situation 
requiring multiple and rapid sampling within a small time-frame in rabbits (i.e., PK or 
endocrinology studies). 
9.2.2. Pharmacokinetic (PK) study  
 
The PK study demonstrated that rabbits can readily tolerate a single GaM dose (50 mg/kg 
BW p.o.). PK parameters were estimated in both healthy and EPE-infected animals (See Chapter 
7), with estimates more similar to healthy adult horses (Cmax, tmax, elimination rate constant and 
half-life) than neonatal foals. Although those experiments in horses used a smaller dose than ours 
(20 mg/kg BW p.o.), they also utilized neonatal foals, or adult horses.  We used juvenile rabbits 
(7-9 weeks old), as they were more comparable to the susceptible age for EPE, although they 
have a different physiology and body composition than neonates (Martens, et al., 2007a; Arnold, 
et al., 2010; Chaffin, et al., 2010).  In the rabbit model, one bolus dose of GaM did not appear to 
alter gross pathology appearance, histopathology and IHC of tissues of EPE-infected animals, 
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and it did not change the serological response and the fecal shedding after infection. However, 
the concentrations of gallium and iron in the intestinal tissues showed an expected decrease of 
tissue content of both metals, due to disease.  This was particularly apparent for iron, despite it 
being available in the diet, throughout the experiment, and GaM being administered only once 
(See Chapter 7). 
9.2.3. Synchrotron Radiation Analysis 
  
An accompanying experiment to this second phase was based on synchrotron radiation 
analysis, to compare gallium, copper, zinc (-alpha and -beta), and iron’s (-alpha and -beta) 
fluorescence and spectroscopy values, in intestinal tissues of healthy and EPE-infected rabbits 
treated with GaM.  This study failed to yield results due to the beam-line restricted “limits of 
detection” abilities and microscopic staging malfunction.  The concentrations for gallium were in 
the range of ppb (ng/g); and for iron in the range of ppm (g/g), but as many oligoelements in 
biological matrices, their location is diffuse within cells and tissues, rather than focused in only 
one point.  I suggest that, for synchrotron radiation analysis on specific anatomical structures, a 
better method of slides’ preparation needs to be tested. Specific targets (e.g., epithelial cells) 
cannot be analyzed without a few reference points (i.e., visible staining or cross wires). Also 
beam-lines’ scientists could invest in a few methodology-development studies, so that reference 
“limits of detection” can be available to appropriately design investigation of biological material 
of animal origin and anatomic tissue (See Appendix A). 
9.2.4. Efficacy Study 
 
Of the potential uses for the GaM PK study results, one represented the last part of this 
dissertation’s project (See Chapter 8).  A safe dosing interval of the same dose of GaM used in 
the PK study (50 mg/kg BW p.o., q 48 h) was derived for EPE-infected rabbits from the 
estimated PK parameters (See Chapter 7) to administer multiple times in an efficacy study 
utilizing the rabbit model.    
GaM was compared to the leading clinical treatment for EPE, doxycycline (positive 
control), and to a sham-treatment (negative control).  Although all rabbits appeared to tolerate 
the multiple treatments, no changes were observed in the serological response and the fecal 
shedding, but, more importantly it led to no better IHC grading for EPE lesions, when compared 
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to doxycycline, or sham treatment.  Actually, lesions consistent with L. intracellularis infection 
were visible in jejunum and ileum of all rabbits, but were much less pronounced in the 
doxycycline group, particularly with a notable improvement progressing from proximal to distal, 
in the jejunum (See Chapter 8).  However, as the presence of lesions was not a clear cut between 
infected treated animals and infected non-treated controls, our findings cannot be as definitive as 
initially we had wished. The considerations about possible age limitations of the rabbit models 
have been prospected above in the paragraph 9.1. and should be born in mind if a future efficacy 
study on the EPE model is prospected.   
9.2.5 Considerations and Discussion 
 
In light of these results, along with a worsened iron tissue content and apparent 
sequestration of gallium in the highly lymphatic tissue of the caecal appendix, due to prolonged 
GaM administration, the options of pursuing further research on GaM in animal models 
(surrogate species or same species) should probably be reconsidered, or avoided (Fenwick, et al., 
2009).  In fact, GaM not only failed to affect the L. intracellularis infection in this study, but also 
R. equi and a few Staphylococcus spp. in other studies (Martens, et al., 2007b; Coleman, et al., 
2010 ; Arnold, et al., 2012).   
Recently, research results on GaM’s efficacy versus R. equi were published, showing a 
failure to prevent disease, as a prophylactic treatment was started even before infection, trying to 
achieve a desired serum concentration, matched to the minimum inhibitory concentration (MIC) 
adequate to inhibit bacterial growth (Coleman, et al., 2010; Chaffin, et al., 2011).  Thus, unless a 
MIC study in vitro for L. intracellularis elucidates a few steps in dose choice or formulation, and 
supports further investigation, GaM antimicrobial research may have a limited future. Moreover, 
prolonged treatment with GaM may interfere with the normal host’s iron metabolism. This 
interference could potentially add complications and exacerbation to the disease, or delay the 
progression of recovery (See Chapter 8). 
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CHAPTER 10   
CONCLUSIONS 
“Securus iudicat orbis terrarum” 
“The verdict of the world is conclusive” 
                                                           St. Augustine 
10.1.1. Findings: Rabbits infected with equine strain L. intracellularis constitute a mild 
and humane infection model for Equine Proliferative Enteropathy (EPE), without overt disease, 
but a possible transient weight loss, with detectable immunohistochemistry (IHC) lesions, 
marked fecal shedding of L. intracellularis DNA and detectable specific antibodies (IgG) in 
serum.  
 10.1.2. Future implications: The rabbit EPE infection model could be used to substitute 
for foals in pharmacological and vaccine studies, and to clarify the epidemiological role of 
wildlife subclinical carriers, in the context of EPE geographical distribution. 
 
10.2.1. Findings: Contrary to the published reports of successful cross- infections after 
challenging hamsters with a porcine strain of L. intracellularis (agent of Porcine Proliferative 
Enteropathy - PPE), hamsters infected with EPE strain, do not develop evidence of clinical 
disease, seroconversion (IgG),  gross pathology or IHC detectable lesions. Similarly rabbits 
infected with a PPE strain do not develop evidence of clinical disease or gross and IHC 
detectable lesions, although they showed a mild to moderate seroconversion and fecal shedding 
of bacterial DNA.  
10.2.2. Future implications: Hamsters should not be used to model EPE infection and  
rabbits should not be used to model PPE disease in future research, but their ability to shed L. 
intracellularis increases the importance of subclinical and resistant carriers in the environment. 
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However, such a host-specificity restriction could depend on the specific genetic subspecies of L. 
intracellularis, which will need further genetic investigation 
 
10.3.1. Findings: A moleskin “ear-shaped” adhesive bandage, applied over the ear of a 
catheterized central artery was developed, simulating a skin embedded injection port. It 
simplified and refined (according to the “Three Rs” CCAC’s tenet) repeated blood sampling, 
restraint and timeliness in the rabbits’ pharmacokinetic study, but it could be applied to any other 
study that requires repeated blood sampling in rabbits.  
10.3.2. Future implications: This technique was intended for short-term 12 h study only. 
However it could be modified to maintain a catheter for longer than 12 h. 
 
10.4.1. Findings: Gallium maltolate (GaM) was safe to administer orally as a single 
bolus dose (50 mg/kg) to healthy and EPE-infected rabbits. Pharmacokinetic parameters related 
to the total body exposure to the drug, and its disposition, were estimated. A dosing interval for 
EPE-infected rabbits (q 48 h) was derived.  Our results were closer to estimates in adult horses 
(treated with 20 mg/kg), than the ones in neonatal foals. GaM administration significantly 
decreased iron concentration in several intestinal sections’ tissue.  This decrease was greater in 
EPE infected rabbits, as tissue oligoelement concentrations were overall reduced.  
 
10.4.2. Future implications: As no absorption and bioavailability parameters could be 
estimated, due to the restrictions of an oral dosing only, an intravenous administration study 
should be carried out before initiating any further investigation. Knowledge, of the real 
bioavailability of this compound will be fundamental for future studies, should the need arise. 
 
 
10.5.1. Findings: GaM was safe to administer in multiple oral administrations (50 mg/kg 
q 48 h) to EPE-infected rabbits.  GaM was compared to control medium-only and doxycycline 
administrations in EPE infected rabbits. When this occurred, IHC lesions, fecal shedding and 
serological response did not show any improved efficacy of GaM.  Moreover, repeated treatment 
caused significant reduction of intestinal iron tissue concentration.  
 
10.5.2. Future implications: GaM efficacy and minimum inhibitory concentration 
(MIC) studies should only be tried on pure cell-culture L. intracellularis, as the trials performed 
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in this project (and in other studies) showed that its efficacy is no better, or worse, than the 
current clinical therapies, and the only justification to use GaM in vivo again should be on the 
grounds of promising MIC findings.  
  
245 
 
 
 
CHAPTER 11 
  
BIBLIOGRAPHIC REFERENCES 
 
1.  Abrams-Ogg T. Nonregenerative anemia. In: Ettinger SJ, Feldman EC, eds. Textbook of 
Veterinary Internal Medicine. 7th ed. St. Louis, Miss: Elsevier Saunders: 788-797. (2010). 
 
2.  Alderton M.R., Borland R. & Coloe P.J. Experimental reproduction of porcine proliferative 
enteritis. Journal of Comparative Pathology. 106:159-167. (1992). 
 
3.  Alexander F. Factors affecting the blood sugar concentration in horses. Quarterly journal of 
experimental physiology and cognate medical sciences 40: 24-31. (1955). 
 
4.   Almond P.K. & Bilkei G. Effects of oral vaccination against Lawsonia intracellularis on 
growing-finishing pig's performance in a pig production unit with endemic porcine 
proliferative enteropathy (PPE). Deutsche Tierarztliche Wochenschrift 113:232-235. (2006). 
 
5.  Altmann S., Brandt C.R., Murphy C.J., Patnaikuni R., Takla T., Toomey M., Nesbit B., 
McIntyre K., Covert J., Dubielzig R., Leatherberry G., Adkins E. & Kodihalli S. Evaluation of 
therapeutic interventions for vaccinia virus keratitis. Journal of Infectious Diseases 203: 683-
690. (2011). 
 
6.  Amend N.K., Loeffler D.G., Ward B.C. & Van Hoosier G.L. Jr. Transmission of enteritis in 
the Syrian hamster. Journal of the American Association for Laboratory Animal Science. 26: 
566-572. (1976). 
 
7.  An Y.H., Kang Q.K. & Arciola C.R. Animal models of osteomyelitis. International Journal 
of Artificial Organs 29: 407-420. (2006). 
 
8.   Andrews, N.C. Iron homeostasis: insights from genetics and animal models. Nature Reviews 
Genetics 1: 208-217. (2000). 
 
9.   Argenzio R.A. & Hintz H.F. Effect of diet on glucose entry and oxidation rates in ponies. 
Journal of Nutrition. 102: 879-892. (1972). 
 
10.  Argenzio R.A., Lowe J.E., Pickard D.W. & Stevens C.E. Digesta passage and water 
exchange in the equine large intestine. American Journal of Physiology. 226: 1035-1042. 
(1974) (a). 
 
246 
 
11.  Argenzio R.A., Southworth M. & Stevens C.E. Sites of organic acid production and 
absorption in the equine gastrointestinal tract. American Journal of Physiology. 226: 1043-
1050. (1974) (b). 
 
12.  Argenzio R.A. & Stevens C.E. Cyclic changes in ionic composition of digesta in the equine 
intestinal tract. American Journal of Physiology. 228: 1224-1230. (1975). 
 
13.  Argenzio R. General functions of the gastrointestinal tract and their control and integration. 
Dukes Domestic Animal Physiology Textbook, 10th Edition, Cornell University Press: 326-
328.(1984).  
 
14.  Arnold C., Chaffin M.K., Cohen N., Fajt V.R., Taylor R.J. & Bernstein L.R. 
Pharmacokinetics of gallium maltolate after intragastric administration in adult horses. 
American Journal of Veterinary Research 71: 1371-1376. (2010). 
 
15.  Arnold C.E., Bordin A., Lawhon S.D., Libal M.C., Bernstein L.R. & Cohen N.D. 
Antimicrobial activity of gallium maltolate against Staphylococcus aureus and methicillin-
resistant S. aureus and Staphylococcus pseudintermedius: An in vitro study. Veterinary  
Microbiology. 155: 389-394. (2012).  
 
16.   Banin E., Lozinski A., Brady K., Berenshtein E., Butterfield P., Moshe M., Chevion M., 
Greenberg E. & Banin E. The potential of desferrioxamine-gallium as an anti-Pseudomonas 
therapeutic agent. Proceedings of the National Academy of Sciences of the United States 105: 
16761-16766. (2008). 
 
17.   Barcia-Macay M., Mouaden F., Mingeot-Leclercq M.P., Tulkens P.M. & Van Bambeke F. 
Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of 
lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic 
fibroblasts). Journal of Antimicrobial Chemotherapy 61: 1288-1294. (2008). 
 
18.   Basaraba R.J. Experimental tuberculosis: the role of comparative pathology in the discovery 
of improved tuberculosis treatment strategies. Tuberculosis 88: S35-47. (2008). 
 
19.   Bauer J.E., Harvey J.W., Asquith R.L., McNulty P.K. & Kivipelto J. Clinical chemistry 
reference values of foals during the first year of life. Equine Veterinary Journal 16: 361-363. 
(1984). 
 
20.   Baverud, V., Franklin A., Gunnarsson A., Gustafsson A. & Hellander-Edman A. 
Clostridium difficile associated with acute colitis in mares when their foals are treated with 
erythromycin and rifampicin for Rhodococcus equi pneumonia. Equine Veterinary Journal 30: 
482-488. (1998). 
 
21.   Beauchamp D., Gourde P., Simard M. & Bergeron M.G. Subcellular localization of 
tobramycin and vancomycin given alone and in combination in proximal tubular cells, 
determined by immunogold labeling. Antimicrobial Agents and Chemotherapy 36: 2204-2210. 
(1992). 
247 
 
 
22.   Berghaus L.J., Giguere S., Sturgill T.L., Bade D., Malinski T.J. & Huang R. Plasma 
pharmacokinetics, pulmonary distribution, and in vitro activity of gamithromycin in foals. 
Journal of Veterinary Pharmacology and Therapeutics.35: 59-66. (2012). 
 
23.   Bergman F. Effect of temperature on intratesticular cryptococcal infection in rabbits. 
Sabouraudia 5: 54-58. (1966). 
 
24.   Bernstein L.R. Mechanisms of therapeutic activity for gallium. Pharmacology Reviews 50: 
665-682. (1998). 
 
25.   Bernstein L.R., Tanner T., Godfrey C. & Noll B. Chemistry and pharmacokinetics of 
gallium maltolate, a compound with high oral gallium bioavailability. Metal Based Drugs 7: 
33-47. (2000). 
 
26.   Berry J.P., Poupon M.F., Galle S. & Escaig F. Role of lysosomes in gallium concentration 
by mammalian tissues. Biologie Cellulaire 51: 43-51. (1984). 
 
27.    Biester H.E. & Schwarte L.H. Intestinal adenoma in swine. American Journal of 
Pathology. 7: 175-185. (1931). 
 
28.   Bihr T.P. Protein-losing enteropathy caused by Lawsonia intracellularis in a weanling foal. 
Canadian Veterinary Journal 44: 65-66. (2003). 
 
29.   Blackham A., Farmer J.B., Radziwonik H. & Westwick J. The role of prostaglandins in 
rabbit monoarticular arthritis. British Journal of Pharmacology 51: 35-44. (1974). 
 
30.   Blair H.C., Teitelbaum S.L., Tan H.L. & Schlesinger P.H. Reversible inhibition of 
osteoclastic activity by bone-bound gallium (III). Journal of Cellular Biochemistry 48: 401-
410. (1992). 
 
31.   Blood-Siegfried, J. & Shelton B. Animal models of sudden unexplained death. FEMS 
Immunology and Medical Microbiology 42: 34-41. (2004). 
 
32.   Bockman R.S. Studies on the mechanism of action of gallium nitrate. Seminars in Oncology 
18: 21-25. (1991). 
 
33.   Boesen H.T., Jensen T.K., Jungersen G., Riber U., Boye M. & Moller K. Development, 
characterization and diagnostic application of a monoclonal antibody specific for a proteinase 
K resistant Lawsonia intracellularis antigen. Veterinary Microbiology. 105: 199-206. (2005). 
 
34.    Bonner M.J., Medway W., Mitruka B.M., Rawnsley H.M. & Vadehera D.V. Animal for 
medical research. New York; J. Wiley and Sons, Inc. :29-31. (1976). 
 
248 
 
35.   Boosinger T.R., Thacker H.L. & Armstrong C.H. Campylobacter sputorum subsp mucosalis 
and Campylobacter hyointestinalis infections in the intestine of gnotobiotic pigs. American 
Journal of Veterinary Research. 46:2152-2156. (1985). 
 
36.   Boothe A.D. & Cheville N.F. The pathology of proliferative ileitis of the golden syrian 
hamster. Pathologia Veterinaria 4: 31-44. (1967). 
 
37.   Boothe H.W., Jones S.A., Wilkie W.S., Boeckh A., Stenstrom K.K. & Boothe D.M. 
Evaluation of the concentration of marbofloxacin in alveolar macrophages and pulmonary 
epithelial lining fluid after administration in dogs. American Journal of Veterinary Research. 
66:1770-1774. (2005). 
 
38.   Boothe D.M., Boeckh A. & Boothe H.W. Evaluation of the distribution of enrofloxacin by 
circulating leukocytes to sites of inflammation in dogs. American Journal of Veterinary 
Research. 70: 16-22. (2009). 
 
39.   Boutrup T.S., Schauser K., Agerholm J.S. & Jensen T.K. Application of a pig ligated 
intestinal loop model for early Lawsonia intracellularis infection. Acta Veterinaria 
Scandinavica 52:17-24. (2010) (a). 
 
40.   Boutrup T.S., Boesen H., Boye M., Agerholm J.S. & Jensen T.K. Early pathogenesis in 
porcine proliferative enteropathy caused by Lawsonia intracellularis. Journal of Comparative 
Pathology. 143: 101-109. (2010) (b). 
 
41.   Boye M., Jensen T.K., Moller K., Leser T.D. & Jorsal S.E. Specific detection of Lawsonia 
intracellularis in porcine proliferative enteropathy inferred from fluorescent rRNA in situ 
hybridization. Veterinary Pathology 35: 153-156. (1998). 
 
42.   Brandsma J.L. The cottontail rabbit papillomavirus model of high-risk HPV-induced 
disease. Methods in Molecular Medicine 119: 217-235. (2005). 
 
43.   Brayton J.J., Yang Q., Nakkula R.J. & Walters J.D. An in vitro model of ciprofloxacin and 
minocycline transport by oral epithelial cells. Journal of Periodontology 73:1267-1272. (2002). 
 
44.   Breau C., Cameron D.W., Desjardins M. & Lee B.C. Oral immunization using HgbA in a 
recombinant chancroid vaccine delivered by attenuated Salmonella typhimurium SL3261 in the 
temperature-dependent rabbit model. Journal of Immunological Methods.375:232-242. (2012). 
 
45.   Brees D.J., Sondhoff A.H., Kluge J.P., Andreasen C.B. & Brown C.M. Lawsonia 
intracellularis-like organism infection in a miniature foal. Journal of the American Veterinary 
Medical Association 215: 511-514, 483. (1999). 
 
46.   Brown C.M. The diagnostic value of the D-xylose absorption test in horses with 
unexplained chronic weight loss. British Veterinary Journal 148:41-44. (1992). 
 
249 
 
47.   Browning G.F., Chalmers R.M., Snodgrass D.R., Batt R.M., Hart C.A., Ormarod S.E., 
Leadon D., Stoneham S.J. & Rossdale P.D. The prevalence of enteric pathogens in diarrhoeic 
thoroughbred foals in Britain and Ireland. Equine Veterinary Journal 23: 405-409. (1991). 
 
48.   Bruder C.E., Piotrowski A., Gijsbers A.A., Andersson R., Erickson S., Diaz de Stahl T., 
Menzel U., Sandgren J., von Tell D., Poplawski A., Crowley M., Crasto C., Partridge E.C., 
Tiwari H., Allison D.B., Komorowski J., van Ommen G.J., Boomsma D.I., Pedersen N.L., den 
Dunnen J.T., Wirdefeldt K. & Dumanski J.P. Phenotypically concordant and discordant 
monozygotic twins display different DNA copy-number-variation profiles. American Journal 
of Human Genetics 82:763-771. (2008). 
 
49.   Bruner H.D., Perkinson J.D. Jr., King E.R., Andrews G.A., Nash J.B. & Brucer M.  
V.Distribution studies on gallium in rats. Radiology 61: 555-570. (1953) (a).  
 
50.   Bruner H.D., Gray J., Root S.W. & Brucer M. VII. Studies of the urinary excretion of 
gallium in man. Radiology 61: 588-590. (1953) (b). 
 
51.   Burman W.J. The value of in vitro drug activity and pharmacokinetics in predicting the 
effectiveness of antimycobacterial therapy: a critical review. American Journal of Medical  
Science. 313:355-363. (1997). 
 
52.   Burman W.J., Gallicano K. & Peloquin C. Comparative pharmacokinetics and 
pharmacodynamics of the rifamycin antibacterials. Clinical Pharmacokinetics 40:327-341. 
(2001). 
 
53.   Campbell D. The Pasteur Institute of Paris. American Journal of Veterinary Medicine 10: 
29-31. (1915). 
 
54.   Campo M.S. Animal models of papillomavirus pathogenesis. Virus Research 89: 249-261. 
(2002). 
 
55.   Cao C., Steinberg T.H., Neu H.C., Cohen D., Horwitz S.B., Hickman S. & Silverstein S.C. 
Probenecid-resistant J774 cell expression of enhanced organic anion transport by a mechanism 
distinct from multidrug resistance. Infectious Agents and Diseases. 2:193-200. (1993). 
 
56.   Cappelletty D.M. Evaluation of an intracellular pharmacokinetic in vitro infection model as 
a tool to assess tuberculosis therapy. International Journal of Antimicrobial Agents. 29: 212-
216. (2007). 
 
57.   Cardiff R.D., Ward J.M. & Barthold S.W. 'One medicine---one pathology': are veterinary 
and human pathology prepared? Laboratory Investigation 88: 18-26. (2008). 
 
58.   Carey M.C., Small D.M. & Bliss C.M. Lipid digestion and absorption. Annual Review of 
Physiology. 45: 651-677. (1983). 
 
250 
 
59.   Carlier M.B., Scorneaux B., Zenebergh A., Desnottes J.F. & Tulkens P.M. Cellular uptake, 
localization and activity of fluoroquinolones in uninfected and infected macrophages. Journal 
of Antimicrobial Chemotherapy 26 Suppl B: 27-39. (1990). 
 
60.   Carroll S.F., Guillot L. & Qureshi S.T. Mammalian model hosts of cryptococcal infection. 
Comparative Medicine 57:9-17. (2007). 
 
61.   Carryn S., Chanteux H., Seral C., Mingeot-Leclercq M.P., Van Bambeke F. & Tulkens P.M. 
Intracellular pharmacodynamics of antibiotics. Infectious Diseases Clinics of North America 
17:615-634. (2003). 
 
62.   Carryn S., Van Bambeke F., Mingeot-Leclercq M.P. & Tulkens P.M. Comparative 
intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, 
gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant 
concentrations. Antimicrobial Agents and Chemotherapy 46: 2095-2103. (2002). 
 
63.   Casadevall A. Host as the variable: model hosts approach the immunological asymptote. 
Infection and Immunity 73:3829-3832. (2005). 
 
64.    Caspary W.F. Physiology and pathophysiology of intestinal absorption. American Journal 
of Clinical Nutrition 55: 299S-308S. (1992). 
 
65.    Castro M.M., Kandasamy A.D., Youssef N. & Schulz R. Matrix metalloproteinase inhibitor 
properties of tetracyclines: therapeutic potential in cardiovascular diseases. Pharmacological 
Research. 64: 551-560. (2011). 
 
66.    Chaffin M.K., N.D. Cohen & Martens R.J. Chemoprophylactic effects of azithromycin 
against Rhodococcus equi-induced pneumonia among foals at equine breeding farms with 
endemic infections. Journal of the American Veterinary Medical Association 232: 1035-1047. 
(2008). 
 
67.    Chaffin M.K., Fajt V., Martens R.J., Arnold C.E., Cohen N.D., O'Conor M., Taylor R.J. & 
Bernstein L.R. Pharmacokinetics of an orally administered methylcellulose formulation of 
gallium maltolate in neonatal foals. Journal of Veterinary Pharmacology and Therapeutics. 33: 
376-382. (2010). 
 
68.    Chaffin M.K., Cohen N.D., Martens R.J., O'Conor M. & Bernstein L.R. Evaluation of the 
efficacy of gallium maltolate for chemoprophylaxis against pneumonia caused by Rhodococcus 
equi infection in foals. American Journal of Veterinary Research. 72: 945-957. (2011). 
 
69.    Chambers H.F. Ceftobiprole: in-vivo profile of a bactericidal cephalosporin. Clinical 
Microbiology and Infection. 12 (Supplement 2): 17-22. (2006). 
 
70.    Chang K., Kurtz H.J., Ward G.E. & Gebhart C.J. Immunofluorescent demonstration of 
Campylobacter hyointestinalis and Campylobacter sputorum subsp mucosalis in swine 
251 
 
intestines with lesions of proliferative enteritis. American Journal of Veterinary Research. 45: 
703-710. (1984). 
 
71.    Chapman J.L., Nichols D.K., Martinez M.J. & Raymond J.W. Animal models of 
orthopoxvirus infection. Veterinary Pathology 47: 852-870. (2010). 
 
72.    Chen Y.K. & Lin L.M. DMBA-induced hamster buccal pouch carcinoma and VX2-induced 
rabbit cancer as a model for human oral carcinogenesis. Expert Review of Anticancer Therapy 
10:1485-1496. (2010). 
 
73.    Chikh Z., Ha-Duong N.T., Miquel G. & El Hage Chahine J.M. Gallium uptake by 
transferrin and interaction with receptor 1. Journal of Biologic Inorganic Chemistry 12: 90-
100. (2007). 
 
74.    Chitambar C.R. & Zivkovic Z. Uptake of gallium-67 by human leukemic cells: 
demonstration of transferrin receptor-dependent and transferrin-independent mechanisms. 
Cancer Research 47: 3929-3934. (1987). 
 
75.    Chitambar C.R. Medical applications and toxicities of gallium compounds. Journal of 
Environmental Research and Public Health 7: 2337-2361. (2010). 
 
76.    Chou C.H. & Walters J.D. Clarithromycin transport by gingival fibroblasts and epithelial 
cells. Journal Dental Research 87:777-781. (2008). 
 
77.    Chua A.C., Graham R.M., Trinder D. & Olynyk J.K. The regulation of cellular iron 
metabolism. Critical Reviews in Clinical Laboratory Sciences. 44: 413-459. (2007). 
 
78.    Clemons K.V., Capilla J. & Stevens D.A. Experimental animal models of 
coccidioidomycosis. Annals of the New York Academy of Science. 1111: 208-224. (2007). 
 
79.    Clifford R., Ruth M. & Liberati T. 24-hour intravenous infusion via the marginal ear vein 
in the New Zealand White rabbit. Contemporary Topics in Laboratory Animal Sciences 35: 44-
46. (2003). 
 
80.    Cocito C. Antibiotics of the virginiamycin family, inhibitors which contain synergistic 
components. Microbiological Reviews 43: 145-192. (1979). 
 
81.    Coleman M., Kuskie K., Liu M., Chaffin K., Libal M., Giguere S., Bernstein L. & Cohen 
N. In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi. 
Veterinary  Microbiology. 146: 175-178. (2010). 
 
82.    Collery P., Keppler B., Madoulet C. & Desoize B. Gallium in cancer treatment. Critical 
Reviews in Oncology/Hematology 42: 283-296. (2002). 
 
83.    Collery P., Millart H., Lamiable D., Vistelle R., Rinjard P., Tran G., Gourdier B., Cossart 
C., Bouana J.C., Pechery C., Etienne J.C., Choisy H. & Dubois de Montreynaud J.M. Clinical 
252 
 
pharmacology of gallium chloride after oral administration in lung cancer patients. Anticancer 
Research 9:353-356. (1989). 
 
84.    Collins A.M., Love R.J., Jasni S. & McOrist S. Attempted infection of mice, rats and 
chickens by porcine strains of Lawsonia intracellularis. Australian Veterinay Journal 77: 120-
122. (1999). 
 
85.    Collins A.M., Love R.J., Pozo J. Smith S.H. & McOrist S. Studies on the ex vivo survival 
of Lawsonia intracellularis. Journal of Swine Health and Production 8: 211-215. (2000). 
 
86.    Collins A.M. & Love RJ. Re-challenge of pigs following recovery from proliferative 
enteropathy. Veterinary Microbiology. 120: 381-386. (2007). 
 
87.    Collins A.M., Fell S., Pearson H. & Toribio J.A. Colonisation and shedding of Lawsonia 
intracellularis in experimentally inoculated rodents and in wild rodents on pig farms. 
Veterinary  Microbiology.150: 384-388. (2011). 
 
88.    Collins J.E., Libal M.C. & Brost D. Proliferative enteritis in two pups. Journal of the 
American Veterinary Medical Association. 183: 886-889. (1983). 
 
89.    Cooper D.M., Swanson D.L. & Gebhart C.J. Diagnosis of proliferative enteritis in frozen 
and formalin-fixed, paraffin-embedded tissues from a hamster, horse, deer and ostrich using a 
Lawsonia intracellularis-specific multiplex PCR assay. Veterinary Microbiology. 54: 47-62. 
(1997) (a). 
 
90.    Cooper D.M., Swanson D.L., Barns S.M. & Gebhart C.J.  Comparison of the 16S 
ribosomal DNA sequences from the intracellular agents of proliferative enteritis in a hamster, 
deer, and ostrich with the sequence of a porcine isolate of Lawsonia intracellularis. 
International Journal of Systemic Bacteriology 47: 635-639. (1997) (b). 
 
91.    Cooper, D.M. & Gebhart C.J. Comparative aspects of proliferative enteritis. Journal of the 
American Veterinary Medical Association. 212: 1446-1451. (1998). 
 
92.    Craig W.A. & Ebert S.C. Continuous infusion of beta-lactam antibiotics. Antimicrobial 
Agents and Chemotherapy 36: 2577-2583. (1992). 
 
93.    Crichton R. Iron metabolism: from molecular mechanism to clinical consequences. 3rd Ed. 
West Sussex, UK: J.Wiley & Sons: 17-56; 141-325. (2009). 
 
94.    Crowell-Davis S.L. & Houpt K.A. Coprophagy by foals: effect of age and possible 
functions. Equine Veterinary Journal 17: 17-19. (1985). 
 
95.    Crowell-Davis S.L. Developmental behavior. Veterinary Clinics of North America. Equine 
Practice 2: 573-590. (1986). 
 
253 
 
96.    Dauvillier J., Picandet V., Harel J., Gottschalk M., Desrosiers R., Jean D., & Lavoie J.P. 
Diagnostic and epidemiological features of Lawsonia intracellularis enteropathy in 2 foals. 
Canadian Veterinary Journal 47: 689-691. (2006). 
 
97.    Davis J.L., Little D., Blikslager A.T. & Papich M.G. Mucosal permeability of water-
soluble drugs in the equine jejunum: a preliminary investigation. Journal of Veterinary 
Pharmacology and Therapeutics. 29: 379-385. (2006) (a). 
 
98.    Davis, J.L., Salmon, J.H. & Papich, M.G. Pharmacokinetics and tissue distribution of 
doxycycline after oral administration of single and multiple doses in horses. American Journal 
of Veterinary Research 67: 310-316. (2006) (b). 
 
99.    DeLeon K., Balldin F., Watters C., Hamood A., Griswold J., Sreedharan S. & Rumbaugh 
K.P. Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally 
injured mice. Antimicrobial Agents and Chemotherapy 53: 1331-1337. (2009).  
 
100. Deprez P., Chiers K., Gebhart C.J., Ducatelle R., Lefere L., Vanschandevijl K. & van 
Loon G. Lawsonia intracellularis infection in a 12-month-old colt in Belgium. Veterinary 
Records 157:774-776. (2005). 
 
101. Diehl K., Hull R., Morton D., Pfister R., Rabemampianina Y., Smith D., Vidal J. & 
Vorstenbosch C.v.d. A good practice guide to the administration of substances and removal of 
blood, including routes and volumes. Journal of Applied Toxicology. 21: 15-23. (2001). 
 
102. Dorian M., Grellet J. & Saux M.C. Uptake of quinolones by in-vitro human monocyte 
derived macrophages. Journal of Pharmacy and Pharmacology 53: 735-741. (2001). 
 
103. Drancourt M. & Raoult D. Methodology of antibiotics testing for intracellular pathogens.  
In: Raoult, D. Ed Antimicrobial agents and intracellular pathogens. CRC Press, Boca Raton, 
FL: 71-85. (1993). 
 
104. Drolet R., Larochelle D. & Gebhart C.J. Proliferative enteritis associated with Lawsonia 
intracellularis (ileal symbiont intracellularis) in white-tailed deer. Journal of Veterinary 
Diagnostic Investigation. 8: 250-253. (1996). 
 
105. Drozd M., Kassem I.I., Gebreyes W. & Rajashekara G. A quantitative polymerase chain 
reaction assay for detection and quantification of Lawsonia intracellularis. Journal of 
Veterinary Diagnostic Investigation. 22: 265-269. (2010). 
 
106. Duhamel G.E. & Wheeldon E.B. Intestinal adenomatosis in a foal. Veterinary Pathology 
19: 447-450. (1982). 
 
107. Duhamel G.E., Klein E.C., Elder R.O. & Gebhart C.J. Subclinical proliferative 
enteropathy in sentinel rabbits associated with Lawsonia intracellularis. Veterinary Pathology 
35: 300-303. (1998). 
 
254 
 
108. Dvorak H.F. & Waksman B.H. Primary immunization of lymph node cells in millipore 
chambers by exposure to homograft antigen. Journal of Experimental Medicine 116: 1-16. 
(1962). 
 
109. Dyer J., Fernandez-Castano Merediz E., Salmon K.S., Proudman C.J., Edwards G.B. & 
Shirazi-Beechey S.P. Molecular characterisation of carbohydrate digestion and absorption in 
equine small intestine. Equine Veterinary Journal 34: 349-358. (2002). 
 
110. Dzanis D.A. The Association of American Feed Control Officials Dog and Cat Food 
Nutrient Profiles: substantiation of nutritional adequacy of complete and balanced pet foods in 
the United States. Journal of Nutrition. 124: 2535S-2539S. (1994). 
 
111. Earhart, C. Chapter 9: Iron uptake via the enterobactin system. In: Iron transport in 
bacteria. Ed. Crosa J.H., Mey A.R., Payne S.M.: 133 - 146. (2004). 
 
112. Easmon C.S. & Crane J.P. Cellular uptake of clindamycin and lincomycin. British 
Journal of Experimental Pathology 65: 725-730. (1984). 
 
113. East L.M., Savage C.J., Traub-Dargatz J.L., Dickinson C.E. & Ellis R.P. Enterocolitis 
associated with Clostridium perfringens infection in neonatal foals: 54 cases (1988-1997). 
Journal of the American Veterinary Medical Association. 212:1751-1756. (1998). 
 
114. Elder R.O., Duhamel G.E., Mathiesen M.R., Erickson E.D., Gebhart C.J. & Oberst R.D. 
Multiplex polymerase chain reaction for simultaneous detection of Lawsonia intracellularis, 
Serpulina hyodysenteriae, and salmonellae in porcine intestinal specimens. Journal of 
Veterinary Diagnostic Investigation. 9: 281-286. (1997). 
 
115. Feary D.J. & Hassel D.M. Enteritis and colitis in horses. Veterinary Clinics of North 
America. Equine Practice 22:437-479, ix. (2006). 
 
116. Feary D.J., Gebhart C.J. & Pusterla N. Lawsonia intracellularis proliferative enteropathy 
in a foal. Schweizer Archiv für Tierheilkunde 149: 129-133. (2007). 
 
117. Fecteau M.E., Palmer J.E. & Wilkins P.A. Neonatal care of high-risk cloned and 
transgenic calves. Veterinary Clinics of North America. Food Animal Practice 21: 637-653, vi. 
(2005). 
 
118. Fecteau M.E., Whitlock R.H., Fyok T.L., McAdams S.C., Boston R.C. & Sweeney R.W. 
Antimicrobial activity of gallium nitrate against Mycobacterium avium subsp. 
paratuberculosis in neonatal calves. Journal of Veterinary Internal Medicine 25: 1152-1155. 
(2011). 
 
119. Fenoy S., Ollero M.D., Guillen J.L. & del Aguila C. Animal models in ocular 
toxocariasis. Journal of Helminthology 75:119-124. (2001). 
 
255 
 
120. Fenwick N., Griffin G. & Gauthier C. The welfare of animals used in science: how the 
"Three Rs" ethic guides improvements. Canadian Veterinary Journal 50: 523-530. (2009). 
 
121. Firshman A.M. & Valberg S.J. Factors affecting clinical assessment of insulin sensitivity 
in horses. Equine Veterinary Journal 39: 567-575. (2007). 
 
122. Flisser A., Avila G., Maravilla P., Mendlovic F., Leon-Cabrera S., Cruz-Rivera M., Garza 
A., Gomez B., Aguilar L., Teran N., Velasco S., Benitez M. & Jimenez-Gonzalez D.E. Taenia 
solium:current understanding of laboratory animal models of taeniosis. Parasitology 137: 347-
357. (2010). 
 
123. Fondacaro, J.D. Intestinal ion transport and diarrheal disease. American Journal of 
Physiology. 250(1 Pt 1): G1-8. (1986). 
 
124. Ford D.M., Dahl R.H., Lamp C.A. & Molitoris B.A. Apically and basolaterally 
internalized aminoglycosides colocalize in LLC-PK1 lysosomes and alter cell function. 
American Journal of Physiology. 266(1 Pt 1): C52-57. (1994). 
 
125. Fox J.G., Shen Z., Muthupalani S., Rogers A.R., Kirchain S.M., Dewhirst F.E. Chronic 
hepatitis, hepatic dysplasia, fibrosis, and biliary hyperplasia in hamsters naturally infected with 
a novel Helicobacter classified in the H. bilis cluster. Journal of Clinical Microbiology. 47: 
3673-3681. (2009). 
 
126. Frank N., Fishman C.E., Gebhart C.J. & Levy M. Lawsonia intracellularis proliferative 
enteropathy in a weanling foal. Equine Veterinary Journal 30: 549-552. (1998). 
 
127. Frazer M.L. Lawsonia intracellularis infection in horses: 2005-2007. Journal of 
Veterinary Internal Medicine 22: 1243-1248. (2008). 
 
128. Frederick J., Giguere S. & Sanchez L.C. Infectious agents detected in the feces of 
diarrheic foals: a retrospective study of 233 cases (2003-2008). Journal of Veterinary Internal 
Medicine 23:1254-1260. (2009). 
 
129. Freeman D.E., Ferrante P.L., Kronfeld D.S. & Chalupa W. Effect of food deprivation on 
D-xylose absorption test results in mares. American Journal of Veterinary Research. 50:1609-
1612. (1989). 
 
130. Friedman M., Bednár V., Klimes J., Smola J., Mrlík V. & Literák I. Lawsonia 
intracellularis in rodents from pig farms with the occurrence of porcine proliferative 
enteropathy. Letters in Applied Microbiology. 47: 117-121. (2008). 
 
131. Frisk C.S. & Wagner J.E. Experimental hamster enteritis: an electron microscopic study. 
American Journal of Veterinary Research. 38: 1861-1868. (1977). 
 
256 
 
132. Fujita N.K., Hukkanen J. & Edwards J.E. Jr. Experimental hematogenous 
endophthalmitis due to Cryptococcus neoformans. Investigative Ophthalmology and Visual 
Science 24: 368-375. (1983). 
 
133. Ganapathy M.E., Huang W., Rajan D.P., Carter A.L., Sugawara M., Iseki K., Leibach 
F.H. & Ganapathy V. Beta-lactam antibiotics as substrates for OCTN2, an organic 
cation/carnitine transporter. Journal of Biological Chemistry 275:1699-1707. (2000). 
 
134. Garg R. & Dube A. Animal models for vaccine studies for visceral leishmaniasis. Indian 
Journal of Medical Research 123:439-454. (2006). 
 
135. Gebhart C.J., Ward G.E., Chang K. & Kurtz H.J. Campylobacter hyointestinalis (new 
species) isolated from swine with lesions of proliferative ileitis. American Journal of 
Veterinary Research. 44:361-367. (1983). 
 
136. Gebhart C.J., Lin G.F., McOrist S.M., Lawson G.H. & Murtaugh M.P. Cloned DNA 
probes specific for the intracellular Campylobacter-like organism of porcine proliferative 
enteritis. Journal of Clinical Microbiology 29:1011-1015. (1991). 
 
137. Gebhart C.J., Barns S.M., McOrist S., Lin G.F. & Lawson G.H.K. Ileal symbiont 
intracellularis, an obligate intracellular bacterium of porcine intestines showing a relationship 
to Desulfovibrio species. International Journal of Systematic Evolutionary Microbiology  43: 
533-538. (1993). 
 
138. Gebhart C.J., McOrist S., Lawson G.H., Collins J.E. & Ward G.E. Specific in situ 
hybridization of the intracellular organism of porcine proliferative enteropathy. Veterinary 
Pathology 31: 462-467. (1994). 
 
139. Gibson G.R., Macfarlane G.T. & Cummings J.H. Sulphate reducing bacteria and 
hydrogen metabolism in the human large intestine. Gut 34: 437-439. (1993). 
 
140. Giger U. Regenerative anemias caused by blood loss or hemolysis. In: Ettinger SJ, 
Feldman EC, eds. Textbook of Veterinary Internal Medicine. 6th ed. St. Louis, Missouri: 
Elsevier Saunders: 1886-1908. (2005). 
 
141. Giguere S., Jacks S., Roberts G.D., Hernandez J., Long M.T. & Ellis C. Retrospective 
comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with 
Rhodococcus equi pneumonia. Journal of Veterinary Internal Medicine 18: 568-573. (2004). 
 
142. Girijavallabhan V. & Miller M. Chapter 27: therapeutic uses of iron (III) chelators and 
their antimicrobial conjugates. In: Iron transport in bacteria. Eds.Crosa J.H., Mey A.R., Payne 
S.M. (2004). 
 
143. Gnarpe J., Eriksson K. & Gnarpe H. In vitro activities of azithromycin and doxycycline 
against 15 isolates of Chlamydia pneumoniae. Antimicrobial Agents and Chemotherapy. 40: 
1843-1845. (1996). 
257 
 
 
144. Graham J. Common procedures in rabbits. Veterinary Clinics of North America. Exotic 
AnimalsPractice 9: 367-388. (2006). 
 
145. Greek J. & Shanks N. Thoughts on animal models for human disease and treatment. 
Journal of the American Veterinary Medical Association. 235: 363; Author reply: 364. (2009). 
 
146. Greenwood, D. In vitro veritas? Antimicrobial susceptibility tests and their clinical 
relevance. Journal of Infectious Diseases 144: 380-385. (1981). 
 
147. Griffin G. Establishing a Three Rs programme at the Canadian Council on Animal Care. 
Alternative to Laboratory Animals 37 (Supplement 2): 63-67. (2009). 
 
148. Guedes R.M., Gebhart, C.J., Winkelman N.L., Mackie-Nuss R.A., Marsteller T.A., Deen 
J. Comparison of different methods for diagnosis of porcine proliferative enteropathy. 
Canadian Journal of Veterinary Research 66: 99-107. (2002) (a). 
 
149. Guedes R.M., Gebhart C.J., Winkelman N.L. & Mackie-Nuss R.A. A comparative study 
of an indirect fluorescent antibody test and an immunoperoxidase monolayer assay for the 
diagnosis of porcine proliferative enteropathy. Journal of Veterinary Diagnostic Investigation. 
14: 420-423. (2002) (b). 
 
150. Guedes R.M., Gebhart C.J., Deen J. & Winkelman N.L. Validation of an 
immunoperoxidase monolayer assay as a serologic test for porcine proliferative enteropathy. 
Journal of Veterinary Diagnostic Investigation. 14:528-530. (2002) (c). 
 
151. Guedes R.M., Gebhart C.J., Armbruster G.A. & Roggow B.D. Serologic follow-up of a 
repopulated swine herd after an outbreak of proliferative hemorrhagic enteropathy. Canadian 
Journal Veterinary Research. 66: 258-263. (2002) (d). 
 
152. Guedes R.M. & Gebhart C.J. Onset and duration of fecal shedding, cell-mediated and 
humoral immune responses in pigs after challenge with a pathogenic isolate or attenuated 
vaccine strain of Lawsonia intracellularis. Veterinary Microbiology. 91: 135-145. (2003) (a). 
 
153. Guedes R.M. & Gebhart C.J. Comparison of intestinal mucosa homogenate and pure 
culture of the homologous Lawsonia intracellularis isolate in reproducing proliferative 
enteropathy in swine. Veterinary Microbiology. 93: 159-166. (2003) (b). 
 
154. Guedes R.M. & Gebhart C.J. Preparation and characterization of polyclonal and 
monoclonal antibodies against Lawsonia intracellularis. Journal of Veterinary Diagnostic 
Investigation. 15: 438-446. (2003) (c). 
 
155. Guedes R.M., Winkelman N.L. & Gebhart C.J. Relationship between the severity of 
porcine proliferative enteropathy and the infectious dose of Lawsonia intracellularis. 
Veterinary Records 153:432-433. (2003). 
 
258 
 
156. Guimarães-Ladeira C.V., Palhares M.S., Oliveira J.S., Ramirez M.A. & Guedes R.M. 
Faecal shedding and serological cross-sectional study of Lawsonia intracellularis in horses in 
the state of Minas Gerais, Brazil. Equine Veterinary Journal 41(6): 593-596. (2009). 
 
157. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., 
Nussberger S., Gollan J.L. & Hediger M.A. Cloning and characterization of a mammalian 
proton-coupled metal-ion transporter. Nature 388: 482-488. (1997). 
 
158. Gunshin H., Fujiwara Y., Custodio A.O., Direnzo C., Robine S. & Andrews N.C. 
Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta 
and liver. Journal of Clinical Investigation 115:1258-1266. (2005). 
 
159. Gunther R.D. & Wright E.M.  Na+, Li+, and Cl- transport by brush border membranes 
from rabbit jejunum. Journal of Membrane Biology 74: 85-94. (1983). 
 
160. Guy J.S., Breslin J.J., Breuhaus B., Vivrette S. & Smith L.G. Characterization of a 
coronavirus isolated from a diarrheic foal. Journal of Clinical Microbiology 38:4523-4526. 
(2000). 
 
161. Guyton A.C., Hall J. Eds. Digestion and absorption in the gastrointestinal tract. In: 
Textbook of Medical Physiology, 11th Ed.: 808-817. (2005) (a). 
 
162. Guyton A.C., Hall J. Eds. Protein metabolism. In: Textbook of Medical Physiology, 11th 
Ed.: 852-857. (2005) (b). 
 
163. Guyton A.C., Hall J. Eds. Lipid metabolism. In: Textbook of Medical Physiology, 11th 
Ed.: 840-850. (2005) (c). 
 
164. Haake D.A. Hamster model of leptospirosis. Current Protocols in Microbiology Chapter 
12: E-12. (2006). 
 
165. Hall T.J. & Chambers T.J. Gallium inhibits bone resorption by a direct effect on 
osteoclasts. Bone Miner 8: 211-216. (1990) 
 
166. Hammerschlag M.R. Antimicrobial susceptibility and therapy of infections caused by 
Chlamydia pneumoniae. Antimicrobial Agents and Chemotherapy. 38: 1873-1878. (1994). 
 
167. Hand W.L. & King-Thompson N.L. Membrane transport of clindamycin in alveolar 
macrophages. Antimicrobial Agents and Chemotherapy 21: 241-247. (1982). 
 
168. Hand W.L., Corwin R.W., Steinberg T.H. & Grossman G.D. Uptake of antibiotics by 
human alveolar macrophages. American Review Respiratory Disease. 129: 933-937. (1984). 
 
169. Harcourt-Brown F. Biological characteristics of the domestic rabbit (Oryctolagus 
cuniculi). Texbook of Rabbit Medicine - By F. Harcourt-Brown, Butterworth-Heinemann - 
Reed Elsevier Group, Woburn, MA 01801, USA Chapter 1:1-18. (2002) (a). 
259 
 
 
170. Harcourt-Brown F. The rabbit consultation and clinical techniques. Texbook of Rabbit 
Medicine - By F. Harcourt-Brown, Butterworth-Heinemann - Reed Elsevier Group, Woburn, 
MA. Chapter 3:52-93. (2002) (b). 
 
171. Harrington J.R., Martens R.J., Cohen N.D. & Bernstein L.R. Antimicrobial activity of 
gallium against virulent Rhodococcus equi in vitro and in vivo. Journal of Veterinary 
Pharmacology and Therapeutics. 29:121-127. (2006). 
 
172. Harris, W.R. & Pecoraro V.L. Thermodynamic binding constants for gallium transferrin. 
Biochemistry 22: 292-299. (1983). 
 
173. Harvey J.W. Microcytic anemia. In: Feldman B.F., Zinkl J.G., Jain M.C. Eds. Schalm’s 
Veterinary Hematology. 5th ed. Philadephia, Penn. Lippincott, Williams and Wilkins: 200-204. 
(2000). 
 
174. Harvey J.W. Iron metabolism and its disorders. In: Kaneko J.J., Harvey J.W., Bruss M.L. 
Eds. Clinical Biochemistry of domestic animals. 6th Ed. Burlington, Mass. Elsevier: 259-285. 
(2008). 
 
175. Hayashi K., Teramoto N. & Akagi T. Animal in vivo models of EBV-associated 
lymphoproliferative diseases: special references to rabbit models. Histology and 
Histopathology 17: 1293-1310. (2002). 
 
176. Henderson D.A., Inglesby T.V., Bartlett J.G., Ascher M.S., Eitzen E., Jahrling P.B., 
Hauer J., Layton M., McDade J., Osterholm M.T., O'Toole T., Parker G., Perl T., Russell P.K. 
& Tonat K.  Smallpox as a biological weapon: medical and public health management. 
Working Group on Civilian Biodefense. Journal of the American Medical Association. 281: 
2127-2137. (1999). 
 
177. Herbst W., Hertrampf B., Schmitt T., Weiss R. & Baljer G. Diagnosis of Lawsonia 
intracellularis using the polymerase chain reaction (PCR) in pigs with and without diarrhea 
and other animal species. Deutsche Tierarztliche Wochenschrift 110: 361-364. (2003). 
 
178. Holyoake P.K., Cutler R.S., Caple I.W. & Monckton R.P. Enzyme-linked immunosorbent 
assay for measuring ileal symbiont intracellularis-specific immunoglobulin G response in sera 
of pigs. Journal of Clinical Microbiology. 32: 1980-1985. (1994). 
 
179. Horiuchi N., Watarai M., Kobayashi Y., Omata Y. & Furuoka H. Proliferative 
enteropathy involving Lawsonia intracellularis infection in rabbits (Oryctlagus cuniculus). 
Journal of Veterinary Medical Science.70: 389-392. (2008). 
 
180. Horowitz H.W., Hsieh T.C., Aguero-Rosenfeld M.E., Kalantarpour F., Chowdhury I., 
Wormser G.P. & Wu J.M. Antimicrobial susceptibility of Ehrlichia phagocytophila. 
Antimicrobial Agents and Chemotherapy. 45: 786-788. (2001). 
 
260 
 
181. Hotchkiss C.E. & Merritt A.M. Mucus secretagogue activity in cecal contents of rabbits 
with mucoid enteropathy.  Journal of the American Association for Laboratory Animal 
Science. 46: 179-186. (1996). 
 
182. Hotchkiss C.E., Shames B., Perkins S.E. & Fox J.G. Proliferative enteropathy of rabbits: 
the intracellular Campylobacter-like organism is closely related to Lawsonia intracellularis. 
Journal of the American Association for Laboratory Animal Science. 46: 623-627. (1996). 
 
183. Hotta K., Niwa M., Hirota M., Kanamori Y., Matsuno H., Kozawa O., Otsuka T., Matsui 
N. & Uematsu T. Regulation of fluoroquinolone uptake by human neutrophils: involvement of 
mitogen-activated protein kinase. Journal of Antimicrobial Chemotherapy 49: 953-959. (2002). 
 
184. http://www.fda.gov/cder/guidelines.htm USFDA CDER Guidance to Industry (draft) 
Gingivitis: Development and Evaluation of Drugs for Treatment or Prevention. (2005). 
 
185. Ives T.J., Marston E.L., Regnery R.L., Butts J.D. & Majerus T.C. (2000). In vitro 
susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined 
by immunofluorescent antibody analysis of infected vero cell monolayers. Journal of 
Antimicrobial Chemotherapy 45: 305-310. 
 
186. Jacks S.S., Giguere S. & Nguyen A. In vitro susceptibilities of Rhodococcus equi and 
other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials. 
Antimicrobial Agents and Chemotherapy 47:1742-1745. (2003). 
 
187. Jacobs A. Use of nontraditional animals for evaluation of pharmaceutical products. 
Expert Opinion on Drug Metabolism and Toxicology 2: 345-349. (2006). 
 
188. Jacobson M., Englund S. & Ballagi-Pordany A. The use of a mimic to detect polymerase 
chain reaction-inhibitory factors in feces examined for the presence of Lawsonia 
intracellularis. Journal of Veterinary Diagnostic Investigation. 15: 268-273. (2003). 
 
189. Jacobson M., Aspan A., Konigsson M.H., Segerstad C.H., Wallgren P., Fellstrom C., 
Jensen-Waern M. & Gunnarson A. Routine diagnostics of Lawsonia intracellularis performed 
by PCR, serological and post mortem examination, with special emphasis on sample 
preparation methods for PCR. Veterinary Microbiology. 102: 189-201. (2004). 
 
190. Jacobson M., Fellstrom C. & Jensen-Waern M. Porcine proliferative enteropathy: An 
important disease with questions remaining to be solved. Veterinary Journal 184:264-268. 
(2010). 
 
191. Jacoby R.O., Osbaldiston G.W. & Jonas A.M. Experimental transmission of atypical ileal 
hyperplasia of hamsters. Journal of the American Association for Laboratory Animal Science. 
25:465-473. (1975). 
 
192. Jacoby, R.O. Transmissible ileal hyperplasia of hamsters. I. Histogenesis and 
immunocytochemistry. American Journal of Pathology. 91: 433-450. (1978). 
261 
 
193. Jasni S., McOrist S. & Lawson G.H. Reproduction of proliferative enteritis in hamsters 
with a pure culture of porcine ileal symbiont intracellularis. Veterinary Microbiology. 41: 1-9. 
(1994) (a). 
 
194. Jasni S, McOrist S. & Lawson G.H.K. Experimentally induced proliferative enteritis in 
hamsters: an ultrastructural study. Research in Veterinary Science. 56:186-192. (1994) (b). 
 
195. Jassal M.S., Nedeltchev G.G., Osborne J. & Bishai W.R. A modified scoring system to 
describe gross pathology in the rabbit model of tuberculosis. BMC Microbiology. 11: 49. 
(2011). 
 
196. Jeffrey G.P., Basclain K., Allen T.L. Molecular regulation of transferrin receptor and 
ferritin expression in the rat gastrointestinal tract. Gastroenterology 110:790-800. (1996). 
 
197. Jenner, E. An inquiry into the causes and effects of the variole vaccine, or cow-pox. 
London Sow. (1798). 
 
198. Jensen T.K., Møller K., Leser T.D. & Jorsal S.E. Comparison of histology, 
immunohistochemistry and polymerase chain reaction for detection of Lawsonia intracellularis 
in natural porcine proliferative enteropathy.  European Journal of Veterinary Pathology 3:115-
118, 121-123. (1997). 
 
199. Jensen T.K., Boesen H.T., Vigre H., Boye M. Detection of Lawsonia intracellularis in 
formalin-fixed porcine intestinal tissue samples: comparison of immunofluorescence and in-
situ hybridization, and evaluation of the effects of controlled autolysis. Journal of Comparative 
Pathology. 142: 1-8. (2010). 
 
200. Johnson E.A. & Jacoby R.O. Transmissible ileal hyperplasia of hamsters. II. 
Ultrastructure. American Journal of Pathology. 91: 451-468. (1978). 
 
201. Johnson J.D., Hand W.L., Francis J.B., King-Thompson N. & Corwin R.W. Antibiotic 
uptake by alveolar macrophages. Journal of Laboratory and Clinical Medicine 95:429-439. 
(1980). 
 
202. Johnson-Delaney C. Anatomy and physiology of the rabbit and rodent gastrointestinal 
system. Proceedings of the Association of Avian Veterinarians - 2006: 9-17. (2006). 
 
203. Jonas A.M., Tomita Y. & Wyand D.S. Enzootic intestinal adenocarcinoma in hamsters. 
Journal of the American Veterinary Medical Association.147: 1102-1108. (1965). 
 
204. Jones G.F., Ward G.E., Murtaugh M.P., Rose R. & Gebhart C.J. Relationship between 
Ileal symbiont intracellularis and porcine proliferative enteritis. Infection and Immunity. 61: 
5237–5244.(1993) (a). 
 
262 
 
205. Jones G.F., Ward G.E., Murtaugh M.P., Lin G. & Gebhart C.J. Enhanced detection of 
intracellular organism of swine proliferative enteritis, ileal symbiont intracellularis, in feces by 
polymerase chain reaction. Journal of Clinical Microbiology 31:2611-2615. (1993) (b). 
 
206. Jones G.F., Davies P.R., Rose R., Ward G.E. & Murtaugh M.P. Comparison of 
techniques for diagnosis of proliferative enteritis of swine. American Journal of Veterinary 
Research. 54:1980-1985. (1993) (c). 
 
207. Jordan D.M., Knittel J.P., Schwartz K.J., Roof M.B. & Hoffman L.J. A Lawsonia 
intracellularis transmission study using a pure culture inoculated seeder-pig sentinel model. 
Veterinary Microbiology. 104: 83-90. (2004). 
 
208. Katiyar S.K. & T.D. Edlind. Enhanced antiparasitic activity of lipophilic tetracyclines: 
role of uptake. Antimicrobial Agents and Chemotherapy. 35: 2198-2202. (1991). 
 
209. Keir S. & Page C. The rabbit as a model to study asthma and other lung diseases. 
Pulmonary Pharmacology & Therapeutics 21: 721-730. (2008). 
 
210. Kemper D.L., Perkins G.A., Schumacher J., Edwards J.F., Valentine B.A., Divers T.J. & 
Cohen N.D. Equine lymphocytic-plasmacytic enterocolitis: a retrospective study of 14 cases. 
Equine Veterinary Journal Supplement 32: 108-112. (2000). 
 
211. Kirkwood K., Martin T., Agnello K. & Kim Y.J. Differential regulation of MMP-13 by 
chemical modified tetracyclines in osteoblasts. Journal of the International Academy of 
Periodontology 6:39-46. (2004). 
 
212. Klauder J.V. Interrelations of human and veterinary medicine; discussion of some aspects 
of comparative dermatology. New England Journal of Medicine 258:170-177. (1958). 
 
213.  Klein E.C., Gebhart C.J. & Duhamel G.E. Fatal outbreaks of proliferative enteritis 
caused by Lawsonia intracellularis in young colony-raised rhesus macaques. Journal of 
Medical Primatology 28:11-18.(1999). 
 
214. Knickelbein R., Aronson P.S., Atherton W. & Dobbins J.W. Sodium and chloride 
transport across rabbit ileal brush border. I. Evidence for Na-H exchange. American Journal of 
Physiology. 245: G504-510. (1983). 
 
215. Knight A., Bailey J. & Balcombe J. Animal carcinogenicity studies: 1. Poor human 
predictivity. Alternatives to Laboratory Animals 34:19-27. (2006) (a). 
 
216. Knight A., Bailey J. & Balcombe J. Animal carcinogenicity studies: 2. Obstacles to 
extrapolation of data to humans. Alternatives to Laboratory Animals 34:29-38. (2006) (b). 
 
217. Knittel J.P., Jordan D.M., Schwartz K.J., Janke B.H., Roof M.B., McOrist S. & Harris 
D.L. Evaluation of antemortem polymerase chain reaction and serologic methods for detection 
263 
 
of Lawsonia intracellularis-exposed pigs. American Journal of Veterinary Research. 59: 722-
726. (1998). 
 
218. Knudtzon J. Plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits 
during laboratory handling procedures. Zeitschrift für Versuchstierkunde. 26: 123-133. (1984). 
 
219. Koch R. An Address on Bacteriological Research. British Medical Journal 2:380-383. 
(1890). 
 
220. Kohno E., Murase S., Nishikata M., Okamura N., Matzno S., Kuwahara T. & Matsuyama 
K. Methods of preventing vinorelbine-induced phlebits: an experimental study in rabbits. 
International Journal of Medical Science 5: 218-223. (2008). 
 
221. Kolachala V.L., Sesikeran B. & Nair K.M. Evidence for a sequential transfer of iron 
amongst ferritin, transferrin and transferrin receptor during duodenal absorption of iron in rat 
and human. World Journal of Gastroenterology 13:1042-1052. (2007). 
 
222. Krasniqi S., Matzneller P., Kinzig M., Sorgel F., Huttner S., Lackner E., Muller M. & 
Zeitlinger M. Blood, tissue, and intracellular concentrations of erythromycin and its metabolite 
anhydroerythromycin during and after therapy. Antimicrobial Agents and Chemotherapy 56: 
1059-1064. (2012). 
 
223. Kroll J.J., Roof M.B. & McOrist S. Evaluation of protective immunity in pigs following 
oral administration of an avirulent live vaccine of Lawsonia intracellularis. American Journal 
of Veterinary Research. 65: 559-565. (2004). 
 
224. Kroll J.J., Eichmeyer M.A., Schaeffer M.L., McOrist S., Harris D.L. & Roof M.B. 
Lipopolysaccharide-based enzyme-linked immunosorbent assay for experimental use in 
detection of antibodies to Lawsonia intracellularis in pigs. Clinical and Diagnostic Laboratory 
Immunology 12:693-699. (2005). 
 
225. Kutlin A., Roblin P.M. & Hammerschlag M.R. In vitro activities of azithromycin and 
ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Antimicrobial 
Agents and Chemotherapy 43:2268-2272. (1999). 
 
226. Kyriakis S.C., Bourtzi-Hatzopoulou E., Alexopoulos C., Kritas S.K., Polyzopoulou Z., 
Lekkas S. & Gardey L. Field evaluation of the effect of in-feed doxycycline for the control of 
ileitis in weaned piglets. Journal of veterinary medicine. B, Infectious diseases and veterinary 
public health. 49: 317-321. (2002). 
 
227. La Regina M., Fales W.H. & Wagner J.E. Effects of antibiotic treatment on the occurrance 
of experimentally induced proliferative ileitis of hamsters. Journal of the American Association 
for Laboratory Animal Science. 30: 38-41. (1980). 
 
264 
 
228. Ladinig A., Sommerfeld-Stur I. & Weissenbock H. Comparative evaluation of diagnostic 
methods for Lawsonia intracellularis infection in pigs, with emphasis on cases lacking 
characteristic lesions. Journal of Comparative Pathology. 140: 140-148. (2009). 
 
229. Landsverk T. Intestinal adenomatosis in a blue fox (Alopex lagopus). Veterinary 
Pathology 18: 275-278. (1981). 
 
230. Lavoie J.P. & Drolet R. Equine proliferative enteropathy: an emerging disease of foals." 
Equine Veterinary Education 8:183 - 185. (2009). 
 
231. Lavoie J.P., Drolet R., Parsons D., Leguillette R., Sauvageau R., Shapiro J., Houle L., 
Halle G. & Gebhart C.J. Equine proliferative enteropathy: a cause of weight loss, colic, 
diarrhoea and hypoproteinaemia in foals on three breeding farms in Canada. Equine Veterinary 
Journal 32: 418-425. (2000). 
 
232. Lawson G.H. & Rowland A.C. Intestinal adenomatosis in the pig: a bacteriological study. 
Research in Veterinary Science 17:331-336. (1974). 
 
233. Lawson G.H., Rowland A.C., Roberts L., Fraser G. & McCartney E. Proliferative 
haemorrhagic enteropathy. Research in Veterinary Science 27:46-51. (1979). 
 
234. Lawson G.H., Rowland A.C. & MacIntyre N. Demonstration of a new intracellular 
antigen in porcine intestinal adenomatosis and hamster proliferative ileitis. Veterinary 
Microbiology. 10: 303-313. (1985). 
 
235. Lawson G.H., McOrist S., Rowland A.C., McCartney E. & Roberts L. Serological 
diagnosis of the porcine proliferative enteropathies: implications for aetiology and 
epidemiology. Veterinary Records 122:554-557. (1988). 
 
236. Lawson G.H. & McOrist S. The enigma of the proliferative enteropathies: a review. 
Journal of Comparative Pathology.108: 41-46. (1993). 
 
237. Lawson G.H., McOrist S., Jasni S. & Mackie R.A. Intracellular bacteria of porcine 
proliferative enteropathy: cultivation and maintenance in vitro. Journal of Clinical 
Microbiology 31: 1136-1142. (1993). 
 
238. Lawson G.H.K., Mackie R.A., Smith D.G.E. & McOrist. S. Infection of cultured rat 
enterocytes by ileal symbiont intracellularis depends on host cell function and actin 
polymerisation. Veterinary Microbiology. 45: 339-350. (1995). 
 
239. Lemarchand T.X., Tully T.N. Jr., Shane S.M. & Duncan D.E. Intracellular 
Campylobacter-like organisms associated with rectal prolapse and proliferative enteroproctitis 
in emus (Dromaius novaehollandiae). Veterinary Pathology 34: 152-156. (1997). 
 
240. Lawson G.H. & Gebhart C.J. Proliferative enteropathy. Journal of Comparative 
Pathology. 122: 77-100. (2000). 
265 
 
 
241. Leutenegger C.M., Mislin C.N., Sigrist B., Ehrengruber M.U., Hofmann-Lehmann R. & 
Lutz H. Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet 
Immunology and Immunopathology 71: 291-305. (1999). 
 
242. Liedtke C.M. & Hopfer U. Mechanism of Cl- translocation across small intestinal brush-
border membrane. I. Absence of Na+-Cl- cotransport. American Journal of Physiology. 242: 
G263-271. (1982) (a). 
 
243. Liedtke C.M. & Hopfer U. Mechanism of Cl- translocation across small intestinal brush-
border membrane. II. Demonstration of Cl--OH- exchange and Cl- conductance. American 
Journal of Physiology. 242: G272-280. (1982) (b). 
 
244. Lindecrona R.H., Jensen T.K., Andersen P.H. & Moller K.  Application of a 5' nuclease 
assay for detection of Lawsonia intracellularis in fecal samples from pigs. Journal of Clinical 
Microbiology. 40: 984-987. (2002). 
 
245. Logan K.J., Ng P.K., Turner C.J., Schmidt P.R., Terner U.K., Scott J.R., Lentle B.C. & 
Noujaim A.A. Comparative pharmacokinetics of 67 Ga and 59 Fe in humans. International 
Journal of Nuclear Medicine and Biology 8: 271-276. (1981). 
 
246. Lumsden J. H., Rowe R. & Mullen K. Hematology and biochemistry reference values for 
the light horse. Canadian Journal of Comparative Medicine 44: 32-42. (1980). 
 
247. Lyons E.T. & Tolliver S.C. Field test data on small strongyles in evaluation of activity of 
fenbendazole given once a day for 5 consecutive days to thoroughbred yearlings on two farms 
in Kentucky in 2002 and 2003. Parasitology Research 91: 312-315. (2003). 
 
248. Lyons E.T., Tolliver S.C. & Collins S.S. Field studies on endoparasites of Thoroughbred 
foals on seven farms in central Kentucky in 2004. Parasitology Research 98: 496-500. (2006). 
 
249. Ma Y., Specian R.D., Yeh K.Y., Yeh M., Rodriguez-Paris J. & Glass J. The transcytosis 
of divalent metal transporter 1 and apo-transferrin during iron uptake in intestinal epithelium. 
American Journal of Physiology. Gastrointestinal and Liver Physiology 283: G965-974. 
(2002). 
 
250. Ma Y., Yeh M., Yeh K.Y. & Glass J. Iron Imports. V. Transport of iron through the 
intestinal epithelium. American Journal of Physiology. Gastrointestinal and Liver Physiology 
290: G417-422. (2006). 
 
251. Magdesian K.G., Hirsh D.C., Jang S.S., Hansen L.M. & Madigan J.E. Characterization of 
Clostridium difficile isolates from foals with diarrhea: 28 cases (1993-1997). Journal of the 
American Veterinary Medical Association. 220: 67-73. (2002). 
 
252. Magdesian K.G. Neonatal foal diarrhea. Veterinary Clinics of North America. Equine 
Practice 21: 295-312, vi. (2005). 
266 
 
 
253. Mair T.S., Hillyer M.H., Taylor F.G. & Pearson G.R. Small intestinal malabsorption in 
the horse: an assessment of the specificity of the oral glucose tolerance test. Equine Veterinary 
Journal 23: 344-346. (1991). 
 
254. Mandell G.L. & Coleman E. Uptake, transport, and delivery of antimicrobial agents by 
human polymorphonuclear neutrophils. Antimicrobial Agents and Chemotherapy 45:1794-
1798. (2001). 
 
255. Mapes S., Rhodes D.M., Wilson W.D., Leutenegger C.M. & Pusterla N. Comparison of 
five real-time PCR assays for detecting virulence genes in isolates of Escherichia coli from 
septicaemic neonatal foals. Veterinary Records 161: 716-718. (2007). 
 
256. Martens R.J., Mealey K., Cohen N.D., Harrington J.R., Chaffin M.K., Taylor R.J. & 
Bernstein L.R. Pharmacokinetics of gallium maltolate after intragastric administration in 
neonatal foals. American Journal of Veterinary Research. 68: 1041-1044. (2007) (a). 
 
257. Martens R.J., Miller N.A., Cohen N.D., Harrington J.R. & Bernstein L.R. 
Chemoprophylactic antimicrobial activity of gallium maltolate against intracellular 
Rhodococcus equi. Journal of Equine Veterinary Science 27: 341-345. (2007) (b). 
 
258. Martens R.J., Cohen N.D., Fajt V.R., Nerren J.R., Chaffin M.K., Taylor R.J. & Bernstein 
L.R. Gallium maltolate: safety in neonatal foals following multiple enteral administrations. 
Journal of Veterinary Pharmacology and Therapeutics. 33: 208-212. (2010). 
 
259. Masubuchi Y. Metabolic and non-metabolic factors determining troglitazone 
hepatotoxicity: a review. Drug Metabolism and Pharmacokinetics 21: 347-356. (2006). 
 
260. Mates S.M., Patel L., Kaback H.R. & Miller M.H. Membrane potential in anaerobically 
growing Staphylococcus aureus and its relationship to gentamicin uptake. Antimicrobial 
Agents and Chemotherapy 23: 526-530. (1983). 
 
261. McCartney E., Lawson G.H. & Rowland A.C. Behaviour of Campylobacter sputorum 
subspecies mucosalis in gnotobiotic pigs. Research in Veterinary Science 36:290-297. (1984). 
 
262. McClintock, S.A. & Collins A.M. Lawsonia intracellularis proliferative enteropathy in a 
weanling foal in Australia. Australian Veterinary Journal 82:750-752. (2004). 
 
263. McOrist S. & Gebhart C. Proliferative enteropathies. In: Straw B.E., D’Allaire S., 
Mengeling W.L., Taylor D.J. Eds: Diseases of swine, Ames,  Iowa State University Press. 
(1999). 
 
264. McOrist S. & Lawson G.H. Possible relationship of proliferative enteritis in pigs and 
hamsters. Veterinary Microbiology. 15: 293-302. (1987). 
 
267 
 
265. McOrist S., Boid R., Lawson G.H. & McConnell I. Monoclonal antibodies to 
intracellular Campylobacter-like organisms of the porcine proliferative enteropathies. 
Veterinary Records 121:421-422. (1987). 
 
266. McOrist S. & Lawson G.H. Reproduction of proliferative enteritis in gnotobiotic pigs. 
Research in Veterinary Science 46:27-33. (1989). 
 
267. McOrist S., Lawson G.H., Rowland A.C. & MacIntyre N. Early lesions of proliferative 
enteritis in pigs and hamsters. Veterinary Pathology 26: 260-264. (1989). 
 
268. McOrist S., Jasni S., Mackie R.A., MacIntyre N., Neef N. & Lawson G.H. Reproduction 
of porcine proliferative enteropathy with pure cultures of ileal symbiont intracellularis. 
Infection and Immunity.61: 4286-4292. (1993). 
 
269. McOrist S., Mackie R.A., Neef N., Aitken I. & Lawson G.H. Synergism of ileal symbiont 
intracellularis and gut bacteria in the reproduction of porcine proliferative enteropathy. 
Veterinary Records 134: 331-332. (1994) (a). 
 
270. McOrist S., Gebhart C.J. & Lawson G.H. Enterocyte proliferation and intracellular 
bacteria in animals. Gut 35: 1483-1486. (1994) (b). 
 
271. McOrist S., Gebhart C.J. & Lawson G.H. Polymerase chain reaction for diagnosis of 
porcine proliferative enteropathy. Veterinary Microbiology. 41: 205-212. (1994) (c). 
 
272. McOrist S., Gebhart C.J., Boid R. & Barns S.M. Characterization of Lawsonia 
intracellularis gen. nov., sp. nov., the obligately intracellular bacterium of porcine proliferative 
enteropathy. International Journal Systemic Bacteriology 45: 820-825. (1995) (a). 
 
273. McOrist S., Jasni S., Mackie R.A., Berschneider H.M., Rowland A.C. & Lawson G.H. 
Entry of the bacterium ileal symbiont intracellularis into cultured enterocytes and its 
subsequent release. Research in Veterinary Science 59: 255-260. (1995) (b). 
 
274. McOrist S., Mackie R.A. & Lawson G.H. Antimicrobial susceptibility of ileal symbiont 
intracellularis isolated from pigs with proliferative enteropathy. Journal of Clinical 
Microbiology 33:1314-1317. (1995) (c). 
 
275. McOrist S., Gebhart C.J. & Bosworth B.T. Evaluation of porcine ileum models of 
enterocyte infection by Lawsonia intracellularis. Canadian Journal of Veterinary Research 70: 
155-159. (2006). 
 
276. McOrist S. & Smits R.J. Field evaluation of an oral attenuated Lawsonia intracellularis 
vaccine for porcine proliferative enteropathy (ileitis). Veterinary Records 161;26-28. (2007). 
 
277. Merlo J.L., Sheats M.K., Elce Y., Hunter S., Breuhaus B.A. Outbreak of Lawsonia 
intracellularis on a Standarbred breeding farm in North Carolina. Equine Veterinary Education 
8: 179 -182. (2009). 
268 
 
 
278. Metzger N., Hinchcliff K.W., Hardy J., Schwarzwald C.C. & Wittum T. Usefulness of a 
commercial equine IgG test and serum protein concentration as indicators of failure of transfer 
of passive immunity in hospitalized foals. Journal of Veterinary Internal Medicine 20:382-387. 
(2006). 
 
279. Michalski C.W., Di Mola F.F., Kummel K., Wendt M., Koninger J.S., Giese T., Giese 
N.A. & Friess H. Human inflammatory bowel disease does not associate with Lawsonia 
intracellularis infection. BMC Microbiology 6: 81. (2006). 
 
280. Michelet C., Avril J.L., Arvieux C., Jacquelinet C., Vu N. & Cartier F. Comparative 
activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-
sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenes. Antimicrobial 
Agents and Chemotherapy 41:60-65. (1997). 
 
281. Michelet C., Avril J.L., Cartier F. & Berche P. Inhibition of intracellular growth of 
Listeria monocytogenes by antibiotics. Antimicrobial Agents and Chemotherapy 38:438-446. 
(1994). 
 
282. Mitchell, B.F. & Taggart M.J. Are animal models relevant to key aspects of human 
parturition? American Journal of Physiology: Regulatory, Integrative and Comparative 
Physiology. 297: R525-545. (2009). 
 
283. Molbak L., Johnsen K., Boye M., Jensen T.K., Johansen M., Moller K. & Leser T.D. The 
microbiota of pigs influenced by diet texture and severity of Lawsonia intracellularis infection. 
Veterinary Microbiology.128: 96-107. (2008). 
 
284. Montenez J.P., Van Bambeke F., Piret J., Brasseur R., Tulkens P.M. & Mingeot-Leclercq 
M.P. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, 
erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided 
conformational analysis and studies on acellular and cell culture models. Toxicology and 
Applied Pharmacology 156:129-140. (1999). 
 
285. Moon H.W., Cutlip R.C., Amtower W.C. & Matthews P.J. Intraepithelial vibrio 
associated with acute typhlitis of young rabbits. Veterinary Pathology 11: 313-326. (1974). 
 
286. Moon J.E., Ellis M.W., Griffith M.E., Hawley J.S., Rivard R.G., McCall S., Hospenthal 
D.R. & Murray C.K. Efficacy of macrolides and telithromycin against leptospirosis in a 
hamster model. Antimicrobial Agents and Chemotherapy 50:1989-1992. (2006). 
 
287. Morand J.P., Macri J. & Adeli K. Proteomic profiling of hepatic endoplasmic reticulum-
associated proteins in an animal model of insulin resistance and metabolic dyslipidemia. 
Journal of Biological Chemistry 280: 17626-17633. (2005). 
 
288. Morris D.D., Whitlock R.H. & Palmer J.E. Fecal leukocytes and epithelial cells in horses 
with diarrhea. Cornell Vet 73: 265-274. (1983). 
269 
 
 
289. Morton D.B., Jennings M., Buckwell A., Ewbank R., Godfrey C., Holgate B., Inglis I., 
James R., Page C., Sharman I., Verschoyle R., Westfall L. & Wilson A.B. Refining procedures 
for the administration of substances. Report of the BVAAWF/FRAME/RSPCA/UFAW joint 
working group on refinement. Laboratory Animals 45: 1-41. (2001). 
 
290. Moulder J.W. Comparative biology of intracellular parasitism. Microbiology Reviews 49: 
298-337. (1985). 
 
291. Mullaney T.P. & Brown C.M. Iron toxicity in neonatal foals. Equine Veterinary Journal 
20: 119-124. (1988). 
 
292. Murakata K., Sato A., Yoshiya M., Kim S., Watarai M., Omata Y. & Furuoka H. 
Infection of different strains of mice with Lawsonia intracellularis derived from rabbit or 
porcine proliferative enteropathy. Journal of Comparative Pathology. 139: 8-15. (2008). 
 
293. Murphy D., Reid S.W. & Love S. Modified oral glucose tolerance test as an indicator of 
small intestinal pathology in horses. Veterinary Records 140:342-343. (1997). 
 
294. Naigamwalla D., Webb J. & Giger U. Iron deficiency anemia. Canadian Veterinary 
Journal 53:250-257. (2012). 
 
295. Najar I., Oberti J., Teyssier J. & Caravano R. Kinetics of the uptake of rifampicin and 
tetracycline into mouse macrophages. In vitro study of the early stages. Pathologie Biologie 
(Paris) 32:85-89. (1984). 
 
296. Nalca A. & Nichols D.K. Rabbitpox: a model of airborne transmission of smallpox. 
Journal of General Virology 92: 31-35. (2011). 
 
297. Nambiar P.R., Kirchain S.M., Courmier K., Xu S., Taylor N.S., Theve E.J., Patterson 
M.M. & Fox J.G. Progressive proliferative and dysplastic typhlocolitis in aging syrian 
hamsters naturally infected with Helicobacter spp.: a spontaneous model of inflammatory 
bowel disease. Veterinary Pathology 43: 2-14. (2006). 
 
298. Nathues H & Beilage E. Diagnosis of Lawsonia intracellularis infection in pigs after 
vaccination or antimicrobial treatment. Deutsche Tierarztliche Wochenschrift 115: 404-409. 
(2008). 
 
299. Nathues H, Holthaus K & Beilage E. Quantification of Lawsonia intracellularis in 
porcine faeces by real-time PCR. Journal of Applied Microbiology 107: 2009-2016. (2009). 
 
300. Nessa K., Gross N.T., Jarstrand C., Johansson A. & Camner P. In vivo interaction 
between alveolar macrophages and Cryptococcus neoformans. Mycopathologia. 139: 1-7. 
(1997). 
 
270 
 
301. Nix D.E., Goodwin S.D., Peloquin C.A., Rotella D.L. & Schentag J.J. Antibiotic tissue 
penetration and its relevance: models of tissue penetration and their meaning. Antimicrobial 
Agents and Chemotherapy. 35: 1947-1952. (1991). 
 
302. Norris S.J. & Edmondson D.G. In vitro culture system to determine MICs and MBCs of 
antimicrobial agents against Treponema pallidum subsp. pallidum (Nichols strain). 
Antimicrobial Agents and Chemotherapy. 32: 68-74. (1988). 
 
303. Olakanmi O., Britigan B.E. & Schlesinger L.S. Gallium disrupts iron metabolism of 
mycobacteria residing within human macrophages. Infection and Immunity. 68:5619-5627. 
(2000). 
 
304. Olson H., Betton G., Robinson D., Thomas K., Monro A., Kolaja G., Lilly P., Sanders J., 
Sipes G., Bracken W., Dorato M., Van Deun K., Smith P., Berger B. & Heller A. Concordance 
of the toxicity of pharmaceuticals in humans and in animals. Regulatory Toxicology and 
Pharmacology 32:56-67. (2000). 
 
 
305. Page A.E., Slovis N.M., Gebhart C.J., Wolfsdorf  K., Mapes S.M. & Pusterla N. Serial 
use of serologic assays and fecal PCR assays to aid in identification of subclinical Lawsonia 
intracellularis infection for targeted treatment of Thoroughbred foals and weanlings. Journal 
of the American Veterinary Medical Association. 238:1482-1489. (2011) (a). 
 
306. Page A.E., Stills H.F., Chander Y., Gebhart C.J. & Horohov D.W. Adaptation and 
validation of a bacteria-specific enzyme-linked immunosorbent assay for determination of 
farm-specific Lawsonia intracellularis seroprevalence in central Kentucky Thoroughbreds. 
Equine Veterinary Journal 43 (Supplement 40) :25-31. (2011) (b). 
 
307. Page A.E., Loynachan A.T., Bryant U., Stills H.F. Jr., Adams A.A., Gebhart C.J., 
Pusterla N. & Horohov D.W. Characterization of the interferon gamma response to Lawsonia 
intracellularis using an equine proliferative enteropathy challenge (EPE) model. Veterinary 
Immunology and Immunopathology 143:55-65. (2011) (c). 
 
308. Page A.E., Fallon L.H., Bryant U.K., Horohov D.W., Luna T.W., Marsh P.S., Slovis 
N.M., Sprayberry K.A. & Loynachan A.T. Acute deterioration and death with necrotizing 
enteritis associated with Lawsonia intracellularis in 4 weanling horses. Journal of Veterinary 
Internal Medicine 26:1476-1480.(2012). 
 
309. Paillard D., Grellet J., Dubois V., Saux M.C. & Quentin C. Discrepancy between uptake 
and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic 
cell model. Antimicrobial Agents and Chemotherapy 46:288-293. (2002). 
 
310. Pakandl M., Hlaskova L., Poplstein M., Chroma V., Vodicka T., Salat J. & Mucksova J. 
Dependence of the immune response to coccidiosis on the age of rabbit suckling. Parasitology  
Research 103: 1265-1271. (2008). 
 
271 
 
311. Palmer J.E., Whitlock R.H., Benson C.E., Becht J.L., Morris D.D. & Acland H.M. 
Comparison of rectal mucosal cultures and fecal cultures in detecting Salmonella infection in 
horses and cattle. American Journal of Veterinary Research. 46: 697-698. (1985). 
 
312. Pascual A., Tsukayama D., Kovarik J., Gekker G. & Peterson P. Uptake and activity of 
rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes. European 
Journal of Clinical Microbiology 6:152-157. (1987). 
 
313. Paul-Murphy J. Critical care of the rabbit. Veterinary Clinics of North America. Exotic 
Animals Practice 10: 437-461. (2007). 
 
314. Payne S. & Mey A.R. Chapter 14: Pathogenic Escherichia coli, Shigella, and Salmonella. 
In: Iron transport in bacteria. Ed. Crosa, J.H., Mey, A.R., Payne S.M.: 199 - 218. (2004). 
 
315. Pedersen K.S., Holyoake P., Stege H. & Nielsen J.P. Diagnostic performance of different 
fecal Lawsonia intracellularis-specific polymerase chain reaction assays as diagnostic tests for 
proliferative enteropathy in pigs: a review. Journal of Veterinary Diagnostic Investigation. 22: 
487-494. (2010). 
 
316. Perfect J.R., Lang S.D. & Durack D.T. Chronic cryptococcal meningitis: a new 
experimental model in rabbits. American Journal of Pathology 101: 177-194. (1980). 
 
317. Perletti G., Skerk V., Magri V., Markotic A., Mazzoli S., Parnham M.J., Wagenlehner 
F.M. & Naber K.G. Macrolides for the treatment of chronic bacterial prostatitis: an effective 
application of their unique pharmacokinetic and pharmacodynamic profile (Review). 
Molecular Medicine Reports 4:1035-1044. (2011). 
 
318. Pickard D.W. & Stevens C.E. Digesta flow through the rabbit large intestine. American 
Journal of Physiology. 222(5): 1161-1166. (1972). 
 
319. Pierce J.R. Walter Reed - 1851-1902. In: Builders of Trust: Biographical profiles from 
the Medical Corps Coin. Sanders Marble  Ed. Borden Institute, Fort Detrick, MD.: 71-85. 
(2011). 
 
320. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. 
Gastroenterology 139: 393-408, 408 e391-392. (2010). 
 
321. Pollina G.F., Zagotto G., Maritan P., Iacopetti I. & Busetto R. Pharmacokinetics of 
gallium nitrate after oral administration in adult horses--pilot study. Journal of Veterinary 
Pharmacology and Therapeutics 35: 489-494. (2012). 
 
322. Powell D.G., Dwyer R.M., Traub-Dargatz J.L., Fulker R.H., Whalen J.W. Jr., J. 
Srinivasappa J., Acree W.M. & Chu H.J. Field study of the safety, immunogenicity, and 
efficacy of an inactivated equine rotavirus vaccine. Journal of the American Veterinary 
Medical Association. 211: 193-198. (1997). 
 
272 
 
323. Prokesch R.C. & Hand W.L. Antibiotic entry into human polymorphonuclear leukocytes. 
Antimicrobial Agents and Chemotherapy 21:373-380. (1982). 
 
324. Pusterla N., Higgins J.C., Smith P., Mapes S. & Gebhart C. Epidemiological survey on 
farms with documented occurrence of equine proliferative enteropathy due to Lawsonia 
intracellularis. Veterinary Records 163:156-158 (2008) (a). 
 
325. Pusterla N., Mapes S., Rejmanek D. & Gebhart C. Detection of Lawsonia intracellularis 
by real-time PCR in the feces of free-living animals from equine farms with documented 
occurrence of equine proliferative enteropathy. Journal of Wildlife Diseases. 44: 992-998. 
(2008) (b). 
 
326. Pusterla N. & Gebhart C. Equine proliferative enteropathy caused by Lawsonia 
intracellularis. Equine Veterinary Education 8:415 - 418. (2009). 
 
327. Pusterla N., Jackson R., Wilson R., Collier J., Mapes S. & Gebhart C. Temporal detection 
of Lawsonia intracellularis using serology and real-time PCR in Thoroughbred horses residing 
on a farm endemic for equine proliferative enteropathy. Veterinary Microbiology.136: 173-
176. (2009) (a). 
 
328. Pusterla N., Hilton H., Wattanaphansak S., Collier J.R., Mapes S.M., Stenbom R.M. & 
Gebhart C. Evaluation of the humoral immune response and fecal shedding in weanling foals 
following oral and intra-rectal administration of an avirulent live vaccine of Lawsonia 
intracellularis. Veterinary Journal 182: 458-462. (2009) (b). 
 
329. Pusterla N., Collier J., Mapes S.M., Wattanaphasak S. & Gebhart C. Effects of 
administration of an avirulent live vaccine of Lawsonia intracellularis on mares and foals. 
Veterinary Records 164:783-785. (2009). 
 
330. Pusterla N., Wattanaphansak S., Mapes S., Collier J., Hill J., DiFrancesco M., & Gebhart 
C. Oral infection of weanling foals with an equine isolate of Lawsonia intracellularis, agent of 
equine proliferative enteropathy. Journal of Veterinary Internal Medicine 24:622-627. (2010) 
(a). 
 
331. Pusterla N., Jackson R., Mapes S.M., Noland J., Stenbom R.M. & Gebhart C. Lawsonia 
intracellularis: humoral immune response and fecal shedding in weanling foals following 
intra-rectal administration of frozen-thawed or lyophilized avirulent live vaccine. Veterinary 
Journal 186:110-112. (2010) (b). 
 
332. Pusterla N., Mapes S., Johnson C., Slovis N., Page A. & Gebhart C. Comparison of feces 
versus rectal swabs for the molecular detection of Lawsonia intracellularis in foals with equine 
proliferative enteropathy. Journal of Veterinary Diagnostic Investigation. 22: 741-744. (2010) 
(c). 
 
273 
 
333. Pusterla N., Mapes S. & Gebhart C. Further investigation of exposure to Lawsonia 
intracellularis in wild and feral animals captured on horse properties with equine proliferative 
enteropathy. Veterinary Journal 194:253-255.(2012) (a). 
 
334. Pusterla N., Vannucci F.A., Mapes S.M., Nogradi N., Collier J.R., Hill J.A., DiFrancesco 
M., White A.M., Akana N.K., Simonek G. & Gebhart C.J. Efficacy of an avirulent live vaccine 
against Lawsonia intracellularis in the prevention of proliferative enteropathy in 
experimentally infected weanling foals. American Journal of Veterinary Research.73:741-746. 
(2012) (b). 
 
335. Pusterla N., Sanchez-Migallon Guzman D., Vannucci F.A., Mapes S., White A., 
DiFrancesco M. & Gebhart C. Transmission of Lawsonia intracellularis to weanling foals 
using feces from experimentally infected rabbits. Veterinary Journal 195:241-243. (2012) (c). 
336. Pusterla N, Mapes S & Gebhart C. Lawsonia intracellularis-specific interferon gamma 
gene expression by peripheral blood mononuclear cells in vaccinated and naturally infected 
foals. Veterinary Journal 192:249-251. (2012) (d). 
 
337. Pusterla N., Mapes S., Wademan C., White A., Ball R., Sapp K., Burns P., Ormond C., 
Butterworth K., Bartol J. & Magdesian G. Emerging outbreaks associated with equine 
coronavirus in adult horses. Veterinary Microbiology. 162: 228-231 (2013). 
 
338. Ramirez-Iglesias J.R., Eleizalde M.C., Gomez-Pineres E. & Mendoza M. Trypanosoma 
evansi: a comparative study of four diagnostic techniques for trypanosomosis using rabbit as an 
experimental model. Experimental Parasitology 128: 91-96. (2011). 
 
339. Raymond K. & Dertz E. Chapter 1: Biochemical and physical properties of siderophores. 
In: Iron transport in bacteria. Eds. Crosa J.H., Mey A.R., Payne S.M.: 3-17. (2004). 
 
340. Reigstad C.S., Hultgren S.J., Gordon J.I. Functional genomic studies of uropathogenic 
Escherichia coli and host urothelial cells when intracellular bacterial communities are 
assembled. Journal Biological Chemistry: 282(21259-21267). (2007). 
 
341. Renard C., Vanderhaeghe H.J., Claes P.J., Zenebergh A. & Tulkens P.M. Influence of 
conversion of penicillin G into a basic derivative on its accumulation and subcellular 
localization in cultured macrophages. Antimicrobial Agents and Chemotherapy 31: 410-416. 
(1987). 
 
342. Reuter D. & Schneider-Schaulies J. Measles virus infection of the CNS: human disease, 
animal models, and approaches to therapy. Medical Microbiology and Immunology 199:261-
271. (2010). 
 
343. Rice A.D., Adams M.M., Lampert B., Foster S., Lanier R., Robertson A., Painter G. & 
Moyer R.W. Efficacy of CMX001 as a prophylactic and presymptomatic antiviral agent in 
New Zealand white rabbits infected with Rabbitpox virus, a model for Orthopoxvirus 
infections of humans. Viruses 3: 63-82. (2011). 
 
274 
 
344. Richter B., Ladinig A., Nedorost N. & Weissenböch H. A TaqMan quantitative 
polymerase chain reaction assay for the detection of Lawsonia intracellularis in fecal and 
tissue samples from pigs. Journal of Veterinary Diagnostic Investigation. 22: 70-73. (2010). 
 
345. Riviere J.E. Ed. Chapter 12: Dosage Regimens. In: Comparative pharmacokinetics –
Principles Techniques and Applications 2
nd
 Edition Wiley Blackwell, Ames, IA, USA :241-255. 
(2011). 
346. Roberts L., Rowland A.C. & Lawson G.H. Experimental reproduction of porcine 
intestinal adenomatosis and necrotic enteritis. Veterinary Records 100:12-13. (1977). 
 
347. Roberts M.C. & Hill F.W. The oral glucose tolerance test in the horse. Equine Veterinary 
Journal 5: 171-173. (1973). 
 
348. Roberts M.C. The D(+) xylose absorption test in the horse. Equine Veterinary Journal 6: 
28-30. (1974). 
 
349. Roberts, M.C. Carbohydrate digestion and absorption studies in the horse. Research in 
Veterinary Science 18:64-69. (1975).  
 
350. Roberts M.C. & P. Norman P. A re-evaluation of the D (+) xylose absorption test in the 
horse. Equine Veterinary Journal 11: 239-243. (1979). 
 
351. Roberts M.C. Chapter 13.4 Malabsorption syndromes and maldigestion: 
pathophysiology, assessment, management and outcome. In:Reed S.M., Bayly W.M, Sellon 
D.C. Eds. Equine Internal Medicine. 2nd Ed., St Louis, MO. Elsevier: 796 - 801. (2004). 
 
352. Rooney D. Ch. 5: Applied Nutrition. In: Reed S.M., Bayly W.M., Sellon D.C. Eds. Equine 
Internal Medicine 2nd Ed. St Louis, MO. Elsevier: 235-272. (2004). 
 
353. Rosenthal N. & Brown S. The mouse ascending: perspectives for human-disease models. 
Nature Cell Biology 9: 993-999. (2007). 
 
354. Rowland A.C., Lawson G.H. & Maxwell A. Intestinal adenomatosis in the pig: 
occurrence of a bacterium in affected cells. Nature 243: 417. (1973). 
 
355. Rowland, A.C. & Lawson G.H. Intestinal adenomatosis in the pig: immunofluorescent 
and electron microscopic studies. Research in Veterinary Science 17: 323-330. (1974). 
 
356. Rowland A.C. & Lawson G.H. Intestinal adenomatosis in the pig: a possible relationship 
with a haemorrhagic enteropathy. Research in Veterinary Science 18: 263-268. (1975). 
 
357. Rowland A.C. Porcine intestinal adenomatosis: a possible relationship with necrotic 
enteritis, regional ileitis and proliferative haemorrhagic enteropathy. Veterinary Records. 
97:178-181. (1975). 
 
275 
 
358. Rowland, A.C. & Hutchings D.A. Necrotic enteritis and regional ileitis in pigs at 
slaughter. Veterinary Records. 103:338-339. (1978). 
 
359. Rudnev A.V., Foteeva L.S., Kowol C., Berger R., Jakupec M.A., Arion V.B., Timerbaev 
A.R. & Keppler B.K. Preclinical characterization of anticancer gallium(III) complexes: 
solubility, stability, lipophilicity and binding to serum proteins. Journal of Inorganic 
Biochemistry 100: 1819-1826. (2006). 
 
360. Ruhr L.P., Nicholson S.S., Confer A.W. & Blakewood B.W. Acute intoxication from a 
hematinic in calves. Journal of the American Veterinary Medical Association. 182: 616-618. 
(1983). 
 
361. Runner M.N. Comparative pharmacology in relation to teratogenesis. Fed Proc 26:1131-
1136. (1967). 
 
362. Sagar J., Sales K., Seifalian A. & Winslet M. Doxycycline in mitochondrial mediated 
pathway of apoptosis: a systematic review. Anticancer Agents in Medicinal Chemistry 10:556-
563. (2010). 
 
363. Sampieri F., Hinchcliff K.W. & Toribio R.E. Tetracycline therapy of Lawsonia 
intracellularis enteropathy in foals. Equine Veterinary Journal 38: 89-92. (2006). 
 
364. Sandberg A., Hessler J.H., Skov R.L., Blom J.& Frimodt-Moller N. Intracellular activity 
of antibiotics against Staphylococcus aureus in a mouse peritonitis model. Antimicrobial 
Agents and Chemotherapy 53:1874-1883. (2009). 
 
365. Schnappinger D. & Hillen W. Tetracyclines: antibiotic action, uptake, and resistance 
mechanisms. Arch Microbiol 165: 359-369. (1996). 
 
366. Schoeb T.R. & Fox J.G. Enterocecocolitis associated with intraepithelial Campylobacter-
like bacteria in rabbits (Oryctolagus cuniculus). Veterinary Pathology 27: 73-80. (1990). 
 
367. Schoevers E.J., van Leengoed L.A., Verheijden J.H. & Niewold T.A. Effects of 
enrofloxacin on porcine phagocytic function. Antimicrobial Agents and Chemotherapy 43: 
2138-2143. (1999). 
 
368. Schofield P.N., Bard J.B., Booth C., Boniver J., Covelli V., Delvenne P., Ellender M., 
Engstrom W., Goessner W., Gruenberger M., Hoefler H., Hopewell J., Mancuso M., Mothersill 
C., Potten C.S., Quintanilla-Fend L., Rozell B., Sariola H., Sundberg J.P. & Ward  A. 
Pathbase: a database of mutant mouse pathology. Nucleic Acids Research 32: D512-515. 
(2004). 
 
369. Schulz S., Steinhart H. & Mutters R. Chronic osteomyelitis in a new rabbit model. 
Journal of Investigative Surgery 14: 121-131. (2001). 
 
276 
 
370. Schumacher J., Schumacher J., Rolsma M., Brock K.V. & Gebhart C.J. Surgical and 
medical treatment of an Arabian filly with proliferative enteropathy caused by Lawsonia 
intracellularis. Journal of Veterinary Internal Medicine 14:630-632. (2000). 
 
371. Schumann K., Brennan K., Weiss M., Pantopoulos K. & Hentze M.W. Rat duodenal 
IRP1 activity and iron absorption in iron deficiency and after HO perfusion. European Journal 
of Clinical Investigation 34:275-282. (2004). 
 
372. Seral C., Carryn S., Tulkens P.M. & Van Bambeke F. Influence of P-glycoprotein and 
MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in 
macrophages infected by Listeria monocytogenes or Staphylococcus aureus. Journal of 
Antimicrobial Chemotherapy 51: 1167-1173. (2003) (a). 
 
373. Seral C., Michot J.M., Chanteux H., Mingeot-Leclercq M.P., Tulkens P.M. & Van 
Bambeke F. Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 
murine macrophages. Antimicrobial Agents and Chemotherapy 47: 1047-1051. (2003) (b). 
 
374. Shandil R.K., Jayaram R., Kaur P., Gaonkar S., Suresh B.L., Mahesh B.N., Jayashree R., 
Nandi V., Bharath S. & Balasubramanian V. Moxifloxacin, ofloxacin, sparfloxacin, and 
ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and 
pharmacodynamic indices that best predict in vivo efficacy. Antimicrobial Agents and 
Chemotherapy 51: 576-582. (2007). 
 
375. Shanks N., Greek R. & Greek J. Are animal models predictive for humans? Philosopy, 
Ethics and Humanities in Medicine 4:2. (2009). 
 
376. Shimizu C., Shibahara T., Takai S., Kasuya K., Chikuba T., Murakoshi N., Kobayashi H. 
& Kubo M. Lawsonia intracellularis and virulent Rhodococcus equi infection in a 
thoroughbred colt. Journal of Comparative Pathology.143:303-8. (2010). 
 
377. Shirazi-Beechey S.P. Molecular biology of intestinal glucose transport. Nutrition 
Research Reviews 8: 27-41. (1995). 
 
378. Sigler A., Schubert P., Hillen W. & Niederweis M. Permeation of tetracyclines through 
membranes of liposomes and Escherichia coli. European Journal of Biochemistry 267:527-
534. (2000). 
 
379. Smith D.G. Identification of equine proliferative enteropathy. Equine Veterinary Journal 
30: 452-453. (1998). 
 
380. Smith D.G. & Lawson G.H. Lawsonia intracellularis: getting inside the pathogenesis of 
proliferative enteropathy. Veterinary Microbiology. 82: 331-345. (2001). 
 
381. Smith S.H. & McOrist S. Development of persistent intestinal infection and excretion of 
Lawsonia intracellularis by piglets. Research in Veterinary Science 62: 6-10. (1997). 
 
277 
 
382. Somani J., Bhullar V.B., Workowski K.A., Farshy C.E. & Black C.M. Multiple drug-
resistant Chlamydia trachomatis associated with clinical treatment failure. Journal of 
Infectious Diseaes 181: 1421-1427. (2000). 
 
383. Somers G.F. Relative oral toxicity of some therapeutic iron preparations. British Medical 
Journal 2: 201-203. (1947).  
 
384. Spaulding A.R., Lin Y.C., Merriman J.A., Brosnahan A.J., Peterson M.L. & Schlievert 
P.M. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious 
illnesses. Vaccine 30:5099-5109. (2012). 
 
385. Stanford M.M., Werden S.J. & McFadden G. Myxoma virus in the European rabbit: 
interactions between the virus and its susceptible host. Veterinary Research 38: 299-318. 
(2007). 
 
386. Staples R.E. & Holtkamp D.E. Effects of parental thalidomide treatment on gestation and 
fetal development. Experimental Molecular Pathology Supplement 2: 81-106. (1963). 
 
387. Starzynski R.R., Gralak M.A., Smuda E. & Lipinski P. A characterization of the activities 
of iron regulatory protein 1 in various farm animal species. Cellular and Molecular Biology 
Letters. 9(4A): 651-664. (2004). 
 
388. Sternberg G. A Textbook of Bacteriology. New York: William Wood and Company. 278-
279. (1901). 
 
389. Stills H.F. Jr, Hook R.R. Jr. & Sprouse R.F. Utilization of monoclonal antibodies to 
evaluate the involvement of Campylobacter jejuni in proliferative ileitis in Syrian hamsters 
(Mesocricetus auratus). Infection and Immunity. 55: 2240-2246. (1987). 
 
390. Stills H.F. Jr. & Hook R.R. Jr. Experimental production of proliferative ileitis in Syrian 
hamsters (Mesocricetus auratus) by using an ileal homogenate free of Campylobacter jejuni. 
Infection and Immunity. 57: 191-195. (1989). 
 
391. Stills H.F. Jr. Isolation of an intracellular bacterium from hamsters (Mesocricetus 
auratus) with proliferative ileitis and reproduction of the disease with a pure culture. Infection 
and Immunity. 59: 3227-3236. (1991). 
 
392. Stills H.F., Fox J.G., Paster B.J. & Dewhirst F.E. A new Chlamydia spp strain SFPD 
isolated from transmissible proliferative ileitis in hamsters. Microbial Ecology in Health 
Disease: Special issue, Campylobacter VI: 599. (1991). 
 
393. Stockholm SL & Scott. M.A. Eds. Fundamentals of Veterinary Clinical Pathology. 2nd 
ed. Ames, Iowa: Blackwell Publishing: 105-150. (2002). 
 
394. Suchow M. & Douglas F. Exprimental methodology. The laboratory rabbit - CRC Press, 
Boca Raton, FL, Chapter 5:71-105. (1997). 
278 
 
 
395. Sundberg J.P., Ward J.M. & Schofield P. Where's the mouse info? Veterinary Pathology 
46: 1241-1244. (2009). 
 
396. Sundberg, J. P. & Schofield P.N. One medicine, one pathology, and the one health 
concept. Journal of American Veterinary Medical Association 234:1530-1531. (2009). 
 
397. Sweeney R.W. Laboratory evaluation of malassimilation in horses. Veterinary Clinics of 
North America. Equine Practice 3:507-514. (1987). 
 
398. Thompson K., Molina R.M., Donaghey T., Brain J.D. & Wessling-Resnick M. Iron 
absorption by Belgrade rat pups during lactation. American Journal of Physiology. 
Gastrointestinal Liver Physiology 293: G640-644. (2007). 
 
399. Tipper D.J. & Strominger J.L. Mechanism of action of penicillins: a proposal based on 
their structural similarity to acyl-D-alanyl-D-alanine. Proceedings of the National Academy of 
Sciences of the United States 54: 1133-1141. (1965). 
 
400. Togami K., Chono S. & Morimoto K.  Distribution characteristics of clarithromycin and 
azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in 
lung epithelial lining fluid and alveolar macrophages. Biopharmaceutics & Drug Disposition. 
32: 389-397. (2011). 
 
401. Tomanova K., Literak I., Klimes J., Pavlacik L., Mrlik V. & Smola J. Lawsonia 
intracellularis in wild mammals in the Slovak Carpathians. Journal Wildlife Diseases. 39: 407-
411. (2003). 
 
402. Topol E.J. Failing the public health--rofecoxib, Merck, and the FDA. New England 
Journal of Medicine 351:1707-1709. (2004). 
 
403. Tsan M.F. Mechanism of gallium-67 accumulation in inflammatory lesions. Journal of 
Nuclear Medicine. 26: 88-92. (1986). 
 
404. Tsutsumi V. & Shibayama M. Experimental amebiasis: a selected review of some in vivo 
models. Archives of Medical Research. 37: 210-220. (2006). 
 
405. Tulkens P. & Trouet A. The uptake and intracellular accumulation of aminoglycoside 
antibiotics in lysosomes of cultured rat fibroblasts. Biochemical Pharmacology. 27: 415-424. 
(1978). 
 
406. Tulkens P.M. Intracellular distribution and activity of antibiotics. European Journal of 
Clinical Microbiology & Infectious Diseases 10:100-106. (1991). 
 
407. Ullmann, A. Pasteur-Koch: Distinctive Ways of Thinking about Infectious Diseases. 
Microbe (American Society for Microbiology) 2: 383-387. (2007). 
 
279 
 
408. Urquhart, K. Diarrhoea in foals. In Practice 3: 22-23, 25, 27, 29. (1981). 
 
409. Vallabhajosula S.R., Harwig J.F., Siemsen J.K. & Wolf W. Radiogallium localization in 
tumors: blood binding and transport and the role of transferrin. Journal of Nuclear Medicine 
21: 650-656. (1980). 
 
410. Vallet C.M., Marquez B., Ngabirano E., Lemaire S., Mingeot-Leclercq M.P., Tulkens 
P.M.& Van Bambeke F. Cellular accumulation of fluoroquinolones is not predictive of their 
intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a 
pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages. 
International Journal of Antimicrobial Agents 38: 249-256. (2011). 
 
411. Van Bambeke F., Gerbaux C., Michot J.M., d'Yvoire M.B., Montenez J.P. & Tulkens 
P.M. Lysosomal alterations induced in cultured rat fibroblasts by long-term exposure to low 
concentrations of azithromycin. Journal of Antimicrobial Chemotherapy 42: 761-767. (1998). 
 
412. Van Bambeke F., Michot J.M. & Tulkens P.M. Antibiotic efflux pumps in eukaryotic 
cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and 
toxicodynamics. Journal of Antimicrobial Chemotherapy 51: 1067-1077. (2003). 
 
413. Van den Wollenberg L., Butler C.M., Houwers D.J., de Grootv M.W., Panhuijzen H., van 
Maanen C. & van Oldruitenborgh-Oosterbaan M.M. Lawsonia intracellularis-associated 
proliferative enteritis in weanling foals in the Netherlands. Tijdschrift voor diergeneeskunde 
136: 565-570. (2011). 
 
414. Vandenberghe J. & Hoorens J. Campylobacter species and regional enteritis in lambs. 
Research in Veterinary Science 29: 390-391. (1980). 
 
415. Vanderhyden B.C., Shaw T.J. & Ethier J.F. Animal models of ovarian cancer. 
Reproductive Biology and Endocrinology 1: 67. (2003). 
 
416. Vannucci F.A., Borges E.L., de Oliveira J.S. & Guedes R.M. Intestinal absorption and 
histomorphometry of Syrian hamsters (Mesocricetus auratus) experimentally infected with 
Lawsonia intracellularis. Veterinary Microbiology. 145: 286-291. (2010). 
 
417. Vannucci F.A., Pusterla N., Mapes S.M. & Gebhart C.J. Evidence of host adaptation in 
Lawsonia intracellularis infections. Veterinary Research 43: 53-62. (2012). 
 
418. Verron E., Masson M., Khoshniat S., Duplomb L., Wittrant Y., Baud'huin M., Badran Z., 
Bujoli B., Janvier P., Scimeca J.C., Bouler J.M. & Guicheux J. Gallium modulates osteoclastic 
bone resorption in vitro without affecting osteoblasts. British Journal of Pharmacology 
159:1681-1692. (2010). 
 
419. Wagner J.E., Owens D.R. & Troutt H.F. Proliferative ileitis of hamsters: electron 
microscopy of bacteria in cells. American Journal of Veterinary Research. 34: 249-252. 
(1973). 
280 
 
 
420. Wall R.J. & Shani M. Are animal models as good as we think? Theriogenology 69:2-9. 
(2008). 
 
421. Walsh J.J. "Louis Pasteur." Catholic Encyclopedia. New York: Robert Appleton 
Company. (1913). 
 
422. Walters J.D., Zhang F.& Nakkula R.J. Mechanisms of fluoroquinolone transport by 
human neutrophils. Antimicrobial Agents and Chemotherapy 43:2710-2715. (1999). 
 
423. Walters J.D. Characterization of minocycline transport by human neutrophils. Journal of 
Periodontology. 77:1964-1968. (2006). 
 
424. Warrell R.P. Jr., Skelos A., Alcock N.W. & Bockman R.S. Gallium nitrate for acute 
treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis. 
Cancer Research 46:4208-4212. (1986). 
 
425. Watarai M., Yamato Y., Horiuchi N., Kim S., Omata Y., Shirahata T. & Furuoka H. 
Enzyme-linked immunosorbent assay to detect Lawsonia intracellularis in rabbits with 
proliferative enteropathy. Journal of Veterinary Medical Science 66: 735-737. (2004). 
 
426. Watarai M, Yoshiya M, Sato A & Furuoka H. Cultivation and characterization of 
Lawsonia intracellularis isolated from rabbit and pig. Journal of Veterinary Medical Science. 
70: 7731-7733. (2008). 
 
427. Wattanaphansak S., Asawakarn T., Gebhart C.J. & Deen J. Development and validation 
of an enzyme-linked immunosorbent assay for the diagnosis of porcine proliferative 
enteropathy. Journal of Veterinary Diagnostic Investigation. 20: 170-177. (2008). 
 
428. Wattanaphansak S., Singer R.S. & Gebhart C.J. In vitro antimicrobial activity against 10 
North American and European Lawsonia intracellularis isolates. Veterinary Microbiology. 
134: 305-310. (2009) (a). 
 
429. Wattanaphansak S., Singer R.S., Isaacson R.E., Deen J., Gramm B.R. & Gebhart C.J. In 
vitro assessment of the effectiveness of powder disinfectant (Stalosan F) against Lawsonia 
intracellularis using two different assays. Veterinary Microbiology. 136: 403-407. (2009) (b). 
 
430. Wattanaphansak S., Gebhart C.J., Anderson J.M. & Singer R.S. Development of a 
polymerase chain reaction assay for quantification of Lawsonia intracellularis. Journal of 
Veterinary Diagnostic Investigation. 22: 598-602. (2010). 
 
431. Wei R.H., Thomas P.B., Samant D.M., Schechter J.E., Mircheff A.K. & Trousdale M.D. 
Autoimmune dacryoadenitis and sialadenitis induced in rabbits by intravenous injection of 
autologous lymphocytes activated ex vivo against lacrimal antigens. Cornea 31: 693-701. 
(2012). 
 
281 
 
432. Weisburg W.G., Barns S.M., Pelletier D.A. & Lane D.J. 16S ribosomal DNA 
amplification for phylogenetic study. Journal of Bacteriology 173: 697-703. (1991). 
 
433. Weiss D.J. Iron and copper deficiencies and disorders of iron metabolism. In: Weiss D.J, 
Wardrop K.J. Eds. Schalm’s Veterinary Hematology. 6th Ed. Ames, IA, Blackwell Publishing: 
167-171. (2010). 
 
434. Weiss S.T., McLeod H.L., Flockhart D.A., Dolan M.E., Benowitz N.L., Johnson J.A., 
Ratain M.J. & Giacomini K.M. Creating and evaluating genetic tests predictive of drug 
response. Nature Reviews Drug Discovery 7:568-574. (2008). 
 
435. Weissenböck H., Mrakovcic M., Ladinig A. & Fragner K. In situ hybridization for 
Lawsonia intracellularis--specific 16s rRNA sequence in paraffin-embedded tissue using a 
digoxigenin-labeled oligonucleotide probe. Journal of Veterinary Diagnostic Investigation. 19: 
282-285. (2007). 
 
436. Wilde J., Eiden J. & Yolken R. Removal of inhibitory substances from human fecal 
specimens for detection of group A rotaviruses by reverse transcriptase and polymerase chain 
reactions. Journal of Clinical Microbiology 28:1300-1307. (1990). 
 
437. Willems H. & Reiner G. A multiplex real-time PCR for the simultaneous detection and 
quantitation of Brachyspira hyodysenteriae, Brachyspira pilosicoli and Lawsonia 
intracellularis in pig faeces. Berliner und Münchener tierärztliche Wochenschrift 123: 205-
209. (2010). 
 
438. Williams N.M., Harrison L.R. & Gebhart C.J. Proliferative enteropathy in a foal caused 
by Lawsonia intracellularis-like bacterium. Journal of Veterinary Diagnostic Investigation. 8: 
254-256. (1996). 
 
439. Womble A., Giguere S. & Lee E.A. Pharmacokinetics of oral doxycycline and 
concentrations in body fluids and bronchoalveolar cells of foals. Journal of Veterinary 
Pharmacology and Therapeutics 30:187-193. (2007). 
 
440. Wong D.M., Alcott C.J., Sponseller B.A., Young J.L. & Sponseller B.T. Impaired 
intestinal absorption of glucose in 4 foals with Lawsonia intracellularis infection. Journal of 
Veterinary Internal Medicine 23:940-944. (2009). 
 
441. Wright E.M. The intestinal Na+/glucose cotransporter. Annual Review of Physiology 55: 
575-589. (1993). 
 
442. Yee S.B., Hatkin J.M., Dyer D.N., Orr S.A. & Pitt M.L. Aerosolized Bacillus anthracis 
infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment. 
Comparative Medicine 60: 461-468. (2010). 
 
282 
 
443. Yeh J.Y., Kim T.J., Park S.Y., Song C.S., Yoon Y.D., Kim S.K., Lee J.B. & Choi I.S. 
Isolation of Lawsonia intracellularis in Korea and reproduction of proliferative enteropathy in 
pigs and hamsters. Journal of Veterinary Medical Science 68: 499-501. (2006). 
 
444. Yeh J.Y., J.H. Lee, Yeh H.R., Kim A., Lee J.Y., Hwang J.M., Kang B.K., Kim J.M., 
Choi I.S. & Lee J.B. Antimicrobial susceptibility testing of two Lawsonia intracellularis 
isolates associated with proliferative hemorrhagic enteropathy and porcine intestinal 
adenomatosis in South Korea. Antimicrobial Agents and Chemotherapy 55:4451-4453. (2011). 
 
445. Zak, O. & Sande M. Eds. Handbook of animal infection models. London, UK: Academic 
Press, Inc. 721-776. (1999). 
 
446. Zhang P., Gebhart C.J., Burden D. & Duhamel G.E. Improved diagnosis of porcine 
proliferative enteropathy caused by Lawsonia intracellularis using polymerase chain reaction-
enzyme-linked oligosorbent assay (PCR-ELOSA). Molecular and Cellular Probes 14: 101-
108. (2000). 
 
447. Zhou Z., Ren J., Liu H., Gu G. & Li J. Pandrug-resistant isolate of Klebsiella pneumoniae 
causes less damage than drug-susceptible isolates in a rabbit model. Clinincal & Investigative 
Medicine. 34: E38-44. (2011). 
 
448. Zhu Z., Stevenson D., Schechter J.E., Mircheff A.K., Atkinson R. & Trousdale M.D. 
Lacrimal histopathology and ocular surface disease in a rabbit model of autoimmune 
dacryoadenitis. Cornea 22: 25-32. (2003). 
 
449. Zuerner R.L., Alt D.P. & Palmer M.V. Development of chronic and acute golden syrian 
hamster infection models with Leptospira borgpetersenii serovar Hardjo. Veterinary Pathology 
49:403-411. (2012). 
  
283 
 
APPENDIX A 
DATA FROM SYNCHROTRON RADIATION ANALYSIS 
 “Even the longest journey starts with a single step.” 
                                   Attributed to Lao Tzu 
Experiments for the limits of detection of Gallium maltolate (GaM) in intestinal tissues after oral 
treatment were conducted in 6 New Zealand White female rabbits, 2.2-2.7 Kg BW. Three does 
were uninfected prior to treatment and 3 were infected with Lawsonia intracellularis inocula a 
week before GaM treatment, as described in Chapters 4 and 7.  Gastro-intestinal tissue samples 
were collected, as described in Chapter 4, with 10 m sections mounted on pure quartz slides to 
be analyzed at the Canadian Light Source third generation synchrotron, VESPERS beamline (Jun 
2 – 4th  2010 and Sept 14 – 18th 2010).  
Due to time restrictions, synchrotron radiation data were collected from one section of mid-
jejunum/rabbit and one section of caecal tip/rabbit and compared to a blank section of mid-
jejunum and caecal tip, respectively, from an infected untreated rabbit (RABBIT 1G). 
Results were such that rarely the tissue anatomical structures were discernible and in every case 
they appeared as moved from the original area, initially chosen on the basis of the inside-the-
hutch camera references and H & E stained adjacent reference section. During experiments a 
skip-stepping default was experienced repeatedly due to a glitch in the sample stage motors for 
fine tuning of the sample in front of the detector. More importantly, lack of staining of our 
samples (as required by the analytical technique) rendered orientation most difficult in paraffin 
embedded samples, where no exact landmarks are visible, unless under bright direct light source.   
The findings demonstrated that the amount of elemental gallium in tissue of treated animals is 
very low, in the order of ppb measurements, as confirmed by Inductively Plasma Coupled (IPC) 
Mass Spectrometry (MS) analysis on the same tissues. Our experiments confirmed that detection 
through hard x-ray technique is difficult, more so because a confirmation of the finding through 
x-ray absorption spectroscopy for such small quantities is not provided by the capacity of the 
VESPERS beamline.  
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The reasons behind the lack of success of these experiments can be related to either:  
1) Low sensibility for small elemental quantities in the beamline instruments (detector), or  
2) Necessity of higher synchrotron energy for detection of the element specific fluorescence, 
when present in tissues in such small amounts, particularly when easily overshadowed by other 
elements, such as Iron, Zinc or Copper that are present in ranges of entire orders of magnitude 
greater than what applicable for gallium. The statistical analysis in the biomedical terms could 
not be carried out as the number of the findings were exiguous (1 sample/rabbit with 3 
rabbits/group and some findings were not relevant to the analysis).  
The fluorescence map analysis was conducted through SMAK software (Sam's Microprobe 
Analysis Kit – Webb, Software and documentation. available at: http://www-
ssrl.slac.stanford.edu/~swebb.); whereas the statistical analysis in regards of the values of the 
single elements collected, through fluorescence maps and spectra was conducted through 
Principal Component Analysis (PCA) (Jolliffe, 2002).  
PCA was invented in 1901 by Karl Pearson,
 
is a mathematical procedure that uses an orthogonal 
transformation to convert a set of observations of possibly correlated variables into a set of 
values of uncorrelated variables called principal components (Pearson, 1901) The number of 
principal components is less than, or equal to, the number of original variables. This 
transformation is defined so that the first principal component accounts for as much of the 
variability in the data as possible, whereas each following component in turn has the highest 
variance possible under the constraint that it be uncorrelated to the previous components 
(orthogonal). Principal components are guaranteed to be independent only if the data set is 
jointly normally distributed. PCA is sensitive to the relative scaling of the original variables, and 
it has different nomenclature depending on the field of application (discrete Karhunen–Loève 
transform (KLT), the Hotelling transform or proper orthogonal decomposition (POD)). 
Currently it is mostly used as a tool in exploratory data analysis and for making predictive 
models. PCA can be done by eigenvalue decomposition of a data covariance matrix or singular 
value decomposition of a data matrix, usually after mean centering the data for each attribute. 
The results of a PCA are usually discussed in terms of component scores (the transformed 
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variable values corresponding to a particular data point) and loadings (the weight by which each 
standardized original variable should be multiplied to get the component score) (Shaw, 2003).  
PCA is the simplest of the true eigenvector-based multivariate analyses. Often, its operation can 
be thought of as revealing the internal structure of the data in a way which best explains the 
variance in the data. If a multivariate dataset is visualised as a set of coordinates in a high-
dimensional data space (1 axis per variable), PCA can supply the user with a lower-dimensional 
picture, a "shadow" of this object when viewed from its (in some sense) most informative 
viewpoint. This is done by using only the first few principal components so that the 
dimensionality of the transformed data is reduced (Jolliffe, 2002).  PCA is closely related to 
factor analysis; indeed, some statistical packages deliberately conflate the two techniques. True 
factor analysis makes different assumptions about the underlying structure and solves 
eigenvectors of a slightly different matrix (Jolliffe, 2002).  
The SMAK program offers a software to perform PCA on the data collected through the 
VESPERS beamline and allowed us to analyze the findings of each samples. Unfortunately, not 
having detected, beyond reasonable doubt in any of the samples the element of gallium, further 
analysis was unnecessary and the major data obtained is herein collected for archival purposes. 
Furthermore although the data appears in a non-summarized form, such a complete collection 
was deemed necessary, as no common grouping criteria could be found for each sample.  
1. Pearson, K. (1901) "On Lines and Planes of Closest Fit to Systems of Points in Space" (PDF).  
Philosophical Magazine 2 (6): 559–572. http://stat.smmu.edu.cn/history/pearson1901.pdf. 
2. Shaw PJA (2003) Multivariate statistics for the Environmental Sciences, Hodder-Arnold. 
ISBN 0-3408-0763-6. 
3.  Jolliffe I.T. Principal Component Analysis, Series: Springer Series in Statistics, 2nd ed., 
Springer, NY, 2002, XXIX, 487 p. 28 illus.  
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A.1. Beamline set-up 
 
Energy was set up at 12 keV 
Integration time: 20 seconds/point 
Stepsize: 10 m (June experiment) 5 m (September experiment)  
Region of interest set-ups (for both session of experimental analysis) [X-RAY DATA 
BOOKLET -- Center for X-ray Optics and Advanced Light Source -- Lawrence Berkeley 
National Laboratory, 2009] as illustrated in the Table A.1. 
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Table A.1. Region of interest (ROI) set ups for Gallium analysis 
Element  Level analyzed Lower limit (eV) Higher limit (eV) 
Gallium  Ga k  9100  9400 
Calcium  Ca k  3500 3900 
Copper  Cu k  7800 8200 
Iron Fe k  6200 6600 
Iron Fe k  6800 7200 
Zinc  Zn k  8440 8840 
Zinc  Zn k  9410 9770 
-  Background low 4800 5200 
-  Background high 14900 15100 
 
Table A.1. ROI’s definition provided for the elements of interest (Calcium, Copper, Gallium, 
Iron k  and k , Zinc k  and k ) a lower limit of detection (in eV) and an upper limit of 
detection, including the typical fluorescence and x-ray absorption of energy of each given 
element. This defines the elemental “footprint”, which is unique for each element of the periodic 
table. To ensure that background scatter was excluded adequately from our analysis, a low and a 
high set-ups for background scatter were also defined prior to analysis.  
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A.2 Sample set-up 
The following pages will report in detail, in the same order for each sample, the data 
collected in the form of fluorescence maps (8 images per sample) as each ROI - indicated in 
Table A.1.- is reported.  For each sample the size of the area to map ranged between 250 m x 
250m and 300 m X 300 m, as the long integration time for each step analysed would have 
rendered the analysis impractical in the time allotted. A colour code system has been set for each 
map image as “Jet”: with red range = high concentration; yellow range = medium-high 
concentration; green range = medium-low concentration; and blue range = low concentration.  
The full burgundy field indicates an oversaturation of fluorescence due to mix signals reading.  
Also a table reporting the correlation analysis is available, to define statistically the 
chances of having detected Gallium vs. the other elements selected. Finally the PCA analysis 
images show the main component curves with particular attention to indicate where the Gallium 
should have projected a visible curve/jump on the graph (corresponding to the ROI previously 
defined). 
The samples scanned are jejunum sections in the first group of analysis and cecum tip in 
the second group of analysis.  In order of listing therefore will follow: fluorescence maps, 
correlation to gallium detection tables and PCA analysis for each sample. Data will be 
commented in the figures’ or tables’ legends.  In order:  
a) Negative control (n=1, Rabbit 1G), infected untreated samples: a.1.) jejunum 
fluorescence maps (Figures A.1.1. to A.1.8.); Correlation analysis results are represented in 
Table A.2.; PCA results are represented in Figures A.1.9. and A.1.10. a.2) cecum fluorescence 
maps (Figure A.8.1. to A.8.9.). Correlation analysis results are represented in Table A.9.; the 
PCA analysis results are represented in Figure A.8.10 - A.8.12. 
b) Positive control (n=3, Rabbits 2C, 2D, 2F) uninfected treated samples:  
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b.1.) jejunum fluorescence maps (Figures A.2.1. to A.2.8. for Rabbit 2C; Figures 
A.3.1. to A.3.9. for Rabbit 2D; and Figures A.4.1. to A.4.9. for Rabbit 2F); Correlation 
analysis results are represented in Table A.3. for Rabbit 2C; Table A.4. for Rabbit 2D; 
Table A.5. for Rabbit 2F; PCA results are represented in Figures A.2.9. - A.2.11. for Rabbit 
2C; Figures A.3.10. - A.3.11. for Rabbit 2D; Figure A.4.10. for Rabbit 2F.  
b.2) cecum fluorescence maps (Figures A.9.1. to A.9.9. for Rabbit 2C (plus 
addendum A.9.14 through A.9.16); Figures A.10.1. to A.10.9. for Rabbit 2D; and Figures 
A.11.1. to A.11.9. for Rabbit 2F (plus addendum A.11.10.- A.11.12); Correlation analysis 
results are represented in Table A.10. for Rabbit 2C; Table A.11. for Rabbit 2D; Table 
A.12. for Rabbit 2F; PCA results are represented in Figures A.9.10. - A.9.13. for Rabbit 2C; 
Figures A.10.10. - A.10.13. for Rabbit 2D; Figures A.11.13. - A.11.16. for Rabbit 2F.  
c) Target sample (n=3, Rabbits 4E, 4G, 4H) infected and treated samples:  
c.1.) jejunum fluorescence maps (Figures A.5.1. to A.5.9. for Rabbit 4E; Figures 
A.6.1. to A.6.9. for Rabbit 4G; and Figures A.7.1. to A.7.9. for Rabbit 4H); Correlation 
analysis results are represented in Table A.6. for Rabbit 4E; Table A.7. for Rabbit 4G; 
Table A.8. for Rabbit 4H; PCA results are represented in Figures A.5.10. - A.5.12. for 
Rabbit 4E; Figures A.6.10. - A.6.11. for Rabbit 4G; Figures A.7.10. - A.7.12. for Rabbit 4H.  
c.2) cecum fluorescence maps (Figures A.12.1. to A.12.9. for Rabbit 4E; Figures 
A.13.1. to A.13.9. for Rabbit 4G; and Figures A.14.1. to A.14.9. for Rabbit 4H); Correlation 
analysis results are represented in Table A.13. for Rabbit 4E; Table A.14. for Rabbit 4G; 
Table A.15. for Rabbit 4H; PCA results are represented in Figures A.12.10. - A.12.12. for 
Rabbit 4E; Figures A.13.10. - A.13.12. for Rabbit 4G; Figures A.14.0. - A.14.12. for Rabbit 
4H.  
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Figures A.1.1. to A.1.8.  Rabbit 1 G Untreated infected control  –  Jejunum sample. 
Fluorescence maps. 
                            
Figure A.1.1. Calcium k                                            Figure A.1.2. Iron k  
                          
Figure A.1.3.  Iron K                                          Figure A.1.4.  Zinc k  
                          
Figure A.1.5. Gallium k                                              Figure A.1.6. Zinc k  
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Figure A.1.7. Background scatter lower end            Figure A.1.8. Background scatter higher end 
Figures A.1.1. to A.1.8. Fluorescence maps. In this sample analysis, potential anatomical 
landmarks are grossly estimated from maps of Fe k  Ca k  and Zn k . Zinc and Iron are 
somehow opposite in appearance. Unfortunately the map location obtained is not matching what 
was chosen at the beginning of the analysis.   
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Table A.2. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.41 -10.01999 57262.1463 
Cu k  0.92 1.664063 1152.8842 
Fe k  5.96
-6
 -0.0129017 6601.3 
Fe k  0.53 0.7974821 1230.82 
Zn k  0.24 -1.70464073 15551.79 
Zn k  0.85 1.189159 1793.97 
Background low 0.83 0.96172 39.769 
Background high 0.95 19.287085 -2462.5179 
 
Table A.2. Correlation: R
2
 values are provided in the first column whereas slope and intercept 
of the correlation line are provided in the 2
nd
 and 3
rd
 columns. No gallium was detected in the 
untreated infected control, as expected. However, regardless of its known absence, background 
scatter energy, both low and high correlated to inexistent data with high r
2
 values, showing a 
doubtful ability for the detector to record the right fluorescence signal.  
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Figure A.1.9. PCA: Component 1. 
  
Figure A.1.10. PCA: Component 4. 
 
Figures A.1.9 and A.1.10 - PCA Analysis. In component 1, no detectable Ga k  peak is visible 
in the selected ROI (yellow interrupted line), as expected. On the other hand, in component 4, the 
peaks for Fe k  Fe k  and Zn k  are well discernible (labels). 
Fe k 
Fe k 
Zn k 
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Figures A.2.1. to A.2.8.  Rabbit 2C - Uninfected treated control – Jejunum sample. 
Fluorescence maps.  
                  
Figure A.2.1 Calcium k                                    Figure A.2.2.Iron k  
             
Figure A.2.3. Iron k                                                          Figure A.2.4 Zinc k  
            
Figure A.2.5. Gallium k                                        Figure A.2.6.  Zinc k  
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Figure A2.7.Background scatter higher end           Figure A.2.8. Background scatter lower end 
Figures A.2.1. to A.2.8. Fluorescence maps: In this sample analysis, potential anatomical 
landmarks are grossly estimated from maps Fe k , Ca k  and Zn k . Zinc and iron are 
somehow opposite, unfortunately the map location obtained is not matching what was chosen at 
the beginning of the analysis. 
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Table A.3. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.46 1.27533 1325.08345 
Cu k  0.92 1.79918 377.9566 
Fe k  0.42 1.30568 672.935 
Fe k  0.87 1.036957 76.629399 
Zn k  0.45 1.502523 1953.608648 
Zn k  0.90 1.565903 202.8178 
Background low 0.90 0.946659 -37.492276 
Background high 0.94 18.170999 -3.387846 
 
Table A.3. Correlation: R
2
 values are provided in the first column, whereas slope and intercept 
of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Although not much was detected 
on the fluorescence maps in the uninfected treated control, Cu k  Fe k  Zn k 
andbackground scatter energy, both low and high, correlated to very feeble data, with high r2 
values (≥ 90%), showing a doubtful ability for the detector to record the right fluorescence signal 
for gallium.  
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Figure A.2.9. PCA: Component 1  
 
Figure A.2.10. PCA: Component 1, close-up image.  
 
  
See close up 
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Figure A.2.11. PCA: Component 3 
 
PCA analysis: In Component 1. No detectable Ga k  peak is visible on scatter shoulder, 
whereas possibly a Zn k  peak on the said shoulder could be visible. In Component 3: the 
scatter generated noise is too big and it masks any peak that is not major, such as for Fe k  and 
Ca k .  
  
299 
 
Figures A.3.1. to A.3.9. Rabbit 2D  - Uninfected treated control – Jejunum sample. 
Fluorescence maps. 
 
                        
Figure A.3.1 Calcium k                                               Figure A.3.2.  Copper k  
                           
Figure A.3.3 Iron k                                               Figure A.3.4.  Iron k  
                        
Figure A.3.5.Zinc k                                               Figure A.3.6. Zinc k  
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 Figure A.3.7. Gallium k  
                         
Figure A.3.8 Background scatter lower end                Figure A.3.9.Background scatter higher end 
Figures A.3.1 – A.3.9. Fluorescence maps: In this sample analysis, potential anatomical 
landmarks are difficult to be grossly estimated from maps of Fe k  Ca k  and Zn k . 
Furthermore based on the coordinates selected and the ones recorded (motor and camera 
discrepancies), the map location obtained is not matching the chosen area for the analysis. 
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Table A.4. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.65 2.084988 -480.581647 
Cu k  0.95 1.77639 454.75752 
Fe k  0.42 1.54166 -523. 6469 
Fe k  0.90 1.056127 24.891482 
Zn k  0.58 1.675958 740.06465 
Zn k  0.94 1.54404 261.222698 
Background low 0.93 0.910397 169.836561 
Background high 0.96 18.019053 1651.6919 
 
Table A.4. Correlation: R
2
 values are provided in the first column, whereas slope and intercept 
of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Although not much was detected 
on the fluorescence maps in the uninfected treated control, Cu k  Fe k  Zn k 
andbackground scatter energy, both low and high, correlated well to very feeble data, with 
high r
2
 values (> 90%), showing a doubtful ability for the detector to record the right 
fluorescence signal for gallium.  
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Figure A.3.10. PCA: Component 1 
 
Figure A.3.11.PCA: Component 3 
 
PCA analysis: No appearance of a Gallium peak is noted on PCA components 1 and 3. 
Component 4 and higher are too scattered/noisy to be considered analytically helpful.  
Zn k beta? 
Zn k alpha 
Fe k alpha 
Fe k beta 
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Figures A.4.1. to A.4.9.  Rabbit 2F - Uninfected treated control – Jejunum sample. 
Fluorescence maps. 
 
                           
Figure A.4.1. Calcium k                                               Figure A.4.2. Copper k  
                              
Figure A.4.3. Iron k                                                       FigureA.4.4.  Iron k  
                               
Figure A.4.5. Zinc k                                                    Figure A.4.6. Zinc k  
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Figure A.4.7. Gallium k  
                      
Figure A.4.8.Background scatter lower end               Figure A.4.9. Background scatter higher end 
Figures A.4.1 – A.4.9. Fluorescence maps: Again the high resemblance of maps of Fe k Zn 
k  Ga k  and Cu k  with the background scatter of both lower and higher ends, is fairly 
obvious. Very mild anatomical landmarks are somewhat discernible in Zn and Fe k 's maps, 
although likely are not detailed enough to make a precise reference to the anatomical site 
analysed.  
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Table A.5. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.03 1.234004 2775.176 
Cu k  0.92 1.863117 430.60602 
Fe k  0.46 1.107286 1208.72575 
Fe k  0.89 0.957053 418.277862 
Zn k  0.38 1.762516 740.8549 
Zn k  0.92 1.555237 248.324067 
Background low 0.91 0.876281 299.300 
Background high 0.94 19.17968 -3906.857094 
 
Table A.5. Correlation: R
2
 values are provided in the first column, whereas slope and intercept 
of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Although not much was detected 
on the fluorescence maps in the uninfected treated control, Cu k  Fe k  Zn k 
andbackground scatter energy, both low and high, correlated well to very feeble data high r2 
values (> 89%), showing a doubtful ability for the detector to record the right fluorescence signal 
for gallium.  
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Figure A.4.10. PCA: Component 1  
 
Figure A.4.10. PCA analysis: shows no Gallium peak on the component 1 analysis, and only Fe 
k  and Zn k  peaks in component 3, besides scatter signal. 
  
Zn k beta 
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Figures A.5.1. to A.5.9. Rabbit 4E - Lawsonia intracellularis infected and treated –  
Jejunum sample. Fluorescence maps. 
 
                     
Figure A.5.1 Calcium k                                              Figure A.5.2. Copper k  
 
                        
Figure A.5.3. Iron k                                               Figure A.5.4. Iron k  
                           
Figure A.5.5. Zinc k                                                Figure A.5.6. Zinc k  
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Figure  A.5.7. Gallium k  
                    
Figure A.5.8.Background scatter lower end             Figure A.5.9. Background scatter higher end 
Figures A.5.1. – A.5.9. Fluorescence maps: An appearance of anatomical structure is 
recognizable only in the Fe k  and Ca k  maps.  Zn k  has only a very vague appearance of 
tissutal structure. However none of these maps definition will be sufficient to relate this analysis 
to a specific location on the sample. No structure at all visible on the other maps. 
  
309 
 
Table A.6. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.18 0.241365 -1272.561 
Cu k  0.99 0.998 466.48059 
Fe k  0.83 0.2018 2031.715 
Fe k  0.99 0.25725 394.121 
Zn k  0.98 1.01663 4001.6974 
Zn k  0.99 1.237822 295.51616 
Background low 0.99 0.06956 9.67816 
Background high 0.99 0.71011 -270.7562 
 
Table A.6. Correlation: R
2
 values are provided in the first column, whereas slope and intercept 
of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Although not much was detected 
on the fluorescence maps in the infected treated control, Cu k  Fe k  Zn k Zn k 
andbackground scatter energy, both low and high, correlated well to very feeble data high r2 
values (> 98%), showing a doubtful ability for the detector to record the right fluorescence signal 
for gallium.  
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Figure A.5.10. PCA: Component 1. 
 
Figure A.5.11.PCA: Component 3. 
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Figure A.5.12.PCA: Component 4. 
 
 
PCA analysis: No detection of Ga k  Zn k  Fe k  or Cu k he only peaks discernible in 
Component 4 are Fe and Zn k ’s. The other elemental peaks are masked by the scatter signal. 
 
 
  
Fe k alpha 
Zn k alpha 
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Figures A.6.1. to A.6.9. Rabbit 4G - Lawsonia intracellularis infected and treated –  
Jejunum sample. Fluorescence maps. 
 
                                 
Figure A.6.1. Calcium k                                          Figure A.6.2. Copper k  
                               
Figure A.6.3   Iron k                                               Figure A.6.4. Iron k  
                             
Figure A.6.5   Zinc k                                              Figure A.6.6 Zinc k  
313 
 
  
Figure A.6.7. Gallium k  
 
                    
Figure A.6.8.Background scatter lower end             Figure A.6.9. Background scatter higher end 
Figures A.6.1 –A.6.9. Fluorescence maps: In most elemental fluorescence maps of this set of 
analyses, an anatomical structure is not discernible at all. Mainly some hint of structure is 
recognizable in Fe k  and Ca k  and barely perceptible in Zn k .  
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Table A.7. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.15 0.105256 -29.978003 
Cu k  0.98 0.674341 5989.751348 
Fe k  0.71 0.1818 4902.0901 
Fe k  0.98 0.261759 222.908 
Zn k  0.96 0.954722 13852.306 
Zn k  0.99 1.20796 3482.339118 
Background low 0.97 0.07157 -135.109988 
Background high 0.99 0.689794 2346.2549 
 
Table A.7. Correlation: R
2
 values are provided in the first column, whereas slope and intercept 
of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Although not much structure was 
detected on the fluorescence maps in the infected treated control, Cu k  Fe k  Zn k Zn k 
andbackground scatter energy, both low and high, correlated too well to very feeble data, with 
high r
2
 values (> 96%), showing a doubtful ability for the detector to record the right 
fluorescence signal for gallium.  Also, to note is that data elements usually not at all correlated, a 
high R
2
 is shown (71% for Fe k ). The doubt is that something emitting similar fluorescence 
signal, regardless of the element (mostly overwhelming or null) was mapped instead of tissue. 
Could that be glass/quartz of paraffin?  
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Figure A.6.10. PCA: Component 1 
 
Figure A.6.11. PCA: Component 3 
 
 
Figures A.6.10. - A.6.11. PCA Analysis: No elemental peak is noticeable (likely masked by the 
scatter signal shoulder), for Ga k  Zn k , Zn k , Fe k , and Cu k . May be the scatter 
wave is too long to distinguish any specific metal characteristics, even in case that we did not 
map glass or paraffin, but legitimate tissue. 
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Figures A.7.1. to A.7.9. Rabbit 4H - Lawsonia intracellularis infected and treated –  
Jejunum sample. Fluorescence maps. 
 
                              
Figure A.7.1. Calcium k                                            Figure A.7.2 Copper k  
                               
Figure A.7.3. Iron k                                                 Figure A.7.4. Iron k  
                               
Figure A.7.5. Zinc k                                                  Figure A.7.6. Zinc k  
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Figure A.7.7. Gallium k  
                    
FigureA.7.8. Background scatter lower end              Figure A.7.9.  Background scatter higher end 
Figures A.7.1. – A.7. 9. Fluorescence maps: Anatomical landmarks are not obvious, once 
again, except for Fe k  and Ca k  (slightly more defined). In addition, the energy injection 
within the mapping time (upper quarter) is not helpful in defining the areas of interest, due to the 
marked contrast in energy intensity. Once again Ga k  looks much alike Zn k , Zn k , Fe k 
, Cu k  and both ends of the background scatter signal shoulder. 
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Table A.8. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.12 0.16083 2850.319 
Cu k  0.99 0.708873 -356.2897 
Fe k  0.75 0.20963 -609.8286 
Fe k  0.99 0.264915 -193.0506 
Zn k  0.99 1.031291 -468.92256 
Zn k  0.999 1.2333 -158.160162 
Background low 0.99 0.07122 -72.7349 
Background high 0.999 0.716905 -152.0740 
 
Table A.8. Correlation: R
2
 values are provided in the first column, whereas slope and intercept 
of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Although not much structure was 
detected on the fluorescence maps in the infected treated control, Cu k  Fe k  Zn k Zn k 
andbackground scatter energy, both low and high, correlated too well to very feeble data, with 
high r
2
 values (≥ 99%), showing a doubtful ability for the detector to record the right 
fluorescence signal for gallium.  Also, to note is that data elements usually not at all correlated, a 
high R
2
 is shown (75% for Fe k ). The doubt is that something emitting similar fluorescence 
signal, regardless of the element (mostly overwhelming or null) was mapped instead of tissue. 
Could that be glass/quartz of paraffin?  
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Figure A.7.10. PCA: Component 1  
 
Figure A.7.11. PCA: Component 1: close-up 
 
 
 
See close up 
Fe k alpha Zn k alpha 
Cu k alpha? 
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Figure A.7.12. PCA: Component 3. 
 
 
PCA Analysis: No elemental peak is noticeable, as likely it is masked by the very large scatter 
signal shoulder, for Ga k  Zn k , Zn k , Fe k The only ones recognizable are Fe k  and 
Ca k  and potentially Cu k , but it is dubious. 
  
Fe k alpha 
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Figures A.8.1. to A.8.9. Rabbit 1G - Lawsonia intracellularis infected and untreated –  
Cecum sample. Fluorescence maps. 
 
            
Figure A.8.1 Calcium k                                Figure A.8.2. Copper k  
            
Figure A.8.3. Iron k                                      Figure A.8.4. Iron k  
                
Figure A.8.5.Zinc k                                        Figure A.8.6. Zinc k  
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Figure A.8.7. Gallium k  
                         
Figure A.8.8. Background scatter lower end            Figure A.8.9  Background scatter higher end 
Figures A.8.1 – A.8.9. Fluorescence maps: Some anatomical structure is recognizable on the 
lower right corner of each fluorescence map. However, it is different than the area originally 
chosen for analysis, as it should have occupied the whole map space. As suspected during 
collection of data, the sample stage skip-stepped with respect to the detector, and the micro-
camera did not record such a change. 
 
  
323 
 
Table A.9. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.41 5.940566 -27119.64 
Cu k  0.90 1.2750 218.5209 
Fe k  0.12 2.436354 -15303.298 
Fe k  0.48 0.930019 -2122.4678 
Zn k  0.50 1.6434 -2772.764 
Zn k  0.97 1.770 74.57269 
Background low 0.92 0.64 -55.7519 
Background high 0.97 12.015 6844.8416 
 
Table A.9. Correlation: R
2
 values are provided in the first column, whereas slope and intercept 
of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Although not  gallium was present 
(untreated subject), Cu k  Zn k andbackground scatter energy, both low and high, correlated 
well to inexistent data, with high r
2
 values (≥ 90%), showing a doubtful ability for the detector to 
record the right fluorescence signal for gallium.  In this case a low correlation with Fe k  is 
noted as well (48%).  
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Figure A.8.10. PCA: Component 1 
  
Figure A.8.11. PCA: Component 2.  
 
 
Ca k alpha 
Fe k alpha 
Fe k beta 
Zn k beta 
Zn k alpha 
Fe k alpha 
Fe k beta 
Zn k alpha 
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Figure A.8.12. PCA: Component 3. 
 
PCA Analysis: On component 1 all the peaks of interest are discernible: Ca k Cu k Fe k 
Fe k Zn k Zn k (although this last one is pretty obviously buried in the background 
scatter peak’s shoulder). As expected there is no gallium. Both components 2 and 3 report the 
named peaks as well. 
 
 
 
  
Fe k alpha 
Zn k alpha 
Fe k beta 
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Figures A.9.1. to A.9.9. Rabbit 2C - Uninfected treated control – Cecum sample. 
Fluorescence maps. 
 
                      
Figure A.9.1.  Calcium k                                     Figure A.9.2. Copper k  
                        
Figure A.9. 3. Iron k                                              Figure A.9.4. Iron k  
                       
Figure A.9.5.  Zinc k                                            Figure A.9.6.  Zinc k  
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Figure A.9.7. Gallium k  
                     
Figure A.9.8.Background scatter lower end             Figure A.9.9.  Background scatter higher end 
 
Fluorescence maps: several element channels report marked details in opposite corners (top left 
and bottom right), including Fe k Fe k Ga k Ca k Cu k and Zn k However it is 
to be verified what is really imaged in the Gallium channel is gallium and not an association  of 
detection of Cu k  Zn k  and Ga k or more simplyCu k and Zn k only. Also, 
although placeability of this map could be feasible, the sample stage sidestepped as we obviously 
mapped a large gap in the sample (rather than sample itself) having relevant materials only at the 
edge of the map. Such objective was not desirable and likely the mapping of this sample will not 
be useful for future fruition.  
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 Table A.10. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.005 0.40582 -21370.02 
Cu k  0.87 1.53372 -1765.60116 
Fe k  0.07 1.38103 -3864.133 
Fe k  0.67 0.6729 417.916199 
Zn k  0.46 1.319236 -853.301 
Zn k  0.85 1.495795 2454.2 
Background low 0.77 0.528798 977.7682 
Background high 0.75 10.1648 22749.539 
 
Table A.10. Correlation: R
2
 values are provided in the first column, whereas slope and 
intercept of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Although gallium 
detected feebly, Cu k  Zn k andbackground scatter energy, both low and high, correlated 
well to weak data, with medium-high r
2
 values (≥ 75%), showing a doubtful ability for the 
detector to record the right fluorescence signal for gallium.   
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Figure A.9.10.  PCA: Component 1  
 
 Figure A.9.11. PCA: Component 1, close-up view. 
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Figure A.9.12. PCA: Component 2. 
 
Figure A.9.13. PCA: Component 3. 
 
PCA Analysis:  On component 1 the possible location of Zn k peak andGa k are somewhat 
buried in the higher end background scatter shoulder. However, in Component 2 and 3 Ga k is 
visible after Cu k andZn k as a small peak (9170 – 9220 eV, ROI limits at 9100 – 9400). 
Although a peak is present, I’m still skeptical about its significance because of the lack of XAS 
to confirm it and the inability to determine if I’m mapping intestinal lumen content or intestinal 
wall, which was ultimately what I was aiming to analyze. 
Fe k alpha 
Fe k beta 
Zn k alpha 
Cu k alpha? 
Ga k alpha??? 
Ga k alpha? 
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Addendum: Further fluorescence maps for Rabbit 2C 
In the addendum, there is a further analysis conducted to compare gallium and zinc findings to 
ascertain if the peak detected was truly Gallium. Unfortunately the incapability of conducting X-
ray absorption spectroscopy (XAS) at VESPERS is detrimental to our results, because we could 
not prove beyond reasonable doubt that the peak detected is Gallium (Figures A.9.14 to A.9.16). 
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Figures A.9.14. to A.9.16. Addendum. 
   
Figure A.9.14 Gallium k  minus Background scatter (higher end) 
 
                                 
Figure A.9.15 Gallium k  minus Copper k Figure A.9.16. Gallium k  minus Zinc k  
 
Figures A.9.14. - A.9.16. Fluorescence maps subtractions. The images were obtained 
subtracting mathematically  from the values of each step in the Gallium fluorescence map the 
values from each step of fluorescence maps obtained from higher-end back ground scatter, 
Copper k  and Zinc k  channels, whose ROI’s have similar or adjacent voltage to Gallium.  
The results were a complete “null value” and confirmed the suspicion that chances of having  
really detected gallium were very small, and more likely the findings were only pertinent to 
detections of elements from overlapping ROIs.  
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Figures A.10.1. to A.10.9. Rabbit 2D - uninfected and treated – Cecum sample. 
Fluorescence maps. 
 
                 
Figure A.10.1.  Calcium k                                 Figure A.10.2.  Copper k  
                 
Figure A.10.3. Iron k                                     Figure A.10.4. Iron k  
                  
Figure A.10.5 Zinc k                                      Figure A.10.6 Zinc k  
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Figure A.10.7. Gallium k  
 
                    
Figure A.10.8. Background scatter lower end       Figure A.10.9.  Background scatter higher end 
Figures A.10.1. –A.10.2. Fluorescence maps: Some anatomical landmark is barely perceptible 
from elemental channels of Ca k Cu k Fe k Fe k Zn k  No high concentration spot 
of gallium was detected in what should be animal tissue. Moreover background scatter (high and 
low end), Ga k and Zn k look very much alike each other, with no distinction in the 
appearance of fluorescence maps. 
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Table A.11. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.05 15.3593 -131305.137 
Cu k  0.82 1.14237 1816.1535 
Fe k  0.34 0.7907 667.30825 
Fe k  0.93 0.65109 387.9919 
Zn k  0.35 0.8473 2663.52858 
Zn k  0.96 1.6918 455.889 
Background low 0.94 0.579212 464.9330 
Background high 0.95 11.7734 6307.2438 
 
Table A.11. Correlation: R
2
 values are provided in the first column, whereas slope and 
intercept of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Although gallium 
detected feebly, Cu k Fe k Zn k andback ground scatter energy, both low and high, 
correlated well to weak data, with medium-high r
2
 values (≥ 82%), showing a doubtful ability for 
the detector to record the right fluorescence signal for gallium.   
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Figure A.10.10 PCA: Component 1  
 
Figure A.10.11 PCA: Component 1, close-up. 
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Figure A.10.12 PCA: Component 2.  
 
Figure A.10.13. PCA: Component 3.  
 
PCA Analysis:  On component 1 the possible locations of Zn k peak andGa k respectively 
are annulled/buried in the higher end background scatter shoulder.  Also, no Fe k norFe k 
are recognizable.  In component 2 a very small Fe k is detectable, and Component 3 is very 
noisy, although iron and zinc peaks are probably recognizable. 
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Figures A.11.1. to A.11.9. Rabbit 2F - uninfected and treated – Cecum sample. 
Fluorescence maps. 
 
                         
Figure A.11.1. Calcium k                                            Figure A.11.2 Copper k 
                          
Figure A.11.3. Iron k                                                   Figure A.11.4. Iron k 
                         
Figure A.11.5.   Zinc k                                              Figure A.11.6. Zinc k 
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Figure A.11.7.   Gallium k 
 
              
Figure A.11.8 Background scatter lower end          Figure A.11.9   Background scatter higher end 
Figures A.11.1. – A.11.9 Fluorescence maps: For the first and only time in this experiment, 
anatomical structures are easily recognizable in every elemental channel fluorescence map. Also 
the gallium fluorescence map is astoundingly beautiful in comparison to all the previous ones, as 
it is comparable for details to iron, zinc and calcium. 
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Table A.12. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.24 11.797 -116006.39 
Cu k  0.83 2.0846 -8406.6979 
Fe k  0.65 4.8248 -41944.269 
Fe k  0.90 0.92303 -2502.6956 
Zn k  0.68 4.6218 -37653.329 
Zn k  0.88 1.29924 4707.781 
Background low 0.66 0.3352 3002.996 
Background high 0.43 5.1284 77729.65 
 
Table A.12. Correlation: R
2
 values are provided in the first column, whereas slope and 
intercept of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Gallium was detected 
considerably well and differently than usual feebly, Cu k Fe k Zn k were variable between 
medium and medium high r
2
. Back ground scatter energy, both low and high, were not as well 
correlated well to Gallium data, differently than previously noted. However, the higher 
correlations seem to be with those elements that, when subtracted, give a zero result and a null 
fluorescence map. 
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Rabbit 2 F - Addendum: Fluorescence maps, elemental subtraction. 
  
Figure A.11.10  Gallium k  minus Background scatter (high) 
  
Figure A.11.11 Gallium k  minus Copper k  
  
Figure A.11.12 Gallium k  minus Zinc k 
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Figure A.11.13. PCA: Component 1.  
 
Figure A.11.14. PCA: Component 1, close-up view. 
 
 
 
Fe k alpha  
Fe k beta 
Ca k alpha 
Zn  k alpha 
Cu  k alpha 
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Figure A.11.15. PCA: Component 2  
 
Figure A.11.16. PCA: Component 3. 
 
Fe k alpha  
Fe k beta 
Zinc k beta 
Zinc k alpha 
Gallium k alpha ? 
Cu  k alpha 
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Figures A.11.13 –A.11.16. PCA analysis: On component 1 Ga k andZn k  are buried in the 
higher end scatter shoulder, whereas Fe k Fe k Cu k Zn k and Ca k are clearly 
visible. On components 2 and 3 Ga k andZn k  peaks appear distinct and adjacent, not 
included in the large amount of background scatter. However, a simple mathematical map 
subtraction reports a null result when we subtract from a gallium fluorescence map’s set of 
values the set of values deriving from fluorescence maps of Zn k  Cu k and higher end 
background scatter signal, as shown in the addendum – Rabbit 2F). 
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Figures A.12.1. to A.12.9. Rabbit 4E - Lawsonia intracellularis infected and treated – 
Cecum sample. Fluorescence maps. 
                          
Figure A.12.1. Calcium k                                       Figure A.12.2. Copper k  
                             
Figure A.12.3. Iron k                                             Figure A.12.4.  Iron k   
                                                
Figure A.12.5. Zinc k                                              Figure A.12.6. Zinc k  
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Figure A.12.7.  Gallium k  
                    
Figure A.12.8.Background scatter lower end       Figure A.12.9. Background scatter higher end 
Figures A.12.1 – A.12.9. Fluorescence maps: Maps show some recognizable anatomical 
structure for Fe k  and Ca k  However these same structure references are barely 
recognizable in Zn k  and Cu k , likely because of the side- stepping of the stage motors and 
the beam itself, whose flux kept being interrupted during this sampling. 
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Table A.13. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.29 0.37847 -29779.81 
Cu k  0.96 0.775013 -6892.461179 
Fe k  0.47 0.2934 -9809.2031 
Fe k  0.97 0.272347 -1534.3678 
Zn k  0.99 1.04944 -3017.10304 
Zn k  0.99 1.223121 966.86041 
Background low 0.98 0.07092 -175.20539 
Background high 0.99 0.6975 499.83406 
 
Table A.13. Correlation: R
2
 values are provided in the first column, whereas slope and 
intercept of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Gallium was detected 
feebly, if at all, with Cu k Fe k Zn k, as well as the background scatter energy (low and 
high ends) showing high r
2 (≥ 96%). Back ground scatter energy, both low and high, were not as 
well correlated well to Gallium data, differently than previously noted. However, the higher 
correlations seem to be with those elements that, when subtracted, give a zero result and a null 
fluorescence map. 
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Figure A.12.10. PCA: Component 1 
 
Figure A.12.11.PCA: Component 2. 
 
  
Fe k alpha 
Zn k alpha 
Fe k alpha 
Fe k beta 
Zn k alpha 
Cu k alpha 
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Figure A.12.12. PCA: Component 3 
  
Figures A.12.10 – A.12.12. PCA analysis: High scatter signal “noise” in component 3 is likely 
not consistent with any specific peak of interest (Ga k or Zn k The only ones recognizable 
are mainly in component 2, as they are not very clear in component 1, are Fe k  and Ca k  
Zn k, and potentially Cu k  but they should be confirmed because the scatter signal shoulder 
is very large and rises very much before the 10000 eV threshold. 
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Figures A.13.1. to A.13.9. Rabbit 4G - Lawsonia intracellularis infected and treated – 
Cecum sample. Fluorescence maps. 
 
                    
Figure A.13.1.Calcium k                                      Figure A.13.2  Copper k  
                  
Figure A.13.3 Iron k                                              Figure A.13.4  Iron k  
                     
Figure A.13.5. Zinc k                                                    Figure A.13.6. Zinc k  
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Figure A.13.7. Gallium k  
                       
Figure A.13.8.Background scatter lower end           Figure A.13.9. Background scatter higher end 
Figures A.13.1 – A.13.9. Fluorescence maps: As noted previously in this experiment, 
fluorescence maps show some recognizable anatomical landmark in the Fe k  and Ca k  
channels. Nothing at all is distinguishable in the channels set for other elements’ fluorescence, as 
most of them look like background scatter signal.  
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Table A.14. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.81 0.104722 -1014.5405 
Cu k  0.99 0.6990 819.5353 
Fe k  0.80 0.17668 2690.395 
Fe k  0.99 0.25133 941.71066 
Zn k  0.99 1.01494 1936.8852 
Zn k  0.999 1.2329 39.009286 
Background low 0.98 0.0668 420.88045 
Background high 0.99 0.70696 85.52276 
 
Table A.14. Correlations: R
2
 values are provided in the first column, whereas slope and 
intercept of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Although not much 
structure was detected on the fluorescence maps in the infected treated rabbit, Cu k  Fe k  Zn 
k Zn k andbackground scatter energy, both low and high, correlated too well to very feeble 
data, with high r
2
 values (> 98%), showing a doubtful ability for the detector to record the right 
fluorescence signal for gallium, particularly in the case of Fe k  and Ca k . With this 
knowledge, and the PCA results, we can speculate that the background scatter signal was too 
large to allow appropriate detection of other elements’ fluorescence. Also, to note is that data 
elements usually not at all correlated, a high R
2
 is shown (80% for Fe k ). The doubt is that 
something emitting similar fluorescence signal, regardless of the element (mostly overwhelming 
or null) was mapped instead of tissue.  
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Figure A.13.10. PCA: Component 1.  
  
Figure A.13.11. PCA: Component 2. 
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Figure A.13.12. PCA: Component 3. 
 
Figures A.13.10. – A.13.12. PCA analysis. Component 1 shows a very large background 
shoulder which likely cancels (in other words, it absorbs it in full) Zn k and likely (if any was 
detected) Ga k   Components 2 and 3 show Fe k   peaks, but do not show anything else of 
interest. Larger components are just increasing levels of scatter signal. 
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Figures A.14.1. to A.14.9. Rabbit 4H - Lawsonia intracellularis infected and treated – 
Cecum sample. Fluorescence maps. 
 
                  
Figure A.14.1.  Calcium k                                     Figure A.14.2. Copper k  
                          
Figure A.14.3. Iron k                                              Figure A.14.4 Iron k 
                   
Figure A.14.5. Zinc k                                            Figure A.14.6. Zinc k  
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Figure A.14.7. Gallium k   
               
Figure A.14.8 Background scatter lower end           Figure A.14.9  Background scatter higher end 
Figures A.14.1 – A.14.9. Fluorescence maps: the appearance of the elemental fluorescence 
detected is, once again, showing lack of anatomical specific landmarks, although this time some 
structure is discernible in Fe k and Ca k and, yet much more approximate, inFe k  Zn k 
 and Cu k  
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Table A.15. Correlations (R
2
) between elements: comparisons with Gallium. 
 Ga k  Slope Intercept 
Ga k  1 1 0 
Ca k  0.55 0.36219 -6761.6759 
Cu k  0.98 0.741828 -2526.419 
Fe k  0.28 0.41387 -20105.942 
Fe k  0.91 0.29568 -3222.855 
Zn k  0.99 1.060981 -1633.829 
Zn k  0.998 1.2192 1444.299 
Background low 0.98 0.07313 -225.57183 
Background high 0.99 0.73662 -939.4531 
 
Table A.15. Correlations: R
2
 values are provided in the first column, whereas slope and 
intercept of the correlation line are provided in the 2
nd
 and 3
rd
 columns. Although not much 
structure was detected on the fluorescence maps in the infected treated rabbit, Cu k  Fe k  Zn 
k Zn k andbackground scatter energy, both low and high, correlated too well to very feeble 
data, with high r
2
 values (> 91%), showing a doubtful ability for the detector to record the right 
fluorescence signal for gallium.  
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Figure A.14.10. PCA: Component 1.  
 
Figure A.14.11. PCA: Component 2.  
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Figure A.14.12. PCA: Component 3 
 
Figures A.14.10- A.14.12. PCA analysis: In component 1 Fe k Ca k Zn k  and Cu k 
whereas all the other elemental fluorescence peaks are not noticeable because absorbed 
entirely by the large background scatter signal shoulderIn component 2 Fe k  Fe k  Zn k  
and Cu k are visible, whereas in component 3 the same elements are overshadowed again with 
background scatter noise. 
 
 
 
 
 
 
